UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, ~~2024~~2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-40677

PLUM ~~ACQUISTION~~ACQUISITION CORP. III

(Exact name of registrant as specified in its charter)

Cayman Islands		98-1581691
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

2021 Fillmore St., #2089,

San Francisco, CA

94115

(Address of principal executive offices)

(Zip Code)

+1 (929) 529-7125

(Registrant’s telephone number, including area code)

Securities registered pursuant to section 12(b) of the Act:

None.

Securities registered pursuant to Section 12(g) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A ordinary shares included as part of the Units, par value $0.0001 per share	PLMJF	OTC Market
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	PLMWF	OTC Market
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant to acquire one Class A ordinary share	PLMUF	OTC Market

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

The aggregate market value of the Class A ordinary shares held by non-affiliates of the registrant, computed as of June 30, ~~2024~~2025 (the last business day of the registrant’s most recently completed second fiscal quarter) was approximately $3411,~~011~~480,~~349~~000.

There were 1907,~~016,833~~486 Class A ordinary shares and 7,062,500 Class B ordinary shares of the registrant outstanding on March 24, ~~2025~~2026.

DOCUMENTS INCORPORATED BY REFERENCE

None.

TABLE OF CONTENTS

Part I		1
Item 1.	Business	116
Item 1A.	Risk Factors	1348
Item 1B.	Unresolved Staff Comments	4348
Item 1C.	Cybersecurity	4348
Item 2.	Properties	4348
Item 3.	Legal Proceedings	4348
Item 4.	Mine Safety Disclosures	4348
PART II		4449
Item 5.	Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities	4449
Item 6.	[Reserved]	4550
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4550
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	5362
Item 8.	Financial Statements and Supplementary Data	5362
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	5362
Item 9A.	Controls and Procedures	5362
Item 9B.	Other Information	5463
Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	5463
PART III		5564
Item 10.	Directors, Executive Officers and Corporate Governance	5564
Item 11.	Executive Compensation	6170
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	6171
Item 13.	Certain Relationships and Related Transactions and Director Independence	6473
Item 14.	Principal Accountant Fees and Services	6676
PART IV		6777
Item 15.	Exhibits and Financial Statement Schedules	6777
SIGNATURES		6979

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K (this “Report”), including, without limitation, statements under the heading “~~management~~Management’s Discussion and Analysis of Financial Condition and ~~Results~~ Results of Operations,” includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”). These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our ability to consummate any acquisition or other business combination and any other statements that are not statements of current or historical facts. These ~~statements~~ statements are based on management’s current expectations, but actual results may differ materially due to various factors, including, ~~but~~ but not limited to:

●

our ability to select an appropriate target business or businesses;

●

our ability to complete our initial business combination;

●

our expectations around the performance of a prospective target business or businesses;

●

our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;

●

our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;

●

our potential ability to obtain additional financing to complete our initial business combination and continue as a going concern;

●

our pool of prospective target businesses;

●

the ability of our officers and directors to generate a number of potential business combination opportunities;

●

our public securities’ potential liquidity and trading;

●

the lack of a market for our securities;

●

the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or

●

the trust account not being subject to claims of third parties.

The forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurances that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These risks and others described under “Risk Factors” may not be exhaustive.

PART I

References in this report to “we,” “us” or the “Company” refer to Plum Acquisition Corp. III (f/k/a Alpha Partners Technology Merger Corp.). References to our “management” or our “management team” refer to our officers and directors. References to the “Sponsor” refer to Mercury Capital, LLC, a Delaware limited liability company. References to the “Original Sponsor” refer to Alpha Partners Technology Merger Sponsor LLC, a Delaware limited liability company. References to our “initial shareholders” refer to the holders of Founder Shares.

Item 1. Business

Introduction

We are a blank check company incorporated on February 5, 2021 as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Initial Business Combination”). We will not be limited to a particular industry or geographic region in our identification and acquisition of a prospective partner company.

Our Sponsor is Mercury Capital, LLC, a Delaware limited liability company (the “Sponsor”). Our original Sponsor was Alpha Partners Technology Merger Sponsor LLC, a Delaware limited liability company (the “Original Sponsor”). The registration statement for our initial public offering (“IPO,” “Initial Public Offering” or the “public offering”) was declared effective on July 27, 2021. On July 30, 2021, we consummated our IPO of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $250.0 million, and incurring offering costs of approximately $13.75 million, of which $8.75 million was for deferred underwriting commissions (see Note 3 to our financial statements included in this Annual Report on Form 10-K for the year ended December 31, ~~2024, filed with the Securities and Exchange Commission, the “SEC”, on July 1, 2024~~2025). We granted the underwriter a 45-day option to purchase up to an additional 3,750,000 Units at the IPO price to cover over-allotments, if any. On August 3, 2021, the underwriters partially exercised the over-allotment option, and the closing of the issuance and sale of the additional 3,250,000 Units (the “Over-Allotment Units”) occurred on August 5, 2021. The issuance by the Company of the Over-Allotment Units at a price of $10.00 per unit resulted in total gross proceeds of approximately $32.5 million (the “Over-Allotment Proceeds”).

Simultaneously with the closing of the IPO, we consummated the private placement (the “Private Placement”) of 800,000 units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”), at a price of $10.00 per Private Placement Unit with the Original Sponsor and anchor investors, generating gross proceeds of $8.0 million (see Note 4 to our financial statements included in this Annual ~~Report~~ Report on Form 10-K for the year ended December 31, ~~2024~~2025). Simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the private placement with the Original Sponsor of 65,000 units (the “Additional Private Placement Units”), ~~generating~~ generating total proceeds of $650,000 (the “Private Placement Proceeds” and, together with the “Over-Allotment Unit Proceeds”, the “Proceeds”).

Upon the closing of the IPO and the Private Placement, approximately $282.5 million ($10.00 per Unit) of the net proceeds of the IPO and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invests only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. In addition, a certain anchor investor advanced an aggregate amount of approximately $500,681 to the Company to cover the purchase of Private Placement Units. In April 2021, the Company repaid $681 to the anchor investor. Upon the closing of the Initial Public Offering, the remaining advance of $500,000 was applied to the purchase of the Private Placement Units which the Company has since repaid.

On December 27, 2023, the Company, Original Sponsor, and Sponsor entered into a purchase agreement (“Purchase Agreement”), pursuant to the purchased 3,902,648 Founder Units, ~~each~~ each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B share, and became entitled to 70% of the 2,030,860 Founder Units that Original Sponsor placed in escrow at the closing of the Purchase Agreement to the extent such Founder Units are not allocated to investors who hold and do not redeem their Class A Ordinary Shares of ~~Plum~~the Company at the time of ~~Plum’s~~the Initial Business Combination, for an aggregate purchase price of $1.

Subsequently, on January 26, 2024, the Company, the Original Sponsor, and the Sponsor entered into a first amendment to Purchase Agreement (“Amendment No. 1 to the Purchase Agreement”), to correct the number of shares that the Original Sponsor shall retain to be 665,000 Class A private placement units and 1,128,992 Class B founder units. On August 22, 2024, the Company, the Original Sponsor, and the Sponsor entered into a second amendment to Purchase Agreement (“Amendment No. 2 to the Purchase Agreement”) which revises the founder-unit forfeiture and transfer mechanics by requiring the acquirer to absorb all forfeitures or investor incentive transfers up to 2,030,860 founder units, allocating excess forfeitures 78% to the acquirer and 22% to the sponsor, while also establishing that 2,030,860 sponsor units will be held in escrow for potential transfer to sponsor anchors, with any remaining escrowed units allocated 70% to the acquirer and 30% to the sponsor at closing. On September 5, 2025, the Company, the Original Sponsor, and the Sponsor entered into a third amendment to Purchase Agreement (“Amendment No. 3 to the Purchase Agreement”) that provides that any Sponsor Incentive Units (as defined in the Sponsor Support Agreement) that have been retained by the Sponsor after the Closing, up to half of such Sponsor Incentive Units may be transferred prior to the Closing to a third party, with any Sponsor Incentive Units remaining after such transfer subject to allocation between the Sponsor and the Original Sponsor as provided for in the Purchase Agreement.

Our management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that we will be able to complete an Initial Business Combination successfully.

We must complete one or more Initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the agreement to enter into the Initial Business Combination. However, we will only complete an Initial Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the prospective partner or otherwise acquires a controlling interest in the prospective partner sufficient for it not to be required to register as an investment company under the Investment Company Act.

1If we are unable to complete an Initial Business Combination by July 30, 2026 (pursuant to the July 2025 Extraordinary General Meeting (as defined below), the “Second Combination Period”), we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to consummate a Business Combination within the Second Combination Period.

IfAs weapproved ~~are~~by ~~unable~~its tostockholders ~~complete~~at anthe ~~Initial Business~~extraordinary ~~Combination~~general ~~within~~meeting 24held ~~months~~on ~~from the closing of the Initial Public Offering (as amended to~~ July 3027, ~~2025~~2023 ~~pursuant to~~ (the ~~January~~“July ~~2025~~ 2023 Extraordinary General Meeting~~, the “Combination Period~~”), wethe ~~will~~Company ~~(i) cease~~filed ~~all~~the ~~operations~~amended ~~except~~and ~~for~~restated memorandum ~~the~~and ~~purpose~~articles of ~~winding~~ ~~up;~~association (~~ii) as~~the ~~promptly~~“Amended asand ~~reasonably~~Restated ~~possible~~Memorandum ~~but~~and ~~not~~Articles ~~more~~of ~~than~~Association”) ~~ten~~on ~~business~~July ~~days thereafter~~28, ~~redeem the Public Shares~~2023, at awhich ~~per-share~~extended ~~price, payable in cash, equal to~~ the ~~aggregate~~date ~~amount~~by ~~then~~which ~~on deposit in~~ the ~~Trust~~Company ~~Account,~~has ~~including~~to ~~interest~~consummate ~~earned~~a ~~on the~~business ~~funds~~combination ~~held~~from inJuly ~~the~~30, ~~Trust~~2023 ~~Account and not previously released~~ to usJuly ~~to pay our income taxes~~30, ~~if any (less up to $100~~2024,~~000~~ ofor ~~interest~~such earlier todate ~~pay~~as ~~dissolution~~shall ~~expenses)~~be ~~divided~~determined by the ~~number~~Company’s board of ~~the~~directors. ~~then-outstanding~~In ~~Public~~connection ~~Shares,~~with ~~which redemption will completely extinguish Public Shareholders’ rights as shareholders (including~~ the ~~right~~July to2023 ~~receive~~Extraordinary ~~further~~General ~~liquidation distributions~~Meeting, ~~if any); and (iii) as~~ ~~promptly as reasonably possible following such redemption, subject to~~ the ~~approval~~holders of ~~the remaining shareholders and the board of directors~~13, ~~liquidate and dissolve~~532,591 ~~subject~~Class inA ~~the~~ordinary ~~case~~shares, ofproperly ~~clauses~~exercised ~~(ii) and~~their ~~(iii),~~right to ~~our~~redeem ~~obligations~~their ~~under~~shares ~~Cayman~~for ~~Islands~~cash ~~law~~at toa ~~provide~~redemption ~~for~~price ~~claims~~ of ~~creditors~~approximately ~~and the requirements of other applicable law~~$10.41 ~~There~~per ~~will~~share, befor noan aggregate redemption ~~rights~~amount orof ~~liquidating~~approximately ~~distributions~~$140,838,808. ~~with respect~~After tothose ~~our~~redemptions, ~~warrants~~approximately $153,169,659 ~~which~~remained ~~will~~in ~~expire worthless if we fail to consummate a Business Combination within~~ the ~~Combination~~Company’s ~~Period~~trust account.

As approved by its stockholders at the extraordinary general meeting held on July 27, 2023 (the “July Extraordinary General meeting, the Company filed the amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) on July 28, 2023, which extended the date by which the Company has to consummate a business combination from July 30, 2023 to July 30, 2024, or such earlier date as shall be determined by the Company’s board of directors. In connection with the July Extraordinary General Meeting, the holders of 13,532,591 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of approximately $140,838,808. After those redemptions, approximately $153,169,659 remained in the Company’s trust account.2

As approved by its stockholders at the ~~January~~extraordinary general meeting held on January 29, 2024 (the “January 2024 Extraordinary General Meeting”), the Company filed an amended and restated memorandum and articles of association (the “Second Amended and Restated Memorandum and Articles of Association”) on February 1, 2024, which (i) extended the date by which the Company has to consummate a business combination from July 30, 2024 to January 30, 2025, or such earlier date as shall be determined by the Company’s board of directors and (ii) changed the name of the Company from Alpha Partners Technology Merger Corp. to Plum Acquisition Corp. III.

As approved by its stockholders at the ~~January~~extraordinary general meeting held on January 16, 2025 (the “January 2025 Extraordinary General Meeting”), the Company filed an amended and restated memorandum and articles of association (the “Third Amended and Restated Memorandum and Articles of Association”) on January 17, 2025, which (i) extended the date by which the Company has to consummate a business combination from January 30, 2025 to July 30, 2025, or such earlier date as shall be determined by the Company’s board of directors and (ii) removed language from Article 49.4 of our Amended and Restated Memorandum and Articles of Association stating, in relevant part, that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, such business combination.

OnAs ~~December~~approved ~~27,~~by ~~2023,~~its ~~the~~stockholders ~~Company,~~at the ~~Original~~extraordinary ~~Sponsor,~~general ~~and~~meeting ~~Sponsor~~held ~~entered~~on ~~into~~July a15, ~~purchase~~2025 ~~agreement~~ (the “~~Purchase~~July ~~Agreement”),~~2025 ~~pursuant~~Extraordinary toGeneral ~~which, at a closing on December 28, 2023, Sponsor (i~~Meeting”) ~~purchased 3~~,~~902,648~~ ~~founder units of~~ the Company ~~from~~filed ~~the~~an ~~Original~~amended ~~Sponsor,~~and ~~each unit consisting of one Class B~~restated ~~ordinary~~memorandum ~~share~~ and ~~one-third~~articles of ~~one~~association ~~redeemable warrant to acquire one Class B ordinary share, which founder units are subject to forfeiture in certain circumstances, and~~ (~~ii) became entitled to 70% of~~ the ~~2,030,860~~“Fourth ~~founder~~Amended ~~units~~and ~~that~~Restated ~~Original~~Memorandum ~~Sponsor placed in escrow at the Closing to the extent such founder units are allocated to investors who hold~~ and doArticles ~~not redeem their Class A ordinary shares~~ of ~~the~~Association”) ~~Company at~~on ~~the time of the Company’s Initial Business Combination~~July 16, ~~for an aggregate purchase price of $1. Original Sponsor agreed to pay~~2025, or ~~cause~~which ~~its~~extended ~~affiliates~~the todate ~~pay,~~by ~~certain~~which ~~liabilities of~~ the Company ~~accrued and outstanding as of the Closing. Following the closing, Original Sponsor~~ has ~~no further obligations with respect~~ to ~~the~~consummate ~~Company,~~a ~~and~~business ~~Sponsor~~combination ~~has assumed all obligations relating~~ to ~~the~~July ~~Company. Subsequently~~30, ~~on January 26~~2026, ~~2024,~~or ~~the~~such ~~Company,~~earlier ~~the Original Sponsor, and Sponsor entered into an amended purchase agreement (the “Amended~~date ~~Purchase~~as ~~Agreement”), to correct the number of shares that the Original Sponsor~~ shall ~~retain to~~ be ~~665,000~~determined ~~Class~~by Athe ~~private~~Company’s ~~placement units~~board ~~and~~of ~~1,128,992 Class B founder units~~directors.

In connection with the January 2024 Extraordinary General Meeting, the holders of 12,433,210 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.78 per share, for an aggregate redemption amount of $134,059,215. After the redemptions, $24,629,032 remained in the Company’s Trust Account.

In connection with the January 2025 Extraordinary General Meeting, the holders of 2,132,366 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.24 per share, for an aggregate redemption amount of $23,975,464. After the redemptions, $1,707,149 remained in the Company’s Trust Account.

2In connection with the July 2025 Extraordinary General Meeting, the holders of 109,347 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.45 per share, for an aggregate redemption amount of $1,252,434. After the redemptions, $486,624 remained in the Company’s Trust Account.

In connection with the extraordinary general meeting held on December 22, 2025 (the “December 2025 Extraordinary General Meeting”), the holders of 24,136 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.61 per share, for an aggregate redemption amount of $280,219. The redemption is contingent upon the consummation of the Business Combination and will occur as promptly as practicable following the closing thereof; if the Business Combination is not consummated, the redeemed shares will be returned to the respective holders.

Recent Developments

Business Combination Agreement

On August 22, 2024, the Company, Plum III Amalco Corp., a corporation formed under the Laws of the Province of British Columbia and a direct, wholly owned subsidiary of the Company (“Amalco”), Plum III Merger Corp., a corporation formed under the Laws of the Province of British Columbia (“PubCo”), and Tactical Resources Corp., a corporation formed under the Laws of the Province of British Columbia (“TRC” or “Tactical”), entered into a Business Combination Agreement (as may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement,” and the transactions contemplated thereby, collectively, the “Business Combination”), pursuant to which, among other things and subject to the terms and conditions contained in the Business Combination Agreement, (i) the Company shall transfer by way of continuation from the Cayman Islands to the Province of British Columbia in accordance with the Cayman Islands Companies Act (As Revised) (the “Companies Act”) and continue as a corporation under the Laws of the Province of British Columbia in accordance with the applicable provisions of the Business Corporations Act (British Columbia) (the “BCBCA”) (the “Domestication”), (ii) following the Domestication, the Company shall amalgamate with PubCo (the “Plum Amalgamation”) to form one corporate entity and PubCo will survive the Plum Amalgamation, and (iii) immediately following the Plum Amalgamation, TRC and Amalco shall amalgamate (the “TRC Amalgamation” and, together with the Plum Amalgamation, the “Amalgamations”) to form one corporate entity and TRC will survive the TRC Amalgamation.

Pursuant to the Plum Amalgamation, which will take place after the Domestication and on the date on which the closing of the Business Combination will occur (the “Closing” and such date the “Closing Date”):

●

each Unit shall be automatically divided, and the holder thereof shall be deemed to hold one Class A Share and one-third of one Warrant in accordance with the terms of the applicable Unit;

●

each Class A ordinary share and Class B ordinary share will be exchanged on a one-for-one basis, for a common share in the authorized share capital of PubCo (a “PubCo Common Share”); and

●

each Warrant shall automatically be converted into a warrant (each, a “PubCo Assumed Plum Warrant”) to purchase a number of PubCo Common Shares determined in accordance with the terms of such Warrant.

On the Closing Date, pursuant to the TRC Amalgamation, among other things:

●

each common share of TRC (“a TRC Common Share”) (other than any cancelled TRC common shares or dissenting shares) shall automatically be exchanged for the right to receive a number of PubCo Common Shares equal to the TRC Exchange Ratio (as defined in the Business Combination Agreement) (the aggregate of all such PubCo Common Shares, the “Arrangement Consideration Shares”). Any Arrangement Consideration Shares exchanged for TRC Common Shares which were subject to any vesting or forfeiture terms shall continue to be governed by such terms from and after the effective time of the TRC Amalgamation;

●

each of the dissenting shares shall be cancelled and shall thereafter represent only the right to receive the applicable payments set forth in the Plan of Arrangement (as defined in the Business Combination Agreement);

●

each option to buy TRC Common Shares granted under TRC’s employee stock plan shall be assumed by PubCo and converted into an option to purchase PubCo Common Shares (each, a “Converted TRC Option”), subject to the same terms and conditions as were previously applicable, except that (A) the number of TRC Common Shares subject to such Converted TRC Option shall be increased by multiplying the number of shares previously issuable thereunder by the TRC Exchange Ratio, rounded down to the nearest whole PubCo Common Share, and (B) the per share exercise price shall be reduced by dividing the previous exercise price thereof by the TRC Exchange Ratio (rounded up to the nearest cent);

●

each restricted stock unit granted under TRC’s employee stock plan shall be assumed by PubCo and converted into a restricted stock unit in respect of PubCo Common Shares (each, a “Converted TRC RSU”), subject to the same terms and conditions as were previously applicable thereto, except that such Converted TRC RSU shall be in respect of a number of PubCo Common Shares equal to the product of (A) the number of shares previously subject to such TRC RSU and (B) the TRC Exchange Ratio;

●

each warrant to buy TRC Common Shares granted under TRC’s employee stock plan shall automatically be converted into a warrant to purchase PubCo Common Shares (each, a “PubCo Assumed TRC Warrant”), and such PubCo Assumed TRC Warrant shall continue to be governed by the same terms and conditions as were previously applicable, except that (A) the number of TRC Common Shares subject to such PubCo Assumed TRC Warrant shall be increased by multiplying the number of shares previously issuable thereunder by the TRC Exchange Ratio, rounded down to the nearest whole PubCo Common Share, and (B) the per share exercise price shall be reduced by dividing the previous exercise price thereof by the TRC Exchange Ratio (rounded up to the nearest cent); and

●

each common share in Amalco shall automatically be exchanged for one validly-issued, fully paid and nonassessable common share of TRC.

The Business Combination Agreement contains customary representations and warranties of the parties thereto with respect to, among other things: corporate organization; authorization to enter into the Business Combination Agreement; capitalization; financial statements; undisclosed liabilities; litigation; compliance with laws; material contracts; company benefit plans; labor matters; taxes; insurance; permits; property; intellectual property, data privacy and security; environmental matters; absence of changes; brokers; transactions with affiliates; consents and requisite governmental approvals; and related party transactions.

On December 10, 2024, the Company and TRC entered into an amendment (the “First Amendment”) to the Business Combination Agreement, which among other things, provides (a) that Plum will apply for and effect a listing of Plum’s publicly-traded securities with OTC Markets Group (“OTC Markets”), which listing will take effect no later than ten business days following any delisting of such Plum securities from Nasdaq on January 27, 2025 (the “Nasdaq De-Listing Date”), (b) that Plum shall prepare and file with the U.S. Securities and Exchange Commission (“SEC”) a proxy statement for the purpose of amending the Amended and Restated Memorandum and Articles of Association of Plum (the “Articles”) to (i) extend the deadline for Plum to consummate an Initial Business Combination from January 30, 2025 to July 30, 2025 (the “Extension Amendment Proposal”) and (ii) remove the requirement in Plum’s Articles that Plum have net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, an Initial Business Combination (the “NTA Amendment Proposal” and such requirement, the “NTA Requirement”), (c) that Plum comply with all applicable rules and regulations of Nasdaq or OTC Markets, as applicable, (d) that Plum use commercially reasonable efforts to ensure that Plum’s publicly-traded securities continue to be qualified to trade on OTC Markets from and after the Nasdaq De-Listing Date, (e) that the parties use commercially reasonable efforts to cause Plum’s publicly-traded securities to be delisted from OTC Markets as of the Company Amalgamation Effective Time or as soon as practicable thereafter, (f) that the closing condition requiring Pubco to satisfy the NTA Requirement shall not be applicable in the event that Plum’s shareholders approve the NTA Amendment Proposal and Plum amends the Articles to remove the NTA Requirement, and (g) that the Agreement End Date shall be automatically extended to July 30, 2025 in the event that Plum’s shareholders approve the Extension Amendment Proposal and Plum amends the Articles to extend its deadline to consummate an Initial Business Combination to July 30, 2025.

On January 28, 2025, the Company and TRC entered into ana second amendment (the “Second Amendment”) to the Business Combination Agreement which provides that certain recently issued convertible debentures of Tactical (and future issuances of convertible debentures by Tactical, if any, to the extent permitted under the Business Combination Agreement) shall be subject to the same terms under the Business Combination Agreement.

On July 30, 2025, the Company and TRC entered into a third amendment (the “Third Amendment”) to the Business Combination Agreement. The Third Amendment provides for (a) an acknowledgement that TRC may effect a reverse stock split prior to the closing at a ratio not to exceed 25 to 1; (b) an extension of the Agreement End Date (as defined in the Business Combination Agreement) to July 30, 2026; and (c) a lock-up of certain PubCo shares to be issued in the Business Combination. Specifically, the Third Amendment provides that 80% to 85% of the PubCo shares to be issued to stockholders of TRC (the “Arrangement Consideration Shares”) shall be subject to restrictions on transfer for a period of six months following the closing. In connection with the Third Amendment, certain employees and affiliates of TRC have entered into a Key Company Securityholder Lock-up Agreement whereby each of them has agreed that 100% of the Arrangement Consideration Shares issued to them shall be subject to restrictions on transfer for a period of six months following the closing.

At the December 2025 Extraordinary General Meeting, the Company shareholders approved (i) as a special resolution, the proposed Domestication; (ii) the Business Combination Agreement; (iii) four separate resolutions regarding the governance provisions contained in the PubCo closing articles; (iv) the issuance of PubCo Common Shares in connection with the Business Combination, and the issuance of an aggregate of up to $100,000,000 of PubCo Common Shares from time to time to YA II PN, Ltd., a Cayman Islands exempted company (“Yorkville”); and (v) the issuance of PubCo Common Shares pursuant to the PubCo Omnibus Equity Incentive Plan.

Amendment to Sponsor Support Agreement

On September 5, 2025, the Company, TRC, Pubco, the Sponsor, the Original Sponsor and certain shareholders of the Company entered into an amendment (the “Sponsor Support Agreement Amendment”) to the Sponsor Support Agreement, dated as of August 22, 2024 (as amended, the “Sponsor Support Agreement”).

The Sponsor Support Agreement Amendment provides that, immediately prior to the closing of the Business Combination, to the extent that any Sponsor Incentive Units (as defined in the Sponsor Support Agreement) have not been transferred by the Sponsor to PIPE Investors, Company Public Shareholders or other third parties as provided for in the Sponsor Support Agreement, such remaining Sponsor Incentive Units will be retained by the Sponsor subject to vesting based on the achievement of certain trading prices of the Pubco Common Shares after the closing of the Business Combination, as described in more detail in the Sponsor Support Agreement Amendment. In the event that such trading prices have not been achieved on or before the tenth anniversary of the closing of the Business Combination, such Sponsor Incentive Units shall be surrendered to Pubco for cancellation for no consideration and shall cease to represent any interest in Pubco, effective as of such date.

Amendments to Purchase Agreement

On August 22, 2024, the Company, the Original Sponsor, and the Sponsor entered into Amendment No. 2 to the Purchase Agreement which revises the founder-unit forfeiture and transfer mechanics by requiring the acquirer to absorb all forfeitures or investor incentive transfers up to 2,030,860 founder units, allocating excess forfeitures 78% to the acquirer and 22% to the sponsor, while also establishing that 2,030,860 sponsor units will be held in escrow for potential transfer to sponsor anchors, with any remaining escrowed units allocated 70% to the acquirer and 30% to the sponsor at closing.

On September 5, 2025, the Sponsor, the Company and the Original Sponsor entered into Amendment No. 3 to the Purchase Agreement that provides that, to the extent that any Sponsor Incentive Units have been retained by the Sponsor after the closing of the Business Combination, up to half of such Sponsor Incentive Units may be transferred prior to the closing of the Business Combination to a third party, with any Sponsor Incentive Units remaining after such transfer subject to allocation between the Sponsor and the Original Sponsor as provided for in the Purchase Agreement.

OTC Listing

As previously announced, our Class A ordinary shares, warrants and units were subject to delisting under the applicable rules of The Nasdaq Stock Market LLC (“Nasdaq”) if we did not regain compliance with such rules prior to or on January 27, 2025. As a result, after market close on January 27, 2025, trading in our securities was suspended on Nasdaq with immediate effect. A Form 25-NSE was later filed with the SEC, which terminated the listing of our securities on Nasdaq.

On January 28, 2025, our Class A ordinary shares, warrants and units were listed and began trading on the Pink Current tier of the OTC Markets. Our Class A ordinary shares, warrants and units are listed under the symbols “PLMJF”, “PLMWF”, and “PLMUF”, respectively.

Effecting Our Initial Business Combination

General

We are not presently engaged in, and we will not engage in, any operations for an indefinite period of time following the public offering. We intend to effectuate our Initial Business Combination using cash from the proceeds of the public offering and the sale of the private placement units, our equity, debt or a combination of these as the consideration to be paid in our Initial Business Combination. We may seek to complete our Initial Business Combination with a company or business that may be financially unstable or in its early stages of development or growth, which would subject us to the numerous risks inherent in such companies and businesses.

If our Initial Business Combination is paid for using equity or debt, or not all of the funds released from the Trust Account are used for payment of the consideration in connection with our Initial Business Combination or used for redemptions of our Class A ordinary shares, we may apply the balance of the cash released to us from the Trust Account for general corporate purposes, including for maintenance or expansion of operations of the post- business combination company, the payment of principal or interest due on indebtedness incurred in completing our Initial Business Combination, to fund the purchase of other companies or for working capital.

4We may need to obtain additional financing to complete our Initial Business Combination, either because the transaction requires more cash than is available from the proceeds held in our Trust Account, or because we become obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with such business combination. There are no prohibitions on our ability to issue securities or incur debt in connection with our Initial Business Combination.

We may need to obtain additional financing to complete our Initial Business Combination, either because the transaction requires more cash than is available from the proceeds held in our Trust Account, or because we become obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with such business combination. There are no prohibitions on our ability to issue securities or incur debt in connection with our Initial Business Combination. We are not currently a party to any arrangement or understanding with any third-party with respect to raising any additional funds through the sale of securities, the incurrence of debt or otherwise.

Sources of Prospective Partner Businesses

On August 22, 2024, we entered into the Business Combination Agreement. Since entering into the Business Combination Agreement, we have not been actively searching for a business partner. However, we may in the future decide to initiate a new business partner search in connection with an alternative Initial Business Combination.

We anticipate that prospective partner business candidates will be brought to our attention from various unaffiliated sources, including investment market participants, private equity groups, investment banking firms, consultants, accounting firms and large business enterprises. Prospective partner businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us through calls or mailings. These sources may also introduce us to prospective partner businesses in which they think we may be interested on an unsolicited basis, since some of these sources will have read this prospectus and know what types of businesses we are targeting. Our officers and directors, as well as their affiliates, may also bring to our attention prospective partner business candidates that they become aware of through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In addition, we expect to receive a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us as a result of the business relationships of our officers and directors. While we do not presently anticipate engaging the services of professional firms or other individuals that specialize in business acquisitions on any formal basis, we may engage these firms or other individuals in the future, in which event we may pay a finder’s fee, consulting fee or other compensation to be determined in an arm’s length negotiation based on the terms of the transaction. We will engage a finder only to the extent our management determines that the use of a finder may bring opportunities to us that may not otherwise be available to us or if finders approach us on an unsolicited basis with a potential transaction that our management determines is in our best interest to pursue. Payment of finder’s fees is customarily tied to completion of a transaction, in which case any such fee will be paid out of the funds held in the Trust Account. In no event, however, will our Sponsor or any of our existing officers or directors, or their respective affiliates paid by us any finder’s fee, consulting fee or other compensation prior to, or for any services they render in order to effectuate, the completion of our Initial Business Combination (regardless of the type of transaction that it is). Some of our officers and directors may enter into employment or consulting agreements with the post-business combination company following our Initial Business Combination. The presence or absence of any such fees or arrangements will not be used as a criterion in our selection process of an acquisition candidate.

We are not prohibited from pursuing an Initial Business Combination with a company that is affiliated with our Sponsor, officers or directors. In the event we seek to complete our Initial Business Combination with a company that is affiliated with our Sponsor or any of our officers or directors, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that such Initial Business Combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context.

Each of our officers and directors presently has, and any of them in the future may have, additional, fiduciary or contractual obligations to other entities, including any future special purpose acquisition companies we expect they may be involved in and entities that are affiliates of our Sponsor, pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law.

Evaluation of a Prospective Partner Business and Structuring of Our Initial Business Combination

In evaluating a prospective partner business, we expect to conduct an extensive due diligence review which may encompass, as applicable and among other things, meetings with incumbent management and employees, document reviews, interviews of customers and suppliers, inspection of facilities and a review of financial and other information about the prospective partner and its industry. We will also utilize our management team’s operational and capital planning experience. If we determine to move forward with a particular prospective partner, we will proceed to structure and negotiate the terms of the business combination transaction.

The time required to select and evaluate a prospective partner business and to structure and complete our Initial Business Combination, and the costs associated with this process, are not currently ascertainable with any degree of certainty. Any costs incurred with respect to the identification and evaluation of, and negotiation with, a prospective partner business with which our Initial Business Combination is not ultimately completed will result in our incurring losses and will reduce the funds we can use to complete another business combination. The Company will not pay any consulting fees to members of our management team, or their respective affiliates, for services rendered to or in connection with our Initial Business Combination. In addition, we have agreed not to enter into a definitive agreement regarding an Initial Business Combination without the prior consent of our Sponsor.

Lack of Business Diversification

For an indefinite period of time after the completion of our Initial Business Combination, the prospects for our success may depend entirely on the future performance of a single business. Unlike other entities that have the resources to complete business combinations with multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in a single line of business. By completing our Initial Business Combination with only a single entity, our lack of diversification may:

●

subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our Initial Business Combination; and

●

cause us to depend on the marketing and sale of a single product or limited number of products or services.

Limited Ability to Evaluate the Prospective Partner’s Management Team

Although we intend to closely scrutinize the management of a prospective partner business when evaluating the desirability of effecting our Initial Business Combination with that business, our assessment of the prospective partner business’s management may not prove to be correct. In addition, the future management may not have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our management team, if any, in the prospective partner business cannot presently be stated with any certainty. The determination as to whether any of the members of our management team will remain with the combined company will be made at the time of our Initial Business Combination. While it is possible that one or more of our directors will remain associated in some capacity with us following our Initial Business Combination, it is unlikely that any of them will devote their full efforts to our affairs subsequent to our Initial Business Combination. Moreover, we cannot assure you that members of our management team will have significant experience or knowledge relating to the operations of the particular prospective partner business.

We cannot assure you that any of our key personnel will remain in senior management or advisory positions with the combined company. The determination as to whether any of our key personnel will remain with the combined company will be made at the time of our Initial Business Combination.

Following a business combination, we may seek to recruit additional managers to supplement the incumbent management of the prospective partner business. We cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.

Shareholders May Not Have the Ability to Approve ~~Our~~Any ~~Initial~~Alternative Business Combination and Approval of Our Current Business Combination Does Not Guarantee its Completion

WeAlthough our shareholders approved the proposed Business Combination in connection with the December 2025 Extraordinary General Meeting, the transaction has not yet closed. If the currently approved Business Combination is not consummated for any reason, we may seek to enter into a revised or alternative Business Combination (the “Alternative Business Combination”). In such a case, we may conduct redemptions without a shareholder vote pursuant to the tender offer rules of the SEC subject to the provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association. However, we will seek shareholder approval if it is required by applicable law or stock exchange listing requirement, or we may decide to seek shareholder approval for business or other reasons.

The decision as to whether we will seek shareholder approval of a proposed business combination in those instances in which shareholder approval is not required by law will be made by us, solely in our discretion, and will be based on business and reasons, which include a variety of factors, including, but not limited to:

●

the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company;

●

the expected cost of holding a shareholder vote;

●

the risk that the shareholders would fail to approve the proposed business combination;

●

other time and budget constraints of the company; and

●

additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders.

Permitted Purchases and Other Transactions with Respect to Our Securities

If we seek shareholder approval of ~~our~~an ~~Initial~~Alternative Business Combination and we do not conduct redemptions in connection with ~~our~~such ~~Initial~~Alternative Business Combination pursuant to the tender ~~offer~~ offer rules, our Sponsor, directors, executive officers, advisors or their affiliates may purchase public shares or warrants in privately-negotiated transactions or in the open market either prior to or following the completion of ~~our~~the ~~Initial~~Alternative Business Combination. Additionally, at at any time at or prior to ~~our~~an Alternative Initial Business Combination, subject to applicable securities laws (including with respect to material nonpublic information), our Sponsor, directors, executive officers, advisors or their affiliates may enter into transactions with investors and others to provide them with incentives to acquire public shares, vote their public shares in favor of ~~our~~such ~~Initial~~ Alternative Business Combination or not redeem their public shares. However, they have no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. None of the funds in the Trust Account will be used to purchase public shares or warrants in such transactions. If they engage in such transactions, they will be restricted from making any such purchases when they are in possession of any material non-public information not disclosed to the seller or if such purchases are prohibited by Regulation M under the Exchange Act.

In the event that our Sponsor, directors, officers, advisors or their affiliates purchase shares in privately-negotiated transactions from public shareholders who have already elected to exercise their redemption rights or submitted a proxy to vote against our Initial Business Combination, such selling shareholders would be required to revoke their prior elections to redeem their shares and any proxy to vote against our Initial Business Combination. We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the purchasers will be required to comply with such rules.9

~~The~~In ~~purpose~~the ofevent ~~any~~that ~~such~~our ~~transaction~~Sponsor, ~~could~~directors, beofficers, toadvisors ~~(i) vote~~or intheir ~~favor~~affiliates ofpurchase ~~the~~shares ~~Initial~~in ~~Business~~privately-negotiated ~~Combination~~transactions ~~and~~from ~~thereby~~public ~~increase~~shareholders ~~the~~who ~~likelihood~~have ofalready ~~obtaining~~elected ~~shareholder~~to exercise ~~approval~~their ~~of the~~redemption ~~Initial~~rights ~~Business~~or ~~Combination,~~submitted ~~(ii) reduce~~a ~~the~~proxy ~~number~~to ofvote ~~public~~against ~~warrants~~an ~~outstanding~~Alternative orBusiness ~~vote~~Combination, such ~~warrants~~selling onshareholders ~~any~~would be ~~matters~~required ~~submitted~~ to ~~the~~revoke ~~warrant~~their ~~holders~~prior ~~for~~elections ~~approval~~to inredeem ~~connection~~their ~~with~~shares ~~our~~and ~~Initial~~any ~~Business~~proxy ~~Combination~~to orvote ~~(iii) satisfy~~against athe ~~closing~~Alternative ~~condition~~Business inCombination. anWe ~~agreement~~do ~~with~~not acurrently ~~prospective~~anticipate ~~partner~~ that ~~requires~~such uspurchases, toif ~~have~~any, awould ~~minimum~~constitute ~~net~~a ~~worth~~tender oroffer asubject ~~certain~~to ~~amount~~the oftender ~~cash~~offer atrules under the Exchange ~~closing~~Act ofor ~~our Initial~~a ~~Business~~going-private ~~Combination,~~transaction ~~where~~subject itto ~~appears~~the ~~that~~going-private ~~such~~rules ~~requirement~~under ~~would~~the ~~otherwise~~Exchange ~~not~~Act; behowever, ~~met.~~if ~~Any~~the ~~such~~purchasers ~~purchases~~determine at the time of ~~our~~any ~~securities may~~such ~~result~~purchases inthat the ~~completion~~purchases ofare ~~our~~subject ~~Initial~~to ~~Business~~such ~~Combination~~rules, ~~that~~the ~~may~~purchasers ~~not~~will ~~otherwise~~be ~~have~~required ~~been~~to ~~possible~~comply with such rules.

The purpose of any such transaction could be to (i) vote in favor of the Alternative Business Combination and thereby increase the likelihood of obtaining shareholder approval of the Alternative Business Combination, (ii) reduce the number of public warrants outstanding or vote such warrants on any matters submitted to the warrant holders for approval in connection with the Alternative Business Combination or (iii) satisfy a closing condition in an agreement with a prospective partner that requires us to have a minimum net worth or a certain amount of cash at the closing of the Alternative l Business Combination, where it appears that such requirement would otherwise not be met. Any such purchases of our securities may result in the completion of an Alternative Business Combination that may not otherwise have been possible.

In addition, if such purchases are made, the public “float” of our Class A ordinary shares or public warrants may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.

~~Our~~In the event of an Alternative Business Combination, our Sponsor, officers, directors and/or their affiliates anticipate that they may identify the shareholders with whom our Sponsor, officers, directors or their affiliates may pursue privately-negotiated transactions by either the shareholders contacting us directly or by our receipt of redemption requests submitted by shareholders (in the case of Class A ordinary shares) following our mailing of tender offer or proxy materials in connection with ~~our~~an ~~Initial~~Alternative Business Combination. To the extent that our Sponsor, officers, directors, advisors or their affiliates enter into a private transaction, they would identify and contact only potential selling or redeeming shareholders who have expressed their election to redeem their shares for a pro rata share of the Trust Account or vote against ~~our~~the ~~Initial~~Alternative Business Combination, whether or not such shareholder has already submitted a proxy with respect to ~~our~~the ~~Initial~~Alternative Business Combination but only if such shares have not already been voted at the general meeting related to ~~our~~such ~~Initial~~Alternative Business Combination. Our Sponsor, executive officers, directors, advisors or their affiliates will select which shareholders to purchase shares from based on the negotiated price and number of shares and any other factors that they may deem relevant, and will be restricted from purchasing shares if such purchases do not comply with Regulation M under the Exchange Act and the other federal securities laws.

Our Sponsor, officers, directors and/or their affiliates will be restricted from making purchases of shares if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange Act. We expect any such purchases would be reported by such person pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements.

Redemption Rights for Public Shareholders upon Completion of Our Initial Business Combination

We will provide our public shareholders with ~~the~~ the opportunity to redeem all or a portion of their public shares upon the completion of our Initial Business Combination, regardless of whether such shareholder votes on such proposed Initial Business Combination, and if they do vote, regardless of whether they vote for or against such proposed initial business combination, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of our Initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any, divided by the number of then-outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is initially anticipated to be $10.00 per public share. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of our Initial Business Combination with respect to our warrants. Further, we will not proceed with redeeming our public shares, even if a public shareholder has properly elected to redeem its shares, if an Initial Business Combination does not close. Our Sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares acquired during or after the public offering by them in connection with (i) the completion of our Initial Business Combination and (ii) a shareholder vote to approve an amendment to our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination by July 30, ~~2025~~2026 or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination).

Limitations on Redemptions

The proposed Initial Business Combination may require: (i) cash consideration to be paid to the prospective partner or its owners, (ii) cash to be transferred to the prospective partner for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions in accordance with the terms of the proposed business combination. In the event the aggregate cash consideration we would be required to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the Initial Business Combination or redeem any shares, and all Class A ordinary shares submitted for redemption will be returned to the holders thereof.

Manner of Conducting Redemptions

We will provide our public shareholders with ~~the~~ the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of ~~our~~an ~~Initial~~Alternative Business Combination either (i) in connection with a general meeting called to approve ~~the~~such ~~Initial~~Alternative Business Combination or (ii) by means of a tender offer. The decision as to whether we will seek shareholder approval of a proposed business combination or conduct a tender offer ~~will~~ will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require us to seek shareholder approval under applicable law or stock exchange listing requirement or whether we were deemed to be a foreign private issuer (which would require a tender offer rather than seeking shareholder approval under SEC rules). Asset acquisitions and share purchases would not typically require shareholder approval while direct mergers with our company and any transactions where we issue more than 20% of our issued and outstanding ordinary shares (excluding the private placement shares underlying the private placement units) or seek to amend our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association would typically require shareholder approval. We currently intend to conduct redemptions in connection with a shareholder vote unless shareholder approval is not required by applicable law or stock exchange listing requirement or we choose to conduct redemptions pursuant to the tender offer rules of the SEC for business or other reasons.

If we held a shareholder vote to approve ~~our Initial~~an Alternative Business Combination, we will, pursuant to our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association:

●

conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and

●

file proxy materials with the SEC.

In the event that we seek shareholder approval of ~~our~~an ~~Initial~~Alternative Business Combination, we will distribute proxy materials and, in connection therewith, provide our public shareholders with the redemption rights described above upon completion of the ~~Initial~~Alternative Business Combination.

8If we seek shareholder approval, we will complete the Alternative Business Combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. In such case, our Sponsor and each member of our management team have agreed to vote their founder shares and public shares in favor of the Alternative Business Combination. As a result, in addition to our initial shareholders’ founder shares and private placement shares, we would need none of the public shares sold in the public offering to be voted in favor of the Alternative Business Combination in order to have such Alternative Business Combination approved. Each public shareholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or vote at all. In addition, our Sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of any Initial Business Combination and (ii) a shareholder vote to approve an amendment to our Fourth Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination by July 30, 2026 or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination).

If we seek shareholder approval, we will complete our Initial Business Combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. In such case, our Sponsor and each member of our management team have agreed to vote their founder shares and public shares in favor of our Initial Business Combination. As a result, in addition to our initial shareholders’ founder shares and private placement shares, we would need none (assuming all issued and outstanding shares are voted and the over-allotment option is not exercised) of the 25,000,000 public shares sold in the public offering to be voted in favor of an Initial Business Combination in order to have our Initial Business Combination approved. Each public shareholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or vote at all. In addition, our Sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of an Initial Business Combination and (ii) a shareholder vote to approve an amendment to our Third Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination by July 30, 2025 or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination).11

If we conduct redemptions pursuant to the tender offer rules of the SEC, we will, pursuant to our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association:

●

conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and

● file tender offer documents with the SEC prior to completing ~~our~~the ~~Initial~~Alternative Business Combination which contain substantially the same financial and other information about the ~~Initial~~Alternative Business Combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.

Upon the public announcement of ~~our~~an ~~Initial Business~~Alternative Business Combination, if we elect to conduct redemptions pursuant to the tender offer rules, we and our Sponsor will terminate any plan ~~established~~ established in accordance with Rule 10b5-1 to purchase Class A ordinary shares in the open market, in order to comply with Rule 14e-5 ~~under~~ under the Exchange Act.

In the event we conduct redemptions pursuant to to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a) under ~~the~~ the Exchange Act, and we will not be permitted to complete ~~our~~the ~~Initial~~Alternative Business Combination until the expiration of the tender offer period. In addition, the tender offer will be conditioned on public shareholders not tendering more than the number of public shares we are permitted to redeem. If public shareholders tender more shares than we have offered to purchase, we will withdraw the tender offer and not complete such ~~Initial~~Alternative Business Combination.

Limitation on Redemption Upon Completion of ~~Our~~an ~~Initial~~Alternative Business Combination If We Seek Shareholder Approval

If we seek shareholder approval of ~~our~~an ~~Initial~~Alternative Business Combination and we do not conduct redemptions in connection with ~~our~~such ~~Initial~~Alternative Business Combination pursuant to the tender ~~offer~~ offer rules, our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association provide that a public shareholder, together with any ~~affiliate~~ affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined ~~under~~ under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in the public offering, which we refer to as “Excess Shares,” without our prior consent. We believe this ~~restriction~~ restriction will discourage shareholders from accumulating large blocks of shares, and subsequent attempts by such holders to use their ability to exercise their redemption rights against a proposed business combination as a means to force us or our management to purchase their shares at a significant premium to the then-current market price or on other undesirable terms. Absent this provision, a public ~~shareholder~~ shareholder holding more than an aggregate of 15% of the shares sold in the public offering could threaten to exercise its redemption rights if such holder’s shares are not purchased by us, our Sponsor or our management at a premium to the then-current market price or on other undesirable terms. By limiting our shareholders’ ability to redeem no more than 15% of the shares sold in the public offering without our prior consent, we believe we will limit the ability of a small group of shareholders to unreasonably attempt to block our ability to complete our Initial Business Combination, particularly in connection with a business combination with a prospective partner ~~that~~ that requires as a closing condition that we have a minimum net worth or a certain amount of cash.

However, we would not restrict our shareholders’ ability to vote all of their shares (including Excess Shares) for or against ~~our~~an ~~Initial~~Alternative Business Combination.

Tendering Share Certificates in Connection with a Tender Offer or Redemption Rights

Public shareholders seeking to exercise their redemption rights in connection with an Alternative Business Combination, whether they are record holders or hold their shares in “street name,” will be required to either tender their certificates (if any) to our transfer agent prior to the date set forth in the proxy solicitation or tender offer materials, as applicable, mailed to such holders, or to deliver their shares to the transfer agent electronically using The Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, at the holder’s option, in each case up to two business days prior to the initially scheduled vote to approve ~~the~~such business combination. The proxy solicitation or tender offer materials, as applicable, that we will furnish to holders of our public shares in connection with ~~our~~the ~~Initial~~Alternative Business Combination will indicate the applicable delivery requirements, which will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. Accordingly, a public shareholder would have from the time we send out our tender offer materials until the close of the tender offer period, or up to two business days prior to the initially scheduled vote on the proposal to approve the business combination if we distribute proxy materials, as applicable, to tender its shares if it wishes to seek to exercise its redemption rights. Given the relatively short period in which to exercise redemption rights, it is advisable for shareholders to use electronic delivery of their public shares.

912

There is a nominal cost associated with the above-referenced tendering process and the act of certificating the shares or delivering them through the DWAC system. The transfer agent will typically charge the tendering broker a fee of approximately $80.00 and it would be up to the broker whether or not to pass this cost on to the redeeming holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise redemption rights to tender their shares. The need to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such delivery must be effectuated.

In order to perfect redemption rights in connection with their business combinations, many blank check companies would distribute proxy materials for the shareholders’ vote on an Initial Business Combination, and a holder could simply vote against a proposed business combination and check a box on the proxy card indicating such holder was seeking to exercise his or her redemption rights. After the business combination was approved, the company would contact such shareholder to arrange for him or her to deliver his or her certificate to verify ownership. As a result, the shareholder then had an “option window” after the completion of the business combination during which he or she could monitor the price of the company’s shares in the market. If the price rose above the redemption price, he or she could sell his or her shares in the open market before actually delivering his or her shares to the company for cancellation. As a result, the redemption rights, to which shareholders were aware they needed to commit before the general meeting, would become “option” rights surviving past the completion of the business combination until the redeeming holder delivered its certificate. The requirement for physical or electronic delivery prior to the meeting ensures that a redeeming shareholder’s election to redeem is irrevocable once the business combination is approved.

Any request to redeem such shares, once made, may be withdrawn at any time up to two business days prior to the initially scheduled vote on the proposal to approve the business combination, unless otherwise agreed to by us. Furthermore, if a holder of a public share delivered its certificate in connection with an election of redemption rights and subsequently decides prior to the applicable date not to elect to exercise such rights, such holder may simply request that the transfer agent return the certificate (physically or electronically). It is anticipated that the funds to be distributed to holders of our public shares electing to redeem their shares will be distributed promptly after the completion of ~~our~~an ~~Initial~~Alternative Business Combination.

If ~~our~~an ~~Initial~~Alternative Business Combination is not ~~approved~~ orapproved ~~completed~~ for any reason, then our public shareholders who elected to exercise their redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the Trust Account. In such case, we will promptly return any certificates delivered by public holders who elected to redeem their shares.

Redemption of Public Shares and Liquidation If No Initial Business Combination

Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association provide that we will have until July 30, ~~2025~~2026 to consummate an Initial Business Combination. If we have not consummated an Initial Business Combination by July 30, ~~2025~~2026, we will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses and any withholding taxes) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to consummate an Initial Business Combination by July 30, ~~2025~~2026. Our Fourth ~~Third~~ Amended and Restated Memorandum and Articles of Association will provide that, if we wind up for any other reason prior to ~~the~~ the consummation of our Initial Business Combination, we will follow the foregoing procedures with respect to the liquidation of the ~~Trust~~ Trust Account as promptly as reasonably possible but not more than ten business days thereafter, subject to applicable Cayman Islands law.

Our Sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any founder shares they hold if we fail to consummate an Initial Business Combination by July 30, ~~2025~~2026 (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if we fail to complete our Initial Business Combination within the prescribed time frame).

1013

Our Sponsor, executive officers and directors have agreed, pursuant to a written agreement with us, that they will not propose any amendment to our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our ~~public~~ public shares if we do not complete our Initial Business Combination by July 30, ~~2025~~2026 or (B) with respect to any other provision ~~relating~~ relating to the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination), unless we provide our public shareholders with the opportunity to redeem their public shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares. If this optional redemption right is exercised with respect to an excessive number of public shares such that we cannot satisfy the net tangible asset requirement, we would not proceed with the amendment or the related redemption of our public shares at such time. This redemption right shall apply in the event of the approval of any such amendment, whether proposed by our Sponsor, any executive officer or director, or any other person.

We expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be funded with up to $100,000 of funds from the Trust Account available to us to pay dissolution expenses, although we cannot assure you that there will be sufficient funds for such purpose.

If we were to expend all of the net proceeds of the public offering and the sale of the private placement units, other than the funds held in the Trust Account, and without taking into account interest, if any, earned on the Trust Account, the per-share redemption amount received by shareholders upon our dissolution would be $10.00. The proceeds held in the Trust Account could, however, become subject to the claims of our creditors which would have higher priority than the claims of our public shareholders. We cannot assure you that the actual per-share redemption amount received by shareholders will not be less than $10.00. While we intend to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors’ claims.

Although we will seek to have all vendors, service providers, prospective partner businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of our public shareholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against the Trust Account including, but not limited, to fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the Trust Account. If any third-party refuses to execute an agreement waiving such claims to the monies held in the Trust Account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third-party that has not executed a waiver if management believes that such third-party’s engagement would be significantly more beneficial to us than any alternative. Examples of possible instances where we may engage a third-party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and William Blair & Company, L.L.C. will not execute an agreement with us waiving such claims to the monies held in the Trust Account. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the Trust Account for any reason. In order to protect the amounts held in the Trust Account, our Sponsor has agreed that it will be liable to us if and to the extent any claims by a third-party (other than Marcum LLP, our independent registered public accounting firm) for services rendered or products sold to us (other than our independent registered public accounting firm), or a prospective partner business with which we have discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, provided that such liability will not apply to any claims by a third-party or prospective partner business that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under our indemnity of the underwriters of the public offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third-party, our Sponsor will not be responsible to the extent of any liability for such third-party claims. However, we have not asked our Sponsor to reserve for such indemnification obligations, nor have we independently verified whether our Sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our Sponsor’s only assets are securities of our company. Therefore, we cannot assure you that our Sponsor would be able to satisfy those obligations. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective partner businesses.

In the event that the proceeds in the Trust Account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay our income tax obligations, and our Sponsor asserts that it is unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our Sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against our Sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular instance. Accordingly, we cannot assure you that due to claims of creditors the actual value of the per-share redemption price will not be less than $10.00 per public share.

We will seek to reduce the possibility that our Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective partner businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Our Sponsor will also not be liable as to any claims under our indemnity of the underwriters of the public offering against certain liabilities, including liabilities under the Securities Act. In the event that we liquidate and it is subsequently determined that the reserve for claims and liabilities is insufficient, shareholders who received funds from our Trust Account could be liable for claims made by creditors, however such liability will not be greater than the amount of funds from our Trust Account received by any such shareholder.

If we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, the funds held in the Trust Account could be subject to applicable bankruptcy or insolvency law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the Trust Account, we cannot assure you we will be able to return $10.00 per public share to our public shareholders. Additionally, if we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our shareholders. Furthermore, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our company to claims of punitive damages, by paying public shareholders from the Trust Account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.

Our public shareholders will be entitled to receive funds from the Trust Account only (i) in the event of the redemption of our public shares if we do not complete our Initial Business Combination by July 30, ~~2025~~2026, (ii) in connection with a shareholder vote to amend our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary ~~shares~~ shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if if we do not complete our Initial Business Combination by July 30, ~~2025~~2026, or (B) with respect to any other provision relating to ~~the~~ the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination), or (iii) if they redeem their respective shares for cash upon the completion of the Initial Business Combination. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an Initial Business Combination or liquidation if we have not consummated an Initial Business Combination by July 30, ~~2025~~2026, with respect to such Class A ordinary shares so redeemed. In no other circumstances will a shareholder have any right or interest of any kind to or in the Trust Account. In the event we seek ~~shareholder~~ shareholder approval in connection with ~~our~~an ~~Initial~~Alternative Business Combination, a shareholder’s voting in connection with ~~the~~such business ~~combination~~ combination alone will not result in a shareholder’s redeeming its shares to us for an applicable pro rata share of the Trust Account. ~~Such~~ Such shareholder must have also exercised its redemption rights described above. These provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association, like all provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association, may be amended with a shareholder vote.

Competition

In identifying, evaluating and selecting a prospective partner business for our Initial Business Combination, we may encounter intense competition from other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged buyout funds, public companies, and operating businesses seeking strategic acquisitions. Many of these entities are well established and have extensive experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these competitors possess greater financial, technical, human and other resources than us. Our ability to acquire larger prospective partner businesses will be limited by our available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a prospective partner business. Furthermore, our obligation to pay cash in connection with our public shareholders who exercise their redemption rights may reduce the resources available to us for our Initial Business Combination and our outstanding warrants, and the future dilution they potentially represent, may not be viewed favorably by certain prospective partner businesses. Either of these factors may place us at a competitive disadvantage in successfully negotiating an Initial Business Combination.

Facilities

We currently maintain our executive offices at 2021 Fillmore St. #2089, San Francisco, CA 94115.

Employees

We currently have two executive officers: Kanishka Roy and Steven Handwerker. These individuals are not obligated to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to our affairs until we have completed our Initial Business Combination. The amount of time they will devote in any time period will vary based on whether a prospective partner business has been selected for our Initial Business Combination and the stage of the business combination process we are in. We do not intend to have any full time employees prior to the completion of our Initial Business Combination.

Available Information

We maintain a website at https://plumpartners.com. We are required to file Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q with the SEC on a regular basis, and are required to disclose certain material events (e.g., changes in corporate control, acquisitions or dispositions of a significant amount of assets other than in the ordinary course of business and bankruptcy) in a Current Report on Form 8-K. The SEC maintains an Internet website that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. The SEC’s Internet website is located at http://www.sec.gov. In addition, the Company will provide copies of these documents without charge upon request from us in writing at 2021 Fillmore St. #2089, San Francisco, CA 94115 or by telephone at +1 (929) 529-7125.

Item 1A. Risk Factors

An investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together with the other information contained in this Annual Report on Form 10-K, the IPO prospectus associated with our public offering and the Registration Statement, before making a decision to invest in our securities. If any of the following events occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could decline, and you could lose all or part of your investment.

RISKS RELATING TO OUR SEARCH FOR, AND CONSUMMATION OF OR INABILITY TO CONSUMMATE, A BUSINESS COMBINATION

Our working capital position and our proximity to the deadline for completing the Initial Business Combination raise substantial doubt about our ability to continue as a “going concern.”

As of December 31, ~~2024~~2025, the Company had $2749,~~418~~870 in cash held outside of the Trust Account. On January 3, 2024 the Company entered into a subscription agreement by and among ~~the~~ the Company, Mercury Capital, LLC and Palmeira Investment Limited (the “Subscription Agreement”) whereby the Company may ~~raise~~ raise up to $1,500,000. ~~Even~~Also, in July 2024, the Company entered into a promissory note with Sponsor (the ~~Subscription~~“Sponsor ~~Agreement~~Promissory Note”), pursuant to which the ~~Company~~Sponsor may ~~not~~loan ~~have~~up ~~sufficient~~to ~~cash~~$1,500,000 to ~~operate~~the ~~for~~Company. atThe ~~least~~funds that will be loaned to the ~~next~~Company under the Sponsor 12Promissory ~~months~~Note ~~from~~consist ~~the~~of ~~issuance~~a portion of the ~~financial~~up ~~statements.~~to ~~The~~$1,500,000 ~~Sponsor~~that orwas anloan ~~affiliate~~to of the Sponsor, orby ~~certain~~the ofInvestor pursuant to the ~~Company’s~~Subscription ~~officers~~Agreement. ~~and~~If ~~directors~~the ~~may~~Company completes a Business Combination, ~~but~~the ~~are~~Company ~~not~~would ~~obligated~~repay ~~to,~~the ~~loan~~Sponsor Promissory Note. In the ~~Company~~event ~~funds~~that asa Business Combination does not close, the Company may beuse ~~required~~a ~~under~~portion of proceeds held outside the ~~Working~~Trust ~~Capital~~Account ~~Loans~~to ~~(as~~repay ~~defined~~the Sponsor Promissory Note, but no proceeds held in ~~Note~~the 5Trust Account would be used to repay the ~~accompanying~~Sponsor ~~financial~~Promissory ~~statements)~~Note. ~~There~~Up isto no$1,500,000 ~~assurance~~of ~~that~~such loans may be convertible into warrants of the Company’s ~~Business~~at ~~Combination~~a ~~will~~price beof ~~successful or~~$1.50 ~~successful~~per ~~within~~warrant at the ~~Combination~~option ~~Period~~of ~~or that~~ the Sponsor. orThe anwarrants ~~affiliate~~would ofbe identical to the ~~Sponsor,~~Private Placement orWarrants. ~~certain~~On ofApril 24, 2025, the Company’s ~~officers~~ and ~~directors~~Sponsor ~~will~~entered ~~loan~~an amendment to increase the ~~Company~~maximum ~~funds~~amount asof the Sponsor Promissory Note to $2,200,000 and up to $2,200,000 may be ~~required~~converted ~~under~~into Private Placement Warrants at a price of $1.50 per warrant at the ~~Working~~option of ~~Capital~~the ~~Loans~~Sponsor.

~~The~~Even with the Subscription Agreement and the Sponsor Promissory Note the Company ~~will~~may not have ~~until~~sufficient ~~July~~cash ~~30,~~to ~~2025~~operate ~~to complete~~for at least the ~~Business~~next ~~Combination~~12 months from the issuance of the financial statements. IfThe aSponsor ~~Business~~or ~~Combination~~an isaffiliate ~~not~~of ~~consummated~~the bySponsor, ~~July~~or 30certain of the Company’s officers and directors may, ~~2025~~but ~~there~~are ~~will~~not obligated to, loan the Company funds as may be arequired ~~mandatory~~under ~~liquidation~~the Working Capital Loans (as defined in Note 5 to the accompanying financial statements). ~~and~~There ~~subsequent~~is ~~dissolution~~no ofassurance that the Company,’s ~~unless~~Business Combination will be successful or successful within the ~~shareholders~~Second ~~approve~~Combination Period or that the Sponsor or an ~~amendment~~affiliate toof the ~~Third~~Sponsor, ~~Amended~~or ~~and~~certain ~~Restated~~of ~~Memorandum~~ the Company’s officers and ~~Articles~~directors ofwill ~~Association~~loan tothe ~~further~~Company ~~extend~~funds as may be required under the ~~date~~Working Capital Loans.

In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Codification (“ASC”) Topic 205-40 Presentation of Financial Statements—Going Concern, management has determined the factors disclosed above and the July 30, 2025 Business Combination Period deadline raise substantial doubt about the Company’s ability to continue as a going concern through one year from the date that these financial statements are filed. The accompanying financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.16

~~Our~~The ~~shareholders~~Company ~~may~~will ~~not~~have beuntil ~~afforded~~July an30, ~~opportunity~~2026 to ~~vote on~~complete ~~our~~the ~~proposed~~ Initial Business Combination,. ~~which~~If ~~means~~an weInitial ~~may~~Business ~~complete~~Combination ~~our~~is ~~Initial~~not ~~Business~~consummated ~~Combination~~by ~~even~~July ~~though~~30, 2026 there will be a ~~majority~~mandatory liquidation and subsequent dissolution of ~~our~~ the Company, unless the shareholders doapprove ~~not~~an ~~support~~amendment ~~such~~to athe ~~combination.~~Fourth Amended and Restated Memorandum and Articles of Association to further extend the date.

WeIn ~~may~~connection ~~choose~~with ~~not~~the toCompany’s ~~hold a shareholder vote~~assessment ~~before~~of wegoing ~~complete~~concern ~~our~~considerations ~~Initial~~in ~~Business~~accordance ~~Combination~~with ifFASB’s ~~the~~Accounting ~~business~~Standards ~~combination~~Codification ~~would~~(“ASC”) ~~not~~Topic ~~require~~205-40 ~~shareholder approval under applicable~~Presentation ~~law~~of orFinancial ~~stock~~Statements—Going ~~exchange listing requirement. For instance~~Concern, ifmanagement wehas ~~were~~determined ~~seeking to acquire a prospective partner business where~~ the ~~consideration we~~factors ~~were~~disclosed ~~paying~~above inand the ~~transaction~~July ~~was all cash~~30, we2026 ~~would~~Initial ~~typically not be required to seek shareholder approval to complete such a transaction.~~Business ~~Except~~Combination ~~for~~deadline asraise ~~required~~substantial bydoubt ~~applicable~~about ~~law or stock exchange listing requirement,~~ the ~~decision~~Company’s asability to ~~whether~~continue weas ~~will seek shareholder approval of~~ a ~~proposed~~going ~~business~~concern ~~combination~~through orone ~~will~~year ~~allow~~from ~~shareholders~~the date tothat ~~sell~~these ~~their~~financial ~~shares~~statements toare usfiled. inThe aaccompanying ~~tender~~financial ~~offer~~statements ~~will~~do benot ~~made~~include byany ~~us,~~adjustments ~~solely in~~relating ~~our~~to ~~discretion, and will be based on a variety of factors, such as~~ the ~~timing~~ recovery of the ~~transaction~~recorded ~~and~~assets ~~whether~~or the ~~terms~~classification of the ~~transaction would~~liabilities ~~otherwise~~that ~~require~~might usbe tonecessary ~~seek~~should ~~shareholder~~the ~~approval.~~Company ~~Accordingly,~~be weunable ~~may~~to ~~complete~~continue ~~our~~as ~~Initial Business Combination even if holders~~a ofgoing ~~a majority of our issued and outstanding ordinary shares do not approve of the business combination we complete~~concern.

Our shareholders may not be afforded an opportunity to vote on any alternative Initial Business Combination, which means we may complete an alternative Initial Business Combination even though a majority of our shareholders do not support such a combination.

Although our shareholders approved the proposed Business Combination in connection with the December 2025 Extraordinary General Meeting, the transaction has not yet closed. If the currently approved Business Combination is not consummated for any reason, we may seek to enter into a revised or alternative Initial Business Combination (the “Alternative Business Combination”). We may choose not to hold a shareholder vote before we complete an Alternative Business Combination if the business combination would not require shareholder approval under applicable law or stock exchange listing requirement. For instance, if we were seeking to acquire a prospective partner business where the consideration we were paying in the transaction was all cash, we would typically not be required to seek shareholder approval to complete such a transaction. Except for as required by applicable law or stock exchange listing requirement, the decision as to whether we will seek shareholder approval of a proposed business combination or will allow shareholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors, such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek shareholder approval. Accordingly, we may complete an Alternative Business Combination even if holders of a majority of our issued and outstanding ordinary shares do not approve of such business combination.

Please see Item 1 – “Business—Effecting Our Initial Business Combination—Permitted Purchases and Other Transactions with Respect to Our Securities” for additional information.

Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash.

At the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of any prospective partner businesses. Since our board of directors may complete a business combination without seeking shareholder approval, public shareholders may not have the right or opportunity to vote on the business combination, unless we seek such shareholder approval. Accordingly, your only opportunity to affect the investment decision regarding a potential business combination may be limited to exercising your redemption rights within the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public shareholders in which we describe ~~our~~any ~~Initial~~Alternative Business Combination.

If we seek shareholder approval of ~~our~~an ~~initial~~Alternative ~~business~~Business ~~combination~~Combination, our Sponsor and members of our management team have agreed to vote in favor of such ~~Initial~~Alternative Business Combination, regardless of how ~~our~~ our public shareholders vote.

Our Sponsor and Original Sponsor own, on an as-converted basis, 34approximately 97.120% of our outstanding ordinary shares ~~(excluding~~as ~~the private placement shares underlying the private placement units) immediately following the completion~~ of ~~the~~December ~~public~~31, ~~offering~~2025. Our Sponsor and members of our management team also may from time to time purchase Class A ordinary shares prior to ~~our~~any Initial Business Combination. Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association ~~will~~ provide that, if we seek shareholder approval, we will complete our Initial Business Combination or an Alternative Business Combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. As a result, in addition to the shares owned by our Original Sponsor and shares owned by our Sponsor, we would need none ~~(assuming all issued and outstanding shares are voted and the over-allotment option is not exercised)~~ of the ~~25,000,000~~ public shares sold in the public offering to be voted in favor of an ~~Initial~~Alternative Business Combination in order to have ~~our~~such ~~Initial~~Alternative Business Combination approved. If we seek shareholder approval of ~~our~~an ~~Initial~~Alternative Business Combination, the agreement by our Sponsor and each member of our management team to vote in favor of ~~our~~such ~~Initial~~Alternative Business Combination will increase the likelihood that we will receive the requisite ~~shareholder~~ shareholder approval for such ~~Initial~~Alternative Business Combination.

The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination prospective partners, which may make it difficult for us to enter into a business combination with a prospective partner.

We may seek to enter into a business combination transaction agreement with a prospective partner that requires as a closing condition that we have a minimum net worth or a certain amount of cash. If too many public shareholders exercise their redemption rights, we would not be able to meet such closing condition and, as a result, would not be able to proceed with the business combination. Prospective partners will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction with us.

The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.

We will not know how many shareholders may exercise their redemption rights in connection with a vote for approval of ~~the~~an Alternative Business Combination, and therefore need to structure any ~~the~~such transaction based on our expectations as to the number of shares that will be submitted for redemption. If a large number of shares are submitted for redemption, we may need to restructure the transaction to reserve a greater portion of the cash in the Trust Account or arrange for additional third-party financing. Raising additional third-party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. The above considerations may limit our ability to complete the most desirable business combination available to us or optimize our capital structure. The amount of the deferred underwriting commissions payable to the underwriters will not be adjusted for any shares that are redeemed in connection with an ~~Initial~~Alternative Business Combination. The per-share amount we will distribute to shareholders who properly exercise their redemption rights will not be reduced by the deferred underwriting commission and after such redemptions, the amount held in trust will continue to reflect our obligation to pay the entire deferred underwriting commissions.

The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our Initial Business Combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.

If our Initial Business Combination agreement, or any Alternative Business Combination agreement, requires us to use a portion of the cash in the Trust Account to pay the purchase price, or requires us to have a minimum amount of cash at closing, the probability that our Initial Business Combination would be unsuccessful is increased. If our Initial Business Combination is unsuccessful, you would not receive your pro rata portion of the funds in the Trust Account until we liquidate the Trust Account. If you are in need of immediate liquidity, you could attempt to sell your shares in the open market; however, at such time our shares may trade at a discount to the pro rata amount per share in the Trust Account. In either situation, you may suffer a material loss on your investment or lose the benefit of funds expected in connection with our redemption until we liquidate or you are able to sell your shares in the open market.

14The requirement that we consummate an Initial Business Combination by July 30, 2026 may give potential prospective partner businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination prospective partners, in particular as we approach our dissolution deadline, which could undermine our ability to complete our Initial Business Combination on terms that would produce value for our shareholders.

~~The~~Any ~~requirement~~potential prospective partner business with which we enter into negotiations concerning a business combination will be aware that we must consummate an Initial Business Combination by July 30, ~~2025~~2026. ~~may~~Consequently, ~~give~~such ~~potential~~ prospective partner ~~businesses~~business may obtain leverage over us in negotiating a business combination, ~~and may limit~~knowing ~~the~~that ~~time~~if we ~~have~~do innot ~~which~~complete toour ~~conduct~~Initial ~~due~~Business ~~diligence~~Combination onwith ~~potential~~that particular prospective partner business, ~~combination~~we may be unable to complete our Initial Business Combination with any prospective ~~partners,~~partner inbusiness. ~~particular~~This risk will increase as we ~~approach~~get closer to the time frame described ~~our~~above. ~~dissolution~~In ~~deadline~~addition, ~~which~~we ~~could~~may ~~undermine~~have ~~our~~limited ~~ability~~time to ~~complete~~conduct due diligence and may enter into our Initial Business Combination on terms that we would ~~produce value~~have ~~for~~rejected ~~our~~upon ~~shareholders.~~a more comprehensive investigation.

~~Any~~Our ~~potential~~ability ~~prospective~~to ~~partner business with which we enter into negotiations concerning a business combination will be aware that we must~~ consummate an Initial Business Combination ~~by July 30~~, ~~2025. Consequently, such prospective partner business~~ may ~~obtain~~be materially ~~leverage~~adversely ~~over~~affected usby inglobal ~~negotiating~~economic aand ~~business~~geopolitical ~~combination~~events, ~~knowing~~ ~~that~~macroeconomic ~~if we do not complete our Initial Business Combination with that particular prospective partner business~~conditions, weincluding ~~may~~the beimpact ~~unable to~~of ~~complete our Initial Business Combination with any prospective partner business. This risk will increase as we get closer to the time~~government ~~frame~~actions ~~described~~and ~~above. In addition~~regulations, weand ~~may~~the ~~have~~status ~~limited~~of ~~time~~debt ~~to conduct due diligence~~ and ~~may~~equity ~~enter into our Initial Business Combination on terms that we would have rejected upon a more comprehensive investigation~~markets.

Our ability to consummate ana ~~Initial~~transaction ~~Business~~may ~~Combination,~~be dependent on the ability to raise equity and debt financing which may be ~~materially~~ ~~adversely~~impacted ~~affected~~by global economic and geopolitical events, including as a result of increased market volatility and decreased market liquidity and third-party financing being unavailable on terms acceptable to us or at all. Government actions and regulations, such as tariffs and trade protection measures, may also negatively impact the ~~status~~Company’s ability to consummate an Initial Business Combination, or the operations of ~~debt~~a target business with which the Company ultimately consummates a Business Combination, may be materially and ~~equity~~adversely ~~markets~~affected.

Our ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by global economic and geopolitical events, including as a result of increased market volatility and decreased market liquidity and third-party financing being unavailable on terms acceptable to us or at all.18

InOngoing ~~February~~global ~~2022~~conflicts, anincluding ~~armed conflict escalated between Russia and Ukraine. The sanctions announced by~~ the ~~United~~war ~~States and other countries against Russia and Belarus following Russia’s~~in ~~invasion of~~ Ukraine ~~to date include restrictions on selling or importing goods, services, or technology in or from affected regions~~ and ~~travel~~ ~~bans~~the ~~and~~Russian ~~asset freezes impacting connected individuals and political~~sanctions, ~~military, business, and financial organizations in Russia and Belarus. The United States and other countries could impose wider sanctions and take other actions should~~ the ~~conflict~~Israel-Hamas ~~further escalate. Separately~~war, ~~in October 2023, Israel~~ and ~~certain~~the ~~Iranian-backed Palestinian forces began an armed~~ conflict in ~~Israel,~~ ~~the Gaza Strip~~Iran, ~~and~~continue ~~surrounding areas, which threatens~~ to ~~spread~~create tosignificant ~~other~~geopolitical ~~Middle Eastern countries including Lebanon~~ and ~~Iran~~economic uncertainty. AsThe ~~a result of the ongoing Hamas/Israel conflicts and/or other future global conflicts, the~~ Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and potential future sanctions on the world economy and the specific impact on the Company’s financial position, results of operations or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

We may not be able to consummate an Initial Business Combination by July 30, ~~2025~~2026, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may receive only $10.00 per share, or less than such amount in certain circumstances, and our warrants will expire worthless.

We may not be able to consummate an Initial Business Combination by July 30, ~~2025~~2026. Our ability to complete our Initial Business Combination may be negatively impacted by general market conditions, volatility in the capital and debt markets, meeting national exchange listing requirements, and the other risks described herein. If we have not consummated an Initial Business Combination within such applicable time period, we will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses and any withholding tax), divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association will provide that, if we wind up for any other reason prior to the consummation of our Initial Business Combination, we will follow the foregoing procedures with respect to the liquidation of the Trust Account as promptly as reasonably possible but not more than ten business days thereafter, subject to applicable Cayman Islands law. In either such case, our public shareholders may receive only $10.00 per public share, or less than $10.00 per public share, on the redemption of their shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.

If we seek shareholder approval of ~~our~~an ~~Initial~~Alternative Business Combination, our Sponsor, directors, executive officers, advisors and their affiliates may elect to purchase public shares or warrants, which may ~~influence~~ influence a vote on a proposed business combination and reduce the public “float” of our Class A ordinary shares or public warrants.

If we seek shareholder approval of ~~our~~an ~~Initial~~Alternative Business Combination and we do not conduct redemptions in connection with ~~our~~such ~~initial~~ business combination pursuant to the tender offer rules, our Sponsor, directors, executive officers, advisors or their affiliates may purchase public shares or warrants in privately-negotiated transactions or in the open market either prior to or following the completion of ~~our~~the ~~Initial~~Alternative Business Combination. Any such price ~~per~~ per share may be different than the amount per share a public shareholder would receive if it elected to redeem its shares in connection with ~~our~~the ~~Initial~~Alternative Business Combination. Additionally, at any time at or prior to ~~our~~an ~~Initial~~Alternative Business Combination, subject to applicable securities laws (including with respect to material nonpublic information), our Sponsor, directors, officers, advisors or any of their respective affiliates may enter into transactions with investors and others to provide them with incentives to acquire public shares, vote their public shares in favor of ~~our~~the ~~Initial~~Alternative Business Combination or not redeem their public shares. However, they are under no ~~obligation~~ obligation or duty to do so and they have no current commitments, plans or intentions to engage in such transactions and have not formulated ~~any~~ any terms or conditions for any such transactions. None of the funds in the Trust Account will be used to purchase public shares or warrants in such transactions.

15In the event that our Sponsor, directors, executive officers, advisors or their affiliates purchase shares in privately-negotiated transactions from public shareholders who have already elected to exercise their redemption rights, such selling shareholders would be required to revoke their prior elections to redeem their shares. The purpose of any such transaction could be to (1) vote in favor of the business combination and thereby increase the likelihood of obtaining shareholder approval of the business combination, (2) reduce the number of public warrants outstanding or vote such warrants on any matters submitted to the warrant holders for approval in connection with an Alternative Business Combination or (3) satisfy a closing condition in an agreement with a prospective partner that requires us to have a minimum net worth or a certain amount of cash at the closing of an Alternative Business Combination, where it appears that such requirement would otherwise not be met. Any such purchases of our securities may result in the completion of an Alternative Business Combination that may not otherwise have been possible. In addition, if such purchases are made, the public “float” of our Class A ordinary shares or public warrants may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements. See Item 1—“Business—Effecting Our Initial Business Combination— Shareholders May Not Have the Ability to Approve Any Alternative Business Combination and Approval of Our Current Initial Business Combination Does Not Guarantee its Completion” for a description of how our Sponsor, directors, executive officers, advisors or their affiliates will select which shareholders to purchase securities from in any private transaction.

In the event that our Sponsor, directors, executive officers, advisors or their affiliates purchase shares in privately-negotiated transactions from public shareholders who have already elected to exercise their redemption rights, such selling shareholders would be required to revoke their prior elections to redeem their shares. The purpose of any such transaction could be to (1) vote in favor of the business combination and thereby increase the likelihood of obtaining shareholder approval of the business combination, (2) reduce the number of public warrants outstanding or vote such warrants on any matters submitted to the warrant holders for approval in connection with our Initial Business Combination or (3) satisfy a closing condition in an agreement with a prospective partner that requires us to have a minimum net worth or a certain amount of cash at the closing of our Initial Business Combination, where it appears that such requirement would otherwise not be met. Any such purchases of our securities may result in the completion of our Initial Business Combination that may not otherwise have been possible. In addition, if such purchases are made, the public “float” of our Class A ordinary shares or public warrants may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements. See Item 1—“Business—Effecting Our Initial Business Combination—Shareholders May Not Have the Ability to Approve Our Initial Business Combination” for a description of how our Sponsor, directors, executive officers, advisors or their affiliates will select which shareholders to purchase securities from in any private transaction.19

Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our Initial Business Combination. If we have not consummated our Initial Business Combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our Trust Account and our warrants will expire worthless.

We expect to encounter intense competition from other entities having a business objective similar to ours, including private investors (which may be individuals or investment partnerships), other blank check companies and other entities, domestic and international, competing for the types of businesses we intend to acquire. Many of these individuals and entities are well established and have extensive experience in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries. Many of these competitors possess greater technical, human and other resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted with those of many of these competitors. While we believe there are numerous prospective partner businesses we could potentially acquire with the net proceeds of the public offering and the sale of the private placement units, our ability to compete with respect to the acquisition of certain prospective partner businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain prospective partner businesses. Furthermore, we are obligated to offer holders of our public shares the right to redeem their shares for cash at the time of our Initial Business Combination in conjunction with a shareholder vote or via a tender offer. Prospective partner companies will be aware that this may reduce the resources available to us for our Initial Business Combination. Any of these obligations may place us at a competitive disadvantage in successfully negotiating a business combination. If we have not consummated our Initial Business Combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our Trust Account and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.

Insufficient cash held outside of the trust account could limit the amount available to fund our search for a prospective partner business or businesses and our ability to complete our Initial Business Combination, and we will require us to depend on loans from our Sponsor, its affiliates or members of our management team or other potential lenders to fund our search and to complete our Initial Business Combination.

Of the net proceeds of the public offering and the sale of the private placement units, approximately $1,750,000 was available to us initially outside the trust account to fund our working capital requirements. Of the funds available to us, we expect to use a portion of the funds available to us to pay fees to consultants to assist us with our search for a prospective partner business. We could also use a portion of the funds as a down payment or to fund a “no-shop” provision (a provision in letters of intent designed to keep prospective partner businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such prospective partner businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into a letter of intent where we paid for the right to receive exclusivity from a prospective partner business and were subsequently required to forfeit such funds (whether as a result of our breach or otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a prospective partner business.

If we are required to seek additional capital, we would need to borrow funds from our Sponsor, its affiliates, members of our management team or other third parties to operate or may be forced to liquidate. Neither our Sponsor, members of our management team nor their affiliates is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or from funds released to us upon completion of our Initial Business Combination. Up to $1,500,000 of such loans may be convertible into units of the post-business combination entity at a price of $10.00 per unit at the option of the lender. The warrants would be identical to the private placement units. If we have not consummated our Initial Business Combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.

The securities in which we invest the funds held in the Trust Account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.00 per share.

The proceeds held in the Trust Account will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that we are unable to complete our Initial Business Combination or make certain amendments to our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association, our public shareholders are entitled to receive their pro-rata share of the proceeds held in the Trust Account, plus any interest income, net of taxes paid or payable (less, in the case we are unable to complete our Initial Business Combination, $100,000 of interest). Negative interest rates could reduce the value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.00 per share.

If, after we distribute the proceeds in the Trust Account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, a bankruptcy or insolvency court may seek to recover such proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our board of directors and us to claims of punitive damages.

If, after we distribute the proceeds in the Trust Account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our shareholders. In addition, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by paying public shareholders from the Trust Account prior to addressing the claims of creditors.

If, before distributing the proceeds in the Trust Account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.

If, before distributing the proceeds in the Trust Account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy or insolvency law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the Trust Account, the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.

If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our Initial Business Combination.

On January 24, 2024, the SEC adopted a series of new rules relating to SPACs (the “SPAC Rules”) that provided guidance describing the extent to which SPACs could become subject to regulation under the Investment Company Act and the regulations thereunder. Whether a SPAC is an investment company will be a question of facts and circumstances. We can give no assurance that a claim will not be made that we have been operating as an unregistered investment company.

If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including:

●

restrictions on the nature of our investments; and

●

restrictions on the issuance of securities, each of which may make it difficult for us to complete our Initial Business Combination.

In addition, we may have imposed upon us burdensome requirements, including:

●

registration as an investment company with the SEC;

●

adoption of a specific form of corporate structure; and

●

reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to.

In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading of securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business will be to identify and complete a business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.

We do not believe that our anticipated principal activities will subject us to the Investment Company Act. Since our initial public offering, the proceeds held in the trust account have only been invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intend to avoid being deemed an “investment company” within the meaning of the Investment Company Act. An investment in our securities is not intended for persons who are seeking a return on investments in government securities or investment securities. The trust account is intended as a holding place for funds pending the earliest to occur of either: (i) the completion of our Initial Business Combination; (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our Third Amended and Restated Memorandum and Articles Of Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination within the combination period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an Initial Business Combination within the combination period, our return of the funds held in the trust account to our public shareholders as part of our redemption of the public shares. If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete a business combination. If we have not consummated our Initial Business Combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.21

We do not believe that our anticipated principal activities will subject us to the Investment Company Act. Since our initial public offering, the proceeds held in the trust account have only been invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intend to avoid being deemed an “investment company” within the meaning of the Investment Company Act. An investment in our securities is not intended for persons who are seeking a return on investments in government securities or investment securities. The trust account is intended as a holding place for funds pending the earliest to occur of either: (i) the completion of our Initial Business Combination; (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our Fourth Amended and Restated Memorandum and Articles Of Association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination within the combination period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an Initial Business Combination within the combination period, our return of the funds held in the trust account to our public shareholders as part of our redemption of the public shares. If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete a business combination. If we have not consummated our Initial Business Combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.

Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our Initial Business Combination and results of operations.

We are subject to the laws and regulations, and interpretations and applications of such laws and regulations, of national, regional, state, and local governments and non-U.S. jurisdictions. In particular, we are required to comply with certain SEC and other legal and regulatory requirements, and our consummation of an Initial Business Combination may be contingent upon our ability to comply with certain laws, regulations, interpretations and applications and any post-business combination company may be subject to additional laws, regulations, interpretations and applications. Compliance with, and monitoring of, the foregoing may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time, and those changes could have a material adverse effect on our business, including our ability to negotiate and complete an Initial Business Combination. A failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an Initial Business Combination. The Commission has, in the past year, adopted certain rules and may, in the future adopt other such rules, which may have a material effect on our activities and on our ability to consummate an Initial Business Combination.

Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.

If we are forced to enter into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment if it was proved that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary course of business. As a result, a liquidator could seek to recover some or all amounts received by our shareholders. Furthermore, our directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, thereby exposing themselves and our company to claims, by paying public shareholders from the Trust Account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons. We and our directors and officers who knowingly and willfully authorized or permitted any distribution to be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course of business would be guilty of an offence and may be liable for a fine of $18,292.68 and imprisonment for five years in the Cayman Islands.

We may not hold an annual general meeting until after the consummation of our Initial Business Combination.

There is no requirement under the Companies Act for us to hold annual or extraordinary general meetings to appoint directors. Until we hold an annual general meeting, public shareholders may not be afforded the opportunity to appoint directors and to discuss company affairs with management. Our board of directors is divided into three classes with only one class of directors being appointed in each year and each class (except for those directors appointed prior to our first annual general meeting) serving a three-year term.

Because we are not limited to evaluating a prospective partner business in a particular industry sector with which to pursue our Initial Business Combination, you will be unable to ascertain the merits or risks of any particular prospective partner business’s operations.

We may pursue business combination opportunities in any sector, except that we will not, under our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association, be permitted to effectuate our Initial Business Combination solely with another blank check company or similar company with nominal operations. To the extent we complete our Initial Business Combination, we may be affected by numerous risks inherent in the business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular prospective partner business, we cannot assure you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a prospective partner business. We also cannot assure you that an investment in our units will ~~ultimately~~ ultimately prove to be more favorable to investors than a direct investment, if such opportunity were available, in a business combination ~~prospective~~ prospective partner. Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value.

Although we have identified general criteria and guidelines that we believe are important in evaluating prospective partner businesses, we may enter into our Initial Business Combination with a prospective partner that does not meet such criteria and guidelines, and as a result, the prospective partner business with which we enter into our Initial Business Combination may not have attributes entirely consistent with our general criteria and guidelines.

Although we have identified general criteria ~~and~~ and guidelines for evaluating prospective partner businesses, it is possible that a prospective partner business with which we enter ~~into~~ into our Initial Business Combination will not have all of these positive attributes. If we complete our Initial Business Combination ~~with~~ with a prospective partner that does not meet some or all of these guidelines, such combination may not be as successful as a combination ~~with~~ with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective business combination ~~with~~ with a prospective partner that does not meet our general criteria and guidelines, a greater number of shareholders may exercise their ~~redemption~~ redemption rights, which may make it difficult for us to meet any closing condition with a prospective partner business that requires us to have a minimum net worth or a certain amount of cash. In addition, if shareholder approval of the transaction is required by applicable ~~law~~ law or stock exchange listing requirements, or we decide to obtain shareholder approval for business or other reasons, it may be more ~~difficult~~ difficult for us to attain shareholder approval of ~~our~~an ~~Initial~~Alternative Business Combination if the prospective partner business does not meet our general criteria and guidelines. If we have not consummated our Initial Business Combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our Trust Account and our warrants will expire worthless.

We are not required to obtain an opinion from an independent accounting or investment banking firm, and consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our shareholders from a financial point of view.

Unless we complete our Initial Business Combination with an affiliated entity, we are not required to obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that the price we are paying is fair to our shareholders from a financial point of view. If no opinion is obtained, our shareholders will be relying on the judgment of our board of directors, who will determine fair market value based on standards generally accepted by the financial community. Such standards used will be disclosed in our proxy solicitation or tender offer materials, as applicable, related to our Initial Business Combination.

Our initial shareholders may receive additional Class A ordinary shares if we issue shares to consummate an Initial Business Combination.

The founder shares will automatically convert into Class A ordinary shares on the first business day following the consummation of our Initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the public offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the Initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the Initial Business Combination and any private placement warrants issued to our Sponsor, members of our management team or any of their affiliates upon conversion of working capital loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not consummated our Initial Business Combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our Trust Account and our warrants will expire worthless.

We anticipate that the investigation of each specific prospective partner business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management time and attention and substantial costs for accountants, attorneys and others. If we decide not to complete a specific Initial Business Combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific prospective partner business, we may fail to complete our Initial Business Combination for any number of reasons including those beyond our control. Any such event will result in a loss to us of the related costs incurred which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not consummated our Initial Business Combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our Trust Account and our warrants will expire worthless.

If third parties bring claims against us, the proceeds held in the Trust Account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share.

Our placing of funds in the Trust Account may not protect those funds from third-party claims against us. Although we will seek to have all vendors, service providers, prospective partner businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of our public shareholders, such parties may not execute such agreements, or even if they execute such agreements, they may not be prevented from bringing claims against the Trust Account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the Trust Account. If any third-party refuses to execute an agreement waiving such claims to the monies held in the Trust Account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third-party that has not executed a waiver if management believes that such third- party’s engagement would be significantly more beneficial to us than any alternative.

Examples of possible instances where we may engage a third-party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the Trust Account for any reason. Upon redemption of our public shares, if we have not consummated an Initial Business Combination by July 30, ~~2025~~2026, or upon the exercise of a redemption right in connection with our Initial Business Combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought against us within the ten years following redemption. Accordingly, the per-share redemption amount received by public shareholders could be less than the $10.00 per public share initially held in the Trust Account, due to claims of such creditors. Pursuant to the letter agreement the form of which is filed as an exhibit to the registration statement of which the IPO prospectus forms a part, our Sponsor has agreed that it will be liable to us if and to the extent any claims by a third-party (other than our independent registered public accounting firm) for services rendered or products sold to us, or a prospective partner business with which we have discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, provided that such liability will not apply to any claims by a third-party or prospective partner business that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under our indemnity of the underwriters of the public offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third-party, our Sponsor will not be responsible to the extent of any liability for such third-party claims.

However, we have not asked our Sponsor to reserve for such indemnification obligations, nor have we independently verified whether our Sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our Sponsor’s only assets are securities of our company. Therefore, we cannot assure you that our Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for our Initial Business Combination and redemptions could be reduced to less than $10.00 per public share. In such event, we may not be able to complete our Initial Business Combination, and you would receive such lesser amount per share in connection with any redemption of your public shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective partner businesses.

Our directors may decide not to enforce the indemnification obligations of our Sponsor, resulting in a reduction in the amount of funds in the Trust Account available for distribution to our public shareholders.

In the event that the proceeds in the Trust Account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, and our Sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our Sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against our Sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment and subject to their fiduciary duties may choose not to do so in any particular instance. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the Trust Account available for distribution to our public shareholders may be reduced below $10.00 per public share.

We may engage in a business combination with one or more prospective partner businesses that have relationships with entities that may be affiliated with our Sponsor, executive officers, directors or initial shareholders which may raise potential conflicts of interest.

In light of the involvement of our Sponsor, executive officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our Sponsor, executive officers, directors or initial shareholders. Our directors also serve as officers and board members for other entities, including, without limitation, those described under Item 10—“Directors, Executive Officers and Corporate Governance—Conflicts of Interest.” Our Sponsor, officers and directors may Sponsor, form or participate in other blank check companies similar to ours during the period in which we are seeking an Initial Business Combination. Such entities may compete with us for business combination opportunities. Although we will not be specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria and guidelines for a business combination as set forth in “Proposed Business—Effecting Our Initial Business Combination—Evaluation of a Prospective Partner Business and Structuring of Our Initial Business Combination” and such transaction was approved by a majority of our independent and disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions regarding the fairness to our company from a financial point of view of a business combination with one or more domestic or international businesses affiliated with our Sponsor, executive officers, directors or initial shareholders, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not be as advantageous to our public shareholders as they would be absent any conflicts of interest.

Members of our management team and affiliated companies have been, and may from time to time be, involved in legal proceedings or governmental investigations unrelated to our business.

Members of our management team have been involved in a wide variety of businesses. Such involvement has, and may lead to, media coverage and public awareness. As a result of such involvement, members of our management team and affiliated companies have been, and may from time to time be, involved in legal proceedings or governmental investigations unrelated to our business. Any such proceedings or investigations may be detrimental to our reputation and could negatively affect our ability to identify and complete an Initial Business Combination and may have an adverse effect on the price of our securities.

Since our Sponsor, Original Sponsor, executive officers and directors will lose their entire investment in us if our Initial Business Combination is not completed (other than with respect to public shares they may acquire during or after the public offering), a conflict of interest may arise in determining whether a particular business combination prospective partner is appropriate for our Initial Business Combination.

On February 5, 2021, an affiliate of our Original Sponsor paid $25,000, or approximately $0.003 per unit, to cover for certain offering costs in consideration for 7,187,500 founder units consisting of 7,187,500 founder shares and 2,395,833 founder warrants. Prior to the initial investment in the Company of $25,000 by the affiliate of our Original Sponsor, the Company had no assets, tangible or intangible. The per unit price of the founder units was determined by dividing the amount contributed to the Company by the number of founder units issued. In connection with the expiration of the underwriter’s over-allotment option, our Original Sponsor surrendered 125,000 founder shares. As such, our initial shareholders collectively owned 20% of our issued and outstanding shares as of our initial public offering. The founder shares will be worthless if we do not complete an an Initial Business Combination. In addition, our Original Sponsor and anchor investors have purchased an aggregate of 865,000 private ~~placement~~ placement units, for a purchase price of $8,650,000 in the aggregate. Our Sponsor paid $1 to purchase 3,902,648 Founder Units, each unit ~~consisting~~ consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B share, and became entitled to 70% of the 2,030,860 Founder Units that Original Sponsor placed in escrow at the closing of the Purchase Agreement to the extent such Founder Units are not allocated to investors who hold and do not redeem their Class A Ordinary Shares of Plum at the time of Plum’s Initial Business Combination. IfSubsequently, weon doJanuary ~~not~~26, ~~consummate~~2024, anthe ~~Initial~~Company, ~~Business~~the ~~Combination~~Original bySponsor, ~~July~~and ~~30,~~the ~~2025,~~Sponsor entered into a first amendment to Purchase Agreement to correct the number of shares that the Original Sponsor shall retain to be 665,000 Class A private placement units (and 1,128,992 ~~the~~Class ~~underlying~~B ~~securities)~~founder ~~will~~units. ~~expire~~On ~~worthless.~~August ~~The~~22, ~~personal~~2024, the Company, the Original Sponsor, and ~~financial~~the ~~interests~~Sponsor ofentered ~~our~~into ~~executive~~a ~~officers~~second amendment to Purchase Agreement which revises the founder-unit forfeiture and ~~directors~~transfer ~~may~~mechanics ~~influence~~by requiring the acquirer to absorb all forfeitures or investor ~~their~~incentive ~~motivation~~transfers inup ~~identifying~~to 2,030,860 founder units, allocating excess forfeitures 78% to the acquirer and ~~selecting~~22% ato ~~prospective~~the ~~partner~~sponsor, ~~business~~while ~~combination~~also establishing that 2,030,860 ~~completing~~sponsor anunits ~~Initial~~will ~~Business~~be ~~Combination~~held in escrow for potential transfer to sponsor anchors, with any remaining escrowed units allocated 70% to the acquirer and ~~influencing~~30% to the ~~operation~~sponsor ofat closing. On September 5, 2025, the ~~business~~Company, ~~following~~the Original Sponsor, and the Sponsor ~~Initial~~entered ~~Business~~into ~~Combination.~~a ~~This~~third ~~risk~~amendment ~~may~~to ~~become~~Purchase ~~more~~Agreement ~~acute~~that provides that any Sponsor Incentive Units (as ~~July~~defined ~~30,~~in the Sponsor ~~2025~~Support ~~nears,~~Agreement) ~~which~~that ishave been retained by the ~~deadline~~Sponsor ~~for~~after ~~our~~the ~~consummation~~Closing, up to half of ansuch ~~Initial~~Sponsor ~~Business~~Incentive ~~Combination~~Units may be transferred prior to the Closing to a third party, ~~unless~~with ~~our~~any ~~shareholders~~Sponsor ~~approve~~Incentive anUnits ~~extension~~remaining after such transfer subject to allocation between the ofSponsor and the ~~time~~Original toSponsor ~~consummate~~as anprovided ~~Initial~~for ~~Business~~in ~~Combination~~the Purchase Agreement.

If we do not consummate an Initial Business Combination by July 30, 2026, the private placement units (and the underlying securities) will expire worthless. The personal and financial interests of our executive officers and directors may influence their motivation in identifying and selecting a prospective partner business combination, completing an Initial Business Combination and influencing the operation of the business following the Initial Business Combination. This risk may become more acute as July 30, 2026 nears, which is the deadline for our consummation of an Initial Business Combination, unless our shareholders approve an extension of the time to consummate an Initial Business Combination.

We may issue notes or other debt securities, or otherwise incur substantial debt, to complete our Initial Business Combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us.

Although we have no commitments as of the date of this ~~Form~~Report ~~10-K~~ to issue any notes or other debt securities, or to otherwise incur outstanding debt following the public offering, we may choose to incur substantial debt to complete our Initial Business Combination. We and our officers have agreed that we will not ~~incur~~ incur any indebtedness unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the ~~monies~~ monies held in the Trust Account. As such, no issuance of debt will affect the per-share amount available for redemption from the Trust Account. Nevertheless, the incurrence of debt could have a variety of negative effects, including:

●

default and foreclosure on our assets if our operating revenues after an Initial Business Combination are insufficient to repay our debt obligations;

●

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

●

our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;

●

our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;

●

our inability to pay dividends on our Class A ordinary shares;

●

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;

●

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

●

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

●

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

We may only be able to complete one business combination with the proceeds of the public offering and the sale of the private placement units, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.

The net proceeds from the public offering and the sale of the private placement units provided us with $272,612,500 in the trust account that we may use to complete our Initial Business Combination. The balance of the trust account is $1494,~~707,149~~421 as of ~~January~~December 2331, 2025 ~~after redemptions in connection with extraordinary general meetings to extend the date by which we may complete our Initial Business Combination~~.

We may effectuate our Initial Business Combination with a single-prospective partner business or multiple-prospective partner businesses simultaneously or within a short period of time. However, we may not be able to effectuate our Initial Business Combination with more than one prospective partner business because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating results and the financial condition of several prospective partner businesses as if they had been operated on a combined basis. By completing our Initial Business Combination with only a single entity, our lack of diversification may subject us to numerous economic, competitive and regulatory developments. Further, we would not be able to diversify our operations or benefit from the possible spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete several business combinations in different industries or different areas of a single industry. Accordingly, the prospects for our success may be:

●

solely dependent upon the performance of a single business, property or asset; or

●

dependent upon the development or market acceptance of a single or limited number of products, processes or services.

This lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to our Initial Business Combination.

We may attempt to simultaneously complete business combinations with multiple prospective partners, which may hinder our ability to complete our Initial Business Combination and give rise to increased costs and risks that could negatively impact our operations and profitability.

If we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make it more difficult for us, and delay our ability, to complete our Initial Business Combination. With multiple business combinations, we could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations.

We may attempt to complete our Initial Business Combination with a private company about which little information is available, which may result in a business combination with a company that is not as profitable as we suspected, if at all.

In pursuing our acquisition strategy, we may seek to effectuate our Initial Business Combination with a privately held company. Very little public information generally exists about private companies, and we could be required to make our decision on whether to pursue a potential Initial Business Combination on the basis of limited information, which may result in a business combination with a company that is not as profitable as we suspected, if at all.

We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete our Initial Business Combination with which a substantial majority of our shareholders do not agree.

Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association will not provide a specified maximum redemption threshold. As a result, we may be able to complete our Initial Business Combination even though a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares or, if we seek shareholder approval of ~~our~~an ~~Initial~~Alternative Business Combination and do not conduct redemptions in connection with ~~our~~such ~~Initial~~Alternative Business Combination pursuant to the tender offer rules, have entered into privately-negotiated agreements to sell their shares to our Sponsor, officers, directors, advisors or their affiliates. In the event the aggregate cash consideration we would be required to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete ~~the~~ the business combination or redeem any shares, all Class A ordinary shares submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination.

23In order to effectuate an Initial Business Combination, blank check companies have, in the recent past, amended various provisions of their charters and other governing instruments, including their warrant agreements. We cannot assure you that we will not seek to amend our Fourth Amended and Restated Memorandum and Articles of Association or governing instruments in a manner that will make it easier for us to complete our Initial Business Combination that our shareholders may not support.

In order to effectuate ana ~~Initial~~business ~~Business Combination~~combination, blank check companies have, in the recent past, amended various provisions of their charters and ~~other~~ governing instruments, including their warrant agreements. For example, blank check companies have amended the definition of business combination, increased redemption thresholds, extended the time to consummate an Initial Business Combination and, with respect to their warrants, amended their warrant agreements to require the warrants to be exchanged for cash and/or other securities. WeAmending ~~cannot~~our ~~assure~~Fourth ~~you~~Amended ~~that~~and weRestated Memorandum and Articles of Association will ~~not~~require ~~seek~~at least a special resolution of our shareholders as a matter of Cayman Islands law, meaning the approval of holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, and amending our warrant agreement will require a vote of holders of at least 50% of the public warrants and, solely with respect to ~~amend~~any amendment to the terms of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants, 50% of the number of the then outstanding private placement warrants. In addition, our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association orwill ~~governing~~require ~~instruments~~us into aprovide ~~manner~~our ~~that~~public ~~will~~shareholders ~~make~~with itthe ~~easier~~opportunity to redeem their public shares for uscash if we propose an amendment to our Fourth Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination ~~that~~by July 30, 2026 or (B) with respect to any other provision relating to the rights of holders of our ~~shareholders~~Class A ordinary shares (including extending the deadline ~~may~~for ~~not~~completing ~~support~~our Initial Business Combination). To the extent any of such amendments would be deemed to fundamentally change the nature of any of the securities offered through this registration statement, we would register, or seek an exemption from registration for, the affected securities.

In order to effectuate a business combination, blank check companies have, in the recent past, amended various provisions of their charters and governing instruments, including their warrant agreements. For example, blank check companies have amended the definition of business combination, increased redemption thresholds, extended the time to consummate an Initial Business Combination and, with respect to their warrants, amended their warrant agreements to require the warrants to be exchanged for cash and/or other securities. Amending our Third Amended and Restated Memorandum and Articles of Association will require at least a special resolution of our shareholders as a matter of Cayman Islands law, meaning the approval of holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, and amending our warrant agreement will require a vote of holders of at least 50% of the public warrants and, solely with respect to any amendment to the terms of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants, 50% of the number of the then outstanding private placement warrants. In addition, our Third Amended and Restated Memorandum and Articles of Association will require us to provide our public shareholders with the opportunity to redeem their public shares for cash if we propose an amendment to our Third Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination by July 30, 2025 or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination). To the extent any of such amendments would be deemed to fundamentally change the nature of any of the securities offered through this registration statement, we would register, or seek an exemption from registration for, the affected securities.27

The provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association that relate to the rights of holders of our Class A ordinary shares (and corresponding provisions of the agreement governing the release of funds from our Trust Account) may be amended with the approval of a special resolution which requires the approval of the holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, which is a lower amendment threshold than that of some other blank check companies. It may be easier for us, therefore, to amend our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association to facilitate the completion of an Initial Business Combination that some of our shareholders may not support.

Some other blank check companies have a provision in their charter which prohibits the amendment of certain of its provisions, including those which relate to the rights of a company’s shareholders, without approval by a certain percentage of the company’s shareholders. In those companies, amendment of these provisions typically requires approval by between 90% and 100% of the company’s shareholders. Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association provide that any of its provisions related to the rights of holders of our Class A ordinary shares (including the requirement to deposit proceeds of the public offering and the sale of the private placement units into the Trust Account and not release such amounts except in specified circumstances, and to provide redemption rights to public shareholders) may be amended if approved by special resolution, meaning holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, and corresponding provisions of the trust agreement governing the release of funds from our Trust Account may be amended if approved by holders of at least two-thirds of our ordinary shares; provided that the provisions of our ~~Third~~Fourth Amended and Restated ~~Memorandum~~ Memorandum and Articles of Association governing the appointment or removal of directors or to continue our company in a jurisdiction outside the Cayman Islands prior to our Initial Business Combination may only be amended by a special resolution passed by not less than two-thirds of our ordinary shares who attend and vote at our general meeting which shall include the affirmative vote of a simple majority of our Class B ordinary shares. Our initial shareholders, and their permitted transferees, if any, who collectively beneficially owned, on an as-converted basis, 20% of our Class A ordinary shares upon the closing of the public offering (excluding the private ~~placement~~ placement shares underlying the private placement units and assuming they do not purchase any units in the public offering), will participate in in any vote to amend our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association and/or trust agreement and will have the discretion to vote in any manner they choose. We do not require any additional votes from public shareholders to approve a special resolution. As a result, we may be able to amend the provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association which govern our pre-business combination behavior more easily than some other blank check companies, and this may increase our ability to complete a business combination with which you do not agree. Our shareholders may pursue remedies against us for any breach of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association.

24Our Sponsor, executive officers and directors have agreed, pursuant to agreements with us, that they will not propose any amendment to our Fourth Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination by July 30, 2026 or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination), unless we provide our public shareholders with the opportunity to redeem their Class A ordinary shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares. Our shareholders are not parties to, or third-party beneficiaries of, these agreements and, as a result, will not have the ability to pursue remedies against our Sponsor, executive officers or directors for any breach of these agreements. As a result, in the event of a breach, our shareholders would need to pursue a shareholder derivative action, subject to applicable law.

Our Sponsor, executive officers and directors have agreed, pursuant to agreements with us, that they will not propose any amendment to our Third Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination by July 30, 2025 or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination), unless we provide our public shareholders with the opportunity to redeem their Class A ordinary shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares. Our shareholders are not parties to, or third-party beneficiaries of, these agreements and, as a result, will not have the ability to pursue remedies against our Sponsor, executive officers or directors for any breach of these agreements. As a result, in the event of a breach, our shareholders would need to pursue a shareholder derivative action, subject to applicable law.

Our letter agreement with our Original Sponsor, Sponsor, officers and directors may be amended without shareholder approval.

Our letter agreement with our Original Sponsor, and our officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 185 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our Initial Business Combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.

We may be unable to obtain additional financing to complete our Initial Business Combination or to fund the operations and growth of a prospective partner business, which could compel us to restructure or abandon a particular business combination. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our Trust Account and our warrants will expire worthless.

We may be required to seek additional financing or to abandon the proposed business combination for a variety of reasons, such as the terms of negotiated transactions to purchase shares in connection with our Initial Business Combination, redemptions in connection with our Initial Business Combination, or insufficient funds held outside of the trust account. We cannot assure you that such financing will be available on acceptable terms, if at all. The current economic environment may make it difficult for companies to obtain acquisition financing. To the extent that additional financing proves to be unavailable when needed to complete our Initial Business Combination, we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative prospective partner business candidate. If we have not consummated our Initial Business Combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our Trust Account and our warrants will expire worthless. In addition, even if we do not need additional financing to complete our Initial Business Combination, we may require such financing to fund the operations or growth of the prospective partner business. The failure to secure additional financing could have a material adverse effect on the continued development or growth of the prospective partner business. None of our officers, directors or shareholders is required to provide any financing to us in connection with or after our Initial Business Combination.

Our initial shareholders and Sponsor control a substantial interest in us and thus may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support.

Upon closing of the public offering, our initial shareholders owned, on an as-converted basis, 20% of our issued and outstanding ordinary shares. ~~Our~~As ~~initial~~of ~~shareholders~~December ~~and~~31, 2025, our Sponsor ~~currently~~and Original Sponsor own, on an as-converted basis, approximately 8797.40% of our ~~issued and~~ outstanding ordinary shares ~~as of January 17, 2025~~. Accordingly, they may exert a a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support, including amendments to our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association. If our initial shareholders purchase any additional Class A ordinary shares in the aftermarket or in privately-negotiated transactions, this would increase their control. Neither our Sponsor nor, to our knowledge, any of our officers or directors, have any current intention to purchase additional securities, other than as disclosed in the IPO prospectus. Factors that would be considered in making such additional purchases would include consideration of the current trading price of our Class A ordinary shares. In addition, our board of directors, whose members were appointed by our Sponsor, is is and will be divided into three classes, each of which will generally serve for a term of three years with only one class of directors being appointed in each year. We may not hold an annual general meeting to appoint new directors prior to the completion of our Initial Business Combination, in which case all of the current directors will continue in office until at least the completion of the business combination. If there is an annual meeting, as a consequence of our “staggered” board of directors, only a minority of the board of directors will be considered for appointment and our Sponsor, because of its ownership position, will control the outcome, as only holders of our Class B ordinary shares will have the right to vote on the appointment of directors and to remove directors or or to continue our company in a jurisdiction outside the Cayman Islands prior to our Initial Business Combination. Accordingly, our Sponsor will continue to exert control at least until the completion of our Initial Business Combination. In addition, we have agreed not to ~~enter~~ enter into a definitive agreement regarding an Initial Business Combination without the prior consent of our Sponsor.

Because we must furnish our shareholders with prospective partner business financial statements, we may lose the ability to complete an otherwise advantageous Initial Business Combination with some prospective partner businesses.

The federal proxy rules require that a proxy statement with respect to a vote on a business combination meeting certain financial significance tests include historical and/or pro forma financial statement disclosure in periodic reports. We will include the same financial statement disclosure in connection with our tender offer documents, whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in accordance with, or be reconciled to, accounting principles generally accepted in the United States of America, or GAAP, or international financial reporting standards as issued by the International Accounting Standards Board, or IFRS, depending on the circumstances and the historical financial statements may be required to be audited in accordance with the standards of the Public Company Accounting Oversight Board (United States), or PCAOB. These financial statement requirements may limit the pool of potential prospective partner businesses we may acquire because some prospective partners may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules and complete our Initial Business Combination within the prescribed time frame.

Compliance obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate a business combination, require substantial financial and management resources, and increase the time and costs of completing an acquisition.

Section 404 of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls annually in our Annual Reports on Form 10-K. Only in the event we are deemed to be a large accelerated filer or an accelerated filer and no longer qualify as an emerging growth company, will we be required to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting. The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public companies because a prospective partner business with which we seek to complete our Initial Business Combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.

Our Initial Business Combination and our structure thereafter may not be tax-efficient to our shareholders and warrant holders. As a result of our business combination, our tax obligations may be more complex, burdensome and/or uncertain.

Although we will attempt to structure our Initial Business Combination in a tax-efficient manner, tax structuring considerations are complex, the relevant facts and law are uncertain and may change, and we may prioritize commercial and other considerations over tax considerations. For example, in connection with our Initial Business Combination and subject to any requisite shareholder approval, we may: structure our business combination in a manner that requires shareholders and/or warrant holders to recognize gain or income for tax purposes; effect a business combination with a prospective partner company in another jurisdiction; or reincorporate in a different jurisdiction (including, but not limited to, the jurisdiction in which the prospective partner company or business is located). We do not intend to make any cash distributions to shareholders or warrant holders to pay taxes in connection with our business combination or thereafter. Accordingly, a shareholder or a warrant holder may need to satisfy any liability resulting from our Initial Business Combination with cash from its own funds or by selling all or a portion of the shares received. In addition, shareholders and warrant holders may also be subject to additional income, withholding or other taxes with respect to their ownership of us after our Initial Business Combination.

In addition, we may effect a business combination with a prospective partner company that has business operations outside of the United States, and possibly, business operations in multiple jurisdictions. If we effect such a business combination, we could be subject to significant income, withholding and other tax obligations in a number of jurisdictions with respect to income, operations and subsidiaries related to those jurisdictions. Due to the complexity of tax obligations and filings in other jurisdictions, we may have a heightened risk related to audits or examinations by U.S. federal, state, local and non-U.S. taxing authorities. This additional complexity and risk could have an adverse effect on our after-tax profitability and financial condition.

A material weakness in our internal control over financial reporting has been identified.

In connection with the preparation of our audited ~~consolidated~~ financial statements for the ~~year~~years ended December 31, 2025, 2024 and 2023, our management identified a material weaknesses in our internal control over financial reporting as of December 31, 2025, 2024 and 2023. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

The material weakness identified relates to the compliance with an agreement we entered during the fiscal year ended December 31, 2023, and the recording of necessary accruals in relation to that agreement. Additionally, the Company identified a material weakness in internal controls in relation to proper recording of accruals and stock-based compensation during the fiscal year ended December 31, 2024. While we have processes in place to identify and appropriately apply applicable accounting requirements, we did not identify certain stipulations in the Trust Agreement, and accordingly failed to make appropriate accounting entries.

Management has implemented remediation steps to improve our internal control over financial reporting. However, we cannot assure investors that our efforts will be effective or prevent any future material weakness or significant deficiency in our internal control over financial reporting. If we are unable to remediate the identified deficiency or maintain effective internal controls, we may fail to accurately report our results or prevent the occurrence of malpractices or errors. Failure or ineffectiveness in our internal controls could have a material adverse effect on the business.

2630

RISKS RELATING TO THE POST-BUSINESS COMBINATION COMPANY

Subsequent to our completion of our Initial Business Combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and the price of our securities, which could cause you to lose some or all of your investment.

Even if we conduct extensive due diligence on a prospective partner business with which we combine, we cannot assure you that this diligence will identify all material issues with a particular prospective partner business, that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of the prospective partner business and outside of our control will not later arise. As a result of these factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment or other charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be subject as a result of assuming pre-existing debt held by a prospective partner business or by virtue of our obtaining post-combination debt financing. Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value.

We may have a limited ability to assess the management of a prospective partner business and, as a result, may effect our Initial Business Combination with a prospective partner business whose management may not have the skills, qualifications or abilities to manage a public company.

When evaluating the desirability of effecting our Initial Business Combination with a prospective partner business, our ability to assess the prospective partner business’s management may be limited due to a lack of time, resources or information. Our assessment of the capabilities of the prospective partner business’s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should the prospective partner business’s management not possess the skills, qualifications or abilities necessary to manage a public company, the operations and profitability of the post-combination business may be negatively impacted. Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value.

The officers and directors of an acquisition candidate may resign upon completion of our Initial Business Combination. The loss of a business combination prospective partner’s key personnel could negatively impact the operations and profitability of our post-combination business.

The role of an acquisition candidate’s key personnel upon the completion of our Initial Business Combination cannot be ascertained at this time. Although we contemplate that certain members of an acquisition candidate’s management team will remain associated with the acquisition candidate following our Initial Business Combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.

Our management may not be able to maintain control of a prospective partner business after our Initial Business Combination. Upon the loss of control of a prospective partner business, new management may not possess the skills, qualifications or abilities necessary to profitably operate such business.

We may structure our Initial Business Combination so that the post-business combination company in which our public shareholders own shares will own less than 100% of the equity interests or assets of a prospective partner business, but we will only complete such business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the prospective partner or otherwise acquires a controlling interest in the prospective partner business sufficient for us not to be required to register as an investment company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-business combination company owns 50% or more of the voting securities of the prospective partner, our shareholders prior to our Initial Business Combination may collectively own a minority interest in the post-business combination company, depending on valuations ascribed to the prospective partner and us in the business combination. For example, we could pursue a transaction in which we issue a substantial number of new Class A ordinary shares in exchange for all of the outstanding capital stock, shares or other equity interests of a prospective partner. In this case, we would acquire a 100% interest in the prospective partner. However, as a result of the issuance of a substantial number of new Class A ordinary shares, our shareholders immediately prior to such transaction could own less than a majority of our outstanding Class A ordinary shares subsequent to such transaction. In addition, other minority shareholders may subsequently combine their holdings resulting in a single person or group obtaining a larger share of the company’s shares than we initially acquired. Accordingly, this may make it more likely that our management will not be able to maintain control of the prospective partner business.

Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an Initial Business Combination.

The market for directors and officers liability insurance for special purpose acquisition companies has changed. Fewer insurance companies are offering quotes for directors and officers liability coverage, the premiums charged for such policies have generally increased and the terms of such policies have generally become less favorable. There can be no assurance that these trends will not continue.

The increased cost and decreased availability of directors and officers liability insurance could make it more difficult and more expensive for us to negotiate an Initial Business Combination. In order to obtain directors and officers liability insurance or modify its coverage as a result of becoming a public company, the post-business combination entity might need to incur greater expense, accept less favorable terms or both. However, any failure to obtain adequate directors and officers liability insurance could have an adverse impact on the post-business combination’s ability to attract and retain qualified officers and directors.

In addition, even after we were to complete an Initial Business Combination, our directors and officers could still be subject to potential liability from claims arising from conduct alleged to have occurred prior to the Initial Business Combination. As a result, in order to protect our directors and officers, the post-business combination entity may need to purchase additional insurance with respect to any such claims (“run-off insurance”). The need for run-off insurance would be an added expense for the post-business combination entity, and could interfere with or frustrate our ability to consummate an Initial Business Combination on terms favorable to our investors.

Members of our management team and board of directors have significant experience as founders, board members, officers or executives of other companies. As a result, certain of those persons have been, may be, or may become, involved in proceedings, investigations and litigation relating to the business affairs of the companies with which they were, are, or may in the future be, affiliated. This may have an adverse effect on us, which may impede our ability to consummate an Initial Business Combination.

During the course of their careers, members of our management team and board of directors have had significant experience as founders, board members, officers or executives of other companies. As a result of their involvement and positions in these companies, certain persons were, are now, or may in the future become, involved in litigation, investigations or other proceedings arising out of or relating to the business affairs of such companies or transactions entered into by such companies. Any such litigation, investigations or other proceedings may divert our management team’s and board’s attention and resources away from identifying and selecting a prospective partner business or businesses for our Initial Business Combination and may negatively affect our reputation, which may impede our ability to complete an Initial Business Combination.

We may seek business combination opportunities with a high degree of complexity that require significant operational improvements, which could delay or prevent us from achieving our desired results.

We may seek business combination opportunities with large, highly complex companies that we believe would benefit from operational improvements. While we intend to implement such improvements, to the extent that our efforts are delayed or we are unable to achieve the desired improvements, the business combination may not be as successful as we anticipate.

To the extent we complete our Initial Business Combination with a large complex business or entity with a complex operating structure, we may also be affected by numerous risks inherent in the operations of the business with which we combine, which could delay or prevent us from implementing our strategy. Although our management team will endeavor to evaluate the risks inherent in a particular prospective partner business and its operations, we may not be able to properly ascertain or assess all of the significant risk factors until we complete our business combination. If we are not able to achieve our desired operational improvements, or the improvements take longer to implement than anticipated, we may not achieve the gains that we anticipate. Furthermore, some of these risks and complexities may be outside of our control and leave us with no ability to control or reduce the chances that those risks and complexities will adversely impact a prospective partner business. Such combination may not be as successful as a combination with a smaller, less complex organization.

RISKS RELATING TO OUR MANAGEMENT TEAM

We may not have sufficient funds to satisfy indemnification claims of our directors and executive officers.

We have agreed to indemnify our officers and directors to the fullest extent permitted by law. However, our officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the Trust Account and to not seek recourse against the Trust Account for any reason whatsoever (except to the extent they are entitled to funds from the Trust Account due to their ownership of public shares). Accordingly, any indemnification provided will be able to be satisfied by us only if (i) we have sufficient funds outside of the Trust Account or (ii) we consummate an Initial Business Combination. Our obligation to indemnify our officers and directors may discourage shareholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions.

2832

We may seek acquisition opportunities in industries or sectors which may or may not be outside of our management’s area of expertise.

We will consider a business combination outside of our management’s area of expertise if a business combination prospective partner is presented to us and we determine that such candidate offers an attractive acquisition opportunity for our company. Although our management will endeavor to evaluate the risks inherent in any particular business combination prospective partner, we cannot assure you that we will adequately ascertain or assess all of the significant risk factors. We also cannot assure you that an investment in our units will not ultimately prove to be less favorable to investors in the public offering than a direct investment, if an opportunity were available, in a business combination prospective partner. In the event we elect to pursue an acquisition outside of the areas of our management’s expertise, our management’s expertise may not be directly applicable to its evaluation or operation, and the information contained in the IPO prospectus regarding the areas of our management’s expertise would not be relevant to an understanding of the business that we elect to acquire. As a result, our management may not be able to adequately ascertain or assess all of the significant risk factors. Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value.

We are dependent upon our executive officers and directors and their loss could adversely affect our ability to operate.

Our operations are dependent upon a relatively small group of individuals and, in particular, our executive officers and directors. We believe that our success depends on the continued service of our officers and directors, at least until we have completed our Initial Business Combination. In addition, our executive officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts of interest in allocating their time among various business activities, including identifying potential business combinations and monitoring the related due diligence. We do not have an employment agreement with, or key-man insurance on the life of, any of our directors or executive officers.

The unexpected loss of the services of one or more of our directors or executive officers could have a detrimental effect on us.

Our ability to successfully effect our Initial Business Combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of whom may join us following our Initial Business Combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.

Our ability to successfully effect our Initial Business Combination is dependent upon the efforts of our key personnel. The role of our key personnel in the prospective partner business, however, cannot presently be ascertained. Although some of our key personnel may remain with the prospective partner business in senior management, director or advisory positions following our Initial Business Combination, it is likely that some or all of the management of the prospective partner business will remain in place. While we intend to closely scrutinize any individuals we engage after our Initial Business Combination, we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements.

In addition, the directors and officers of an acquisition candidate may resign upon completion of our Initial Business Combination. The departure of a business combination prospective partner’s key personnel could negatively impact the operations and profitability of our post-combination business. Although we contemplate that certain members of an acquisition candidate’s management team will remain associated with the acquisition candidate following our Initial Business Combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.

Our key personnel may negotiate employment or consulting agreements with a prospective partner business in connection with a particular business combination, and a particular business combination may be conditioned on the retention or resignation of such key personnel. These agreements may provide for them to receive compensation following our Initial Business Combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.

Our key personnel may be able to remain with our company after the completion of our Initial Business Combination only if they are able to negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would render to us after the completion of the business combination. Such negotiations also could make such key personnel’s retention or resignation a condition to any such agreement. The personal and financial interests of such individuals may influence their motivation in identifying and selecting a prospective partner business, subject to his or her fiduciary duties under Cayman Islands law. However, we believe the ability of such individuals to remain with us after the completion of our Initial Business Combination will not be the determining factor in our decision as to whether or not we will proceed with any potential business combination. There is no certainty, however, that any of our key personnel will remain with us after the completion of our initial business combination. We cannot assure you that any of our key personnel will remain in senior management or advisory positions with us. The determination as to whether any of our key personnel will remain with us will be made at the time of our Initial Business Combination. In addition, pursuant to an agreement to be entered into on or prior to the closing of the public offering, our Sponsor, upon and following consummation of an Initial Business Combination, will be entitled to nominate three individuals for appointment to our board of directors, as long as the Sponsor holds any securities covered by the registration and shareholder rights agreement.

2933

Our executive officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our Initial Business Combination.

Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our Initial Business Combination. Each of our executive officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. Our independent directors also serve as officers and board members for other entities. If our executive officers’ and directors’ other business affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels, it could limit their ability to devote time to our affairs which may have a negative impact on our ability to complete our Initial Business Combination. For a complete discussion of our executive officers’ and directors’ other business affairs, please see Item 10—“Directors, Executive Officers and Corporate Governance—Conflicts of Interest.”

Our officers and directors presently have, and any of them in the future may have, additional, fiduciary or contractual obligations to other entities, including another blank check company, and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.

Following the completion of the public offering and until we consummate our Initial Business Combination, we are engaged in the business of identifying and combining with one or more businesses or entities. Each of our officers and directors presently has, and any of them in the future may have, additional fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity, subject to his or her fiduciary duties under Cayman Islands law. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential prospective partner business may be presented to another entity prior to its presentation to us, subject to their fiduciary duties under Cayman Islands law.

In addition, our Sponsor, officers and directors may in the future become affiliated with other blank check companies that may have acquisition objectives that are similar to ours. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential prospective partner business may be presented to such other blank check companies prior to its presentation to us, subject to our officers’ and directors’ fiduciary duties under Cayman Islands law. Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association provide that, to the fullest extent permitted by applicable law (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate ~~opportunity~~ opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the other.

For a complete discussion of our executive officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see Item 10—“Directors, Executive Officers and Corporate Governance—Conflicts of Interest.”

Our executive officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.

We have not adopted a policy that expressly prohibits our directors, executive officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a prospective partner business that is affiliated with our Sponsor, our directors or executive officers, although we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours.

The personal and financial interests of our directors and officers may influence their motivation in timely identifying and selecting a prospective partner business and completing a business combination. Consequently, our directors’ and officers’ discretion in identifying and selecting a suitable prospective partner business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in our shareholders’ best interest. If this were the case, it would be a breach of their fiduciary duties to us as a matter of Cayman Islands law and we or our shareholders might have a claim against such individuals for infringing on our shareholders’ rights. However, we might not ultimately be successful in any claim we may make against them for such reason.

3034

We may engage the underwriters or one of their affiliates to provide additional services to us, which may include acting as financial advisor in connection with an Initial Business Combination or as placement agent in connection with a related financing transaction. The underwriters are entitled to receive deferred commissions that will be released from the trust only on a completion of an Initial Business Combination. These financial incentives may cause the underwriters to have potential conflicts of interest in rendering any such additional services to us after the public offering, including, for example, in connection with the sourcing and consummation of an Initial Business Combination.

We may engage the underwriters or one of their affiliates to provide additional services to us after the public offering, including, for example, identifying prospective partners, providing financial advisory services, acting as a placement agent in a private offering or arranging debt financing. We may pay the underwriters or their affiliate fair and reasonable fees or other compensation that would be determined at that time in an arm’s length negotiation. The underwriters are also entitled to receive deferred commissions that are conditioned on the completion of an Initial Business Combination. The fact that the underwriter or their affiliates’ financial interests are tied to the consummation of a business combination transaction may give rise to potential conflicts of interest in providing any such additional services to us, including potential conflicts of interest in connection with the sourcing and consummation of an Initial Business Combination.

RISKS RELATING TO OUR SECURITIES

If we have not consummated an Initial Business Combination by July 30, ~~2025~~2026, our public shareholders may be forced to wait beyond such date before redemption from our Trust Account.

If we have not consummated an Initial Business Combination by July 30, ~~2025~~2026, the proceeds then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses and subject to any withholding tax), will be used to fund the redemption of our public shares, as further described herein. Any redemption of public shareholders from the Trust Account will be effected automatically by function of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association prior to any voluntary winding up. If we are required to wind up, liquidate the Trust Account and distribute such amount therein, pro rata, to our public shareholders, as part of any liquidation process, such winding up, liquidation and distribution must comply with the applicable provisions of the Companies Act. In that case, investors may be forced to wait beyond July 30, ~~2025~~2026 before the redemption proceeds of our Trust Account become available to them, and they receive the return of their pro rata portion of the proceeds from our Trust Account. We have no obligation to return funds to investors prior to the date of our redemption or liquidation unless, prior thereto, we consummate our Initial Business Combination or amend certain provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association, and only then in cases where investors have sought to redeem their Class A ordinary shares. Only upon our redemption or any liquidation will public shareholders be entitled to distributions if we do not complete our Initial Business Combination and do not amend certain provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association. Our ~~Third~~Fourth Amended and ~~Restated~~ Restated Memorandum and Articles of Association will provide that, if we wind up for any other reason prior to the consummation of our ~~Initial~~ Initial Business Combination, we will follow the foregoing procedures with respect to the liquidation of the Trust Account as promptly as reasonably possible but not more than ten business days thereafter, subject to applicable Cayman Islands law.

Holders of Class A ordinary shares will not be entitled to vote on any appointment or removal of directors and to continue our company in a jurisdiction outside the Cayman Islands prior to our Initial Business Combination.

Prior to our Initial Business Combination, only holders of our founder shares will have the right to vote on the appointment of directors and to continue our company in a jurisdiction outside the Cayman Islands. Holders of our public shares will not be entitled to vote on the appointment of directors or to continue our company in a jurisdiction outside the Cayman Islands during such time. In addition, prior to our Initial Business Combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. Accordingly, you will not have any say in the management of our company prior to the consummation of an Initial Business Combination.

You will not be permitted to exercise your warrants unless we register and qualify the underlying Class A ordinary shares or certain exemptions are available.

We registered the Class A ordinary shares underlying the warrants under the registration statement for the public offering. However, under the terms of the warrant agreement, we have agreed that, as soon as practicable, but in no event later than 15 business days, after the closing of our Initial Business Combination, we will use our commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the public offering or a new registration statement covering the registration under the Securities Act of the Class A ordinary shares issuable upon exercise of the warrants and thereafter will use our commercially reasonable efforts to cause the same to become effective within 60 business days following our Initial Business Combination and to maintain a current prospectus relating to the Class A ordinary shares issuable upon exercise of the warrants until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. We cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not current or correct, complete or the SEC issues a stop order.

If the Class A ordinary shares issuable upon exercise of the warrants are not registered under the Securities Act, under the terms of the warrant agreement, holders of warrants who seek to exercise their warrants will not be permitted to do so for cash and, instead, will be required to do so on a cashless basis in accordance with Section 3(a)(9) of the Securities Act or another exemption. In the event holders exercise their warrants on a cashless basis, the number of Class A ordinary shares that you will receive upon cashless exercise will be based on a formula subject to a maximum amount of shares equal to 0.361 Class A ordinary shares per warrant (subject to adjustment).

In no event will warrants be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration or qualification is available.

If our Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of “covered securities” under Section 18(b)(1) of the Securities Act, we may, at our option, not permit holders of warrants who seek to exercise their warrants to do so for cash and, instead, require them to do so on a cashless basis in accordance with Section 3(a)(9) of the Securities Act; in the event we so elect, we will not be required to file or maintain in effect a registration statement or register or qualify the shares underlying the warrants under applicable state securities laws, and in the event we do not so elect, we will use our commercially reasonable efforts to register or qualify the shares underlying the warrants under applicable state securities laws to the extent an exemption is not available.

Our ability to require holders of our warrants to exercise such warrants on a cashless basis after we call the warrants for redemption or if there is no effective registration statement covering the public resale of the Class A ordinary shares issuable upon exercise of these warrants will cause holders to receive fewer Class A ordinary shares upon their exercise of the warrants than they would have received had they been able to pay the exercise price of their warrants in cash.

If we call the warrants for redemption for cash, we will have the option, in our sole discretion, to require all holders that wish to exercise warrants to do so on a cashless basis. If we choose to require holders to exercise their warrants on a cashless basis or if holders elect to do so when there is no effective registration statement, the number of Class A ordinary shares received by a holder upon exercise will be fewer than it would have been had such holder exercised his or her warrant for cash.

For example, if the holder is exercising 875 public warrants at $11.50 per share through a cashless exercise when the Class A ordinary shares have a fair market value of $17.50 per share, then upon the cashless exercise, the holder will receive 300 Class A ordinary shares. The holder would have received 875 Class A ordinary shares if the exercise price was paid in cash. This will have the effect of reducing the potential “upside” of the holder’s investment in our company because the warrant holder will hold a smaller number of Class A ordinary shares upon a cashless exercise of the warrants they hold.

The warrants may become exercisable and redeemable for a security other than the Class A ordinary shares, and you will not have any information regarding such other security at this time.

In certain situations, including if we are not the surviving entity in our Initial Business Combination, the warrants may become exercisable for a security other than the Class A ordinary shares. As a result, if the surviving company redeems your warrants for securities pursuant to the warrant agreement, you may receive a security in a company of which you do not have information at this time. Pursuant to the warrant agreement, the surviving company will be required to use commercially reasonable efforts to register the issuance of the security underlying the warrants within twenty business days of the closing of an Initial Business Combination.

The grant of registration rights to our initial shareholders may make it more difficult to complete our Initial Business Combination, and the future exercise of such rights may adversely affect the market price of our Class A ordinary shares.

Pursuant to an agreement that was entered into concurrently with the consummation of our IPO, our initial shareholders and their permitted transferees can demand that we register the resale of the Class A ordinary shares into which founder shares are convertible, the private placement units, the private placement shares and the Class A ordinary shares issuable upon exercise of the private placement warrants, and warrants that may be issued upon conversion of working capital loans and the Class A ordinary shares issuable upon conversion of such warrants. The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect on the market price of our Class A ordinary shares. In addition, the existence of the registration rights may make our Initial Business Combination more costly or difficult to conclude. This is because the shareholders of the prospective partner business may increase the equity stake they seek in the combined entity or ask for more cash consideration to offset the negative impact on the market price of our securities that is expected when the securities owned by our initial shareholders or their permitted transferees are registered for resale.

3236

We may issue additional Class A ordinary shares or preference shares to complete our Initial Business Combination or under an employee incentive plan after completion of our Initial Business Combination. We may also issue Class A ordinary shares upon the conversion of the founder shares at a ratio greater than one-to-one at the time of our Initial Business Combination as a result of the anti-dilution provisions contained in our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association. Any such issuances would dilute the interest of our shareholders and likely present other risks.

Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association will authorize the issuance of up to 200,000,000 Class A ordinary shares, par value $0.0001 per share, 20,000,000 Class B ordinary shares, par value $0.0001 per share, and 1,000,000 preference shares, par value $0.0001 per share. There are ~~198~~199,~~983~~092,~~167~~514 and 12,937,500 authorized but unissued Class A ordinary shares and Class B ordinary shares, respectively, available for issuance which amount does not take into account shares reserved for issuance upon exercise of outstanding warrants or shares issuable upon conversion of the Class B ordinary shares, if any. The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions from the Trust Account if we fail to consummate an Initial Business Combination) at the time of our Initial Business Combination or earlier at the option of the holders thereof as described herein and in our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association. Immediately after the public offering, there were no preference shares issued and outstanding.

We may issue a substantial number of additional Class A ordinary shares or preference shares to complete our Initial Business Combination or under an employee incentive plan after completion of our Initial Business Combination. We may also issue Class A ordinary shares in connection with our redeeming the warrants as described in the section entitled “Description of Securities—Warrants—Public Shareholders’ Warrants” in our prospectus filed with the SEC pursuant to Rule 424(b)(4) (File No. 333-253221) or upon conversion of the Class B ordinary shares at a ratio greater than one-to-one at the time of our Initial Business Combination as a result of the anti-dilution provisions as set forth herein. However, our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association will provide, among other things, that prior to or in connection with our Initial Business Combination, we may not issue additional shares that would entitle the holders thereof to (i) receive funds from the Trust Account or (ii) vote on any Initial Business Combination or on any other proposal presented to shareholders prior to or in connection with the completion of an Initial Business Combination. These provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association, like all provisions of our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association, may be amended with a shareholder vote. The issuance of additional ordinary or preference shares:

●

may significantly dilute the equity interest of investors in the public offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares;

●

may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares;

●

could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

●

may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us;

●

may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and

●

may not result in adjustment to the exercise price of our warrants.

3337

We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then-outstanding public warrants, or for amendments necessary for the warrants to be classified as equity. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of our Class A ordinary shares purchasable upon exercise of a warrant could be decreased, all without your approval.

Our warrants will be issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any shareholder or warrant holder to cure any ambiguity or correct any defective provision or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in this prospectus, or to make any amendments that are necessary in the good faith determination of our board of directors (taking into account then existing market precedents) to allow for the warrants to be classified as equity in our financial statements, (provided that our board of directors may not amend pursuant to the proceeding clause (iii), the warrant agreement to increase the exercise price, shorten the exercise period, reduce the $18.00 price trigger as described in the section entitled “Description of Securities—Warrants—Public Shareholders’ Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” in our prospectus filed with the SEC pursuant to Rule 424(b)(4) (File No. 333-253221) or reduce the $10.00 or $18.00 price trigger or amounts set forth in the table described in the section entitled “Description of Securities—Warrants—Public Shareholders’ Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” in our prospectus filed with the SEC pursuant to Rule 424(b)(4) (File No. 333-253221), but otherwise requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders. Accordingly, we may amend the terms of the public warrants (i) in a manner adverse to a holder if holders of at least 50% of the then-outstanding public warrants approve of such amendment and, solely with respect to any amendment to the terms of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants, 50% of the number of the then outstanding private placement warrants or (ii) to the extent necessary for the warrants in the good faith determination of our board of directors (taking into account then existing market precedents) to allow for the warrants to be classified as equity in our financial statements without the consent of any shareholder or warrant holder. Although our ability to amend the terms of the public warrants with the consent of at least 50% of the then-outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash, shorten the exercise period or decrease the number of Class A ordinary shares purchasable upon exercise of a warrant. We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.

Our warrants will be accounted for as a warrant liability and will be recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our Class A ordinary shares or may make it more difficult for us to consummate an Initial Business Combination.

We account for our warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because our warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, we will classify each of the warrants as a liability at its fair value which will be estimated using an internal valuation model. The Company utilized a binomial/lattice model for the initial valuation of the Public Warrants. The ~~subsequent~~ measurement of the Public Warrants as of December ~~31,~~ ~~2024 and December~~ 31, ~~2023~~2025 is classified as Level 12 due to insufficient trading activity. The measurement of the ~~use~~Public Warrants as of anDecember ~~observable~~31, ~~market~~2024 ~~quote~~was inclassified anas ~~active~~Level ~~market~~1 due to significant trading activity under the ticker ~~APTMW~~PLMWF and PLMJW, respectively. ~~The~~In prior periods, the Company utilized a Black-Scholes Option Pricing model for the initial valuation of the Founder Warrants and Private Placement Warrants and the subsequent measurement of the Founder Warrants and Private Placement Warrants. Inherent in pricing models are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield, which are considered Level 3 inputs. ~~However,~~As ~~since a reasonable and acceptable volatility cannot be inferred from the option pricing model performed for the Founder Warrants and Private Placement Warrants as~~ of December 31, ~~2024,~~2025 ~~the fair value of the Founder Warrants~~ and ~~Private Placement Warrants were set equal to the fair value of the Public Warrants. As of December 31~~2024, ~~2024~~ the Founder Warrants, and Private ~~Warrants~~Placement Warrants are classified as level 23 due to the use of an ~~observable market quote for~~ a ~~similar~~Black-Scholes ~~asset~~Option inPricing ~~an active market~~model. The impact of changes in the fair value of our warrants on our earnings may have an adverse effect on the market price of our Class A ordinary shares. In addition, potential prospective partners may seek a blank check company that does not have warrants that are accounted for as a warrant liability, which may make it more difficult for us to consummate an Initial Business Combination with a prospective partner business.

Our warrant agreement will designate the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company.

Our warrant agreement will provide that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.

Notwithstanding the foregoing, these provisions of the warrant agreement will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented to the forum provisions in our warrant agreement. If any action, the subject matter of which is within the scope the forum provisions of the warrant agreement, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any holder of our warrants, such holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

This choice-of-forum provision may limit a warrant holder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and board of directors.

We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.

We have the ability to redeem the outstanding public warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the closing price of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading-day period ending on the third trading day prior to proper notice of such redemption and provided that certain other conditions are met. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. As a result, we may redeem the warrants as set forth above even if the holders are otherwise unable to exercise the warrants. Redemption of the outstanding warrants could force you to (i) exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (ii) sell your warrants at the then-current market price when you might otherwise wish to hold your warrants or (iii) accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, we expect would be substantially less than the market value of your warrants. None of the private placement warrants will be redeemable by us so long as they are held by our Sponsor or its permitted transferees.

In addition, we have the ability to redeem the outstanding public warrants at any time after they become exercisable and prior to their expiration, at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that the closing price of our Class A ordinary shares equals or exceeds $10.00 per share for any 20 trading days within a 30 trading-day period ending on the third trading day prior to proper notice of such redemption and provided that certain other conditions are met, including that holders will be able to exercise their warrants prior to redemption for a number of Class A ordinary shares determined based on the redemption date and the fair market value of our Class A ordinary shares. The value received upon exercise of the warrants (1) may be less than the value the holders would have received if they had exercised their warrants at a later time where the underlying share price is higher and (2) may not compensate the holders for the value of the warrants, including because the number of ordinary shares received is capped at 0.361 Class A ordinary shares per warrant (subject to adjustment) irrespective of the remaining life of the warrants.

None of the private placement warrants will be redeemable by us as (except as set forth under the section entitled “Description of Securities—Warrants—Public Shareholders’ Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” in our prospectus filed with the SEC pursuant to Rule 424(b)(4) (File No. 333-253221)) so long as they are held by our initial shareholders or their permitted transferees.

Our warrants may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our Initial Business Combination.

We issued warrants to purchase 9,416,666 of our Class A ordinary shares as part of the units offered in our IPO. Simultaneously with the closing of the public offering, we issued private placement units that will have underlying warrants to purchase an aggregate of 288,~~334~~333 Class A ordinary shares at $11.50 per share. In addition, if the Sponsor, its affiliates or a member of our management team makes any working capital loans, it may convert up to $1,500,000 of such loans into up to an additional 150,000 private placement units, at the price of $10.00 per unit. We may also issue Class A ordinary shares in connection with our redemption of our warrants.

To the extent we issue ordinary shares for any reason, including to effectuate a business combination, the potential for the issuance of a substantial number of additional Class A ordinary shares upon exercise of these warrants could make us a less attractive acquisition vehicle to a prospective partner business. Such warrants, when exercised, will increase the number of issued and outstanding Class A ordinary shares and reduce the value of the Class A ordinary shares issued to complete the business transaction. Therefore, our warrants may make it more difficult to effectuate a business transaction or increase the cost of acquiring the prospective partner business.

Because each unit contains one-third of one redeemable warrant and only a whole warrant may be exercised, the units may be worth less than units of other blank check companies.

Each unit contains one-third of one redeemable warrant. Pursuant to the warrant agreement, no fractional warrants will be issued upon separation of the units, and only whole units will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of Class A ordinary shares to be issued to the warrant holder. This is different from other offerings similar to ours whose units include one ordinary share and one whole warrant to purchase one whole share. We have established the components of the units in this way in order to reduce the dilutive effect of the warrants upon completion of a business combination since the warrants will be exercisable in the aggregate for one-third of the number of shares compared to units that each contain a whole warrant to purchase one whole share, thus making us, we believe, a more attractive merger partner for prospective partner businesses. Nevertheless, this unit structure may cause our units to be worth less than if a unit included a warrant to purchase one whole share.

A provision of our warrant agreement may make it more difficult for us to consummate an Initial Business Combination.

If (x) we issue additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of our Initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our initial shareholders or their affiliates, without taking into account any founder shares held by our initial shareholders or such affiliates, as applicable, prior to such issuance including any transfer or reissuance of such shares), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our Initial Business Combination, and (z) the volume-weighted average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which we consummate our Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the $10.00 and $18.00 per share redemption trigger prices of the warrants will be adjusted (to the nearest cent) to be equal to 100% and 180% of the Market Value, respectively. This may make it more difficult for us to consummate an Initial Business Combination with a prospective partner business.

Provisions in our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our Class A ordinary shares and could entrench management.

Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association will contain provisions that may discourage unsolicited takeover proposals that shareholders may consider to be be in their best interests. These provisions will include a staggered board of directors, the ability of the board of directors to designate the terms of and issue new series of preference shares, and the fact that prior to the completion of our Initial Business Combination only holders of our Class B ordinary shares, which have been issued to our Sponsor, are entitled to vote on the appointment of directors, which may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.

If a shareholder fails to receive notice of our offer to redeem our public shares in connection with ~~our~~an ~~Initial~~Alternative Business Combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.

We will comply with the proxy rules or tender offer rules, as applicable, when conducting redemptions in connection with ~~our~~an ~~Initial~~Alternative Business Combination. Despite our compliance ~~with~~ with these rules, if a shareholder fails to receive our proxy solicitation or tender offer materials, as applicable, such shareholder ~~may~~ may not become aware of the opportunity to redeem its shares. In addition, the proxy solicitation or tender offer materials, as applicable, that we will furnish to holders of our public shares in connection with ~~our~~an ~~Initial~~Alternative Business Combination will describe the various ~~procedures~~ procedures that must be complied with in order to validly redeem or tender public shares. In the event that a shareholder fails to comply with these procedures, its shares may not be redeemed. See Item 1—“Business—Effecting Our Initial Business Combination—Tendering Share Certificates in Connection with a Tender Offer or Redemption Rights.”

You will not have any rights or interests in funds from the Trust Account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.

Our public shareholders will be entitled to receive funds from the Trust Account only upon the earliest to occur of: (i) our completion of an Initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholder properly elected to redeem, subject to the limitations described herein, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our ~~Third~~ Fourth Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of our obligation to provide ~~holders~~ holders of our Class A ordinary shares the right to have their shares redeemed in connection with our Initial Business Combination or to redeem 100% of our public shares if we do not complete our Initial Business Combination by July 30, ~~2025~~2026 or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares (including extending the deadline for completing our Initial Business Combination), and (iii) the redemption of our public shares if we have not consummated an Initial Business ~~Combination~~ Combination by July 30, ~~2025~~2026, subject to applicable law and as further described herein. Public shareholders who redeem their Class A ~~ordinary~~ ordinary shares in connection with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion of an Initial Business Combination or liquidation if we have not consummated an Initial Business Combination by July 30, ~~2025~~2026, with respect to such Class A ordinary shares so redeemed. In no other circumstances will a public shareholder have any right or interest of any kind in the Trust Account. Holders of warrants will not have any right to the proceeds held in the Trust Account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.

The Company is a Shell Company with Penny Stock.

We are a blank check company incorporated on February 5, 2021 as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. As a result, the Company is a shell company. Rule 405 and 12b-2 of the Exchange Act defines a shell company as an issuer that that has no or nominal operations and either (i) no or nominal assets, (ii) assets consisting solely of cash and cash equivalents; or (iii) assets consisting of any amount of cash and cash equivalents and nominal other assets.

The Company’s common stock is a “penny stock,” as defined in Rule 3a51-1 promulgated by the SEC under the Exchange Act. The penny stock rules require a broker-dealer, prior to a transaction in penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the nature and level of risks in the penny stock market. These disclosure rules have the effect of reducing the level of trading activity in the secondary market for a stock that becomes subject to the penny stock rules. So long as the common stock of the Company is subject to the penny stock rules, it may be more difficult to sell the Company’s common stock.

A shell issuer may also be a blank check company or a blind pool company, a company in the developmental stage, any company that has no specific business plan or purpose, or a company that has as its business plan to merge with or acquire an unidentified third property. Accordingly, the Company may be required, under current and proposed new rules and amendments of the SEC, to provide enhanced disclosures for investor protection in the event that we engage in a merger or acquisition with an unidentified company substantially similar to those required in registration statements for an initial public offering.

Effect of Amended Rule 15c2-11 on the Company’s securities.

The SEC released and published a Final Rulemaking on Publication or Submission of Quotations without Specified Information amending Rule 15c2-11 under the Exchange Act (“Rule 15c2-11,” the “Amended Rule 15c2-11”). To be eligible for public quotations on an ongoing basis, Amended Rule 15c2-11’s modified the “piggyback exemption” that required that (i) the specified current information about the company is publicly available, and (ii) the security is subject to a one-sided (i.e., a bid or offer) priced quotation, with no more than four business days in succession without a quotation. Under Amended Rule 15c2-11, shell companies like the Company may only rely on the piggyback exemption in certain limited circumstances. The Amended Rule 15c2-11 requires, among other requirements, that a broker-dealer has a reasonable basis for believing that information about the issuer of securities is accurate. The Amended Rule 15c2-11 has effected shell issuers and SPACs. Our security holders may find it more difficult to deposit common stock with a broker-dealer, and if deposited, it may be more difficult to trade the securities on the OTC Markets. Our securities may, however, be the subject of unsolicited customer quotations. The Company intends to provide the specified current information under the Exchange Act, but there is no assurance that a broker-dealer will accept our securities or if accepted, that the broker-dealer will rely on our disclosure of the specified current information.

If we seek shareholder approval of our Initial Business Combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of shareholders are deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability to redeem all such shares in excess of 15% of our Class A ordinary shares. 41

If we seek shareholder approval of ~~our~~an ~~Initial~~ Alternative Business Combination and we do not conduct redemptions ~~in connection with our Initial Business Combination~~ pursuant to the tender offer rules, ~~our Third Amended~~ and ~~Restated~~if ~~Memorandum~~you ~~and Articles of Association provide that a public shareholder, together with any affiliate of such shareholder~~ or ~~any other person with whom such shareholder is acting in concert or as~~ a “group” ~~(as defined under Section 13~~ of ~~the~~shareholders ~~Exchange~~are ~~Act),~~deemed ~~will be restricted from redeeming its shares with respect~~ to hold ~~more~~in ~~than~~excess ~~an aggregate~~ of 15% of ~~the shares~~our ~~sold~~Class A inordinary ~~the public offering~~shares, ~~which~~you wewill ~~refer~~lose ~~to as~~ the ~~“Excess Shares,” without our prior consent. However, we would not be restricting our shareholders’~~ ability to ~~vote~~redeem all ofsuch ~~their~~ shares (including Excess Shares) for or against our Initial Business Combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our Initial Business Combination and you could suffer a material loss on your investment in usexcess if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete our Initial Business Combination. And as a result, you will continue to hold that number of ~~shares exceeding~~ 15% ~~and, in order to dispose~~ of ~~such shares, would be required~~our toClass A ~~sell~~ordinary ~~your~~ shares ~~in open market transactions, potentially at a loss~~.

If we seek shareholder approval of an Alternative Business Combination and we do not conduct redemptions in connection with such Alternative Business Combination pursuant to the tender offer rules, our Fourth Amended and Restated Memorandum and Articles of Association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in the public offering, which we refer to as the “Excess Shares,” without our prior consent. However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against the Alternative Business Combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete an Alternative Business Combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete an Alternative Business Combination. And as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required to sell your shares in open market transactions, potentially at a loss.

GENERAL RISK FACTORS

We are a recently incorporated company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.

We are an incorporated exempted company, incorporated under the laws of the Cayman Islands with no operating results, and we will not commence operations until obtaining funding through the public offering. Because we lack an operating history, you have no basis upon which to evaluate our ability to achieve our business objective of completing our Initial Business Combination. We ~~have no plans, arrangements or understandings with any prospective partner business concerning a business combination and~~ may be unable to complete our Initial Business Combination. If we fail to complete our Initial Business Combination, we will never generate any operating revenues.

Past performance by our management team or their respective affiliates may not be indicative of future performance of an investment in us.

Information regarding performance is presented for informational purposes only. Any past experience or performance of our management team and their respective affiliates is not a guarantee of either (i) our ability to successfully identify and execute a transaction or (ii) success with respect to any business combination that we may consummate. You should not rely on the historical record of our management team or their respective affiliates as indicative of the future performance of an investment in us or the returns we will, or are likely to, generate going forward. Our management has no experience in operating special purpose acquisition companies.

We are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to “emerging growth companies” or “smaller reporting companies,” this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.

We are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may deem important. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our Class A ordinary shares held by non-affiliates exceeds $700 million as of any June 30 before that time, in which case we would no longer be an emerging growth company as of the following December 31. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Additionally, we are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of any fiscal year so long as either (1) the market value of our ordinary shares held by non-affiliates did not equal or exceed $250 million as of the prior June 30, or (2) our annual revenues did not equal or exceed $100 million during such completed fiscal year and the market value of our ordinary shares held by non-affiliates did not equal or exceed $700 million as of the prior June 30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.

Because we are incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. federal courts may be limited.

We are an exempted company incorporated under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within the United States upon our directors or executive officers, or enforce judgments obtained in the United States courts against our directors or officers.

Our corporate affairs will be governed by our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association, the Companies Act (as the same may be supplemented or amended from time to time) and the common law of the Cayman Islands. We will also be subject to the federal securities laws of the United States. ~~The~~ The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from English common law, the decisions of whose courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are different from what they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities laws as compared to the United States, and certain states, such as Delaware, may have more fully developed and judicially interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a Federal court of the United States.

We have been advised by Maples and Calder (Cayman) LLP, our Cayman Islands legal counsel that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.

As a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or controlling shareholders than they would as public shareholders of a United States company.

We may reincorporate in another jurisdiction in connection with our Initial Business Combination and such reincorporation may result in taxes imposed on shareholders.

We may, in connection with our Initial Business Combination and subject to requisite shareholder approval under the Companies Act, reincorporate in the jurisdiction in which the prospective partner company or business is located or in another jurisdiction. The transaction may require a shareholder or warrant holder to recognize taxable income in the jurisdiction in which the shareholder or warrant holder is a tax resident or in which its members are resident if it is a tax transparent entity. We do not intend to make any cash distributions to shareholders or warrant holders to pay such taxes.

Shareholders or warrant holders may be subject to withholding taxes or other taxes with respect to their ownership of us after the reincorporation.

After our Initial Business Combination, it is possible that a majority of our directors and officers will live outside the United States and all of our assets will be located outside the United States; therefore investors may not be able to enforce federal securities laws or their other legal rights.

It is possible that after our Initial Business Combination, a majority of our directors and officers will reside outside of the United States and all of our assets will be located outside of the United States. As a result, it may be difficult, or in some cases not possible, for investors in the United States to enforce their legal rights, to effect service of process upon all of our directors or officers or to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties on our directors and officers under United States laws.

We may be a passive foreign investment company, or “PFIC,” which could result in adverse U.S. federal income tax consequences to U.S. investors.

If we are a PFIC for any taxable year (or portion thereof) that is included in the holding period of a U.S. Holder of our Class A ordinary shares or warrants, the U.S. Holder may be subject to adverse U.S. federal income tax consequences and may be subject to additional reporting requirements. Our PFIC status for our current and subsequent taxable years may depend on whether we qualify for the PFIC start-up exception. Depending on the particular circumstances the application of the start-up exception may be subject to uncertainty, and there cannot be any assurance that we will qualify for the start-up exception. Accordingly, there can be no assurances with respect to our status as a PFIC for our current taxable year or any subsequent taxable year. Our actual PFIC status for any taxable year, however, will not be determinable until after the end of such taxable year (and, in the case of the start-up exception, potentially not until after the two taxable years following our current taxable year). Moreover, if we determine we are a PFIC for any taxable year, we will endeavor to provide to a U.S. Holder such information as the Internal Revenue Service (the “IRS”) may require, including a PFIC Annual Information Statement, in order to enable the U.S. Holder to make and maintain a “qualified electing fund” election, but there can be no assurance that we will timely provide such required information, and such election would be unavailable with respect to our warrants in all cases. We urge U.S. investors to consult their tax advisors regarding the possible application of the PFIC rules.

Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss.

We depend on digital technologies, including information systems, infrastructure and cloud applications and services, including those of third parties with which we may deal. Sophisticated and deliberate attacks on, or security breaches in, our systems or infrastructure, or the systems or infrastructure of third parties or the cloud, could lead to corruption or misappropriation of our assets, proprietary information and sensitive or confidential data. As an early stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We may not have sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have adverse consequences on our business and lead to financial loss.

3944

We are subject to the laws and regulations, and interpretations and applications of such laws and regulations, of national, regional, state, and local governments and non-U.S. jurisdictions. In particular, we are required to comply with certain SEC and other legal and regulatory requirements, and our consummation of an Initial Business Combination may be contingent upon our ability to comply with certain laws, regulations, interpretations and applications and any post-business combination company may be subject to additional laws, regulations, interpretations and applications. Compliance with, and monitoring of, the foregoing may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time, and those changes could have a material adverse effect on our business, including our ability to negotiate and complete an Initial Business Combination. A failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an Initial Business Combination. The SEC has, in the past year, adopted certain rules and may, in the future adopt other such rules, which may have a material effect on our activities and on our ability to consummate an Initial Business Combination, including the SPAC Rules described below.

The SEC has recently issued rules relating to certain activities of SPACs. Certain of the procedures that we, a potential business combination target or others may determine to undertake in connection with such proposals may increase our costs and the time needed to complete our Initial Business Combination and may constrain the circumstances under which we could complete an Initial Business Combination. The need for compliance with the SPAC Rules may cause us to liquidate the funds in the Trust Account or liquidate the Company at an earlier time than we might otherwise choose.

The SPAC Rules require, among other items, (i) additional disclosures relating to SPAC business combination transactions; (ii) additional disclosures relating to dilution and to conflicts of interest involving sponsors and their affiliates in both SPAC initial public offerings and SPAC Initial Business Combination; (iii) the use of projections by SPACs in SEC filings in connection with proposed business combination transactions; and (iv) both the SPAC and the target company’s status as co-registrants on de-SPAC transaction registration statements.

In addition, the SEC’s adopting release provided guidance describing circumstances in which a SPAC could become subject to regulation under the Investment Company Act, including its duration, asset composition, business purpose, and the activities of the SPAC and its management team in furtherance of such goals.

Compliance with the SPAC Rules and related guidance may increase the costs and the time needed to negotiate and complete an Initial Business Combination, may constrain the circumstances under which we could complete an Initial Business Combination.

Risks Associated with Acquiring and Operating a Business in Foreign Countries

If we pursue a prospective partner company with operations or opportunities outside of the United States for our Initial Business Combination, we may face additional burdens in connection with investigating, agreeing to and completing such Initial Business Combination, and if we effect such Initial Business Combination, we would be subject to a variety of additional risks that may negatively impact our operations.

If we pursue a prospective partner a company with operations or opportunities outside of the United States for our Initial Business Combination, we would be subject to risks associated with cross-border business combinations, including in connection with investigating, agreeing to and completing our Initial Business Combination, conducting due diligence in a foreign jurisdiction, having such transaction approved by any local governments, regulators or agencies and changes in the purchase price based on fluctuations in foreign exchange rates.

If we effect our Initial Business Combination with such a company, we would be subject to any special considerations or risks associated with companies operating in an international setting, including any of the following:

●

costs and difficulties inherent in managing cross-border business operations;

●

rules and regulations regarding currency redemption;

●

complex corporate withholding taxes on individuals;

●

laws governing the manner in which future business combinations may be effected;

●

exchange listing and/or delisting requirements;

●

tariffs and trade barriers;

●

regulations related to customs and import/export matters;

●

local or regional economic policies and market conditions;

●

unexpected changes in regulatory requirements;

●

longer payment cycles;

●

tax issues, such as tax law changes and variations in tax laws as compared to the United States;

●

currency fluctuations and exchange controls;

●

rates of inflation;

●

challenges in collecting accounts receivable;

●

cultural and language differences;

●

employment regulations;

●

underdeveloped or unpredictable legal or regulatory systems;

●

corruption;

●

protection of intellectual property;

●

social unrest, crime, strikes, riots and civil disturbances;

●

regime changes and political upheaval;

●

terrorist attacks, natural disasters and wars; and

●

deterioration of political relations with the United States.

We may not be able to adequately address these additional risks. If we were unable to do so, we may be unable to complete such Initial Business Combination, or, if we complete such combination, our operations might suffer, either of which may adversely impact our business, financial condition and results of operations.

If our management following our Initial Business Combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws, which could lead to various regulatory issues.

Following our Initial Business Combination, our management may resign from their positions as officers or directors of the company and the management of the prospective partner business at the time of the business combination will remain in place. Management of the prospective partner business may not be familiar with United States securities laws. If new management is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws. This could be expensive and time-consuming and could lead to various regulatory issues which may adversely affect our operations.

After our Initial Business Combination, substantially all of our assets may be located in a foreign country and substantially all of our revenue may be derived from our operations in any such country. Accordingly, our results of operations and prospects will be subject, to a significant extent, to the economic, political and social conditions and government policies, developments and conditions in the country in which we operate.

The economic, political and social conditions, as well as government policies, of the country in which our operations are located could affect our business. Economic growth could be uneven, both geographically and among various sectors of the economy and such growth may not be sustained in the future. If in the future such country’s economy experiences a downturn or grows at a slower rate than expected, there may be less demand for spending in certain industries. A decrease in demand for spending in certain industries could materially and adversely affect our ability to find an attractive prospective partner business with which to consummate our Initial Business Combination and if we effect our Initial Business Combination, the ability of that prospective partner business to become profitable.

Exchange rate fluctuations and currency policies may cause a prospective partner business’ ability to succeed in the international markets to be diminished.

In the event we acquire a non-U.S. prospective partner, all revenues and income would likely be received in a foreign currency, and the dollar equivalent of our net assets and distributions, if any, could be adversely affected by reductions in the value of the local currency. The value of the currencies in our prospective partner regions fluctuate and are affected by, among other things, changes in political and economic conditions. Any change in the relative value of such currency against our reporting currency may affect the attractiveness of any prospective partner business or, following consummation of our Initial Business Combination, our financial condition and results of operations. Additionally, if a currency appreciates in value against the dollar prior to the consummation of our Initial Business Combination, the cost of a prospective partner business as measured in dollars will increase, which may make it less likely that we are able to consummate such transaction.

We may reincorporate in another jurisdiction in connection with our Initial Business Combination, and the laws of such jurisdiction may govern some or all of our future material agreements and we may not be able to enforce our legal rights.

In connection with our Initial Business Combination, we may relocate the home jurisdiction of our business from the Cayman Islands to another jurisdiction. If we determine to do this, the laws of such jurisdiction may govern some or all of our future material agreements. The system of laws and the enforcement of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities or capital.

We are subject to changing law and regulations regarding regulatory matters, corporate governance and public disclosure that have increased both our costs and the risk of non-compliance.

We are subject to rules and regulations by various governing bodies, including, for example, the SEC, which are charged with the protection of investors and the oversight of companies whose securities are publicly traded, and to new and evolving regulatory measures under applicable law. Our efforts to comply with new and changing laws and regulations have resulted in and are likely to continue to result in, increased general and administrative expenses and a diversion of management time and attention from seeking a business combination prospective partner.

Moreover, because these laws, regulations and standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, we may be subject to penalty and our business may be harmed.

Item 1B. Unresolved Staff Comments

None.

Item 1C. Cybersecurity

We are a blank check company with no business operations. Since our initial public offering (“IPO”), our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. We do not engage any assessors, consultants, auditors, or other third parties in connection with any processes for accessing, identifying, and managing material risks from cybersecurity threats. Our board of directors (the “Board”) is generally responsible for the oversight of risks from cybersecurity threats, if there are any. If management determined that there was a cybersecurity incident, management would bring the incident to the Board. Management has no formal committee relating to cybersecurity, nor does any personnel have any specific experience relating to cybersecurity.

We have not encountered any cybersecurity incidents since our IPO.

Item 2. Properties

We currently maintain our executive offices at 2021 Fillmore St. #2089, San Francisco, California 94115. We consider our current office space adequate for our current operations.

Item 3. Legal Proceedings

As of December 31, ~~2024~~2025, to the knowledge of ~~our~~ our management, there was no material litigation, arbitration or governmental proceeding pending against us or any members of our management team in their capacity as such, and we and the members of our management team have not been subject to any such proceeding.

On November 6, 2024, Rigrodsky Law P.A. sent a demand letter to the Company, purportedly on behalf of a stockholder of the Company, alleging deficiencies in the draft registration statement on Form F-4 filed by Plum III Merger Corp., with the U.S. Securities and Exchange Commission on October 29, 2024. The Company believes that the claims made in the demand letter are without merit and no supplemental disclosures are required under applicable law.

Item 4. Mine Safety Disclosures

Not applicable.

4348

PART II

Market Information

Our units, Class A ordinary shares and warrants are listed on the Pink Current tier of the OTC Markets under the symbols “PLMUF,” “PLMJF” and “PLMWF,” respectively. Any over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

Holders

As of March 24, ~~2025~~2026, there were 18 holders of record of our units, 12 ~~holder~~holders of record of our Class A ordinary shares, 2 holders of record of our Class B ordinary shares ~~and~~ and 2 holders of record of our warrants. The number of holders of record does not include a substantially greater number of “street name” holders or beneficial holders whose units, Class A ordinary shares and warrants are held of record by banks, brokers and other financial institutions.

Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings

Unregistered Sales

None.

Use of Proceeds

On July 30, 2021, we consummated our IPO of 25,000,000 units. On August 5, 2021, we issued an additional 3,250,000 units in connection with the underwriters’ partial exercise of their over-allotment option. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class ordinary share for $11.50 per share, subject to adjustment. The units were sold at a price of $10.00 per unit, generating gross proceeds to us of $282,500,000. Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and William Blair & Company, L.L.C. served as the underwriters of the IPO. The securities sold in the IPO were registered under the Securities Act on a registration statement on Form S-1 (File No. 333-253221). The SEC declared the registration statement effective on July 27, 2021.

We granted the underwriter a 45-day option to purchase up to an additional 3,750,000 Units at the IPO price to cover over-allotments, if any. On August 3, 2021, the underwriters partially exercised the over-allotment option, and the closing of the issuance and sale of the additional 3,250,000 Over-Allotment Units occurred on August 5, 2021. The issuance by the Company of the Over-Allotment Units at a price of $10.00 per unit resulted in total gross proceeds of approximately $32.5 million.

Simultaneously with the closing of the IPO, we consummated the Private Placement of 800,000 Private Placement Units at a price of $10.00 per Private Placement Unit with the Original Sponsor and anchor investors, generating gross proceeds of $8.0 million (see Note 4 to our financial statements included in this Report). Simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the private placement with the Original Sponsor of 65,000 units, generating total proceeds of $650,000. Of the $291,150,000 in proceeds we received from our initial public offering and the sale of the Private Placement Units, a total of $272,500,000, including $9,887,500 payable to the underwriter for deferred underwriting commissions, was placed in the Trust Account. In connection with the July Extraordinary General Meeting and the Extension Proposal, the Founder Share Amendment Proposal and the Redemption Limitation Proposal (each as defined below), the holders of 13,532,591 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of $140,838,808. After the redemptions, $153,169,659 remained in our Trust Account. As a result of the Extension Proposal being approved by our shareholders, the Sponsor, or its designee is required to make monthly payments to us equal to the lesser of (a) an aggregate of $225,000 or (b) $0.03 per public share that remains outstanding and is not redeemed in connection with the Extension for each of the twelve (12) subsequent calendar months commencing on July 30, 2023 to the earlier of the Termination Date as extended by the Extension Proposal and the consummation of an Initial Business Combination, which amount will be deposited into the Trust Account. On August 2, 2023, September 7, 2023, October 10, 2023, November 10, 2023, January 10, 2024, and January 25, 2024, $225,000 was deposited into the Company’s Trust Account. As of December 31, 2024, there was a $225,000 deposit into the Trust Account due from related parties representing the extension contribution for January 2024 pursuant to the Purchase Agreement. On January 29, 2024, the Board approved an amended extension proposal, extending the time the Company must complete an Initial Business Combination to January 30, 2025, without the need for any additional extension contributions.49

Simultaneously with the closing of the IPO, we consummated the Private Placement of 800,000 Private Placement Units at a price of $10.00 per Private Placement Unit with the Original Sponsor and anchor investors, generating gross proceeds of $8.0 million (see Note 4 to our financial statements included in this Report). Simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the private placement with the Original Sponsor of 65,000 units, generating total proceeds of $650,000. Of the $291,150,000 in proceeds we received from our initial public offering and the sale of the Private Placement Units, a total of $272,500,000, including $9,887,500 payable to the underwriter for deferred underwriting commissions, was placed in the Trust Account. In connection with the ~~Extension~~July ~~Proposal~~2023 onExtraordinary General Meeting, ~~January~~the 29holders of 13,532,591 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of $140,838,808. After the redemptions, $153,169,659 remained in our Trust Account. In connection with the January 2024 Extraordinary General Meeting, the holders of 12,433,210 Class A ordinary shares, properly ~~elected~~exercised their right to redeem their shares for cash at a redemption price of approximately $10.78 per share, for an aggregate redemption amount of $134,059,215. After the redemptions, $24,629,032 remained in our Trust Account. In connection with the January 2025 Extraordinary General Meeting, the holders of 2,132,366 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.24 per share, for an aggregate redemption amount of $23,975,464. After the redemptions, $1,707,149 remained in our Trust Account. ~~The~~In ~~shareholders~~connection ~~approved~~with the ~~Extension~~July 2025 Extraordinary General Meeting, the holders of 109,347 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.45 per share, for an aggregate redemption amount of $1,252,434. After the redemptions, $486,624 remained in our Trust Account. As a result of the Extension Proposal ~~providing~~being approved by our shareholders at the January 2024 Extraordinary General Meeting, the Sponsor, or its designee is no longer ~~until~~required to make monthly payments to us equal to the lesser of (a) an aggregate of $225,000 or (b) $0.03 per public share that remains outstanding. On August 2, 2023, September 7, 2023, October 10, 2023, November 10, 2023, January 3010, 2024, and January 25, 2024, $225,000, or $1,350,000 in the aggregate, was deposited into the Company’s Trust Account. As approved at the July 2025 Extraordinary General Meeting, the date by which the Company has to ~~complete~~consummate ana ~~Initial~~business ~~Business~~combination ~~Combination~~was extended to July 30, 2026.

44In connection with the December 2025 Extraordinary General Meeting, the holders of 24,136 shares elected to redeem at approximately $11.61 per share, for an aggregate redemption amount of $280,219. The redemption is contingent upon the consummation of the Business Combination and will occur as promptly as practicable following the closing thereof; if the Business Combination is not consummated, the redeemed shares will be returned to the respective holders.

In connection with the Extension Proposal on January 16, 2025, the holders of 2,132,366 shares elected to redeem at approximately $11.24 per share, for an aggregate redemption amount of $23,975,464. After redemptions, $1,707,149 remained in the Trust Account. The shareholders approved the Extension Proposal providing until July 30, 2025 to complete an Initial Business Combination.

Item 6. [Reserved]

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with our audited ~~consolidated~~ financial statements and the notes thereto which are included in “Item 8. ~~Consolidated~~ Financial Statements and Supplementary Data” of this Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements reflecting our current expectations, estimates and assumptions concerning events and financial trends that may affect our future operating results or financial position. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under “~~Special~~Cautionary Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Report.

Overview

We are a blank check company incorporated on February 5, 2021 as a Cayman Island exempted company and formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report as our “Initial Business Combination”. We intend to effectuate our Initial Business Combination using cash from the proceeds of the initial public offering (the “Initial Public Offering”), the private placement of the Private Placement Units (as defined below), the proceeds of the sale of our shares in connection with our Initial Business Combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the Initial Public Offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, loans from the Sponsor or a combination of the foregoing.

On July 30, 2021, we consummated our IPO of 25,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250.0 million, and incurring offering costs of approximately $13.75 million, of which $8.75 million was for deferred underwriting commissions. We granted the underwriter a 45-day option to purchase up to an additional 3,750,000 Units at the IPO price to cover over-allotments, if any. On August 3, 2021, the underwriters partially exercised the over-allotment option, and the closing of the issuance and sale of the additional 3,250,000 Over-Allotment Units occurred on August 5, 2021. The issuance by the Company of the Over-Allotment Units at a price of $10.00 per unit resulted in total gross proceeds of approximately $32.5 million. On December 27, 2023, the underwriters agreed to waive their rights to their portion of the fee payable by the Company for deferred underwriting commissions, with respect to any potential business combination of the Company.

Simultaneously with the closing of the IPO, we consummated the Private Placement of 800,000 units, at a price of $10.00 per Private Placement Unit with Alpha Merger Technology Sponsor LLC (the “Original Sponsor”), generating gross proceeds of $8.0 million. Simultaneously with the issuance and sale of the Over-Allotment Units, the Company consummated the Private Placement with the Original Sponsor of 65,000 Additional Private Placement Units, generating total proceeds of $650,000.

Upon the closing of the IPO, the Private Placement, the sale of the Over-Allotment Units, and the sale of the Over-Allotment Private Placement Units, approximately $282.5 million of the net proceeds were placed in a Trust Account, located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invests only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. In addition, a certain anchor investor advanced an aggregate amount of approximately $500,681 to the Company to cover the purchase of Private Placement Units. In April 2021, the Company repaid $681 to the anchor investor. Upon the closing of the IPO, the remaining advance of $500,000 was applied to the purchase of the Private Placement Units which the Company has since repaid.

We must complete one or more Initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the agreement to enter into the Initial Business Combination. However, we will only complete an Initial Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the prospective partner company or otherwise acquires a controlling interest in the prospective party company sufficient for it not to be required to register as an investment company under the Investment Company Act.

If we are unable to complete an Initial Business Combination within the Second Combination Period, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account ~~and~~ and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by by the number of the then-outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as ~~shareholders~~ shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to consummate an Initial Business Combination within the Second Combination Period.

As of December 31, ~~2024~~2025 and ~~2023~~2024, we held cash of $2749,~~418~~870 and $027,418, respectively, current liabilities of $36,~~151~~025,~~832~~804 and $~~805~~3,151,832, respectively. Further, we expect to continue to incur significant costs in the pursuit of our Initial Business Combination. We cannot assure you that our plans to complete an Initial Business Combination will be successful.

OnExtraordinary ~~December~~General 27, 2023, the Company, the Original Sponsor, and the Sponsor entered into a purchase agreement (the “Purchase Agreement”), pursuant to which, at a closing on December 28, 2023, the Sponsor (i) purchased 3,902,648 founder units of the Company from the Original Sponsor, each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B ordinary share, which founder units are subject to forfeiture in certain circumstances, and (ii) became entitled to 70% of the 2,030,860 founder units that Original Sponsor placed in escrow at the Closing to the extent such founder units are allocated to investors who hold and do not redeem their Class A ordinary shares of the Company at the time of the Company’s Initial Business Combination, for an aggregate purchase price of $1. Original Sponsor agreed to pay, or cause its affiliates to pay, certain liabilities of the Company accrued and outstanding as of the Closing. Following the closing, Original Sponsor has no further obligations with respect to the Company, and the Sponsor has assumed all obligations relating to the Company. Subsequently, on January 26, 2024, the Company, the Original Sponsor, and the Sponsor entered into an amended purchase agreement (the “Amended Purchase Agreement”), to correct the number of shares that the Original Sponsor shall retain to be 665,000 Class A private placement units and 1,128,992 Class B founder units.Meetings

~~Previous~~On ~~Letter~~July 27, 2023, the Company held an Extraordinary General Meeting (the “July 2023 Extraordinary General Meeting”) whereby the shareholders approved an amendment to the amended and restated memorandum and articles of ~~Intent~~association (the “Amended and Restated Memorandum and Articles of Association”). The Amended and Restated Memorandum and Articles of Association extended the date by which the Company has to consummate a business combination from July 30, 2023 to July 30, 2024, or such earlier date as shall be determined by the Company’s board of directors. In connection with the July 2023 Extraordinary General Meeting, the holders of 13,532,591 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of approximately $140,838,808. After those redemptions, approximately $153,169,659 remained in the Company’s trust account.

In our Form 10-Q for the period ended March 31, 2023, we recorded a balance of $374,975 in the receivable related to potential business combination line item on the balance sheet. That balance represented a penalty if the target entity terminated the agreement. The target entity reimbursed the Company for transaction expenses and merger-related activities incurred through that date related to a prospective merger which was not completed. We received payment from the target entity in April 2023.51

On ~~July~~January 2629, ~~2023~~2024, the Company ~~signed~~held aan ~~non-binding~~Extraordinary ~~letter-of-intent~~General Meeting (the “~~LOI~~January 2024 Extraordinary General Meeting”) ~~for~~whereby ashareholders ~~business~~of ~~combination~~the ~~with~~Company ~~Glowforge~~approved ~~Inc.~~an amendment to the Company’s Amended and Restated Memorandum and Articles of Association in order to (i) extend the date by which the Company must consummate its Initial Business Combination, cease its operations and redeem all of its Class A ordinary shares (the “~~Glowforge~~Extension Proposal”) to January 30, ~~creator~~2025, or such earlier date as shall be determined by the Company’s board of ~~award-winning~~directors and (ii) changed 3Dthe ~~laser~~name ~~printers~~of the Company from Alpha Partners Technology Merger Corp. to Plum Acquisition Corp. III.

~~Under~~In connection with the ~~terms~~Extension ofProposal, the Founder ~~LOI~~Share Amendment Proposal and the Redemption Limitation Proposal, the ~~Company~~holders ~~would~~of 12,433,210 Class A ordinary shares, properly exercised ~~become~~their right to redeem their shares for cash at a ~~combined~~redemption ~~entity~~price ~~with~~of ~~Glowforge~~approximately $10.78 per share, ~~with~~for ~~Glowforge~~an aggregate redemption amount of $134,059,215. The payments for these redemptions took place on February 27, 2024, after which $24,629,032 remained in the Company’s Trust ~~existing~~Account. ~~equity~~As ~~holders~~a ~~rolling~~result ~~100%~~ of ~~their~~the ~~equity~~Extension ~~into~~Proposal being approved by the ~~combined~~Company’s shareholders, the Original Sponsor, or its ~~public~~designee ~~company.~~were Inno longer required to make monthly payments to the ~~fourth~~Company ~~quarter~~equal to the lesser of (a) an aggregate of $225,000 or (b) $0.03 per public share that remains outstanding. On each of August 2, 2023, September 7, 2023, October 10, 2023, November 10, 2023, January 10, 2024, and January 25, 2024 $225,000, or $1,350,000 in the ~~LOI~~aggregate, was ~~terminated~~deposited into the Company’s Trust Account.

~~Extraordinary~~To ~~General~~cover ~~Meeting~~these monthly payments and other associated operating expenses, on January 3, 2024, the Company, the Sponsor and Palmeira Investment Limited (the “Investor”) entered into a subscription agreement (the “Subscription Agreement”), pursuant to which the Sponsor may raise up to $1,500,000 from the Investor to fund extension payments and working capital for the Company, including $250,000 upon the execution of the Subscription Agreement, $250,000 on February 1, 2024, and as otherwise called by the Sponsor in its discretion. At the closing of the Company’s Initial Business Combination, the Sponsor will forfeit 0.85 Class B shares, and the Company will issue an equal number of shares of its ordinary share to the Investor, for each dollar funded by the Investor pursuant to the Subscription Agreement. If the Company’s Initial Business Combination does not occur, the Sponsor will not forfeit any shares.

On ~~July~~January 2716, ~~2023~~2025, ~~the~~as ~~Company~~approved ~~held~~by anits ~~Extraordinary~~shareholders ~~General~~at ~~Meeting (~~the ~~“July~~extraordinary ~~Extraordinary~~general ~~General~~meeting ~~Meeting”)~~of ~~whereby~~shareholders, the ~~shareholders~~Company ~~approved~~filed an amendment to ~~the~~its ~~amended~~ Second Amended and ~~restated~~Restated ~~memorandum~~Memorandum and Articles ~~articles~~ of ~~association~~Association (as amended, the “Third Amended and Restated Memorandum and Articles of Association”)~~. The~~ ~~Amended~~on ~~and~~January ~~Restated~~17, 2025, ~~Memorandum~~which ~~and~~(i) ~~Articles of Association~~ extended the date by which the Company has to consummate a business combination ~~from~~ ~~July 30, 2023~~ to July 30, ~~2024~~2025, or such earlier date as shall be determined by the Company’s board of directors and (ii) amended Article 49.4 Into ~~connection~~remove language stating, in relevant ~~with~~part, that the ~~July~~Company ~~Extraordinary~~shall ~~General~~not ~~Meeting~~consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, such business combination (the “NTA Proposal”). The holders of 132,~~532~~132,~~591~~366 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of ~~approximately~~ $1011.4124 per share, for an aggregate redemption amount of ~~approximately~~ $~~140~~23,~~838~~975,~~808~~464. After ~~those~~the redemptions, ~~approximately~~ $~~153~~1,~~169~~707,~~659~~149 remained in the Company’s ~~trust~~Trust ~~account~~Account.

On ~~January~~July 2915, ~~2024~~2025, ~~the~~as ~~Company~~approved ~~held~~by anits ~~Extraordinary~~shareholders ~~General~~at ~~Meeting (~~the ~~“January~~extraordinary ~~Extraordinary~~general ~~General~~meeting ~~Meeting”)~~of ~~whereby~~ shareholders, of the Company ~~approved~~filed an amendment to ~~the~~ ~~Company’s~~its Third Amended and Restated Memorandum and Articles of Association ~~in order to~~ (i)as ~~extend~~amended, the ~~date~~“Fourth byAmended ~~which~~and ~~the~~Restated ~~Company must~~Memorandum ~~consummate~~and ~~its~~Articles ~~Initial~~of ~~Business~~Association”) ~~Combination~~on July 16, 2025, ~~cease~~which ~~its~~extended ~~operations~~the ~~and~~date ~~redeem~~by ~~all~~which ofthe ~~its~~Company ~~Class~~has Ato ~~ordinary~~consummate ~~shares~~a ~~(the~~business ~~“Extension Proposal”)~~combination to ~~January~~July 30, ~~2025~~2026, or such earlier date as shall be determined by the Company’s board of directors. ~~and~~The ~~(ii)~~holders of 109,347 Class A ordinary shares properly exercised their ~~changed~~right ~~the~~to ~~name~~redeem oftheir ~~the~~shares ~~Company~~for ~~from~~cash ~~Alpha~~at ~~Partners~~a ~~Technology~~redemption ~~Merger~~price ~~Corp~~of approximately $11.45 toper ~~Plum~~share, ~~Acquisition~~for ~~Corp.~~an ~~III~~aggregate redemption amount of $1,252,434.

InOn ~~connection~~December ~~with the Extension Proposal~~22, ~~the Founder Share Amendment Proposal and the Redemption Limitation Proposal~~2025, the ~~holders~~Company ~~of 12,433,210 Class A ordinary shares, properly~~shareholders ~~exercised~~approved ~~their~~(i) ~~right~~as ~~to redeem their shares for cash at~~ a ~~redemption~~special ~~price of approximately $10.78 per share~~resolution, ~~for~~the anproposed ~~aggregate~~Domestication; ~~redemption amount~~(ii) ofthe ~~$134,059,215.~~Business ~~The~~Combination ~~payments~~Agreement; ~~for~~(iii) ~~these~~four ~~redemptions~~separate ~~took~~resolutions regarding ~~place~~the ongovernance ~~February~~provisions ~~27,~~contained ~~2024, after which $24,629,032 remained~~ in the ~~Company’s Trust~~PubCo ~~Account.~~closing Asarticles; a(iv) ~~result of~~ the ~~Extension~~issuance ~~Proposal~~of ~~being~~PubCo ~~approved~~Common byShares ~~the~~in ~~Company’s~~connection ~~shareholders,~~ with the ~~Original~~Business ~~Sponsor~~Combination, orand ~~its designee is were no longer required to make monthly payments to~~ the ~~Company~~issuance ~~equal to the lesser~~ of ~~(a)~~ an aggregate of ~~$225,000~~up orto ~~(b)~~ $~~0.03 per public share that remains outstanding. On each of August 2~~100, ~~2023~~000,000 ~~September~~of 7,PubCo ~~2023,~~Common ~~October~~Shares ~~10,~~from ~~2023,~~time ~~November~~to ~~10,~~time ~~2023,~~to ~~January~~Yorkville; ~~10,~~and ~~2024,~~(v) ~~and~~the ~~January~~issuance ~~25,~~of ~~2024~~PubCo ~~$225,000,~~Common orShares ~~$1,350,000~~pursuant into the ~~aggregate,~~PubCo ~~was~~Omnibus ~~deposited~~Equity ~~into~~Incentive ~~the Company’s Trust Account~~Plan.

46In connection with the December 2025 Extraordinary General Meeting, the holders of 24,136 shares elected to redeem at approximately $11.61 per share, for an aggregate redemption amount of $280,219. The redemption is contingent upon the consummation of the Business Combination and will occur as promptly as practicable following the closing thereof; if the Business Combination is not consummated, the redeemed shares will be returned to the respective holders.

To cover these monthly payments and other associated operating expenses, on January 3, 2024, the Company, the Sponsor and Palmeira Investment Limited (the “Investor”) entered into a subscription agreement (the “Subscription Agreement”), pursuant to which the Sponsor may raise up to $1,500,000 from the Investor to fund extension payments and working capital for the Company, including $225,000 upon the execution of the Subscription Agreement, $225,000 on February 1, 2024, and as otherwise called by the Sponsor in its discretion. At the closing of the Company’s Initial Business Combination, the Sponsor will forfeit 0.85 Class B shares, and the Company will issue an equal number of shares of its ordinary share to the Investor, for each dollar funded by the Investor pursuant to the Subscription Agreement. If the Company’s Initial Business Combination does not occur, the Sponsor will not forfeit any shares.52

On January 16, 2025, as approved by its shareholders at the extraordinary general meeting of shareholders, the Company filed an amendment to its Second Amended and Restated Memorandum and Articles of Association (as amended, the “Third Amended and Restated Memorandum and Articles of Association”) on January 17, 2025, which (i) extended the date by which the Company has to consummate a business combination to July 30, 2025 (the “Combination Period”), or such earlier date as shall be determined by the Company’s board of directors (the “Extension Proposal”) and (ii) amended Article 49.4 to remove language stating, in relevant part, that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, such business combination (the “NTA Proposal”). The holders of 2,132,366 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of $11.24 per share, for an aggregate redemption amount of $23,975,464.

Purchase Agreement

On December 27, 2023, the Company, the Original Sponsor and the Sponsor entered into a purchase agreement (the “Purchase Agreement”), pursuant to which, at a closing on ~~December~~ December 28, 2023 (the “Closing”), the Sponsor (i) purchased 3,902,648 founder units of the Company from the Original Sponsor, ~~each~~ each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B share, which Founder ~~Units~~ Units are subject to forfeiture in certain circumstances, and (ii) became entitled to 70% of 2,030,860 Founder Units that the Original ~~Sponsor~~ Sponsor placed in escrow at the Closing to the extent such Founder Units are allocated to investors who hold and do not redeem their Class A ordinary shares of the Company at the time of the Company’s Initial Business Combination, for an aggregate purchase price of $1. On January 26, 2024, the Company, the Original Sponsor, and the Sponsor entered into anAmendment ~~amended~~No. ~~purchase~~1 ~~agreement~~to (the ~~“Amended~~ Purchase Agreement~~”),~~ to correct the number of shares that the Original Sponsor shall retain to be 665,000 Class A private placement units and 1,128,992 Class B founder units.

The Original Sponsor and the Sponsor each agreed to pay $112,500 in extension contributions in each of December 2023 and January 2024. In addition, pursuant to the terms of the Purchase Agreement, the Original Sponsor agreed to pay, or cause its affiliates to pay, certain liabilities of the Company accrued and outstanding as of the Closing and will deliver Founder Units to the Sponsor to the extent such liabilities are unsatisfied or the Original Sponsor’s obligation to make extension contributions is not satisfied.

Following the Closing, the Original Sponsor has no further obligations with respect to the Company and the Sponsor assumed all obligations relating to the Company, including, (i) to cause the Company to file a proxy statement providing public investors of the Company with the option to accept a revised trust extension arrangement or redeem their Class A ordinary shares and receive their pro rata share of the Company’s Trust Account, (ii) to cause the Company to satisfy all of its public reporting requirements as well as taking all action to cause the Company to remain listed on Nasdaq, (iii) the payment of all extension contributions after January 2024 and working capital of the Company, at the discretion of the Sponsor, and (iv) all other obligations of the Original Sponsor related to the Company.

~~Business~~On ~~Combination~~August 22, 2024, the Company, the Original Sponsor, and the Sponsor entered into a second amendment to Purchase Agreement (“Amendment No. 2 to the Purchase Agreement”) which revises the founder-unit forfeiture and transfer mechanics by requiring the acquirer to absorb all forfeitures or investor incentive transfers up to 2,030,860 founder units, allocating excess forfeitures 78% to the acquirer and 22% to the sponsor, while also establishing that 2,030,860 sponsor units will be held in escrow for potential transfer to sponsor anchors, with any remaining escrowed units allocated 70% to the acquirer and 30% to the sponsor at closing.

On September 5, 2025, the Company, the Original Sponsor, and the Sponsor entered into Amendment No. 3 to the Purchase Agreement that provides that any Sponsor Incentive Units (as defined in the Sponsor Support Agreement) that have been retained by the Sponsor after the Closing, up to half of such Sponsor Incentive Units may be transferred prior to the Closing to a third party, with any Sponsor Incentive Units remaining after such transfer subject to allocation between the Sponsor and the Original Sponsor as provided for in the Purchase Agreement.

Business Combination Agreement and Ancillary Transaction Documents

On August 22, 2024, the Company entered into a business combination agreement (the “Original Business Combination Agreement”) with Plum III Merger Corp., a corporation formed under the Laws of the Province of British Columbia (“Pubco”), and Tactical Resources Corp., a corporation formed under the Laws of the Province of British Columbia (“Tactical”) and Plum III Amalco Corp., corporation formed under the Laws of the Province of British Columbia (“Amalco”), pursuant to which the Company will amalgamate pursuant to a Plan of Arrangement under the Business Corporations Act of British Columbia (“BCBCA”) to form one corporate entity, except that the legal existence of Pubco will not cease and Pubco will survive the amalgamation, following its redomicile into the Province of British Columbia, Canada. The business combination agreement and related executed agreements included supporting agreements are more fully described and filed with the Company’s Current Report on Form 8-K filed with the SEC on August 22, 2024.

On December 10, 2024, the Company, and Tactical, entered into an amendment (the “Amendment No. 1”) to the Original Business Combination Agreement, by and between the Company andTactical. The Amendment No. 1 provides that, among other things, upon a delisting from The Nasdaq Stock Market, the Company will use commercially reasonable efforts to list its securities on the OTC Markets Group. As a condition to closing the Business Combination, the Company must relist its securities on The Nasdaq Stock Market. 53

47On December 10, 2024, the Company and Tactical, entered into an amendment (the “Amendment No. 1”) to the Original Business Combination Agreement, by and between the Company and Tactical. The Amendment No. 1 provides that, among other things, upon a delisting from The Nasdaq Stock Market, the Company will use commercially reasonable efforts to list its securities on the OTC Markets Group. As a condition to closing the Business Combination, the Company must relist its securities on The Nasdaq Stock Market.

On January 28, 2025, the Company and Tactical entered into Amendment No. 2 (the “Amendment No. 2” ~~and with Amendment No. 1 and the Original Business Combination Agreement, the “Business Combination Agreement”~~) to the Original Business Combination Agreement, by and between the Company ~~andTactical~~ and Tactical that provides that certain recently issued convertible debentures of Tactical (and future issuances of convertible debentures by Tactical, if any, to the extent permitted under the Business Combination Agreement) shall be subject to the same terms under the Business ~~Combination~~ Combination Agreement, and shall be subject to the same treatment upon closing of the Business Combination, as certain existing convertible ~~debentures~~ debentures issued by Tactical and already subject to the terms of the Business Combination Agreement.

On July 30, 2025, the Company and Tactical entered into Amendment No. 3 (the “Amendment No. 3”) to the Original Business Combination Agreement. Amendment No. 3 provides for (a) an acknowledgement that Tactical may effect a reverse stock split prior to the closing at a ratio not to exceed 25 to 1; (b) an extension of the Agreement End Date (as defined in the Business Combination Agreement) to July 30, 2026; and (c) a lock-up of certain PubCo shares to be issued in the Business Combination. Specifically, Amendment No. 3 provides that 80% to 85% of the PubCo shares to be issued to stockholders of Tactical (the “Arrangement Consideration Shares”) shall be subject restrictions on transfer for a period of six months following the closing of the Business Combination. In connection with Amendment No. 3, certain employees and affiliates of Tactical have entered into a Key Company Securityholder Lock-up Agreement whereby each of them has agreed that 100% of the Arrangement Consideration Shares issued to them shall be subject restrictions on transfer for a period of six months following the closing.

On September 5, 2025, the Company, Tactical, Pubco, the Sponsor, and the Original Sponsor and certain shareholders of the Company entered into the Sponsor Support Agreement Amendment. The Sponsor Support Agreement Amendment provides that, immediately prior to the Closing of the Business Combination, to the extent that any Sponsor Incentive Units (as defined in the Sponsor Support Agreement) have not been transferred by the Sponsor to PIPE Investors, Company shareholders or other third parties as provided for in the Sponsor Support Agreement, such remaining Sponsor Incentive Units will be retained by the Sponsor subject to vesting based on the achievement of certain trading prices of the Pubco Common Shares after the Closing, as described in more detail in the Sponsor Support Agreement Amendment. In the event that such trading prices have not been achieved on or before the tenth anniversary of the Closing, such Sponsor Incentive Units shall be surrendered to Pubco for cancellation for no consideration and shall cease to represent any interest in Pubco, effective as of such date.

On December 22, 2025, the Company shareholders approved (i) as a special resolution, the proposed Domestication; (ii) the Business Combination Agreement; (iii) four separate resolutions regarding the governance provisions contained in the PubCo closing articles; (iv) the issuance of PubCo Common Shares in connection with the Business Combination, and the issuance of an aggregate of up to $100,000,000 of PubCo Common Shares from time to time to Yorkville; and (v) the issuance of PubCo Common Shares pursuant to the PubCo Omnibus Equity Incentive Plan. The holders of 24,136 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.61 per share, for an aggregate redemption amount of $280,219. The redemption is contingent upon the consummation of the Business Combination and will occur as promptly as practicable following the closing thereof; if the Business Combination is not consummated, the redeemed shares will be returned to the respective holders.

OTC Listing

Promissory Note

OnIn ~~January~~July 272024, ~~2025,~~ the Company entered into a promissory note with ~~the~~Mercury ~~Sponsor~~Capital (the “~~Second~~ Sponsor Promissory Note”), pursuant to which the Sponsor ~~loaned~~may loan up to $~~100~~1,500,000 to the Company. The ~~Second~~funds that will be loaned to the Company under the Sponsor Promissory Note ~~bears~~consist noof ~~interest.~~a ~~The~~portion ~~principal~~of ~~amount~~the isup to be$1,500,000 that was ~~repaid~~loan atto the ~~earlier~~Sponsor ofby ~~(i)~~the Investor pursuant to the ~~consummation~~ ofSubscription Agreement. If the Company completes a Business Combination, ~~(ii)~~the Company would repay the ~~date~~Sponsor ofPromissory ~~liquidation,~~Note. orIn ~~(iii)~~the 90event ~~calendar~~that ~~days~~a ~~after~~Business ~~entering~~Combination ~~into~~does not close, the ~~promissory~~Company may use a portion of proceeds ~~note.~~held Ifoutside the ~~Company~~Trust ~~does~~Account ~~not~~to ~~consummate~~repay the ~~Business~~Sponsor ~~Combination~~Promissory orNote, ~~there~~but isno aproceeds ~~liquidation,~~held in the ~~Second~~Trust Account would be used to repay the Sponsor Promissory Note. ~~will not~~Up to $1,500,000 of such loans may be ~~repaid~~convertible ~~and~~into warrants of the ~~principal~~Company ~~amount~~at ~~will~~a beprice ~~forgiven,~~of ~~except~~$1.50 per warrant toat the ~~extent~~option ~~there~~of ~~are~~the ~~funds~~Sponsor. ~~available~~The warrants would be identical to the Private Placement Warrants. The Company ~~outside~~accounts offor the ~~Trust~~Sponsor ~~Account~~Promissory Note within the scope of ASC 815 and has elected to ~~make~~bifurcate ~~repayment~~the embedded derivative within the convertible promissory note. The fair value of the embedded conversion feature upon the issuance of the Sponsor Promissory Note is de minimis.

On April 24, 2025, the Company and Sponsor entered an amendment to increase the maximum amount of the Sponsor Promissory Note to $2,200,000 and up to $2,200,000 may be converted into Private Placement Warrants at a price of $1.50 per warrant at the option of the Sponsor.

On March 18, 2025, April 28, 2025, June 4, 2025, September 29, 2025 and December 15, 2025, the Sponsor loaned $250,000, $100,000, $270,000, 100,000 and $100,000, respectively, to the Company pursuant to the Sponsor Promissory Note. The outstanding balance under the Sponsor Promissory Note as of December 31, 2025 and 2024 was $2,024,867 and $1,204,867, respectively. This balance includes deposits made into the Trust Account by the Sponsor of $112,500 each on January 9, 2024 and January 24, 2024, payments made by the Sponsor on behalf of the Company totaling $243,867, and total draws of $1,556,000.

On January 23, 2025, the Company entered into a promissory note with the Sponsor (the “Second Sponsor Promissory Note”), pursuant to which the Sponsor loaned $100,000 to the Company. The Second Sponsor Promissory Note bears no interest. The principal amount is to be repaid at the earlier of (i) the consummation of the Business Combination, (ii) the date of liquidation, or (iii) 90 calendar days after entering into the promissory note. On May 6, 2025, the Second Sponsor Promissory Note was amended to extend the maturity date by an additional 180 calendar days, resulting in a new expiration date 270 calendar days from the original issuance. On March 30, 2026, the Second Sponsor Promissory Note was further amended to extend the maturity date to July 31, 2026. If the Company does not consummate the Business Combination or there is a liquidation, the Second Sponsor Promissory Note will not be repaid and the principal amount will be forgiven, except to the extent there are funds available to the Company outside of the Trust Account to make repayment.

The outstanding balance under the Sponsor Promissory Note and Second Sponsor Promissory Note as of December 31, 2025 was $2,024,867 and $100,000, respectively. The outstanding balance under the Sponsor Promissory Note and Second Sponsor Promissory Note as of December 31, 2024 was $1,204,867 and $0, respectively.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities for the years ended December 31, ~~2024~~2025 and ~~2023~~2024 were organizational activities, identifying a target company for a business combination, entering into a definitive business combination agreement, and taking steps to complete an Initial Business Combination. We do not expect to generate any operating revenues until after the completion of our Initial Business Combination. We will generate non-operating income in the form of interest and dividend income on cash and investments held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses. For a discussion of ~~2022~~2024, please refer to the Item 7A. Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2023~~2024, filed with the SEC on ~~July~~March 128, ~~2024~~2025.

For the year ended December 31, 2024, we recorded net loss of $2,561,229, which resulted from operating and formation costs of $3,023,383 and a loss on the changes in fair value of warrant liability of $1,447,101, partially offset by interest and dividend income on investments held in the Trust Account of $1,909,255.55

For the year ended December 31, ~~2023~~2025, we recorded net ~~income~~loss of $107,~~418~~199,~~629~~761, which resulted from ~~interest~~operating and ~~dividend~~formation ~~income~~costs ~~on investments held in the Trust Account~~ of $102,~~686~~876,~~002~~506, ~~deal~~ ~~termination~~loss ~~income of $374,975, a gain~~ on ~~a waiver of deferred underwriting commissions by underwriter allocated to Public Warrants of $336,175, a gain on~~ the changes in fair value of ~~convertible promissory note - related party of~~ $954,~~941~~415, ~~and interest income on the bank account of $654~~289, partially offset by ~~operating~~interest and ~~formation~~dividend ~~costs~~income ~~of $833,935, and a loss~~ on ~~the~~cash ~~changes~~held in ~~fair~~the ~~value~~Trust ofAccount ~~warrant liability~~ of $~~241~~92,~~183~~034.

Liquidity, Going Concern and Capital Resources

For the year ended December 31, ~~2024~~2025, net cash used in operating activities was $~~952~~893,~~449,~~328. ~~which~~This ~~resulted~~outflow ~~from~~was ~~interest~~primarily ~~and~~due ~~dividend~~to ~~income~~operating ~~on the investments held in the Trust Account of $1,909,255~~ and ~~net~~formation ~~loss of $2~~costs,~~561,229,~~ partially offset by favorable net changes in ~~working~~operating ~~capital~~assets ofand ~~$1,912,059 a change in fair value of warrant~~ liabilities of $1,~~447~~983,~~101, and stock-based compensation of $158,875~~178.

For the year ended December 31, ~~2023~~2024, net cash used in operating activities was $1929,~~558,003,~~169. ~~which~~This outflow was primarily due to ~~interest~~operating and ~~dividend~~formation ~~income on the investments held in the Trust Account of $10~~costs,~~686,002,~~ ~~a gain on waiver of deferred underwriting commissions by underwriter of $336,175, and a gain on the changes in fair value of the convertible promissory note - related party of $95,941,~~ partially offset by ~~net income of $10,418,629, a loss on the~~ changes in ~~fair~~ ~~value of the warrant liability of $241,183, and changes in~~ working capital of $1,~~099~~935,~~697~~339.

For the year ended December 31, ~~2024~~2025, net cash provided by investing activities was $~~133~~25,~~609~~223,~~215~~678, which was primarily due to cash withdrawn from the Trust Account to pay redeeming ~~shareholders~~ shareholders of $~~134~~25,~~059~~227,~~215~~898 and due from Tactical of $23,280, partially offset by ~~cash~~due ~~deposited~~from ~~into~~PubCo ~~the Trust Account~~ of $~~450~~27,~~000~~500.

48For the year ended December 31, 2024, net cash provided by investing activities was $133,585,935, which was primarily due to cash withdrawn from the Trust Account to pay redeeming shareholders of $134,059,215, partially offset by cash deposited into the Trust Account of $450,000 and due from Tactical of $23,280.

For the year ended December 31, ~~2023~~2025, net cash used ~~provided~~in byfinancing ~~investing~~ activities was $~~139~~24,~~938~~307,~~808~~898, which was primarily due to ~~cash~~payments ~~withdrawn~~of ~~from~~cash ~~the Trust Account~~ to ~~pay~~ redeeming shareholders of $~~140~~25,~~838~~227,~~808~~898, partially offset by ~~cash~~proceeds ~~deposited~~from ~~into~~Sponsor ~~the~~Promissory ~~Trust~~Notes ~~Account~~(as defined in Note 5) related party of $~~900~~920,000.

For the year ended December 31, 2024, net cash used in financing activities was $132,629,348, which was due to payments of cash to redeeming shareholders of $134,059,215, partially offset by proceeds for extension payments from the Old Sponsor of $225,000 and proceeds from Sponsor Promissory Notes related party of $1,204,867.

~~For~~As ~~the~~of ~~year ended~~ December 31, ~~2023,~~2025 ~~net~~and ~~cash used in financing activities was $139~~2024,~~107,674,~~ ~~which~~we ~~was~~had ~~due to payments of~~ cash ~~to redeeming shareholders~~ of $~~140~~49,~~838,808~~870 and ~~a repayment of advance from the Original Sponsor of~~ $627,~~000~~418, ~~partially offset by proceeds from promissory note - related party of $451~~respectively,~~134,~~ ~~proceeds from~~held outside the ~~convertible~~Trust ~~promissory~~Account. ~~note~~We -will ~~related~~use ~~party~~these offunds ~~$1,280,000~~to ~~and~~primarily ~~proceeds~~take ofsteps ~~advance~~to ~~from~~complete ~~the~~an ~~Original~~Initial Business ~~Sponsor of $6,000~~Combination.

As of December 31, 2024 and 2023, we had cash of $27,418 and $0 held outside the Trust Account. We will use these funds to primarily identify and evaluate prospective partner businesses, perform business due diligence on prospective partner businesses, travel to and from the offices, plants or similar locations of prospective partner businesses or their representatives or owners, review corporate documents and material agreements of prospective partner businesses, and structure, negotiate and complete a business combination, and take steps to complete an Initial Business Combination.

We intend to use substantially all of the remaining funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable and deferred underwriting commissions), to complete our Initial Business Combination. We may withdraw interest income (if any) to pay income taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the Trust Account. We expect the interest income earned on the amount in the Trust Account (if any) will be sufficient to pay our income taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our Initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the prospective partner, make other acquisitions and pursue our growth strategies.

In order to fund working capital deficiencies or finance transaction costs in connection with an intended Initial Business Combination, the Sponsor or an affiliate of the Sponsor or or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our Initial ~~Business~~ Business Combination, we may repay such loaned amounts. In the event that our Initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units of the post-business combination company at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Placement Units. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our Initial ~~Business~~ Business Combination, we do not expect to seek loans from parties other than the Sponsor, members of our management team or any of their ~~affiliates~~ affiliates as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account. ~~As of December 31, 2023, the Original Sponsor has forgiven the funds loaned in connection with the Working Capital Loan (as defined in Note 5 of the accompanying financial statements).~~

We have incurred and expect to continue to incur significant costs in pursuit of our Initial Business Combination. As such, we may have insufficient funds available to operate our business for the next 12 months from the date of these financial statements. If we do not complete a business combination, we may have insufficient funds available to operate our business beyond the next 12 months. Moreover, we may need to obtain additional financing either to complete our business combination or because we become obligated to redeem a significant number of Public Shares upon completion of our business combination, in which case we may issue additional securities or incur debt in connection with such business combination. In addition, we intend to target businesses larger than we could acquire with the net proceeds of our IPO and the sale of the private placement warrants and may as a result be required to seek additional financing to complete such proposed Initial Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our business combination. If we are unable to complete our Initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.56

AsWe ofhave ~~December~~incurred ~~31,~~and ~~2024,~~expect weto ~~had~~continue ~~$27,418~~to ~~in cash~~incur ~~held~~significant ~~outside~~costs ofin ~~the~~pursuit ~~Trust~~of ~~Account~~our ~~and~~Initial aBusiness ~~working~~Combination. ~~capital~~As ~~deficit of $3~~such,~~064,428,~~ ~~which~~we may ~~not~~have beinsufficient ~~sufficient~~funds ~~for~~available us to operate ~~for~~our ~~at least~~business for the next 12 months from the ~~issuance~~date of these financial statements. ~~The~~If ~~Sponsor~~we ordo annot ~~affiliate~~complete ofa ~~the~~business ~~Sponsor~~combination, orwe ~~certain~~may ofhave ~~the Company’s~~insufficient ~~officers~~funds ~~and~~available ~~directors may, but are not obligated~~ to, ~~loan~~operate usour ~~funds~~business asbeyond ~~may be required under~~ the ~~Working~~next ~~Capital~~12 ~~Loans~~months. ~~There~~Moreover, iswe nomay ~~assurance that~~need ~~our attempts~~ to ~~find~~obtain aadditional ~~partner~~financing ~~for~~either anto ~~Initial~~complete our ~~Business~~business ~~Combination~~combination ~~will be successful~~ or ~~successful~~because ~~within~~we ~~the~~become ~~Combination~~obligated ~~Period or~~to ~~that~~redeem ~~the~~a ~~Sponsor~~significant ornumber ~~an affiliate~~ of ~~the~~Public ~~Sponsor,~~Shares orupon ~~certain~~completion of ~~the~~our ~~Company’s~~business combination, ~~officers~~in ~~and~~which ~~directors~~case ~~will~~we ~~loan~~may ~~the~~issue ~~Company~~additional ~~funds as~~securities ~~may~~or beincur ~~required~~debt ~~under~~in ~~the~~connection ~~Working~~with ~~Capital~~such ~~Loans~~business ~~(as~~combination. ~~defined~~If inwe ~~Note~~are 5unable ofto ~~the~~complete ~~accompanying~~our ~~financial~~Initial ~~statements).~~Business InCombination ~~August~~because ~~2023,~~ we ~~entered~~ ~~into~~do anot ~~$1,500,000~~have ~~Working~~sufficient ~~Capital~~funds ~~Loan~~available ~~with~~to ~~APTM~~us, ~~Sponsor~~we ~~Sub~~will ~~LLC~~be forced to ~~help~~cease ~~cover~~operations ~~monthly~~and liquidate the Trust Account. ~~contributions~~In ~~and~~addition, ~~other working~~following ~~capital~~our ~~needs.~~business ~~There~~combination, isif nocash ~~guarantee~~on ~~that~~hand ~~these~~is ~~funds~~insufficient, we ~~will~~may beneed ~~sufficient~~ to ~~support~~obtain ~~all~~additional offinancing ~~our~~in ~~working~~order ~~capital~~to ~~needs~~meet our obligations.

As of December 31, 2025, we had $49,870 in cash held outside of the Trust Account and a working capital deficit of $5,940,934, which may not be sufficient for us to operate for at least the next 12 months from the issuance of these financial statements. The Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers ~~will~~and ~~have~~directors ~~until~~may, ~~July 30~~but are not obligated to, ~~2025~~loan us funds as may be required under the Working Capital Loans. There is no assurance that our attempts to ~~complete~~find a partner for an Initial Business Combination. Ifwill anbe ~~Initial~~successful ~~Business~~or successful within the Second Combination Period isor ~~not~~that ~~consummated~~the bySponsor ~~July 30~~or an affiliate of the Sponsor, ~~2025~~or ~~there~~certain of the Company’s officers and directors will beloan the Company afunds ~~mandatory~~as ~~liquidation~~may ~~and~~be ~~subsequent~~required ~~dissolution~~under the Working Capital Loans (as defined in Note 5 of the ~~Company~~accompanying financial statements).

49The Company will have until July 30, 2026 to complete an Initial Business Combination. If an Initial Business Combination is not consummated by July 30, 2026 there will be a mandatory liquidation and subsequent dissolution of the Company unless our date to consummate an Initial Business Combination is further extended.

In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Codification (“ASC”) Topic 205-40 Presentation of Financial Statements- Going Concern, management has determined the factors disclosed above including the July 30, ~~2025~~2026 ~~Combination~~Second Combination Period deadline raise substantial doubt about the Company’s ability to continue as a going concern for the next 12 months ~~from~~ from the date that these financial statements are filed. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of December 31, ~~2024~~2025 or ~~2023~~2024.

Contractual Obligations

Registration and Shareholder Rights Agreement

The holders of the Founder Units, Private Placement Units, warrants underlying the Founder Units and Private Placement Units and units that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the warrants underlying the Founder Units and Private Placement Units and units issued upon conversion of the Working Capital Loans) have registration and shareholder rights to require us to register a sale of any of its securities held by them pursuant to a registration and shareholder rights agreement entered into on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding re-sale demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of an Initial Business Combination. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

We granted the underwriters a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments at the IPO price, less the underwriting discounts and commissions. On August 5, 2021, the underwriters partially exercised the over-allotment option to purchase an additional 3,250,000 Units at an offering price of $10.00 per Unit for an aggregate purchase price of $32,500,000. On September 11, 2021, the remaining option expired.

The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $5,650,000 in the aggregate, upon the closing of the IPO and partial exercise of the over-allotment option. In addition, $0.35 per unit, or $9,887,500 in the aggregate will be payable to the underwriters for deferred underwriting commissions. On December 27, 2023, the underwriters agreed to waive their rights to their portion of the fee payable by the Company for deferred underwriting commissions, with respect to any potential business combination of the Company. Of the total $9,887,500 waived fee, $9,551,325 was recorded as a reduction to accumulated deficit and $336,175 was recorded as a gain on the waiver of deferred underwriting commissions by underwriters in the statements of operations, following a manner consistent with the original allocation of the deferred underwriting fees.

Subscription and Sponsor Promissory Note Agreement

On January 3, 2024, the Company, the Sponsor and Investor entered into a Subscription Agreement, pursuant to which the Sponsor may raise up to $1,500,000 from the Investor to fund extension payments to the Trust Account and working capital for the Company, including $250,000 upon the execution of the Subscription Agreement and $250,000 on February 20, 2024 and as otherwise called by the Sponsor in its discretion. At the closing of the Company’s Initial Business Combination, the Sponsor will forfeit 0.85 Class B shares, and the Company will issue an equal number of shares of its common stock to the Investor, for each dollar funded by the Investor pursuant to the Subscription Agreement. If the Company’s Initial Business Combination does not occur, the Sponsor will not forfeit any shares.

InAs ~~July~~of ~~2024~~December 31, 2025, the ~~Company~~Sponsor ~~entered~~had entered into a ~~promissory note~~series of agreements with ~~Mercury~~various ~~Capital~~subscribers (the “~~Sponsor Promissory Note~~Subscribers”), ~~pursuant~~which toresulted ~~which~~in the ~~Sponsor~~raising ~~may~~of ~~loan up to~~ $1,~~500~~375,000. ~~to the~~Under ~~Company.~~the ~~The~~terms ~~funds~~of ~~that will be loaned to~~ the ~~Company~~agreement ~~under~~ the ~~Sponsor~~Subscribers ~~Promissory~~agreed ~~Note~~to ~~consist~~subscribe ofto a portion of the upSponsor’s toClass ~~$1,500,000 that~~B ~~was~~Ordinary ~~loan~~Shares toon ~~the~~a ~~Sponsor~~contingent basis byin ~~the~~order ~~Investor pursuant~~ to allow the ~~Subscription~~Sponsor ~~Agreement.~~to Iffund ~~the~~such ~~Company~~working ~~completes~~capital ato ~~Business Combination,~~ the Company. ~~would~~Pursuant ~~repay~~to the ~~Sponsor~~agreement, ~~Promissory~~at ~~Note. In~~ the ~~event~~closing ~~that~~of a ~~Business~~business combination ~~Combination~~by ~~does not close,~~ the Company, ~~may~~upon ~~use~~election aby ~~portion of proceeds held outside~~ the ~~Trust Account to repay the~~ Sponsor ~~Promissory Note~~, ~~but no proceeds held in~~ the ~~Trust~~Shares ~~Account~~will ~~would~~ be ~~used~~ transferred to ~~repay~~ the ~~Working Capital Loans~~Subscribers. UpThere towill ~~$1,500,000 of such loans may~~ be ~~convertible~~no ~~into~~accounting impact ~~warrants~~to of the Company atas a ~~price~~result of ~~$1.50 per warrant at~~ the ~~option~~sale of ~~the~~ Sponsor.’s ~~The~~Class ~~warrants~~B ~~would~~Ordinary beShares ~~identical~~ to ~~the Private Placement Warrants~~Subscribers. The Company accounts for the Sponsor Promissory Note within the scope of ASC 815 and has elected to bifurcate the embedded derivative within the convertible promissory note. The fair value of the embedded conversion feature upon the issuance of the Sponsor Promissory Note is de minimis.

In July 2024, the Company entered into a promissory note with Sponsor (the “Sponsor Promissory Note”), pursuant to which the Sponsor may loan up to $1,500,000 to the Company. The funds that will be loaned to the Company under the Sponsor Promissory Note consist of a portion of the up to $1,500,000 that was loan to the Sponsor by the Investor pursuant to the Subscription Agreement. If the Company completes a Business Combination, the Company would repay the Sponsor Promissory Note. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Sponsor Promissory Note, but no proceeds held in the Trust Account would be used to repay the Sponsor Promissory Note. Up to $1,500,000 of such loans may be convertible into warrants of the Company at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to the Private Placement Warrants. The Company accounts for the Sponsor Promissory Note within the scope of ASC 815 and has elected to bifurcate the embedded derivative within the convertible promissory note. The fair value of the embedded conversion feature upon the issuance of the Sponsor Promissory Note is de minimis.

~~The~~On ~~outstanding~~April ~~balance~~24, ~~under~~2025, the Company and Sponsor ~~Promissory~~entered ~~Note~~an asamendment ofto ~~December~~increase ~~31, 2024 was $1,204,867. This balance includes deposits made into~~ the ~~Trust~~maximum ~~Account~~amount byof the Sponsor ofPromissory ~~$112,500~~Note ~~each on~~to ~~January 9~~$2,200,000 ~~2024~~ and ~~January~~up ~~24,~~to ~~2024~~$2,200,000 ~~payments~~may ~~made~~be byconverted ~~the~~into ~~Sponsor~~Private Placement onWarrants ~~behalf~~at ofa ~~the~~price ~~Company~~of ~~totaling~~ $~~243,867,~~1.50 ~~and~~per ~~total~~warrant ~~draw~~at the option of ~~$736,000~~the Sponsor.

On March 18, 2025, April 28, 2025, June 4, 2025, September 29, 2025 and December 15, 2025, the Sponsor loaned $250,000, $100,000, $270,000, $100,000 and $100,000, respectively, to the Company pursuant to the Sponsor Promissory Note. The outstanding balance under the Sponsor Promissory Note as of December 31, 2025 and 2024 was $2,024,867 and $1,204,867, respectively. This balance includes deposits made into the Trust Account by the Sponsor of $112,500 each on January 9, 2024 and January 24, 2024, payments made by the Sponsor on behalf of the Company totaling $243,867, and total draws of $1,556,000.

On January 23, 2025, the Company entered into a promissory note with the Sponsor (the “Second Sponsor Promissory Note”), pursuant to which the Sponsor loaned $100,000 to the Company. The Second Sponsor Promissory Note bears no interest. The principal amount is to be repaid at the earlier of (i) the consummation of the Business Combination, (ii) the date of liquidation, or (iii) 90 calendar days after entering into the promissory note. On May 6, 2025, the Second Sponsor Promissory Note was amended to extend the maturity date by an additional 180 calendar days, resulting in a new expiration date 270 calendar days from the original issuance or October 20, 2025. On March 30, 2026, the Second Promissory Note was further amended to extend the maturity date to July 31, 2026. If the Company does not consummate the Business Combination or there is a liquidation, the Second Sponsor Promissory Note will not be repaid and the principal amount will be forgiven, except to the extent there are funds available to the Company outside of the Trust Account to make repayment. As of December 31, 2025, the total outstanding balance of the Sponsor Promissory Note and Second Sponsor Promissory Note is $2,124,867.

Non-Redemption Agreements

On each of January 17, 2024, January 23, 2024, and January 24, 2024, the Company and the Sponsor entered into non-redemption agreements (each, a “Non-Redemption Agreement”) with one or more unaffiliated third party or parties (the “Investors”) in exchange for each such third party or third parties agreeing not to redeem certain public Class A ordinary shares, $0.0001 par value per share of the Company sold in its initial public offering (the “Non-Redeemed Shares”) at the Adjourned Meeting. In exchange for the foregoing commitments not to redeem such Non-Redeemed Shares, the Sponsor will assign an economic interest in certain of its Founder Shares to the Investor at the rate of 1 Founder Share for each 4 Non-Redeemed Shares. The Company estimated the aggregate fair value of 331,180 Founder Shares transferrable to the Non-Redeeming Shareholders pursuant to the Non-Redemption Agreement to be $367,610 or $1.11 per share. The fair value was determined using a discount for the probability of an Initial Business Combination of 10.95% and a discount of 5% for the lack of redemption rights and the value per Founder Shares as of the valuation date of $10.71. The excess of the fair value of such Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, in substance, the indirect economic interest in the Founder Shares was recognized by the Company as a capital contribution in accordance with Staff Accounting Bulletin Topic 5T by the Sponsor to induce these Non-Redeeming Shareholders not to redeem the Non-Redeemed Shares, with a corresponding charge to additional paid-in capital to recognize the fair value of the Founder Shares subject to transfer as an offering cost.

Consulting Agreement - Stock Based Compensation

On February 12, 2024, the Sponsor entered into an independent contractor agreement and securities transfer agreement concurrently with the Company’s Chief Financial Officer, for services related to due diligence of potential business combination partners and assisting with the negotiation and closing of an Initial Business Combination for the Company. The Chief Financial Officer is entitled to receive a fee for service of $12,500 paid in amounts of $6,250 semi-monthly until the Company completes its Initial Business Combination. These payments will be recorded as operating expenses of the Company. Additionally, the Sponsor has agreed to transfer 365,000 Founder Shares and 175,000 Founder Warrants of the Company to the Chief Financial Officer. At the earlier of the termination of the agreement and an Initial Business Combination, the Chief Financial Officer has agreed to surrender a portion of the Class B ordinary shares based on the cash compensation paid multiplied by 1.5, up to a maximum of 165,000 Founder Shares. Lastly, the Chief Financial Officer shall be paid a success fee of $50,000 that is contingent upon the closing of the Initial Business Combination. The compensation expense related to the Founder Share transfer will be amortized on a straight-line basis from the grant date of February 12, 2024 (the date at which the independent contractor agreement was signed, and the date at which all parties reached a mutual understanding of the key terms and conditions of the share-based payment) to November 1, 2024 (vesting period of 8 months). Such Investment Advisory Agreement was accounted for under ASC 718.

On June 30, 2024, the Sponsor entered into an amendment to the independent contractor agreement. In connection with the amendment, the Sponsor will now assign and transfer all 365,000 Founder Shares and 175,000 Founder Warrants only upon the closing of an Initial Business Combination, and the 165,000 Founder Shares are no longer subject to forfeiture based upon cash compensation paid. As such, the Company determined that this was a modification to the original agreement. As such, as of December 31, 2025, no additional compensation will be recorded for the transfer of the shares until an Initial Business Combination has been consummated. The compensation that has been recorded for year ended December 31, 2024, will remain within the Company’s Statements of Operations for those periods.

Standby Equity Purchase Agreement

On November 7, 2025, Pubco, Tactical and Yorkville entered into a standby equity purchase agreement (the “SEPA”) and a registration rights agreement (the “Registration Rights Agreement”). Pursuant to the SEPA, Yorkville will open a standby equity line for Pubco in the aggregate principal amount of up to $100,000,000. Additionally, Yorkville will advance $7,500,000 to Pubco in the form of a pre-paid advance evidenced by a convertible promissory note on the closing of the Business Combination, and another $2,500,000 to Pubco in the form of a second pre-paid advance with an equivalent note that is not convertible on the date the initial registration statement on form F-1, filed pursuant to the Registration Rights Agreement in connection with the SEPA, becomes effective. $30,000,000 may be available to Pubco in the form of a third pre-paid advance with an equivalent convertible note at such time as agreed to by the Yorkville and Pubco (collectively, the “Yorkville Financing”). Each of the pre-paid advances is subject to an original issue discount, and further advances under the standby equity line are subject to conditions specified in the SEPA. The SEPA expires on the earlier of 36 months or use of all $100,000,000. The Company evaluated the advances under applicable accounting guidance and concluded that the instruments represent freestanding equity-linked financial instruments that are not eligible for equity classification due to contractual delivery limitations that may restrict the number of shares deliverable to the investor. Accordingly, the advances will be accounted for as derivative liabilities, measured at fair value with changes in fair value recognized in earnings. No advances were outstanding as of December 31, 2025.

In addition, on November 7, 2025, the Sponsor entered into an Expenses Payment Agreement with the investor pursuant to which the Sponsor agreed to transfer 1,000,000 Class B ordinary shares to the investor to facilitate the payment of up to $7.0 million of certain expenses related to the SEPA and the business combination. The Company determined that this arrangement represents the settlement of its obligations by a principal stockholder and, in accordance with applicable guidance, records the related expenses with a corresponding credit to additional paid-in capital. As of December 31, 2025, no expenses related to the SEPA had been incurred.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Net (Loss) ~~Income~~ Per Ordinary Share

Net (loss) ~~income~~ per ordinary share is computed by dividing net (loss) ~~income~~ by the weighted-average number of ordinary shares outstanding during the period. Accretion associated with the redeemable Class A ordinary shares is excluded from net (loss) ~~income~~ per share as the redemption value approximates fair value. Therefore, the (loss) ~~income~~ per share calculation allocates ( loss) ~~income~~ shared pro rata between Class A ordinary shares subject to possible redemption and non-redeemable Class A ordinary shares and Class B ordinary shares. As a result, the calculated net (loss) ~~income~~ per share is the same for Class A and Class B ordinary shares. We have not considered ~~the~~ the effect of the warrants sold in the IPO, Private Placement, warrants included in the founder units issued to our Original Sponsor to ~~purchase~~ purchase an aggregate of 12,059,~~166~~165 shares, or the effects of the ~~803~~1,~~245~~349,911 warrants that would be issuable upon conversion of the Subscription Agreement (as defined in Note 5 of the accompanying financial statements) in the calculation of diluted (loss) ~~income~~ per share, because the exercise of the warrants are contingent upon the occurrence of future events. The Private Placement Shares (as defined in Note 4) of the accompanying financial statements) that may be issued upon conversion of the Working Capital Loan are issuable at the option of the holder.

Class A Ordinary Shares Subject to Possible Redemption

All of the 28,250,000 Class A ordinary shares sold as part of the units in the IPO contain a redemption feature which allows for the redemption of such Public Shares in connection with our liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated memorandum and articles of association. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”), redemption provisions not solely within our control require ordinary shares subject to redemption to be classified outside of permanent equity. Therefore, all Public Shares have been classified outside of permanent equity. In connection with the July 2023 Extraordinary General Meeting, the holders of 13,532,591 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of approximately $140,838,808. After those redemptions, approximately $153,169,659 remained in the Company’s trust account. On January 29, 2024, 12,433,210 Class A ordinary shares were tendered for redemption by shareholders for a total value of $134,059,215. The payments for these redemptions took place on February 27, 2024, after which $24,629,032 remained in the Company’s Trust Account. On January 16, 2025, the holders of 2,132,366 Class A ordinary shares elected to redeem at approximately $11.24 per share, for an aggregate redemption amount of $23,975,464. After redemptions, $1,707,149 remained in the Trust Account~~. After the redemptions~~, and there are 151,833 Class A ordinary shares subject to possible redemption remaining outstanding. On July 15, 2025, 109,347 Class A ordinary shares were tendered for redemption by shareholders for a total value of $1,252,434. The payment of these shares took place on July 21, 2025, after which 42,486 Class A ordinary shares subject to possible redemption remained outstanding. On December 22, 2025, the holders of 24,136 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.61 per share, for an aggregate redemption amount of $280,219. The redemption is contingent upon the consummation of the Business Combination and will occur as promptly as practicable following the closing thereof; if the Business Combination is not consummated, the redeemed shares will be returned to the respective holders.

We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

~~Promissory Note - Related Party~~60

~~We account for the~~ Working Capital Loan ~~(as defined in Note 5) under ASC Topic 815, “Derivatives~~ and Hedging” (“ASC 815”). We have made the election under ASC 815-15-25 to account for the Working Capital Loan under the fair value option. As of December 31, 2024, there was no principal amount outstanding under the Working Capital Loan, as the Working Capital Loan was forgiven by the Sponsor. The aggregate fair value of the Working Capital Loan upon issuance was $219,441. The aggregate fair value of the Working Capital Loan was $123,500 upon forgiveness. The Working Capital Loan was forgiven by the Sponsor on December 27, 2023. We account for the Sponsor Promissory Note (as defined in Note 5) within the scope of ASC 815 and has elected to bifurcate the embedded derivative within the convertible promissory note. The fair value of the embedded conversion feature upon the issuance of the Sponsor Promissory Note is de minimis. The outstanding balance under the Sponsor Promissory Note as of December 31, 2024 was $1,204,867. Notes

We account for the Working Capital Loan (as defined in Note 5) under ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). We have made the election under ASC 815-15-25 to account for the Working Capital Loan under the fair value option. As of December 31, 2024, there was no principal amount outstanding under the Working Capital Loan, as the Working Capital Loan was forgiven by the Sponsor. The aggregate fair value of the Working Capital Loan upon issuance was $219,441. The aggregate fair value of the Working Capital Loan was $123,500 upon forgiveness. The Working Capital Loan was forgiven by the Sponsor on December 27, 2023. We account for the Sponsor Promissory Note and Second Sponsor Promissory Note (as defined in Note 5) within the scope of ASC 815 and has elected to bifurcate the embedded derivative within the convertible promissory note. The fair value of the embedded conversion feature upon the issuance of the Sponsor Promissory Note and Second Sponsor Promissory Note is de minimis. The outstanding balance under the Sponsor Promissory Note and Second Sponsor Promissory Note as of December 31, 2025 was $2,024,867 and $100,000, respectively.

Warrant Liabilities

We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC ~~Topic~~ 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are ~~freestanding~~ freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated ~~fair~~ fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The initial fair value of the Public Warrants (as defined in Note 3) was estimated using a binomial/lattice model and the initial and subsequent fair value of the Founder Warrants (as defined in Note 5) and Private Placement Warrants (as defined in Note 4) was estimated using a Black-Scholes Option Pricing Model (see Note 9). ~~Due~~As toof ~~the~~December ~~options~~31, ~~pricing~~2025 ~~model~~and ~~not~~2024, ~~producing~~despite alower ~~meaningful~~trading ~~volatility~~volume ~~for~~on the ~~Founder~~Class ~~Warrants~~A ordinary share and ~~Private~~Public ~~Placement~~Warrants, the fair value of the Public Warrants was based on its traded price as of December 31, ~~2024~~2025 and ~~2023,~~2024. This approach was deemed appropriate as the ~~fair~~implied ~~value~~probability of ~~the~~a ~~Founder~~successful ~~Warrants~~business ~~and~~combination ~~Private~~remained ~~Placement~~within ~~Warrants~~the ~~were~~range ~~set~~observed ~~equal~~in tocomparable ~~the~~publicly traded companies. ~~fair~~The ~~value~~valuation of the ~~Public~~Private Warrants slightly differed, as it was derived using the Black-Scholes option pricing model.

Critical Accounting Estimates

Our financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), which requires us to make estimates, assumptions and judgments that affect the reported amount of assets, liabilities, costs and expenses and related disclosures. Our critical accounting estimates are those estimates that involve a significant level of uncertainty at the time the estimate was made, and changes in them have had or are reasonably likely to have a material effect on our financial condition or results of operations. Accordingly, actual results could differ materially from our estimates. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. Our most critical accounting estimate includes determining the accruals associated with third party providers, the valuation of the Public and Private Placement Warrants, and the valuation of Founder Shares that will be issued in relation to the Non-Redemption Agreements and the consulting agreement.

Recent Accounting Standards

On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. The update will be effective for annual periods beginning after December 15, 2024, and early adoption is permitted. The Company isadopted ~~currently~~ASU ~~evaluating~~2023-09 for the ~~impact~~fiscal year beginning January 1, 2025. The adoption of ~~this~~ASU ~~standard~~2023-09 did not have a material impact on ~~its~~ the Company’s financial statements ~~and~~or related disclosures.

5261

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 8. Financial Statements and Supplementary Data

Our financial statements and notes thereto begin on page F-1 of this Report and are incorporated herein by reference.

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

AsDisclosure ofcontrols ~~December~~and ~~31,~~procedures ~~2024,~~are ~~under the supervision~~controls and ~~with~~other ~~the~~procedures ~~participation~~that ofare ~~our~~designed ~~management,~~to ~~including~~ensure ~~our~~that ~~Chief~~information ~~Executive~~required ~~Officer~~to ~~and~~be disclosed in our ~~Chief~~reports ~~Financial~~filed ~~Officer~~or ~~(together~~submitted under Securities Exchange Act of 1934, as amended (the “~~Certifying Officers~~Exchange Act”), weis ~~carried~~recorded, ~~out~~processed, ansummarized ~~evaluation~~and ofreported within the ~~effectiveness~~time ofperiods specified in the ~~design~~SEC’s rules and ~~operation~~forms. ofDisclosure ~~our~~controls ~~disclosure~~and procedures include, without limitation, controls and procedures asdesigned ~~defined~~to inensure ~~Rules~~that ~~13a-15(e)~~information ~~and~~required ~~15d-15(e)~~to ~~under~~be ~~the~~disclosed ~~Exchange~~in ~~Act.~~our ~~Based~~reports onfiled ~~the~~or ~~foregoing,~~submitted ~~our~~under ~~Certifying~~the ~~Officers~~Exchange ~~concluded~~Act ~~that~~is ~~our~~accumulated and ~~disclosure~~communicated ~~controls~~to ~~and~~our ~~procedures~~management, ~~were~~including ~~not~~our ~~effective~~Chief asExecutive ofOfficer ~~the~~and ~~end~~Chief ofFinancial ~~the~~Officer, ~~period~~to ~~covered~~allow bytimely ~~this~~decisions ~~Report~~regarding required disclosure. The Company identified a material weakness in internal controls related to the compliance with an agreement we entered during the fiscal year ended December 31, 2023, and the recording of necessary accruals in relation to that agreement. Additionally, the Company identified a material weakness in internal controls in relation to proper recording of accruals and stock-based compensation during the fiscal year ended December 31, 2024.

As a result, we performed additional analysis as deemed necessary to ensure that the financial statements included in this Annual Report on Form 10-K were prepared in accordance with UGAAP.S. ~~generally accepted accounting principles.~~ Accordingly, management believes that the financial statements included in this Annual Report on Form 10-K fairly present, in all material respects, the Company’s financial position, results of operations, and cash flows as of the dates, and for the periods presented, in conformity with ~~U.S.~~ GAAP.

~~Disclosure~~As ~~controls~~required ~~and~~by ~~procedures~~Rules ~~are~~13a-15 ~~controls~~ and ~~other~~15d-15 ~~procedures~~under ~~designed~~the Exchange toAct, ~~ensure~~our ~~that~~Chief ~~information~~Executive ~~required~~Officer toand beChief ~~disclosed~~Financial inOfficer ~~our~~carried ~~reports~~out ~~filed~~an orevaluation ~~submitted~~of ~~under~~ the ~~Exchange Act~~effectiveness isof ~~recorded,~~the ~~processed,~~design ~~summarized~~ and operation ~~reported~~of ~~within~~our ~~the~~disclosure ~~time~~controls ~~periods~~and ~~specified~~procedures inas ~~the~~of ~~SEC’s~~December ~~rules~~31, ~~and forms~~2025. ~~Disclosure controls~~Based ~~and~~upon ~~procedures~~their ~~include~~evaluation, ~~without~~our ~~limitation,~~Chief ~~controls~~Executive Officer and ~~procedures~~Chief ~~designed~~Financial toOfficer ~~ensure~~concluded that ~~information~~our ~~required~~disclosure tocontrols beand ~~disclosed in~~procedures ~~our~~(as ~~reports~~defined ~~filed~~in orRules ~~submitted~~13a-15(e) and 15d-15(e) under the Exchange Act) iswere ~~accumulated~~not ~~and communicated to management~~effective, ~~including~~as ~~our~~of ~~Certifying~~December ~~Officers~~31, or ~~persons performing similar functions~~2025, asdue ~~appropriate,~~ to ~~allow~~the ~~timely~~existence ~~decisions~~of ~~regarding~~the ~~required~~material ~~disclosure~~weakness noted above.

Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Management has implemented remediation steps to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for accrued, deferred or contingent expenses and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identifying third-party professionals with whom to consult on complex questions regarding accounting for accrued, deferred or contingent expenses, and improving the processes for sharing, approving and evaluating contractual arrangements and invoices related to accrued, deferred or contingent expenses. We believe that the actions described above will be sufficient to remediate the identified material weakness and strengthen our internal control over financial reporting.62

Management’s Report on Internal Control Over Financial Reporting

As required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over ~~financial~~ financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our ~~consolidated~~ financial statements for external reporting purposes in accordance with GAAP. Our internal control over financial reporting includes those policies and procedures that:

(1)

pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company,

(2)

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

(3)

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our ~~consolidated~~ financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal control over financial reporting as of December 31, ~~2024~~2025. In making these assessments, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013). Based on our assessments and those criteria, management determined that our internal control over financial reporting were not effective as of December 31, ~~2024~~2025.

This Annual Report on Form 10-K does not include an attestation report of internal control from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.

Changes in Internal Control over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. We will expand and improve our review process for complex agreements and the corresponding complex accounting requirements. We plan to further improve our processes by enhancing access to accounting literature, identification of third-party professionals to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement the existing accounting professionals. We additionally plan to enhance our communication with vendors around necessary accruals.

Item 9B. Other Information

None.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not Applicable.

5463

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Our officers and directors are as follows:

Name	Age	Position
Kanishka Roy	4950	President, Chief Executive Officer, and Chairman
Steven Handwerker	3738	Chief Financial Officer
Hume Kyle	6465	Director
Alan Black	6465	Director
David Sable	7172	Director

Kanishka Roy has served as our President and Chief Executive Officer since January 3, 2024 and as Chairman of the board since March 20, 2024. Mr. Roy is a technology and finance veteran, with over 25 years of experience as a technology investment banker, public company executive, and growth investor. Mr. Roy is a co-founder and currently Managing Partner of Plum Partners, a late-stage investment company since 2020. From June 2024, Mr. Roy has served as the Chief Executive Officer and Chairman of Plum Acquisition Corp. IV. From 2021 to September 2024, Mr. Roy served as Chairman and CEO of Plum Acquisition Corp. I, a special purpose acquisition company that merged with Veea Inc. with Veea Inc. as the surviving company. Mr. Roy continues to serve as a director of Veea Inc. From 2010 to 2019, Mr. Roy advised leading Software and Internet companies with mergers and acquisitions (M&A) and capital markets transactions. Mr. Roy served as the Global Head of Tech M&A Origination for Morgan Stanley, where he was responsible for initiating large, industry-transforming mergers, helping clients take a long-term view of the competitive landscape and implementing large, industry-shaping M&A transactions. Over his career, Mr. Roy has participated in over $100 billion of M&A transactions. From 2019 to 2020, he was Global CFO at SmartNews, a multi-billion-dollar AI company with over 20 million monthly average users, and led the strategic finance and growth of a rapidly growing company across multiple geographies. Mr. Roy started his career as a software engineer at two software startups, both of which were acquired by larger public companies, and also worked in executive strategy roles at IBM. Mr. Roy holds an undergraduate degree in Electrical & Computer Engineering and an MBA from the Tuck School of Business at Dartmouth.

Steven Handwerker has served as our Chief Financial Officer since March 20, 2024. From ~~December~~January ~~2023~~2025, Mr. Handwerker has served as athe ~~financial~~Chief ~~consulted~~Financial ~~for~~Officer ~~Events~~and Director of Plum Acquisition Corp.~~com~~ IV. From ~~January~~December ~~2025~~2023, Mr. Handwerker has served as ~~the~~a ~~Chief~~financial ~~Financial~~consultant ~~Officer~~to ~~and~~Events.com, ~~Director~~a ofsoftware company ~~Plum~~building ~~Acquisition~~a ~~Corp.~~comprehensive IVevent management platform. Mr. Handwerker was the Chief Financial Officer of FinServ Acquisition Corp. II from 2021 until the end of 2023. From 2019 to 2021, Mr. Handwerker served as a consultant for FinServ Acquisition Corp. I, and was involved in all aspects of its business and operations. Mr. Handwerker has more than 15 years of experience investing in and covering the financial services and FinTech industries. From 2013 to 2017, he was an Analyst at Citadel’s equity long/short hedge fund platform, covering companies within the financial services and FinTech sectors. Prior to Citadel, Mr. Handwerker was an Investment Banking Analyst in Barclays’ Financial Institutions Group from 2010 to 2013. He received his BBA from Emory University.

Hume Kyle has served as a director since January 15, 2025. Mr. Kyle is a CPA, CA, CFA, with over 40 years of private sector and public accounting experience, including over 25 years working with mining, energy and other natural resources companies in senior management and board roles. Mr. Kyle served as Executive Vice President and Chief Financial Officer of Dundee Precious Metals Inc., a multi-national gold mining company, from 2011 until his retirement on December 31, 2022. Prior to that Mr. Kyle was Vice President, Treasurer and Controller of TransAlta Corporation, a multi-national power generation and wholesale marketing company, from 2009 to 2011, and Vice President, Finance and Chief Financial Officer of Fort Chicago Energy Partners L.P., a pipeline, natural gas liquids processing, and power company, from 2003 to 2009. Mr. Kyle also held increasingly senior finance and accounting roles at Nexfor Inc., Noranda Inc., Deloitte & Touche, and Price Waterhouse & Co. Additionally, Mr. Kyle currently serves on the board of Novagold Resources Inc. (2023 to present) and previously served on the boards of Stornoway Diamond Corporation (2014 to 2019), Alliance Pipeline (2004 to 2009), Aux Sable (2004 to 2009), and the Canadian Association of Income Funds (2005 to 2009), serving on several committees, including the Audit Committee, as Chair. Mr. Kyle holds a Bachelor of Arts degree in Economics and Accounting from the University of Western Ontario, a Graduate Diploma in Public Accounting from McGill University, a CA designation from the Canadian Institute of Chartered Accountants, a CFA designation from the Institute of Chartered Financial Analysts, and a ICD.D designation from the Institute of Corporate Directors.

5564

Alan Black has served as a ~~director~~ director since January 2, 2024. Mr. Black founded Surfspray Capital, LLC in 2017 through which he has advised over a dozen companies ~~including~~ including Looker Data Sciences where he served on the Board and was Chair of the Audit Committee (acquired by Google in 2019); Bill.com Holdings (2019 IPO), and HashiCorp (2021 IPO)~~, and private software companies including Intercom, Komodo Health, Mattermost, Netlify, Nozomi Networks, and others~~. He brings more than 3530 years of experience as an executive leading public and private software enterprises, including IPO experience as CFO at Zendesk (2014 ~~IPO~~) and Openwave Systems (1999 ~~IPO~~). In between those companies, Mr. Black was President and CEO of Intelliden (acquired by IBM in 2010). Mr. Black currently sits on the boards of ~~Nextiva~~Guild Education, Inc., Lambda.ai, Matillion Limited, Nextiva, Inc., and Veea Inc. HeMr. ~~holds~~ Black currently is a ~~Bachelors~~board observer on the boards of ~~Commerce~~Netify, Inc. and aWavefrontAI, ~~Graduate~~Inc. ~~Diploma~~Mr. inBlack ~~Public~~also ~~Accountancy~~founded Surfspray ~~degrees~~Properties ~~from~~LLC ~~McGill~~and ~~University~~Malama inEnergy ~~Montreal~~LLC and is a Strategic Advisor to Matermost, ~~Canada~~Inc., Electric, Inc., and ~~serves~~Pacvue, ~~as the~~Inc. ~~co-Chair~~He ofholds ~~McGill’s~~a ~~Board~~Bachelor of ~~Advisors~~Commerce and ~~for~~a ~~the~~Graduate ~~Western~~Diploma ~~United~~in ~~States~~Public Accountancy degrees from McGill University in Montreal, Canada. Mr. Black ishas ~~now~~ retired from active membership in the Institute of Chartered Accountants of Ontario (Canada) and the Society of Certified Public Accountants (California), inof which ~~professional organizations~~ he was a licensed member of professional organizations for over two decades.

David Sable has served as a ~~director~~ director since January 2, 2024. Mr. Sable is Vice-Chairman of Stagwell Global , a digital first global marketing network. He currently serves as a member of the board of directors of Ethan Allen Interiors Inc. (NYSE: ETD) since November 2021 and of American Eagle Outfitters Inc. (NYSE: AEO) since October 2016. He served as a Senior Advisor to WPP plc. (NYSE: WPP) from January 2019 until March 2021. Previously he was Chairman of VMLY&R, a member of WPP plc., in 2019. Prior to this role, he had served as the Global Chief Executive Officer of Young and Rubicam LLC, until its subsequent merger with VMLY&R. Mr. Sable also served at Wunderman, Inc., a leading customer relationship manager and digital unit of WPP plc as Vice Chairman and Chief Operating Officer, from August 2000 to February 2011. Mr. Sable was previously a Founding Partner and Executive Vice President and Chief Marketing Officer of Genesis Direct, Inc. from June 1996 to September 2000. Mr. Sable also serves as a Strategic Advisor to ShopIN.nyc and Anzu.io. He is a past Chair of the Ad Council’s board of directors, is an executive board member of the United Negro College Fund, and sits on the International Board of the Special Olympics. Mr. Sable attended New York University and Hunter College.

Number and Terms of Office of Officers and Directors

Our board of directors is divided into three classes, with only one class of directors being appointed in each year, and with each class (except for those directors appointed prior to our first annual general meeting) serving a three-year term. The term of office of the first class of directors, consisting of David Sable, will expire at our first annual general meeting. The term of office of the second class of directors, consisting of Alan Black, will expire at our second annual general meeting. The term of office of the third class of directors, consisting of Hume Kyle and Kanishka Roy, will expire at our third annual general meeting.

Prior to the completion of an Initial Business Combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder shares. In addition, prior to the completion of an Initial Business Combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason.

Our Sponsor, upon and following consummation of an Initial Business Combination, will be entitled to nominate three individuals for appointment to our board of directors, as long as the Sponsor holds any securities covered by the registration and shareholder rights agreement.

Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association as it deems appropriate. Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association provide that our officers may consist of one or more chairman of the board, chief executive officer, president, chief financial officer, vice presidents, secretary, treasurer and such other offices as as may be determined by the board of directors.

Director Independence

We have 3 “independent directors” as defined under applicable SEC rules. Our board of directors has determined that Alan Black, David Sable, and Hume Kyle are “independent directors” under applicable SEC rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.

Executive Officer and Director Compensation

None of our executive officers or directors have received any cash compensation for services rendered to us. Commencing on the date that our securities were first listed on Nasdaq through the earlier of consummation of our Initial Business Combination and our liquidation, we ~~will~~agreed to reimburse our Sponsor for office space, secretarial, research and administrative services provided to us, and other obligations of our Sponsor, in the amount of up to $55,000 per month. Any outstanding administrative support fees owed as of December 27, 2023 were forgiven and the agreement was then cancelled. In addition, our Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying prospective partner businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our Sponsor, executive officers or directors, or our or their affiliates. Any such payments prior to an Initial Business Combination will be made using funds held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an Initial Business Combination. Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, will be paid by the company to our Sponsor, executive officers and directors, or any of their respective affiliates, prior to completion of our Initial Business Combination.

After the completion of our Initial Business Combination, directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials or tender offer materials furnished to our shareholders in connection with a proposed business combination. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the directors of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of directors.

We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our Initial Business Combination, although it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain with us after our Initial Business Combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management team’s motivation in identifying or selecting a prospective partner business but we do not believe that the ability of our management team to remain with us after the consummation of our Initial Business Combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment.

Committees of the Board of Directors

Audit Committee

Alan Black, David Sable, and Hume Kyle serve as members of our audit committee. Our board of directors has determined that each of them are independent under applicable SEC rules. Mr. Black serves as the chair of the audit committee. Under applicable SEC rules, all the directors on the audit committee must be independent. Each member of the audit committee is financially literate and our board of directors has determined that Mr. Black and Mr. Kyle each qualify as an “audit committee financial expert” as defined in applicable SEC rules.

The audit committee is responsible for:

	●	meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems;

	●	monitoring the independence of the independent registered public accounting firm;

	●	verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law;

	●	inquiring and discussing with management our compliance with applicable laws and regulations;

	●	pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed;

	●	appointing or replacing the independent registered public accounting firm;

	●	determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent registered public accounting firm regarding financial reporting) for the purpose of preparing or issuing an audit report or related work;

	●	establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies;

	●	monitoring compliance on a quarterly basis with the terms of the public offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of the public offering; and

	●	reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors, with the interested director or directors abstaining from such review and approval.

Nominating Committee

The members of our nominating committee are Alan Black, David Sable, and Hume Kyle. Mr. Kyle serves as chairman of the nominating committee. Our board of directors has determined that each of them are independent.

The nominating committee is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The nominating committee considers persons identified by its members, management, shareholders, investment bankers and others.

Guidelines for Selecting Director Nominees

The guidelines for selecting nominees, which is specified in our nominating committee charter, generally provides that persons to be nominated:

●

should have demonstrated notable or significant achievements in business, education, or public service;

●

should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and

●

should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders.

The nominating committee will consider a number of qualifications relating to management and leadership experience, background and integrity and professionalism in evaluating a person’s candidacy for membership on the board of directors. The nominating committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not distinguish among nominees recommended by shareholders and other persons.

Compensation Committee

The members of our compensation committee are Alan Black and David Sable. Mr. Sable serves as chairman of the compensation committee. Our board of directors has determined that each of them are independent. We adopted a compensation committee charter, which will detail the principal functions of the compensation committee, including:

●

reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;

●

reviewing and approving the compensation of all of our other Section 16 executive officers;

●

reviewing our executive compensation policies and plans;

●

implementing and administering our incentive compensation equity-based remuneration plans;

●

assisting management in complying with our proxy statement and annual report disclosure requirements;

●

approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees;

●

producing a report on executive compensation to be included in our annual proxy statement; and

●

reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.

The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by the SEC.

Compensation Committee Interlocks and Insider Participation

None of our executive officers currently serves, and in the past year has not served, as a member of the compensation committee of any entity that has one or more executive officers serving on our board of directors.

Code of Business Conduct and Ethics and Committee Charters

We have adopted a Code of Ethics applicable to our directors, officers and employees. A copy of the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 8-K. The Company maintains committee charters on our website at https://www.plumpartners.com.

Conflicts of Interest

Under Cayman Islands law, directors and officers owe the following fiduciary duties:

●

duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;

●

duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;

●

directors should not improperly fetter the exercise of future discretion;

●

duty to exercise powers fairly as between different sections of shareholders;

●

duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and

●

duty to exercise independent judgment.

In addition to the above, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience of that director.

As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the Fourth ~~Third~~ Amended and Restated Memorandum and Articles of Association or alternatively by shareholder approval at general meetings.

59Each of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to another entity, pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, and may only decide to present it to us if such entity rejects the opportunity and consummating the same would not violate any restrictive covenants to which such officers and directors are subject. Notwithstanding the foregoing, we may pursue an acquisition opportunity with an entity to which an officer or director has a fiduciary or contractual obligation. Any such entity may co-invest with us in the prospective partner business at the time of our Initial Business Combination, or we could raise additional proceeds to complete the acquisition by issuing to such entity a class of equity or equity-linked securities. Our Fourth Amended and Restated Memorandum and Articles of Association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the other. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our Initial Business Combination.

Each of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to another entity, pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, and may only decide to present it to us if such entity rejects the opportunity and consummating the same would not violate any restrictive covenants to which such officers and directors are subject. Notwithstanding the foregoing, we may pursue an acquisition opportunity with an entity to which an officer or director has a fiduciary or contractual obligation. Any such entity may co-invest with us in the prospective partner business at the time of our Initial Business Combination, or we could raise additional proceeds to complete the acquisition by issuing to such entity a class of equity or equity-linked securities. Our Third Amended and Restated Memorandum and Articles of Association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the other. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our Initial Business Combination.

Furthermore, in no event will our Sponsor or ~~any~~ any of our existing officers or directors, or any of their respective affiliates, be paid by us any finder’s fee, consulting fee or or other compensation prior to, or for any services they render in order to effectuate, the completion of our Initial Business Combination. Further, commencing on the date our securities are first listed on Nasdaq, we ~~will~~agreed ~~also~~to reimburse our Sponsor for office space, secretarial, research and administrative services provided to us, and other obligations of our Sponsor, in the amount of up to $55,000 per month. Any outstanding administrative support fees owed as of December 27, 2023 were forgiven and the agreement was then cancelled.

We cannot assure you that any conflicts will be resolved in our favor.

Limitation on Liability and Indemnification of Officers and Directors

Cayman Islands law does not limit the extent to to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to ~~the~~ the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against willful default, willful neglect, civil fraud or the consequences of committing a crime. Our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association provide for indemnification of our officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own actual fraud, willful default or willful neglect. We entered into agreements with our directors and officers to provide contractual indemnification in addition to the indemnification provided for in our ~~Third~~Fourth Amended and Restated Memorandum and Articles of Association. We have purchased a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some ~~circumstances~~ circumstances and insures us against our obligations to indemnify our officers and directors. We have also entered into indemnity agreements with them.

Our officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account, and have agreed to waive any right, title, interest or claim of any kind they may have in the future as a result of, or arising out of, any services provided to us and will not seek recourse against the trust account for any reason whatsoever (except to the extent they are entitled to funds from the trust account due to their ownership of public shares). Accordingly, any indemnification provided will only be able to be satisfied by us if (i) we have sufficient funds outside of the trust account or (ii) we consummate an Initial Business Combination.

Our indemnification obligations may discourage shareholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions.

We believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Exchange Act requires our officers, directors and persons who own more than ten percent of a registered class of our equity securities to file reports of ownership and changes in ownership with the SEC. Officers, directors and ten percent shareholders are required by regulation to furnish us with copies of all Section 16(a) forms they file. Based solely on review of the copies of such forms furnished to us, or written representations that no Forms 5 were required, we believe that, during the fiscal year ended December 31, ~~2024~~2025, all Section 16(a) filing requirements applicable to our officers and directors were complied with.

Item 11. Executive Compensation

None of our executive officers or directors have received any cash compensation for services rendered to us. Commencing on the date that our securities are first listed on Nasdaq through the earlier of consummation of our Initial Business Combination and our liquidation, we ~~will~~agreed to reimburse our Original Sponsor for office space, secretarial, research and administrative services provided to us, and other obligations of our Original Sponsor, in the amount of up to $55,000 per month. Any outstanding administrative support fees owed as of December 27, 2023 were forgiven and the agreement was then cancelled. In addition, our Original Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying prospective partner businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our Original Sponsor, executive officers or directors, or our or their affiliates. Any such payments prior to an Initial Business Combination will be made using funds held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an Initial Business Combination. Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, will be paid by the company to our Original Sponsor, executive officers and directors, or any of their respective affiliates, prior to completion of our Initial Business Combination.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth information regarding the beneficial ownership of our ordinary shares as of March 24, ~~2025~~2026, by:

●

each person known by us to be a beneficial owner of more than 5% of our issued and ordinary shares;

●

each of our executive officers and directors that beneficially owns ordinary shares; and

●

all our executive officers and directors as a group.

61The following table is based on ordinary shares outstanding at March 24, 2026, of which 907,486 were Class A ordinary shares and 7,062,500 were Class B ordinary shares. Unless otherwise indicated, it is believed that all persons named in the table below have sole voting and investment power with respect to all ordinary shares beneficially owned by them.

The following table is based on ordinary shares outstanding at March 24, 2025, of which 1,016,833 were Class A ordinary shares and 7,062,500 were Class B ordinary shares. Unless otherwise indicated, it is believed that all persons named in the table below have sole voting and investment power with respect to all ordinary shares beneficially owned by them.

	Class A Ordinary Shares					Class B Ordinary Shares
Name of Beneficial Owner	Number of Shares Beneficially Owned		Approximate Percentage of Class			Number of Shares Beneficially Owned		Approximate Percentage of Class			Approximate Percentage of Voting Control
Five Percent Holders
Mercury Capital, LLC⁽¹⁾		—		—			5,933,508		84.0	%		84.0	%
Alpha Partners Technology Merger Sponsor LLC⁽²⁾		665,000		73.3	%		1,128,992		16.0	%		16.0	%
Directors and executive Officers of Plum
Kanishka Roy⁽³⁾		—		—			5,933,508		84.0	%		84.0	%
Steven Handwerker		—		—
Hume Kyle		—		—
Alan Black		—		—
David Sable		—		—
All officers and directors as a group (5 individuals)		—		—			5,933,508		84.0	%		84.0	%

		Class A Ordinary Shares					Class B Ordinary Shares
*	Less than one percent.
Name of Beneficial Owner		Number of Shares Beneficially Owned		Approximate Percentage of Class			Number of Shares Beneficially Owned		Approximate Percentage of Class			Approximate Percentage of Voting Control
(1)	Based on a Schedule 13D/A filed by Mercury Capital, LLC on April 18, 2025. On December 27, 2023, Plum, Alpha Partners Technology Merger Sponsor, LLC, and Mercury Capital, LLC entered into a purchase agreement (“Purchase Agreement”), pursuant to which Mercury Capital, LLC the Sponsor (i) purchased 3,902,648 Founder Units, each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B share, and (ii) became entitled to 70% of the 2,030,860 Founder Units that Original Sponsor placed in escrow at the closing of the Purchase Agreement to the extent such Founder Units are not allocated to investors who hold and do not redeem their Class A Ordinary Shares of Plum at the time of Plum’s initial business combination. All the Founder Units in escrow are accounted for under Mercury Capital, LLC’s interests. The business address of Mercury Capital, LLC is 2021 Fillmore St. #2089, San Francisco, California 94115.
Five Percent Holders
(2)	Alpha Partners Technology Merger Sponsor, LLC paid an aggregate of $25,000 for 7,187,500 Founder Units, each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B share, 125,000 of which were forfeited due to only a partial exercise of the over-allotment option. Additionally, Alpha Partners Technology Merger Sponsor, LLC purchased 665,000 private placement units at an aggregate price of $6,650,000. On December 27, 2023, Alpha Partners Technology Merger Sponsor, LLC entered into a purchase agreement (“Purchase Agreement”), pursuant to which they sold 3,902,648 Founder Units to Mercury Capital, LLC, and put 2,030,860 Founder Units into escrow, of which they are entitled to 30% of the Founder Units in Escrow if they are not allocated to investors who hold and do not redeem their Class A ordinary shares of the Company at the time of the Company’s initial Business Combination. All the Founder Units in escrow are accounted for under Mercury Capital, LLC’s interests. Plum Partners, LLC is the record holder of the share reported herein. The business address of Alpha Partners is 2021 Fillmore St. #2089, San Francisco, California 94115.
Mercury Capital, LLC(1)			—		—			5,933,508		84.01	%		58.11	%
(3)	Kanishka Roy serves as manager for Mercury Capital, LLC and may be deemed to beneficially own shares held by Mercury Capital, LLC by virtue of his control over Mercury Capital, LLC. Mr. Roy disclaims beneficial ownership of such shares other than to the extent of his pecuniary interest in such shares.
Alpha Partners Technology Merger Sponsor LLC(2)			665,000		65.40	%		1,128,992		15.99	%		17.57	%
TD Securities (USA) LLC(3)			217,000		21.34	%							2.13	%
AQR Capital Management, LLC(4)			280,000		27.54	%							2.74	%
Meteora Capital, LLC(5)			220,015		21.64	%							2.62	%
Directors and executive Officers of Plum
Kanishka Roy(6)			—		—			5,933,508		84.01	%		58.11	%
Steven Handwerker			—		—
Hume Kyle			—		—
Alan Black			—		—
David Sable			—		—
All officers and directors as a group (5 individuals)			—		—			5,933,508		84.01	%		58.1	%

*	Less than one percent.
(1)	On December 27, 2023, Plum, Alpha Partners Technology Merger Sponsor, LLC, and Mercury Capital, LLC entered into a purchase agreement (“Purchase Agreement”), pursuant to which Mercury Capital, LLC the Sponsor (i) purchased 3,902,648 Founder Units, each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B share, and (ii) became entitled to 70% of the 2,030,860 Founder Units that Original Sponsor placed in escrow at the closing of the Purchase Agreement to the extent such Founder Units are not allocated to investors who hold and do not redeem their Class A Ordinary Shares of Plum at the time of Plum’s initial business combination. All the Founder Units in escrow are accounted for under Mercury Capital, LLC’s interests. The business address of Mercury Capital, LLC is 2021 Fillmore St. #2089, San Francisco, California 94115.
(2)	Alpha Partners Technology Merger Sponsor, LLC paid an aggregate of $25,000 for 7,187,500 Founder Units, each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B share, 125,000 of which were forfeited due to only a partial exercise of the over-allotment option. Additionally, Alpha Partners Technology Merger Sponsor, LLC purchased 665,000 private placement units at an aggregate price of $6,650,000. On December 27, 2023, Alpha Partners Technology Merger Sponsor, LLC entered into a purchase agreement (“Purchase Agreement”), pursuant to which they sold 3,902,648 Founder Units to Mercury Capital, LLC, and put 2,030,860 Founder Units into escrow, of which they are entitled to 30% of the Founder Units in Escrow if they are not allocated to investors who hold and do not redeem their Class A ordinary shares of the Company at the time of the Company’s initial Business Combination. All the Founder Units in escrow are accounted for under Mercury Capital, LLC’s interests. Plum Partners, LLC is the record holder of the share reported herein. The business address of Alpha Partners is 2021 Fillmore St. #2089, San Francisco, California 94115.
(3)	Based on a Schedule 13G filed by TD Securities (USA) LLC (“TDS”), Cowen and Company, LLC (“CC”), Toronto Dominion Holdings USA Inc – Delaware (“TDH”), TD Group US Holdings LLC – Delaware (“TD GUS”), Toronto Dominion Bank – Canada (Federal Level) (“TD Bank” and together, the “Reporting Persons”) on February 14, 2025. TDS may be deemed to have beneficial ownership of 217,000 Class A ordinary shares. The address of TDS principal office and TDH principal office is 1 Vanderbilt Avenue, New York, New York 10017. The address of TD GUS principal office is 251 Little Falls Drive, Wellington, Delaware 19808. The address of TD Bank principal office is Toronto-Dominion Centre, 66 Wellington Street West, 12th Floor, TD Tower, Toronto, Ontario, Canada M5K 1A2.
(4)	Based on a Schedule 13G filed by AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, AQR Arbitrage, LLC, AQR Global Alternative Offshore Fund, L.P., and AQR Capital Management GP Ltd. (together, the “Reporting Persons”) filed on November 13, 2024. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC. AQR Arbitrage, LLC is deemed to be controlled by AQR Capital Management, LLC. AQR Capital Management, LLC, and AQR Arbitrage, LLC act as investment managers to AQR Global Alternative Investment Offshore Fund, L.P. AQR Capital Management GP Ltd. is the general partner of AQR Global Alternative Investment Offshore Fund, L.P. AQR Capital Management, LLC may be deemed to have beneficial ownership of 280,000 Class A ordinary shares. AQR Capital Management Holdings, Inc. may be deemed to have beneficial ownership of 280,000 Class A ordinary shares. AQR Arbitrage, LLC may be deemed to have beneficial ownership of 280,000 Class A ordinary shares. AQR Global Alternative Investment Offshore Fund, L.P. may be deemed to have beneficial ownership of 213,836 Class A ordinary shares. AQR Capital Management GP Ltd. may be deemed to have beneficial ownership of 213,836 Class A ordinary shares. The business address of the Reporting Persons is One Greenwich Plaza, Greenwich, CT 06830.
(5)	Based on a Schedule 13G filed by Meteora Capital, LLC and Vik Mittal (collectively, the “Reporting Persons”) on February 14, 2025. Meteora Capital, LLC may be deemed to beneficially own 220,015 Class A ordinary shares. Vik Mittal may be deemed to beneficially own 220,015 Class A ordinary shares. The address of the principal business office for the Reporting Person is 1200 N Federal Hwy, #200, Boca Raton FL 33432.
(6)	Kanishka Roy serves as manager for Mercury Capital, LLC and may be deemed to beneficially own shares held by Mercury Capital, LLC by virtue of his control over Mercury Capital, LLC. Mr. Roy disclaims beneficial ownership of such shares other than to the extent of his pecuniary interest in such shares.

Our Sponsor and our officers and directors are deemed to be our “promoters” as such term is defined under the federal securities laws. See Item 13 – “Certain Relationships and Related Transactions, and Director Independence—Related Party Policy” for additional information regarding our relationships with our promoters.

Transfers of Founder Shares and Private Placement Warrants

The founder shares, founder warrants, private placement shares, private placement warrants and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our Sponsor and our management team. Our Sponsor and our management team have agreed not to transfer, assign or sell (i) any of their founder shares until the earliest of (A) one year after the completion of our Initial Business Combination and (B) subsequent to our Initial Business Combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our Initial Business Combination, or (y) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property, and (ii) any of their founder warrants, private placement shares, private placement warrants and Class A ordinary shares issued upon conversion or exercise thereof until 30 days after the completion of our Initial Business Combination. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or prospective partners of our Sponsor or their affiliates, any affiliates of our Sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement shares, private placement warrants or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our Sponsor’s organizational documents upon liquidation or dissolution of our Sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our Initial Business Combination; (h) in the event of our liquidation prior to the completion of our Initial Business Combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our Initial Business Combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement.

Registration and Shareholder Rights

The holders of the founder shares, private placement units, private placement warrants, Class A ordinary shares underlying the private placement warrants and any warrants that may be issued upon conversion of working capital loans (and any Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of working capital loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our Initial Business Combination. However, the registration and shareholder rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the founder shares, as described in the following paragraph, and (ii) in the case of the private placement warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of our Initial Business Combination. We will bear the expenses incurred in connection with the filing of any such registration statements. Except as described herein, our Sponsor and our directors and executive officers have agreed not to transfer, assign or sell (i) their founder shares until the earliest of (A) one year after the completion of our Initial Business Combination and (B) subsequent to our Initial Business Combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our Initial Business Combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property, and (ii) any of their private placement units, private placement shares, private placement warrants and Class A ordinary shares issued upon conversion or exercise thereof until 30 days after the completion of our Initial Business Combination. Any permitted transferees will be subject to the same restrictions and other agreements of our Sponsor with respect to any founder shares, private placement units, private placement shares, private placement warrants and Class A ordinary shares issued upon conversion or exercise thereof. We refer to such transfer restrictions throughout this prospectus as the lock-up. In addition, pursuant to the registration and shareholder rights agreement, our Sponsor, upon and following consummation of an Initial Business Combination, will be entitled to nominate three individuals for appointment to our board of directors, as long as the Sponsor holds any securities covered by the registration and shareholder rights agreement.

6372

Equity Compensation Plans

As of December 31, ~~2024~~2025, we had no compensation plans (including individual compensation arrangements) under which equity securities were authorized for issuance.

Policies and Procedures for Related Party Transactions

Our Board of Directors reviews and approves or ratifies of all related person transactions. The Board reviews, with certain exceptions set forth in Item 404 of Regulation S-K promulgated under the Exchange Act , any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we were or are to be a participant, where the amount involved exceeds or will exceed the lesser of $120,000 or 1% of the average of our total assets as of the end of the last two completed fiscal years and a related person had, has or will have a direct or indirect material interest, including purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person. As provided by our Audit Committee charter, our Audit Committee is responsible for reviewing and approving in advance the related party transactions covered by our related transaction policies and procedures.

A related party transaction reviewed will be considered approved or ratified if it is authorized by the Audit Committee of our Board or the chairperson of the Audit Committee in accordance with the standards set forth in the policy after full disclosure of the related party’s interests in the transaction. As appropriate for the circumstances, the Audit Committee or the chairperson of the Audit Committee, as applicable, shall review and consider:

●

the related party’s interest in the transaction;

●

the approximate dollar value of the amount involved in the related party transaction;

●

the approximate dollar value of the amount of the related party’s interest in the transaction without regard to the amount of any profit or loss;

●

whether the transaction was undertaken in our ordinary course of business;

●

whether the transaction with the related party is proposed to be, or was, entered into on terms no less favorable to us than terms that could have been reached with an unrelated third party;

●

required public disclosure, if any; and

●

any other information regarding the related party transaction in the context of the proposed transaction that would be material to investors in light of the circumstances of the particular transaction.

Founder Shares

On February 5, 2021, an affiliate of our Original Sponsor paid an aggregate of $25,000 to cover certain expenses on behalf of us in exchange for the issuance of 7,187,500 Founder Units, which were subsequently transferred to our Sponsor. Each Founder Unit consists of one Class B ordinary share and one-third of one warrant (the “Founder Warrants”) that has the same terms as the Private Placement Warrants (2,395,833 Founder Warrants in the aggregate). The Class B ordinary shares included in the Founder Units included an aggregate of up to 937,500 Class B ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that our Original Sponsor will own, on an as-converted basis, 20% of our issued and outstanding shares upon completion of the Initial Public Offering. The Founder Warrants included an aggregate of up to 312,500 Founder Warrants subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised. On August 5, 2021 the underwriters partially exercised the over-allotment option to purchase an additional 3,250,000 Units, leaving 125,000 Class B ordinary shares and 41,667 Founder Warrants subject to forfeiture. On September 11, 2021, the remaining option expired. As a result, 125,000 Class B ordinary shares and 41,667 Founder Warrants were forfeited.

6473

Our Original Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell (i) any of their Founder Units or Founder Shares until the earliest of (A) one year after the completion of an Initial Business Combination and (B) subsequent to an Initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after an Initial Business Combination, or (y) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property and (ii) any of their Founder Warrants and Class A ordinary shares issued upon conversion or exercise thereof until 30 days after the completion of an Initial Business Combination. Notwithstanding the foregoing, if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after an Initial Business Combination, the Founder Units or Founder Shares will be released from the lock-up.

On December 27, 2023, the Company, the Original Sponsor, and Sponsor entered into a purchase agreement (the “Purchase Agreement”), pursuant to which, at a closing on December 28, 2023, Sponsor (i) purchased 3,902,648 founder units of the Company from the Original Sponsor, each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B ordinary share, which founder units are subject to forfeiture in certain circumstances, and (ii) became entitled to 70% of the 2,030,860 founder units that Original Sponsor placed in escrow at the Closing to the extent such founder units are allocated to investors who hold and do not redeem their Class A ordinary shares of the Company at the time of the Company’s Initial Business Combination, for an aggregate purchase price of $1. Original Sponsor agreed to pay, or cause its affiliates to pay, certain liabilities of the Company accrued and outstanding as of the Closing. Following the closing, ~~Original~~ Original Sponsor has no further obligations with respect to the Company, and Sponsor has assumed all obligations relating to the Company. Subsequently, on January 26, 2024, the Company, the Original Sponsor, and Sponsor entered into ana ~~amended~~first ~~purchase~~amendment ~~agreement~~to ~~(the “Amended~~ Purchase Agreement~~”),~~ to correct the number of shares that the Original Sponsor shall retain to be 665,000 Class A private placement units and 1,128,992 Class B founder units. On August 22, 2024, the Company, the Original Sponsor, and the Sponsor entered into a second amendment to Purchase Agreement which revises the founder-unit forfeiture and transfer mechanics by requiring the acquirer to absorb all forfeitures or investor incentive transfers up to 2,030,860 founder units, allocating excess forfeitures 78% to the acquirer and 22% to the sponsor, while also establishing that 2,030,860 sponsor units will be held in escrow for potential transfer to sponsor anchors, with any remaining escrowed units allocated 70% to the acquirer and 30% to the sponsor at closing. On September 5, 2025, the Company, the Original Sponsor, and the Sponsor entered into a third amendment to Purchase Agreement that provides that any Sponsor Incentive Units (as defined in the Sponsor Support Agreement) that have been retained by the Sponsor after the Closing, up to half of such Sponsor Incentive Units may be transferred prior to the Closing to a third party, with any Sponsor Incentive Units remaining after such transfer subject to allocation between the Sponsor and the Original Sponsor as provided for in the Purchase Agreement.

The Company and Sponsor intend to enter into non-redemption agreements (the “Non-Redemption Agreements”) with certain shareholders of the Company pursuant to which, if such shareholders do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares (the “Non-Redeemed Shares”) in connection with the January 2024 Extraordinary General Meeting, Sponsor will agree to transfer to such investors ordinary shares of the Company held by Sponsor immediately following the consummation of an Initial Business Combination if they continue to hold such Non-Redeemed Shares through the Extraordinary General Meeting.

Private Placement

Simultaneously with the closing of the Initial Public Offering, our Original Sponsor and certain anchor investors purchased an aggregate of 800,000 Units at a price of $10.00 per private placement unit ($8,000,000 in the aggregate). Each Private Placement Unit is exercisable to purchase one Class A ordinary share (the “Private Placement Shares”) and one-third of one redeemable warrant (the “Private Placement Warrants”) at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units were added to the net proceeds from the Initial ~~Public~~ Public Offering to be held in the Trust Account. If we do not complete a Business Combination within the Second Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.

Simultaneously with the closing of the exercise of the over-allotment option, we consummated the sale of 65,000 over-allotment Private Placement Units at a purchase price of $10.00 per unit in a private placement to our Original Sponsor, generating gross proceeds of $650,000.

Subscription Agreement and Promissory Note – Related Party

On February 5, 2021, we issued the Promissory Note to an affiliate of our Sponsor, pursuant to which we could borrow up to an aggregate of $300,000 to cover expenses related to the Initial Public Offering. The Promissory Note was non-interest bearing and was payable on the earlier of (i) December 31, 2021 or (ii) the consummation of the Initial Public Offering. On August 6, 2021, we repaid the outstanding balance under the Promissory Note.

Subscription Agreement

On January 3, 2024, the Company, Mercury Capital and Investor entered into a Subscription Agreement, pursuant to which Mercury Capital may raise up to $1,500,000 from the Investor to fund extension payments and working capital for the Company, including $250,000 upon the execution of the Subscription Agreement, $250,000 on February 20, 2024, $250,000 on May 6, 2024, and as otherwise called by Mercury Capital in its discretion. At the closing of the Company’s Initial Business Combination, Mercury Capital will forfeit 0.85 Class B shares, and the Company will issue an equal number of shares of its common stock to the Investor, for each dollar funded by the Investor pursuant to the Subscription Agreement. If the Company’s Initial Business Combination does not occur, Mercury Capital will not forfeit any shares.

65In July 2024, the Company entered into a promissory note with Mercury Capital (the “Sponsor Promissory Note”), pursuant to which the Sponsor may loan up to $1,500,000 to the Company. The funds that will be loaned to the Company under the Sponsor Promissory Note consist of a portion of the up to $1,500,000 that was loan to the Sponsor by the Investor pursuant to the Subscription Agreement. If the Company completes a Business Combination, the Company would repay the Sponsor Promissory Note. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Sponsor Promissory Note, but no proceeds held in the Trust Account would be used to repay the Sponsor Promissory Note. Up to $1,500,000 of such loans may be convertible into warrants of the Company at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to the Private Placement Warrants. The Company accounts for the Sponsor Promissory Note within the scope of ASC 815 and has elected to bifurcate the embedded derivative within the convertible promissory note. The fair value of the embedded conversion feature upon the issuance of the Sponsor Promissory Note is de minimis.

On January 23, 2025, the Company entered into a promissory note with the Sponsor (the “Second Sponsor Promissory Note”), pursuant to which the Sponsor loaned $100,000 to the Company. The Second Sponsor Promissory Note bears no interest. The principal amount is to be repaid at the earlier of (i) the consummation of an Initial Business Combination, (ii) the date of liquidation, or (iii) 90 calendar days after entering into the promissory note. On May 6, 2025, the Second Sponsor Promissory Note was amended to extend the maturity date by an additional 180 calendar days, resulting in a new expiration date 270 calendar days from the original issuance. On March 30, 2026, the Second Sponsor Promissory Note was further amended to extend the maturity date to July 31, 2026. If the Company does not consummate the Business Combination or there is a liquidation, the Second Sponsor Promissory Note will not be repaid and the principal amount will be forgiven, except to the extent there are funds available to the Company outside of the Trust Account to make repayment. As of December 31, 2025, the total outstanding balance of the Sponsor Promissory Note and Second Sponsor Promissory Note is $2,124,867.

Administrative Support Agreement

The Company entered into an agreement, commencing on the effective date of the Initial Public Offering, to pay an affiliate of the Original Sponsor $55,000 per month for office space, secretarial and administrative support services. Upon the completion of an Initial Business Combination or liquidation, the Company will cease paying these monthly fees. For the ~~year~~years ended December 31, 2025 and 2024, the Company incurred no expenses under this agreement. ~~For the~~ ~~year ended December 31, 2023, the Company incurred expenses of $660,000 under this agreement and is included in operating and formation costs on the accompanying statement of operations.~~ In connection with the Purchase Agreement on December 27, 2023, the obligations of the Administrative Support Agreement transferred from the Original Sponsor to Sponsor. Any outstanding administrative support fees owed to the Sponsor as of December 27, 2023 were forgiven by the Original Sponsor and the agreement was then cancelled. As of December 31, ~~2024~~ 2025 and ~~2023~~2024, the Company had no outstanding balance for accrued expenses - related party.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our directors and officers may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”). If we complete a Business Combination, we would be obligated to repay the Working Capital Loans. In the event that a Business Combination does not close, we may use any available funds held outside the Trust Account to repay the Working Capital Loans, but no amounts held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, ~~2024~~2025, there were no Working Capital Loans outstanding.

Reimbursements – Related Party

For the year ended December 31, 2024, the Company had no payments to the Sponsor, officers and directors, or any of their respective affiliates as reimbursements for the operating costs of the Company and included within operating and formation costs within the accompanying statement of operations.

For the year ended December 31, 2023, the Company paid $18,738 to the Sponsor as reimbursements for the operating costs of the Company paid for by the Sponsor and included within operating and formation costs within the accompanying statement of operations.

Accounts Payable – Related Party

As of December 31, ~~2024~~2025 and ~~2023~~2024, $~~18,824~~0 and $018, 824, respectively, was payable by the Company to the Sponsor or other related parties for services related to the search for an initial ~~Business~~ Business Combination target.

Standby Equity Purchase Agreement

Item 14. Principal Accountant Fees and Services

The following is a summary of fees paid or to be paid to Marcum LLP, or Marcum, for services rendered.

Audit Fees. During the year ended December 31, ~~2024~~2025 and ~~2023~~2024, fees for our independent registered public accounting firm were approximately $~~254~~307,~~155~~058 and $93254,~~709~~155 for the services Marcum performed in connection with the audit of our December 31, ~~2024~~2025 and ~~2023~~2024 financial statements included in this Annual Report on Form ~~10K~~10-K.

Audit-Related Fees. During the year ended December 31, ~~2024~~2025 and ~~2023~~2024, ~~fees for~~ our independent registered public accounting firm ~~were~~did ~~approximately~~not $0render ~~and~~audit-related ~~$0 for the~~ services ~~Marcum performed in connection with our Initial Public Offering~~.

Tax Fees. During the year ended December 31, ~~2024~~2025 and ~~2023~~2024, our independent registered public accounting firm did not render services to us for tax compliance, tax advice and tax planning.

All Other Fees. During the year ended ~~December~~ December 31, ~~2024~~2025 and ~~2023~~2024, there were no fees billed for products and services provided by our independent registered public accounting firm other than those set forth above.

Pre-Approval Policy

Our audit committee was formed upon the consummation of our Initial Public Offering. As a result, the audit committee did not pre-approve all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit).

6676

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)

The following documents are filed as part of this Report:

(1) ~~Consolidated~~ Financial Statements:

(2)

Financial Statement Schedules:

None.

(3)

Exhibits:

We hereby file as part of this Report the exhibits listed in the attached exhibits index. Exhibits which are incorporated herein by reference can be inspected on the SEC website at www.sec.gov.

Exhibit No.		Description
2.1		Business Combination Agreement, dated August 22, 2024, by and among Plum Acquisition Corp. III, Plum III Amalco Corp., Plum III Merger Corp., and Tactical Resources Corp. (as incorporated by reference to Exhibit 2.1 in the Current Report on Form 8-K, filed with the SEC on August 23, 2025).
2.2		Amendment No. 1 to the Business Combination Agreement, dated December 10, 2024 by and between Plum Acquisition Corp. III and Tactical Resources Corp. (as incorporated by reference to Exhibit 2.1 in the Current Report on Form 8-K, filed with the SEC on December 11, 2024).
2.3		Amendment No. 2 to the Business Combination Agreement, dated January 28, 2025, by and between Plum Acquisition Corp. III and Tactical Resources Corp. (as incorporated by reference to Exhibit 2.3 in the Annual Report on Form 10-K filed with the SEC on March 28, 2025).
2.4		Amendment No. 3 to the Business Combination Agreement, dated July 30, 2025, by and between Plum Acquisition Corp. III and Tactical Resources Corp. (as incorporated by reference to Exhibit 2.1 in the Current Report on Form 8-K, filed with the SEC on August 1, 2025).
3.1		Amendment to Amended and Restated Memorandum and Articles of Association (as incorporated by reference to Exhibit 3.1 in the Current Report on Form 8-K, filed with the SEC on February 7, 2024).
3.2*		Third Amended and Restated Memorandum and Articles of Association.
3.2		Fourth Amended and Restated Memorandum and Articles of Association (as incorporated by reference to Exhibit 3.1 in the Current Report on Form 8-K, filed with the SEC on July 18, 2025).
4.1		Specimen Unit Certificate (Incorporated by reference to the corresponding exhibit to the Company’s Registration Statement on Form S-1/A (333-253221), filed with the SEC on March 12, 2021.
4.2		Specimen Ordinary Share Certificate (~~Incorporated~~incorporated by reference to the corresponding exhibit to the Company’s Registration Statement on Form S-1/A (File 333-253221), filed with the SEC on March 12, 2021.
4.3		Specimen Warrant Certificate (~~Incorporated~~incorporated by reference to the corresponding exhibit to the Company’s Registration Statement on Form S-1/A (File 333-253221), filed with the SEC on March 12, 2021).
4.4		Warrant Agreement, dated July 27, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (~~Incorporated~~incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-40677), filed with the SEC on July 30, 2021).
4.5		Description of Securities (Incorporated by reference to the corresponding exhibit to the Company’s Annual Report on Form 10-K (File No. 001-40677), filed with the SEC on March 31, 2022).
10.1		Purchase Agreement, dated December 27, 2023, by and among Alpha Partners Technology Merger Corp., Alpha Partners Technology Merger Sponsor LLC and Mercury Capital, LLC (incorporated by reference to Exhibit 10.1 in the Current Report on Form 8-K, filed with the SEC on January 5, 2024).
10.2		Subscription Agreement, dated January 3, 2024, by and among Palmeira Investment Limited, Alpha Partners Technology Merger Corp. and Mercury Capital, LLC (as incorporated by reference to Exhibit 10.2 the Current Report on Form 8-K, filed with the SEC on January 5, 2024).

6777

10.3		Form of Non-Redemption Agreement (as incorporated by reference to Exhibit 10.1 in the Current Report on Form 8-K, filed with the SEC on January 16, ~~2025~~2024).
10.4		Company Securityholder Support Agreement, dated August 22, 2024 by and among Plum III Merger Corp., Plum Acquisition Corp. III, Tactical Resources Corp. and certain securityholders of Tactical Resources Corp. (as incorporated by reference to Exhibit 10.1 in the Current Report on Form 8-K, filed with the SEC on August 23, ~~2025~~2024).
10.5		Sponsor Support Agreement, dated August 22, 2024, by and among Plum III Merger Corp., Plum Acquisition Corp. III, Tactical Resources Corp., Mercury Capital, LLC, Alpha Partners Technology Merger Sponsor LLC, and certain other shareholders of Plum Acquisition Corp. III (as incorporated by reference to Exhibit 10.2 in the Current Report on Form 8-K, filed with the SEC on August 23, ~~2025~~2024).
10.6		Sponsor Parties Lock-Up Agreement, dated August 22, 2024, by and among Plum III Merger Corp., Plum Acquisition Corp. III, Mercury Capital, LLC, Alpha Partners Technology Merger Sponsor LLC, and Kanishka Roy (as incorporated by reference to Exhibit 10.3 in the Current Report on Form 8-K, filed with the SEC on August 23, ~~2025~~2024).
10.7		Form of Key Company Securityholder Lock-Up Agreement (as incorporated by reference to Exhibit 10.1 in the Current Report on Form 8-K, filed with the SEC on August 1, 2025).
10.8		Amendment to the Sponsor Support Agreement, dated September 5, 2025, by and among Plum Acquisition Corp. III, Tactical Resources Corp., Plum III Merger Corp., Mercury Capital, LLC, Alpha Partners Technology Merger Sponsor LLC and certain shareholders of Plum (as incorporated by reference to Exhibit 10.1 in the Current Report on Form 8-K, filed with the SEC on September 9, 2025).
10.9		Amendment to the Purchase Agreement, dated September 5, 2025, by and among Mercury Capital, LLC, Plum and Alpha Partners Technology Merger Sponsor LLC (as incorporated by reference to Exhibit 10.2 in the Current Report on Form 8-K, filed with the SEC on September 9, 2025).
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
97.1		Incentive Compensation Recovery Policy of Plum Acquisition Corp. III (as incorporated by reference to Exhibit 97.1 in the Annual Report on Form 10-K filed with the SEC on July 1, 2024).
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.

**	Furnished.

6878

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

March 28, 2025	PLUM ACQUISITION CORP. III
April 1, 2026	PLUM ACQUISITION CORP. III
	/s/ Kanishka Roy
	Name:	Kanishka Roy
	Title:	President, Chief Executive Officer and Chairman

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

/s/ Kanishka Roy	President, Chief Executive Officer and Chairman	~~March~~April 281, ~~2025~~2026
Kanishka Roy
/s/ Steven Handwerker	Chief Financial Officer	~~March~~April 281, ~~2025~~2026
Steven Handwerker
/s/ Hume Kyle Hume Kyle	Director	~~March~~April 281, ~~2025~~2026
/s/ Alan Black Alan Black	Director	~~March~~April 281, ~~2025~~2026
/s/ David Sable David Sable	Director	~~March~~April 281, ~~2025~~2026

6979

PLUM ACQUISITION CORP. III

INDEX TO ~~CONSOLIDATED~~ FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm (PCAOB ID Number 688)	~~F-2~~	F-2
Balance Sheets as of December 31, 2024 and 2023	F-3
Balance Sheets as of December 31, 2025 and 2024		F-3
Statements of Operations for the years ended December 31, 2024, and 2023	F-4
Statements of Operations for the years ended December 31, 2025, and 2024		F-4
Statements of Changes in Shareholders’ Deficit for the years ended December 31, 2024, and 2023	F-5
Statements of Changes in Shareholders’ Deficit for the years ended December 31, 2025, and 2024		F-5
Statements of Cash Flows for the years ended December 31, 2024 and 2023	F-6
Statements of Cash Flows for the years ended December 31, 2025 and 2024		F-6
Notes to Financial Statements	~~F-7 – F-28~~	F-7 – F-26

F-1

~~REPORT~~Report OFof ~~INDEPENDENT~~Independent ~~REGISTERED~~Registered ~~PUBLIC~~Public ~~ACCOUNTING FIRM~~Accounting Firm

To the Shareholders and Board of Directors of ~~Plum Acquisition Corp. III~~

Plum Acquisition Corp. III

Opinion on the Financial Statements

We have audited the accompanying balance sheets of Plum Acquisition Corp. III. (the “Company”) as of December 31, ~~2024~~2025 and ~~2023~~2024, the related statements of operations, changes in shareholders’ deficit and cash flows for each of the two years in the period ended December 31, ~~2024~~2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, based on our audits, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, ~~2024~~ 2025 and ~~2023~~2024, and the results of its operations and its cash flows for each of the two years in the period ended December 31, ~~2024~~2025, in conformity with accounting principles generally accepted in the United States of America.

Explanatory Paragraph -- Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note 1 to the financial statements, the Company is a Special Purpose Acquisition ~~Corporation~~Company that was formed for the purpose of of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses on or before July 30, ~~2025~~2026 or such earlier date as shall be determined by the Company’s board of directors. The Company entered into a business combination agreement with a business combination target on August 22, 2024; however, ~~the~~there ~~completion of this transaction~~ is ~~subject to the approval of the Company’s shareholders among other conditions. There is~~ no assurance that the Company will ~~obtain the necessary approvals,~~ satisfy the required closing conditions, raise the additional capital it needs to fund its operations, and complete the transaction prior to July 30, ~~2025~~2026, if at all. The Company also has no approved plan in place to extend the business combination deadline and fund operations for any period of time after July 30, ~~2025~~ 2026, in the event that it is unable to complete a business combination by that date. These matters raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans with regard to these matters are also described in Note 1. The financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Marcum LLP

Marcum LLP

We have served as the Company’s auditor since 2021.

Houston, TXTexas

~~March~~April 281, ~~2025~~2026

F-2

PLUM ACQUISITION CORP. III

BALANCE SHEETS

	December 31, 2024			December 31, 2023
	December 31, 2025			December 31, 2024
ASSETS
Current assets:
Cash	$	2749,~~418~~870		$	—27,418
Prepaid expenses		367,~~706~~500			2536,~~885~~706
Due from Tactical		~~23,280~~—			—23,280
Extension contribution due from related parties		—			225,000
Due from Merger Co		27,500			—
Total current assets		8784,~~404~~870			~~250~~87,~~885~~404
Investments held in Trust Account		25,630,285			157,330,245
Cash held in Trust Account		494,421			25,630,285
Total Assets	$	25579,~~717,689~~291		$	~~157~~25,~~581~~717,~~130~~689
LIABILITIES AND SHAREHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	~~446~~1,~~328~~120,273		$	—446,328
Accounts payable - related party		~~18,824~~—			—18,824
Accrued expenses and other current liabilities		12,~~481~~780,~~813~~664			~~805~~1,481,813
Promissory note - related party		12,~~204~~124,867			—1,204,867
Total current liabilities		36,~~151~~025,~~832~~804			~~805~~3,151,832
Warrant liabilities		26,~~170~~585,~~651~~940			~~723~~2,~~550~~170,651
Total Liabilities		512,~~322~~611,~~483~~744			~~724~~5,~~355~~322,483
Commitments (Note 6)
Class A ordinary shares subject to possible redemption, 2,284,199 and 14,717,409 shares at redemption value of $11.22 and $10.71 per share at December 31, 2024 and 2023, respectively		25,630,285			157,555,245
Class A ordinary shares subject to possible redemption, 42,486 and 2,284,199 shares at redemption value of approximately $11.64 and $11.22 per share at December 31, 2025 and 2024, respectively		494,421			25,630,285
Shareholders’ Deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—			—
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 865,000 shares issued and outstanding at December 31, 2024 and 2023; excluding 2,284,199 and 14,717,409 shares subject to possible redemption, respectively, at December 31, 2024 and 2023		87			87
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 865,000 shares issued and outstanding at December 31, 2025 and 2024; excluding 42,486 and 2,284,199 shares subject to possible redemption as of December 31, 2025 and 2024, respectively		87			87
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 7,062,500 shares issued and outstanding		706			706
Accumulated deficit		(512,~~235~~527,~~872~~667	)		(~~699~~5,~~263~~235,872	)
Total Shareholders’ Deficit		(512,~~235~~526,~~079~~874	)		(~~698~~5,~~470~~235,079	)
Total Liabilities and Shareholders’ Deficit	$	25579,~~717,689~~291		$	~~157~~25,~~581~~717,~~130~~689

The accompanying notes are an integral part of the financial statements.

F-3

PLUM ACQUISITION CORP. III

STATEMENTS OF OPERATIONS

	Year Ended December 31, 2024			Year Ended December 31, 2023
	Year Ended December 31, 2025			Year Ended December 31, 2024
Operating and formation costs	$	32,~~023~~876,~~383~~506		$	~~833~~3,~~935~~023,383
Loss from operations		(32,~~023~~876,~~383~~506	)		(~~833~~3,~~935~~023,383	)
Other income:
Other income (expense):
Interest income on bank account		—			654
Interest and dividend income on cash held in Trust Account		92,034			1,909,255
Interest and dividend income on investments held in Trust Account		1,909,255			10,686,002
Loss on change in fair value of warrant liabilities		(4,415,289	)		(1,447,101	)
Deal termination income		—			374,975
Net loss	$	(7,199,761	)	$	(2,561,229	)
Gain on change in fair value of convertible promissory note - related party		—			95,941
Basic and diluted weighted average shares outstanding, Class A ordinary shares		231,228			4,186,548
Loss on change in fair value of warrant liabilities		(1,447,101	)		(241,183	)
Basic and diluted net loss per share, Class A ordinary shares	$	(0.88	)	$	(0.21	)
Gain on waiver of deferred underwriting commissions by underwriter allocated to Public Warrants		—			336,175
Basic and diluted weighted average shares outstanding, Non-redeemable Class A ordinary shares and Class B ordinary shares		7,927,500			7,927,500
Net (loss) income	$	(2,561,229	)	$	10,418,629
Basic and diluted net loss per share, Non-redeemable Class A ordinary shares and Class B ordinary shares	$	(0.88	)	$	(0.21	)
Basic weighted average shares outstanding, Class A ordinary shares		5,051,548			23,294,132
Basic and diluted net (loss) income per share, Class A ordinary shares	$	(0.21	)	$	0.34
Diluted weighted average shares outstanding, Class A ordinary shares		5,051,548			23,324,225
Diluted net (loss) income per share, Class A ordinary shares	$	(0.21	)	$	0.34
Basic and diluted weighted average shares outstanding, Class B ordinary shares		7,062,500			7,062,500
Basic and diluted net (loss) income per share, Class B ordinary shares	$	(0.21	)	$	0.34

The accompanying notes are an integral part of the financial statements.

F-4

PLUM ACQUISITION CORP. III

STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE YEAR ENDED DECEMBER 31, ~~2024~~ 2025 AND ~~2023~~2024

	Class A Ordinary Shares				Class B Ordinary Shares				Additional Paid-in			Accumulated			Total Shareholders’
	Shares		Amount		Shares		Amount		Capital			Deficit			Deficit
Balance as of December 31, 2022		865,000	$	87		7,062,500	$	706	$	—		$	(10,718,408	)	$	(10,717,615	)
Waiver of deferred underwriting commissions by underwriter		—		—		—		—		—			9,551,325			9,551,325
Deemed contribution for extension deposit from related party		—		—		—		—		225,000			—			225,000
Deemed contribution for forgiveness of accrued expenses – related party		—		—		—		—		125,940			—			125,940
Deemed contribution for forgiveness of Sponsor loans - related party		—		—		—		—		123,500			—			123,500
Deemed contribution for forgiveness of accounts payable – related party		—		—		—		—		325,194			—			325,194
Proceeds received in excess of initial fair value of convertible promissory note - related party (See Note 5)		—		—		—		—		1,060,559			—			1,060,559
Remeasurement of Class A ordinary shares to redemption amount as of December 31, 2023		—		—		—		—		(1,860,193	)		(9,950,809	)		(11,811,002	)
Net income		—		—		—		—		—			10,418,629			10,418,629
Balance as of December 31, 2023		865,000		87		7,062,500		706		—			(699,263	)		(698,470	)
Remeasurement of Class A ordinary shares to redemption amount as of December 31, 2024		—		—		—		—		(271,375	)		(1,862,880	)		(2,134,255	)
Deemed contribution for extension deposit from the Sponsor		—		—		—		—		112,500			—			112,500
Share based compensation		—		—		—		—		158,875			—			158,875
Reversal of deemed contribution for extension deposit from the Sponsor		—		—		—		—		—			(112,500	)		(112,500	)
Net loss		—		—		—		—		—			(2,561,229	)		(2,561,229	)
Contribution from the Sponsor of shares to be issued under non-redemption agreements		—		—		—		—		367,610			—			367,610
Finance cost of shares to be issued under non-redemption agreements		—		—		—		—		(367,610	)		—			(367,610	)
Balance as of December 31, 2024		865,000		87		7,062,500		706		—			(5,235,872	)		(5,235,079	)
Remeasurement of Class A ordinary shares to redemption amount		—		—		—		—		—			(92,034	)		(92,034	)
Net loss		—		—		—		—		—			(7,199,761	)		(7,199,761	)
Balance as of December 31, 2025		865,000		87		7,062,500		706		—			(12,527,667	)		(12,526,874	)

The accompanying notes are an integral part of the financial statements.

F-5

PLUM ACQUISITION CORP. III

STATEMENTS OF CASH FLOWS

	Year Ended December 31, 2024			Year Ended December 31, 2023
	Year Ended December 31, 2025			Year Ended December 31, 2024
Cash Flows from Operating Activities:
Net (loss) income	$	(2,561,229	)	$	10,418,629
Net loss	$	(7,199,761	)	$	(2,561,229	)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Interest and dividend income on investments held in Trust Account		(1,909,255	)		(10,686,002	)
Interest and dividend income on cash held in Trust Account		(92,034	)		(1,909,255	)
Stock-based Compensation		~~158,875~~—			—158,875
(Loss) gain on change in fair value of warrant liabilities		1,447,101			241,183
Loss on change in fair value of warrant liabilities		4,415,289			1,447,101
Gain on change in fair value of convertible promissory note - related party		—			(95,941	)
Gain on waiver of deferred underwriting commissions by underwriter		—			(336,175	)
Changes in operating assets and liabilities:
Prepaid expenses		~~(10~~29,~~821~~206	)		~~168~~(10,~~062~~821	)
Accounts payable		~~446~~673,~~328~~945			~~(38~~446,~~866~~328	)
Accounts payable - related party		(18,824	)		~~(15~~18,~~377~~824	)
Accrued expenses and other current liabilities		1,~~481~~298,~~008~~851			(1,~~213~~481,~~516~~008	)
Net cash used in operating activities		(~~929~~893,~~169~~328	)		(1929,~~558,003~~169	)
Cash Flows from Investing Activities:
Cash transferred into Trust Account		~~(450,000~~—	)		(~~900~~450,000	)
Due from Tactical		(23,280	)		—
Due from Merger Co		(27,500	)		—
Cash transferred from Trust Account to pay redeeming shareholders		134,059,215			140,838,808
Due from Tactical		23,280			(23,280	)
Net cash provided by investing activities		133,585,935			139,938,808
Cash transferred from Trust Account to pay redeeming shareholders		25,227,898			134,059,215
Net cash provided by investing activities		25,223,678			133,585,935
Cash Flows from Financing Activities:
Proceeds from advance from Sponsor		—			6,000
Proceeds for extension payments from the Old Sponsor		—			225,000
Repayment of advance from Sponsor		—			(6,000	)
Proceeds from promissory note - related party		920,000			—
Proceeds for extension payments from the Old Sponsor		225,000			—
Proceeds from convertible promissory note - related party		—			1,204,867
Proceeds from promissory note - related party		—			451,134
Payment of cash to redeeming shareholders		(25,227,898	)		(134,059,215	)
Proceeds from convertible promissory note - related party		1,204,867			1,280,000
Net cash used in financing activities		(24,307,898	)		(132,629,348	)
Payment of cash to redeeming shareholders		(134,059,215	)		(140,838,808	)
Net Change in Cash		22,452			27,418
Net cash used in financing activities		(132,629,348	)		(139,107,674	)
Cash - Beginning of period		27,418			—
Net Change in Cash		27,418			(726,869	)
Cash - End of period	$	49,870		$	27,418
Cash - Beginning of period		—			726,869
Cash - End of period	$	27,418		$	—
Non-cash investing and financing activities
Excess of cash received over fair value of convertible promissory note - related party	$	—		$	1,060,559
Contribution from the Sponsor of shares to be issued under non-redemption agreements	$	—		$	367,610
Waiver of deferred underwriting commissions by underwriter	$	—		$	9,551,325
Reclassification of Sponsor Extension Payment to Promissory Note - Related Party	$	—		$	112,500
Deemed contribution for forgiveness of accrued expenses – related party	$	—		$	125,940
Remeasurement of Class A ordinary shares subject to redemption to redemption value	$	92,034		$	2,134,255
Deemed contribution for forgiveness of Sponsor loans - related party	$	—		$	123,500
Deemed contribution for forgiveness of accounts payable – related party	$	—		$	325,194
Reclassification of Sponsor Extension Payment to Promissory Note - Related Party	$	112,500		$	—
Remeasurement of Class A ordinary shares subject to redemption to redemption value	$	2,134,255		$	11,811,002
Extension contribution due from related parties	$	—		$	225,000

The accompanying notes are an integral part of the financial statements.

F-6

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND LIQUIDITY

Plum Acquisition Corp. III (fka Alpha Partners Technology Merger Corp.) (the “Company”) is a blank check company incorporated in the Cayman Islands on February 5, 2021. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (aan ” “Initial Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Initial Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On December 27, 2023, the Company, the Original Sponsor (as defined below) and Mercury Capital, LLC (the “Sponsor”) entered into a purchase agreement (the “Purchase Agreement”), pursuant to which, at a closing on December 28, 2023 (the “Closing”), the Sponsor (i) purchased 3,902,648 Founder Units (as defined in Note 5) of the Company from the Original Sponsor, each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B share, which Founder Units are subject to forfeiture in certain circumstances, and (ii) became entitled to 70% of 2,030,860 Founder Units that the Original Sponsor placed in escrow at the Closing to the extent such Founder Units are allocated to investors who hold and do not redeem their Class A ordinary shares of the Company at the time of the Company’s Initial Business Combination, for an aggregate purchase price of $1. Subsequently, on January 26, 2024, the Company, the Original Sponsor, and the Sponsor entered into ana ~~amended~~first ~~purchase~~amendment ~~agreement~~to (the ~~“Amended~~ Purchase Agreement~~”),~~ to correct the number of shares that the Original Sponsor shall retain to be 665,000 Class A private placement units and 1,128,992 Class B founder units. On August 22, 2024, the Company, the Original Sponsor, and the Sponsor entered into a second amendment to Purchase Agreement (“Amendment No. 2 to the Purchase Agreement”) which revises the founder-unit forfeiture and transfer mechanics by requiring the acquirer to absorb all forfeitures or investor incentive transfers up to 2,030,860 founder units, allocating excess forfeitures 78% to the acquirer and 22% to the sponsor, while also establishing that 2,030,860 sponsor units will be held in escrow for potential transfer to sponsor anchors, with any remaining escrowed units allocated 70% to the acquirer and 30% to the sponsor at closing. On September 5, 2025, the Company, the Original Sponsor, and the Sponsor entered into a third amendment to Purchase Agreement (“Amendment No. 3 to the Purchase Agreement”) that provides that any Sponsor Incentive Units (as defined in the Sponsor Support Agreement) that have been retained by the Sponsor after the Closing, up to half of such Sponsor Incentive Units may be transferred prior to the Closing to a third party, with any Sponsor Incentive Units remaining after such transfer subject to allocation between the Sponsor and the Original Sponsor as provided for in the Purchase Agreement.

The Original Sponsor and the Sponsor each agreed to pay $112,500 in extension contributions in each of December 2023 and January 2024. As of December 31, 2023, there was a $112,500 deposit into the Trust Account due from the Sponsor and the Original Sponsor, respectively, representing the December 2023 extension contribution. On January 24, 2024, the second payment of $112,500 was deposited into the Trust Account. In addition, pursuant to the terms of the Purchase Agreement, the Original Sponsor agreed to pay, or cause its affiliates to pay, certain liabilities of the Company accrued and outstanding as of the Closing and will deliver Founder Units to the Sponsor to the extent such liabilities are unsatisfied or the Original Sponsor’s obligation to make extension contributions is not satisfied.

Following the Closing, the Original Sponsor has no further obligations with respect to the Company and the Sponsor assumed all obligations relating to the Company, including, (i) to cause the Company to file a proxy statement providing public investors of the Company with the option to accept a revised trust extension arrangement or redeem their Class A ordinary shares and receive their pro rata share of the Company’s Trust Account (as defined below), (ii) to cause the Company to satisfy all of its public reporting requirements as well as taking all action to cause the Company to remain listed on Nasdaq, (iii) the payment of all extension contributions after January 2024 and working capital of the Company, at the discretion of the Sponsor, and (iv) all other obligations of the Original Sponsor related to the Company.

As of December 31, ~~2024~~2025, the Company had not commenced any operations. All activity ~~for~~from ~~the~~inception ~~year~~through ~~ended~~ December 31, ~~2023~~2025, relates to the search for a prospective Initial Business Combination, entering into a definitive business combination agreement, and steps to complete an Initial Business Combination. The Company will not generate any operating revenues until after the completion of aan Initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest and dividend income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

The registration statement for the Company’s Initial Public Offering was declared effective on July 27, 2021. On July 30, 2021, the Company consummated the Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $250,000,000, which is discussed in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 800,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Alpha Partners Technology Merger Sponsor LLC (the “Original Sponsor”) and certain anchor investors (the “Anchor Investors”), generating gross proceeds of $8,000,000, which is described in Note 4.

F-7

The Company had granted the underwriters in the Initial Public Offering a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments, if any (see Note 6). On August 5, 2021, the underwriters partially exercised the over-allotment option and purchased an additional 3,250,000 Units (the “Over-Allotment Units”), generating gross proceeds of $32,500,000.

Simultaneously with the closing of the exercise of the over-allotment option, the Company consummated the sale of 65,000 units (the “Over-Allotment Private Placement Units”) at a purchase price of $10.00 per unit in a private placement to the Original Sponsor, generating gross proceeds of $650,000.

Upon closing of the Initial Public Offering, the sale of the Private Placement Units, the sale of the Over-Allotment Units, and the sale of the Over-Allotment Private Placement Units, a total of $282,500,000 was placed in a trust account (the “Trust Account”) and was invested only in U.S. government treasury obligations with maturities of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations, until January 8, 2024, when the funds in the Trust Account were transferred to a demand deposit account. The funds remain in the Trust Account until the earlier of: (i) the completion of a Initial Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.

~~The~~At ~~Company~~the ~~will~~extraordinary ~~provide~~general ~~the~~meeting ~~holders~~held ofon ~~its~~December ~~outstanding Public~~22, ~~Shares~~2025 (the “~~Public~~December ~~Shareholders~~2025 Extraordinary General Meeting”), ~~with~~ the ~~opportunity~~Company toshareholders ~~redeem~~approved ~~all~~the orBusiness aCombination ~~portion~~Agreement of(defined above) ~~their~~and ~~Public~~the ~~Shares~~transactions ~~upon~~contemplated ~~the completion~~thereby, ofincluding anthe ~~Initial~~ Business Combination ~~either~~ (idefined above). inIn connection with athe ~~shareholder~~December 2025 ~~meeting~~Extraordinary ~~called~~General toMeeting, ~~approve~~ the ~~Initial~~holders ~~Business Combination~~of or24,136 ~~(ii)~~Class byA ~~means~~ordinary ofshares, aproperly ~~tender~~exercised ~~offer.~~their ~~The~~right ~~decision as~~ to ~~whether~~redeem ~~the~~their ~~Company~~shares for ~~will~~cash ~~seek~~at ~~shareholder approval of~~ a ~~Initial~~redemption ~~Business Combination~~price orof ~~conduct~~approximately a$11.61 ~~tender~~per ~~offer~~share, ~~will~~for bean ~~made~~aggregate byredemption ~~the~~amount ~~Company,~~of ~~solely~~$ ~~in its discretion~~280,219. The ~~Public~~redemption ~~Shareholders~~is ~~will be entitled~~contingent toupon ~~redeem~~the ~~their~~consummation ~~Public~~of ~~Shares~~the ~~for~~Business aCombination ~~pro~~and ~~rata~~will ~~portion~~occur ofas ~~the~~promptly ~~amount~~as ~~then~~practicable infollowing the ~~Trust~~closing ~~Account~~thereof; ~~(initially~~if ~~$10.00~~the ~~per Public Share, plus~~Business ~~any~~Combination ~~pro~~is ~~rata~~not ~~interest~~consummated, ~~earned on~~ the ~~funds~~redeemed ~~held~~shares inwill ~~the~~be ~~Trust~~returned ~~Account and not previously released~~ to the ~~Company~~respective ~~to pay its tax obligations)~~holders. There will be no redemption rights upon the completion of an Initial Business Combination with respect to the Company’s warrants.

IfThe ~~the~~ Company’s ~~seeks~~Original ~~shareholder approval~~Sponsor, ~~the~~officers and directors have agreed ~~Company~~to ~~will~~waive ~~proceed~~(i) ~~with~~redemption anrights ~~Initial~~with ~~Business~~respect ~~Combination~~to iftheir aFounder ~~majority~~Shares ofand ~~the~~Public ~~shares~~Shares ~~voted~~held ~~are~~by ~~voted~~them in ~~favor~~connection ofwith the completion of an Initial Business Combination., If(ii) aredemption ~~shareholder~~rights ~~vote~~with isrespect ~~not~~to ~~required~~any byFounder ~~law~~Shares and ~~the~~Public ~~Company~~Shares ~~does~~held ~~not~~by ~~decide~~them toin ~~hold~~connection with a shareholder vote ~~for~~to ~~business~~approve ~~or other~~an ~~reasons,~~amendment ~~the Company will, pursuant~~ to ~~its third amended and restated memorandum and articles of association (~~the ~~“Third~~ Fourth Amended and Restated Memorandum and Articles of Association~~”),~~ ~~conduct~~that would modify the ~~redemptions~~substance ~~pursuant~~or totiming of the ~~tender~~obligation ~~offer~~to ~~rules~~provide holders of the ~~U.S.~~ ~~Securities~~Class ~~and~~A ~~Exchange~~ordinary ~~Commission~~shares ~~(“SEC”)~~the ~~and~~right ~~file~~to ~~tender~~have ~~offer~~their ~~documents~~shares ~~with~~redeemed ~~the~~in connection ~~SEC~~with ~~prior~~an ~~to completing a~~ Initial Business Combination. ~~If,~~or ~~however,~~to ~~shareholder~~redeem ~~approval~~100% of the ~~transaction~~Public isShares ~~required~~if ~~by law, or~~ the Company ~~decides~~does tonot ~~obtain~~complete ~~shareholder approval~~an ~~for~~Initial ~~business~~Business Combination orby ~~other~~July ~~reasons~~30, ~~the~~2026 ~~Company~~or ~~will~~with ~~offer~~respect to ~~redeem~~any ~~shares~~other inprovision ~~conjunction~~relating ~~with~~to athe ~~proxy~~rights ~~solicitation~~of ~~pursuant~~holders to of the ~~proxy~~Class ~~rules~~A ~~and~~ordinary ~~not~~shares ~~pursuant~~or pre-Initial toBusiness ~~the~~Combination ~~tender~~activity ~~offer~~and ~~rules.~~(iii) Ifrights ~~the~~to ~~Company~~liquidating ~~seeks~~distributions ~~shareholder~~from ~~approval~~the inTrust ~~connection~~Account with arespect ~~Business~~to ~~Combination,~~any Founder ~~the~~Shares ~~Original~~held ~~Sponsor~~if ~~has~~the ~~agreed~~Company fails to ~~vote~~complete ~~its~~an ~~Founder~~Initial ~~Shares~~Business ~~(as~~Combination ~~defined~~by inJuly ~~Note~~30, 5)2025. ~~and~~However, ~~any~~if ~~Public~~the ~~Shares~~Sponsor ~~purchased during~~ or ~~after~~officers ~~the~~and ~~Initial~~directors acquire Public ~~Offering~~Shares in ~~favor~~or ofafter ~~approving~~the an Initial ~~Business~~Public ~~Combination. Additionally~~Offering, ~~each~~such ~~public~~Public ~~shareholder~~Shares ~~may~~will ~~elect~~be entitled to ~~redeem~~liquidating distributions ~~their~~from ~~Public~~the ~~Shares~~Trust ~~irrespective~~Account ofif ~~whether~~the ~~they~~Company ~~vote~~fails ~~for~~to orcomplete ~~against~~an ~~the~~Initial ~~proposed~~Business ~~transaction~~Combination orby ~~don’t~~July ~~vote~~30, ~~at all~~2026.

Notwithstanding the above, if the Company seeks shareholder approval of an Initial Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Third Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

F-8

The Company’s Original Sponsor, officers and directors have agreed to waive (i) redemption rights with respect to their Founder Shares and Public Shares held by them in connection with the completion of an Initial Business Combination, (ii) redemption rights with respect to any Founder Shares and Public Shares held by them in connection with a shareholder vote to approve an amendment to the Third Amended and Restated Memorandum and Articles of Association that would modify the substance or timing of the obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with an Initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete an Initial Business Combination by July 30, 2025 or with respect to any other provision relating to the rights of holders of the Class A ordinary shares or pre-Initial Business Combination activity and (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held if the Company fails to complete an Initial Business Combination by July 30, 2025. However, if the Sponsor or officers and directors acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete an Initial Business Combination by July 30, 2025.

The Company previously had until 24 months from the closing of the Initial Public Offering to complete an Initial Business Combination. On July 27, 2023, the Company’s shareholders approved a proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company must consummate an Initial Business Combination from July 30, 2023 to July 30, 2024. On February 1, 2024, the Company’s shareholders approved a proposal to further amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company must consummate an Initial Business Combination from July 30, 2024 to January 30, 2025.

On January 16, 2025, as approved by its shareholders at the extraordinary general meeting of shareholders, the Company filed an amendment to its ~~amended~~Second Amended and ~~restated~~Restated ~~memorandum~~Memorandum and ~~articles~~ Articles of ~~association~~ Association on January 17, 2025, which (i) extended the date by which the Company has to consummate a business combination to July 30, 2025 ~~(the “Combination Period”)~~, or such earlier date as shall be determined by the Company’s board of directors ~~(the~~ ~~“Extension Proposal”)~~ and (ii) amended Article 49.4 to remove language stating, in relevant part, that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, such business combination ~~(the “NTA Proposal”)~~.

IfOn ~~the~~July ~~Company~~15, ~~is unable to complete an Initial Business Combination within the Combination Period~~2025, ~~the Company will (i) cease all operations except for the purpose of winding up; (ii)~~ as ~~promptly~~approved asby ~~reasonably~~its ~~possible,~~shareholders ~~but~~at ~~not more than ten business days thereafter, redeem~~ the ~~Public Shares, at a per-share price, payable~~extraordinary ingeneral ~~cash,~~meeting ~~equal~~of ~~to the aggregate amount then on deposit in the Trust Account~~shareholders, ~~including interest earned on~~ the ~~funds held in the Trust Account and not previously released to the~~ Company tofiled ~~pay~~an ~~the~~amendment ~~income taxes, if any (less up~~ to ~~$100,000~~its ofThird ~~interest~~Amended toand ~~pay~~Restated ~~dissolution expenses),~~Memorandum ~~divided~~and byArticles ~~the number~~ of ~~the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’~~Association ~~rights~~ (as ~~shareholders~~amended, ~~(including~~ the ~~right~~“Fourth toAmended ~~receive~~and ~~further~~Restated ~~liquidation~~Memorandum ~~distributions,~~and ifArticles ~~any);~~of ~~and (iii~~Association”) ason ~~promptly~~July as16, ~~reasonably possible following such redemption~~2025, ~~subject~~which toextended the date ~~approval~~by ofwhich the ~~remaining~~Company ~~shareholders~~has ~~and~~to ~~the~~consummate ~~board~~a ofbusiness ~~directors,~~combination ~~liquidate~~to ~~and~~July ~~dissolve~~30, ~~subject~~ in2026 (the ~~case~~“Second ofCombination ~~clauses (ii~~Period”) ~~and (iii)~~, ~~to the obligations under Cayman Islands law to provide for claims of creditors and the~~or ~~requirements~~such ofearlier ~~other~~date ~~applicable~~as ~~law.~~shall ~~There will~~ be nodetermined ~~redemption~~by ~~rights or liquidating distributions with respect to~~ the Company’s ~~warrants,~~ ~~which~~board ~~will~~of ~~expire worthless if the Company fails to complete an Initial Business Combination within the Combination Period~~directors.

On August 22, 2024, the Company entered into a business combination agreement (the “Business Combination Agreement”) with a corporation formed under the Laws of the Province of British Columbia (“PubCo”) and Tactical Resources Corp., a corporation formed under the Laws of the Province of British Columbia (“Tactical”), pursuant to which the Company will amalgamate pursuant to a Plan of Arrangement under the Business Corporations Act of British Columbia (“BCBCA”) to form one corporate entity, except that the legal existence of Pubco will not cease and Pubco will survive the amalgamation, following its redomicile into the Province of British Columbia, Canada.F-8

OnIf ~~December~~the ~~10,~~Company ~~2024,~~is ~~the~~unable ~~Company,~~to ~~and~~complete ~~Tactical~~an Initial Business Combination ~~entered~~within ~~into~~the anSecond ~~amendment~~Combination Period (as defined above), the ~~“Amendment~~Company ~~No.~~will 1”(i) tocease all operations except for the ~~Business~~purpose ~~Combination~~of ~~Agreement~~winding up; (ii) as promptly as reasonably possible, ~~Amendment~~but ~~No.~~not 1more ~~provides~~than ~~that~~ten business days thereafter, ~~among other~~redeem ~~things~~the Public Shares, ~~upon~~at a ~~delisting~~per-share ~~from~~price, payable ~~The~~in ~~Nasdaq~~cash, ~~Stock~~equal ~~Market~~to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will ~~use~~completely ~~commercially~~extinguish ~~reasonable~~Public ~~efforts~~Shareholders’ rights as shareholders (including the right to ~~list~~receive ~~its~~further ~~securities~~liquidation distributions, if any); and (iii) as promptly as reasonably onpossible following such redemption, subject to the ~~OTC~~approval ~~Markets~~of ~~Group.~~the Asremaining ashareholders ~~condition~~and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to ~~closing~~the obligations under Cayman Islands law to provide for claims of creditors and the requirements ~~Business~~of ~~Combination~~other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company ~~must~~fails ~~relist~~to ~~its~~complete ~~securities~~an onInitial ~~The~~Business ~~Nasdaq~~Combination ~~Stock Market~~within the Second Combination Period.

On December 10, 2024, the Company, and Tactical entered into an amendment (the “Amendment No. 1”) to the Original Business Combination Agreement, Amendment No. 1 provides that, among other things, upon a delisting from The Nasdaq Stock Market, the Company will use commercially reasonable efforts to list its securities on the OTC Markets Group. As a condition to closing the Business Combination, the Company must relist its securities on The Nasdaq Stock Market.

On January 28, 2025, the Company and Tactical entered into Amendment No. 2 (the “Amendment No. 2”) to the Original Business Combination Agreement. Amendment No. 2 provides that certain recently issued convertible debentures of Tactical (and future issuances of convertible debentures by Tactical, if any, to the extent permitted under the Business Combination Agreement) shall be subject to the same terms under the Business Combination Agreement, and shall be subject to the same treatment upon closing of the business combination contemplated by the Original Business Combination Agreement, as certain existing convertible debentures issued by Tactical and already subject to the terms of the Business Combination Agreement.

The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account.

On July 30, 2025, the Company and Tactical entered into Amendment No. 3 (the “Amendment No. 3”) to the Original Business Combination Agreement. Amendment No. 3 provides for (a) an acknowledgement that Tactical may effect a reverse stock split prior to the closing at a ratio not to exceed 25 to 1; (b) an extension of the Agreement End Date (as defined in the Business Combination Agreement) to July 30, 2026; and (c) a lock-up of certain PubCo shares to be issued in the Business Combination. Specifically, Amendment No. 3 provides that 80% to 85% of the PubCo shares to be issued to stockholders of Tactical (the “Arrangement Consideration Shares”) shall be subject restrictions on transfer for a period of six months following the closing. In connection with Amendment No. 3, certain employees and affiliates of Tactical have entered into a Key Company Securityholder Lock-up Agreement whereby each of them has agreed that 100% of the Arrangement Consideration Shares issued to them shall be subject to restrictions on transfer for a period of six months following the closing.

On September 5, 2025, the Company, Tactical, Pubco, the Sponsor, and the Original Sponsor and certain shareholders of Plum entered into an amendment (the “Sponsor Support Agreement Amendment”) to the Sponsor Support Agreement, dated as of August 22, 2024 (as amended, the “Sponsor Support Agreement”).

The Sponsor Support Agreement Amendment provides that, immediately prior to the Closing of the Business Combination, to the extent that any Sponsor Incentive Units (as defined in the Sponsor Support Agreement) have not been transferred by the Sponsor to PIPE Investors, Plum shareholders or other third parties as provided for in the Sponsor Support Agreement, such remaining Sponsor Incentive Units will be retained by the Sponsor subject to vesting based on the achievement of certain trading prices of the Pubco Common Shares after the Closing, as described in more detail in the Sponsor Support Agreement Amendment. In the event that such trading prices have not been achieved on or before the tenth anniversary of the Closing, such Sponsor Incentive Units shall be surrendered to Pubco for cancellation for no consideration and shall cease to represent any interest in Pubco, effective as of such date.

F-9

On ~~January~~November 287, 2025, ~~the~~Pubco, ~~Company~~Tactical and ~~Tactical~~YA II PN, Ltd., a Cayman Islands exempted company (“Yorkville”) entered into ~~Amendment~~a ~~No.~~standby 2equity purchase agreement (the “~~Amendment~~SEPA”) ~~No.~~and 2a registration rights agreement (the “Registration Rights Agreement”). Pursuant to the ~~Business~~SEPA, ~~Combination~~Yorkville ~~Agreement.~~will ~~Amendment~~open ~~No.~~a 2standby ~~provides~~equity ~~that~~line for ~~certain~~Pubco ~~recently~~in ~~issued~~the ~~convertible~~aggregate ~~debentures~~principal amount of ~~Tactical~~up ~~(and~~to ~~future~~$100,000,000. ~~issuances~~Additionally, Yorkville will advance $7,500,000 to Pubco in the form of a ~~convertible~~pre-paid ~~debentures~~advance evidenced by ~~Tactical~~a convertible promissory note on the closing of the Business Combination, ifand ~~any~~another $2,500,000 to ~~the~~Pubco ~~extent~~in ~~permitted~~the ~~under~~form of a second pre-paid advance with an equivalent note that is not convertible on the ~~Business~~date ~~Combination~~the ~~Agreement)~~initial ~~shall~~registration bestatement on ~~subject~~form F-1, filed pursuant to the ~~same~~Registration ~~terms~~Rights ~~under~~Agreement in connection with the ~~Business~~SEPA, ~~Combination~~becomes ~~Agreement~~effective. $30, ~~and~~000,000 ~~shall~~may be ~~subject~~ available to Pubco in the ~~same~~form ~~treatment~~of ~~upon~~a ~~closing~~third ofpre-paid ~~the~~advance ~~business~~with ~~combination~~an ~~contemplated~~equivalent convertible note at such time as agreed to by the ~~Business~~Yorkville ~~Combination~~and ~~Agreement~~Pubco (collectively, the “~~Business~~Yorkville ~~Combination~~Financing”),. asEach ~~certain~~of ~~existing~~the ~~convertible~~pre-paid ~~debentures~~advances ~~issued~~is bysubject ~~Tactical~~to an original issue discount, and ~~already~~further advances under the standby equity line are subject to conditions specified in the ~~terms~~SEPA. The SEPA expires on the earlier of 36 months or use of all $100,000,000. The Company evaluated the ~~Business~~advances ~~Combination~~under ~~Agreement~~applicable accounting guidance and concluded that the instruments represent freestanding equity-linked financial instruments that are not eligible for equity classification due to contractual delivery limitations that may restrict the number of shares deliverable to the investor. Accordingly, the advances will be accounted for as derivative liabilities, measured at fair value with changes in fair value recognized in earnings. No advances were outstanding as of December 31, 2025.

~~The~~In ~~underwriters~~addition, ~~have~~on ~~agreed~~November to7, ~~waive~~2025, ~~their~~the ~~rights to~~Sponsor ~~their~~entered ~~deferred~~into ~~underwriting~~an ~~commission~~Expenses Payment ~~(see~~Agreement ~~Note~~with 6)the ~~held~~investor inpursuant to which the ~~Trust~~sponsor ~~Account~~agreed into ~~the~~transfer ~~event~~1,000,000 ~~the~~Class ~~Company~~B ~~does~~ordinary ~~not~~shares ~~complete~~to anthe ~~Initial~~investor ~~Business~~to ~~Combination~~facilitate ~~within~~ the ~~Combination~~payment ~~Period~~of ~~and,~~up into ~~such~~$7.0 ~~event,~~million ~~such~~of ~~amounts~~certain ~~will~~expenses berelated ~~included~~to ~~with~~ the ~~other~~SEPA ~~funds~~and ~~held in~~ the ~~Trust~~ ~~Account~~business ~~that~~combination. ~~will~~The beCompany ~~available~~determined that tothis ~~fund~~arrangement represents the ~~redemption~~settlement of ~~the~~its ~~Public~~obligations ~~Shares.~~by Ina ~~the~~principal ~~event~~stockholder ~~of such distribution~~and, itin isaccordance ~~possible~~with ~~that~~applicable guidance, records the ~~per~~related ~~share~~expenses ~~value~~with ofa ~~the~~corresponding ~~assets~~credit ~~remaining~~to ~~available~~additional ~~for~~paid-in ~~distribution~~capital. ~~will~~As beof ~~less~~December ~~than~~31, ~~the~~2025, ~~Initial~~no ~~Public~~expenses ~~Offering~~related ~~price~~to the ~~per~~SEPA ~~Unit~~had ~~($10~~been incurred.~~00).~~

On January 15, 2025, and with immediate effect, Mr. Michael Dinsdale resigned his position as a member of the board of directors (the “Board”) of Plum Acquisition Corp. III (the “Company”). Mr. Dinsdale was a member of the Board’s audit committee and chairman of the Board’s nominating committee. Mr. Dinsdale’s resignation was not the result of any disagreement with the Company on any matter relating to its operation, policies or practices.

On January 15, 2025 and with immediate effect, the Board appointed Mr. Hume Kyle to fill the vacancy resulting from Mr. Dinsdale’s resignation, to serve the remainder of Mr. Dinsdale’s term and to hold office until a successor is appointed or Mr. Kyle’s appointment is ratified. Mr. Kyle was also appointed as a member of the audit committee and as chairman of the nominating committee.

On January 16, 2025, as approved by its shareholders at the extraordinary general meeting of shareholders, the Company filed an amendment to its amended and restated memorandum and articles of association on January 17, 2025, which (i) extended the date by which the Company has to consummate a business combination to July 30, 2025, or such earlier date as shall be determined by the Company’s board of directors and (ii) amended Article 49.4 to remove language stating, in relevant part, that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, such business combination (the “NTA Proposal”).

On February 21, 2025, Plum III Merger Corp. (“Merger Co.”) filed Amendment No. 1 to the Registration Statement on Form F-4 pursuant to which the Company will solicit approval of the Business Combination from the Company’s shareholders. On March 28, 2025, Merger Co. filed Amendment No. 2 to the Registration Statement on Form F-4. On May 22, 2025, Merger Co. filed Amendment No. 3 to the Registration Statement on Form F-4. On June 27, 2025, Merger Co. filed Amendment No. 4 to the Registration Statement on Form F-4. On September 8, 2025, Merger Co. filed Amendment No. 5 to the Registration Statement on Form F-4. On October 17, 2025, Merger Co. filed Amendment No. 6 to the Registration Statement on Form F-4. On November 10, 2025, Merger Co. filed Amendment No. 7 to the Registration Statement on Form F-4 (as amended, the “Form F-4”). On December 1, 2025, the proxy statement/prospectus was filed and the Form F-4 became effective.

In order to protect the amounts held in the Trust Account, the Original Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective partner business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay tax obligations, provided that such liability will not apply to any claims by a third party or prospective partner business that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Original Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective partner businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

F-10

Extraordinary General Meeting

On July 27, 2023, the Company held an Extraordinary General Meeting (the “July Extraordinary General Meeting”) whereby the shareholders approved an amendment to the amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”). The Amended and Restated Memorandum and Articles of Association extended the date by which the Company has to consummate a business combination from July 30, 2023 to July 30, 2024, or such earlier date as shall be determined by the Company’s board of directors. In connection with the July Extraordinary General Meeting, the holders of 13,532,591 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of approximately $140,838,808. After those redemptions, approximately $153,169,659 remained in the Company’s trust account.

On January 29, 2024, the Company held an Extraordinary General Meeting (the “Extraordinary General Meeting”) whereby shareholders of the Company approved an amendment to the Company’s Amended and Restated Memorandum and Articles of Association in order to (i) extend the date by which the Company must consummate its initial business combination, cease its operations and redeem all of its Class A ordinary shares (the “Extension Proposal”) to January 30, 2025, or such earlier date as shall be determined by the Company’s board of directors and (ii) changed the name of the Company from Alpha Partners Technology Merger Corp. to Plum Acquisition Corp. III.

F-10

In connection with the Extension Proposal, the Founder Share Amendment Proposal and the Redemption Limitation Proposal, the holders of 12,433,210 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.78 per share, for an aggregate redemption amount of $134,059,215. The payments for these redemptions took place on February 27, 2024, after which $24,629,032 remained in the Company’s Trust Account. As a result of the Extension Proposal being approved by the Company’s shareholders, the Original Sponsor, or its designee is no longer required to make monthly payments to the Company equal to the lesser of (a) an aggregate of $225,000 or (b) $0.03 per public share that remains outstanding. On August 2, 2023, September 7, 2023, October 10, 2023, November 10, 2023, January 10, 2024, and January 25, 2024 $225,000, or $1,350,000 in the aggregate, was deposited into the Company’s Trust Account.

On January 16, 2025, as approved by its shareholders at the extraordinary general meeting of shareholders, the Company filed an amendment to its Second Amended and Restated Memorandum and Articles of Association ~~(as amended, the “A&R Charter”)~~ on January 17, 2025, which (i) extended the date by which the Company has to consummate a business combination to July 30, 2025 ~~(the “Combination Period”)~~, or such earlier date as shall be determined by the Company’s board of directors ~~(the “Extension Proposal”)~~ and (ii) amended Article 49.4 to remove language stating, in relevant part, that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, such business combination ~~(the “NTA Proposal”)~~. The holders of 2,132,~~336~~366 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of $11.24 per share, for an aggregate redemption amount of $23,975,464. After the redemptions, $1,707,149 remained in the Company’s Trust Account.

~~Letter~~On July 15, 2025, as approved by its shareholders at the extraordinary general meeting of ~~Intent~~shareholders, the Company filed an amendment to its Third Amended and Restated Memorandum and Articles of Association on July 16, 2025, which extended the date by which the Company has to consummate a business combination to July 30, 2026, or such earlier date as shall be determined by the Company’s board of directors. The holders of 109,347 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.45 per share, for an aggregate redemption amount of $1,252,434.

On ~~July~~December 2622, ~~2023~~2025, ~~the~~as ~~Company~~approved ~~signed~~by aits ~~non-binding~~shareholders at the extraordinary ~~letter-~~general meeting of~~-intent~~ ~~(“LOI”)~~shareholders, ~~for~~as aof the close of business ~~combination~~on ~~with~~November ~~Glowforge~~7, ~~Inc.~~2025, the record date for the meeting, whereby the shareholders approved (~~“Glowforge”~~1), ~~creator~~the transfer of ~~award-winning 3D~~Plum ~~laser~~by ~~printers.~~way ~~Under~~of continuation from the ~~terms~~Cayman ofIslands to the ~~LOI~~Province of British Columbia, Canada in accordance with the Company’s Fourth Amended and ~~Glowforge~~Restated ~~would~~Memorandum ~~become~~and Articles of Association and the Cayman Islands Companies Act (As Revised) and the domestication of the Company (the “Domestication”) as a ~~combined~~British ~~entity,~~Columbia corporation in accordance with ~~Glowforge’s~~the ~~existing~~applicable ~~equity~~provisions ~~holders~~of ~~rolling~~the ~~100%~~Business ofCorporations ~~their~~Act ~~equity~~(British ~~into~~Columbia), including the ~~combined~~adoption ~~public~~of ~~company.~~the InDomestication Articles (the ~~fourth~~“Domestication Proposal”), ~~quarter~~(2) ofthe ~~2023~~Business Combination Proposal, ~~the~~(3) ~~LOI~~Advisory ~~was~~Organizational ~~terminated~~Documents Proposals, (4) Nasdaq Proposal, (5) Incentive Plan Proposal and (6) Adjournment Proposal.

AsOn ~~part~~December 22, 2025, the holders of a24,136 ~~terminated~~Class ~~LOI~~A ordinary shares, ~~the~~properly ~~Company~~exercised ~~received payment~~their ~~from~~right ato ~~previous~~redeem ~~business~~their ~~combination~~shares ~~target~~for ~~entity~~cash at a redemption price of approximately $~~374~~11.61 per share,~~975~~ onfor ~~April~~an ~~13,~~aggregate ~~2023.~~redemption ~~That~~amount ~~balance~~of ~~represented~~$280,219. aThe ~~penalty~~redemption ifis ~~the~~contingent ~~target~~upon ~~entity~~the ~~terminated~~consummation of the ~~agreement.~~Business ~~The~~Combination ~~target~~and ~~entity~~will ~~reimbursed~~occur ~~the~~as ~~Company~~promptly ~~for~~as ~~transaction~~practicable ~~expenses~~following ~~and~~the ~~merger-related~~closing ~~activities~~thereof; ~~incurred~~if the Business ~~through~~Combination ~~that~~is ~~date~~not ~~related~~consummated, tothe aredeemed ~~prospective~~shares ~~merger~~will ~~which~~be ~~was~~returned ~~not~~to ~~completed~~the respective holders.

Notices from the Listing Qualifications Department of The Nasdaq

On July 30, 2024, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has failed to comply with Nasdaq Listing Rule IM-5101-2, which requires that a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement.

Pursuant to the Notice, unless the Company timely requests a hearing before The Nasdaq Hearings Panel (the “Panel”), the Company’s securities will be subject to suspension and delisting from The Nasdaq Capital Market at the opening of business on August 6, 2024, and a Form 25F-~~NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq.~~11

Pursuant to the Notice, unless the Company timely requests a hearing before The Nasdaq Hearings Panel (the “Panel”), the Company’s securities will be subject to suspension and delisting from The Nasdaq Capital Market at the opening of business on August 6, 2024, and a Form 25-NSE will be filed with the U.S. Securities and Exchange Commission (“the SEC”), which will remove the Company’s securities from listing and registration on Nasdaq.

The Company timely requested a hearing before the Panel to appeal the Notice and to request sufficient time to complete an initial business combination. A hearing request will stay the suspension of trading on the Company’s securities, and the Company’s securities will continue to trade on The Nasdaq Capital Market until the hearing process concludes and the Panel issues a written decision.

The hearing with the Panel was held on September 5, 2024. On September 23, 2024, the Company received notice from the Nasdaq Office of the General Counsel that the Panel has granted the Company’s request for continued listing on Nasdaq. As disclosed on August 5, 2024, the Company received notice from the Listing Qualifications Department of Nasdaq indicating that the Company has failed to comply with Nasdaq Listing Rule IM-5101-2, which requires that a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. The Panel has granted the Company’s request for continued listing provided that on or before January 27, 2025, the Company will demonstrate compliance with all applicable initial listing standards for the Nasdaq Capital Market.

F-11

On August 8, 2024, the Company received a written notice (the “Second Notice”) from the Listing Qualifications Department of Nasdaq indicating that, for the last 32 consecutive business days, the Market Value of Listed Securities (“MVLS”) for the Company was below the $35 million minimum MVLS requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). The Second Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities.

On November 21, 2024, Nasdaq provided the Company with written confirmation that the Company regained compliance with the MVLS Rule.

On November 25, 2024, the Company received a written notice from the Nasdaq indicating that the Company is delinquent in filing its quarterly report on Form 10-Q for the quarterly period ended September 30, 2024. The Notice has no immediate effect on the listing of the Company’s ordinary share or its public warrants on The Nasdaq Capital Market. Pursuant to the Notice, this matter serves as an additional basis for delisting the Company’s securities from the Nasdaq in light of the Company’s previously reported failure to complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement in accordance with Nasdaq Listing Rule IM-5101-2.

On January 28, 2025, Plum Class A ordinary shares, warrants and units were listed and began trading on the Pink Current tier of the OTC Markets. Plum’s Class A ordinary shares, warrants and units are listed under the symbols “PLMJF”,” “PLMWF”,” and “PLMUF”,” respectively.

Liquidity and Going Concern

As of December 31, ~~2024~~2025, the Company had $2749,~~418~~ 870 in cash held outside of the Trust Account and a working capital deficit of $35,~~064~~940,~~428~~934, which may not be sufficient for the Company to operate for at least the next 12 months from the issuance of the financial statements. There is no assurance that the Company’s attempts to close an Initial Business Combination will be successful within the Second Combination Period. On January 3, 2024, the Company, the Sponsor and Palmeira Investment Limited (the “Investor”) entered into a subscription agreement (the “Subscription Agreement”), pursuant to which the Sponsor may raise up to $1,500,000 from the Investor to fund extension payments and working capital for the Company, including $250,000 upon the execution of the Subscription Agreement, $250,000 on February 1, 2024, and as otherwise called by the Sponsor in its discretion. At the closing of the Company’s initial business combination, the Sponsor will forfeit 0.85 Class B shares, and the Company will issue an equal number of shares of its ordinary share to the Investor, for each dollar funded by the Investor pursuant to the Subscription Agreement.

In July 2024, the Company entered into a promissory note with the Sponsor (the “Sponsor Promissory Note”), pursuant to which the Sponsor may loan up to $1,500,000 to the Company. The funds that will be loaned to the Company under the Sponsor Promissory Note consist of a portion of the up to $1,500,000 that was loan to the Sponsor by the Investor. Up to $1,500,000 of such loans may be convertible into Private Placement Warrants of the Company, at a price of $1.50 per warrant at the option of the Sponsor. On April 24, 2025, the Company and Sponsor entered an amendment to increase the maximum amount of the Sponsor Promissory Note to $2,200,000 and up to $2,200,000 may be converted into Private Placement Warrants at a price of $1.50 per warrant at the option of the Sponsor. The outstanding balance under the Sponsor Promissory Note as of December 31, 2025 and 2024 was $2,024,867 and $1,204,867, respectively.

In July 2024, August 2024 and September 2024, the Sponsor entered into a series of agreements with various undersigned subscribers (the “Subscribers”) which resulted in the raising of $400,000. Under the terms of the agreement the Subscribers agreed to subscribe to a portion of the Sponsor’s Class B Ordinary Shares on a contingent basis in order to allow the Sponsor to fund such working capital to the Company. Pursuant to the agreement, at the closing of a business combination by the Company, upon election by the Sponsor, the Shares will be transferred to the Subscribers.

On January 27, 2025, the Company entered into a promissory note with the Sponsor (the “Second Sponsor Promissory Note”), pursuant to which the Sponsor loaned $100,000 to the Company. The Second Sponsor Promissory Note bears no interest. The principal amount is to be repaid at the earlier of (i) the consummation of the Business Combination, (ii) the date of liquidation, or (iii) 90 calendar days after entering into the promissory note. If the Company does not consummate the Business Combination or there is a liquidation, the Second Sponsor Promissory Note will not be repaid and the principal amount will be forgiven, except to the extent there are funds available to the Company outside of the Trust Account to make repayment.

F-12

~~The~~As ~~Company~~of ~~will~~December ~~have~~31, ~~until~~2025, ~~July~~the 30Sponsor had entered into a series of agreements with various subscribers (the “Subscribers”) which resulted in the raising of $1,375,000. ~~2025~~Under tothe terms of the ~~complete~~agreement the Subscribers agreed to subscribe to a ~~Business~~portion ~~Combination~~of the Sponsor’s Class B Ordinary Shares on a contingent basis in order to allow the Sponsor to fund such working capital to the Company. IfPursuant to the agreement, at the closing of a ~~Business~~business ~~Combination~~combination by isthe ~~not~~Company, ~~consummated~~upon election by ~~July~~the 30Sponsor, ~~2025~~the ~~there~~Shares will be atransferred ~~mandatory~~to ~~liquidation~~the Subscribers. There will be no accounting impact to ~~and~~the ~~subsequent~~Company ~~dissolution~~as a result of the ~~Company~~sale of Sponsor’s Class B Ordinary Shares to Subscribers.

InOn ~~connection~~January ~~with~~23, 2025, the Company’s ~~assessment of~~entered ~~going~~into ~~concern~~a ~~considerations~~promissory innote ~~accordance~~ with the ~~FASB’s~~Sponsor ~~Accounting~~(the ~~Standards~~“Second ~~Codification~~Sponsor ~~(“ASC~~Promissory Note”), ~~Topic~~pursuant ~~205-40~~to ~~Presentation~~which the Sponsor loaned $100,000 to the Company. The Second Sponsor Promissory Note bears no interest. The principal amount is to be repaid at the earlier of ~~Financial~~(i) ~~Statements-~~the ~~Going~~consummation ~~Concern,~~of ~~management~~the ~~has~~Business Combination, ~~determined~~(ii) the ~~liquidity~~date ~~conditions~~of ~~disclosed~~liquidation, ~~above~~or ~~including~~(iii) 90 calendar days after entering into the ~~July~~promissory 30note. On May 6, 2025, ~~Combination~~the ~~Period~~Second Sponsor ~~deadline~~Promissory ~~raise~~Note ~~substantial~~was ~~doubt~~amended ~~about~~to extend the ~~Company’s~~maturity ~~ability~~date toby ~~continue~~an asadditional a180 ~~going~~calendar ~~concern~~days, ~~through~~resulting ~~one year~~in ~~from~~a ~~the~~new expiration date 270 ~~that~~calendar ~~these~~days ~~financial~~from ~~statements~~the ~~are~~original ~~filed~~issuance. ~~These~~On ~~financial~~March ~~statements~~30, do2026, ~~not~~the ~~include~~Second ~~any~~Sponsor ~~adjustments~~Promissory ~~relating~~Note was further amended to extend the maturity date to July ~~recovery~~31, of2026. If the ~~recorded~~Company ~~assets~~does not consummate the Business Combination or there is a liquidation, the Second ~~classification~~Sponsor ofPromissory Note will not be repaid and the ~~liabilities~~principal ~~that~~amount ~~might~~will be ~~necessary~~forgiven, ~~should~~except to the extent there are funds available to the Company beoutside ~~unable~~of the Trust Account to ~~continue~~make repayment. As of December 31, 2025, the balance outstanding from the Sponsor Promissory asNote aand ~~going~~the ~~concern~~Second Sponsor Promissory Note is $2,124,867.

The Company will have until July 30, 2026 to complete a Business Combination. If a Business Combination is not consummated by July 30, 2026 there will be a mandatory liquidation and subsequent dissolution of the Company.

In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Codification (“ASC”) Topic 205-40 Presentation of Financial Statements- Going Concern, management has determined the liquidity conditions disclosed above raise substantial doubt about the Company’s ability to continue as a going concern through one year from the date that these financial statements are filed in the event the Business Combination is not completed. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying ~~consolidated~~ financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the ~~Securities and Exchange Commission (the “~~SEC”).

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. The Company has elected to implement the aforementioned exemptions.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act) of 1934, as amended are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

F-13

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. The initial valuation of the Public Warrants (as defined in Note 3) and Class A ordinary shares subject to redemption, the initial and the quarterly valuation of the Private Placement Warrants (as defined in Note 4), and the valuations for the convertible Note (as defined in Note 5) required management to exercise significant judgement in its estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $2749,~~418~~870 and $027,418 in cash as of December 31, ~~2024~~2025 and ~~2023~~ 2024, respectively. The Company did not have any cash equivalents as of December 31, ~~2024~~2025 orand ~~2023~~2024.

~~Investments~~Cash Held in Trust Account

~~Investments~~On ~~Held~~January in8, ~~Trust~~2024, ~~Account~~the ~~are~~funds ~~classified as~~in ~~trading securities which are presented on~~ the ~~balance~~Trust ~~sheets~~Account atwere ~~fair~~transferred ~~value~~to ata ~~the~~demand ~~end~~deposit ~~of each reporting period~~account. As of December 31, ~~2024~~ 2025 and ~~2023~~2024, the cash ~~investments~~ held in the Trust Account totaled $25494,~~630,285~~421 and $~~157~~25,~~330~~630,~~245~~285, respectively.

Due from Tactical

In accordance with the Business Combination Agreement, the Company covered certain operating expenses on behalf of Tactical, for which Tactical is responsible for reimbursement. As of December 31, 2025 and 2024, the Company ~~has~~was ~~paid~~owed $0 and $23,280, onrespectively, ~~Tactical’s~~for operating expenses incurred on behalf of Tactical.

Due from Merger Co.

The Company covered certain operating expenses on behalf of Merger Co., for which Merger Co. is responsible for reimbursement. As of December 31, 2025 and 2024, the Company was owed $27,500 and $0, respectively, for operating expenses incurred on behalf of Merger Co.

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as a liability at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The initial fair value of the Public Warrants (as defined in Note 3) was estimated using a binomial/lattice model and the fair value of the Founder Warrants (as defined in Note 5) and Private Placement Warrants (as defined in Note 4) was estimated using a Black-Scholes Option Pricing Model (see Note 9). ~~Due~~As toof ~~the~~December 31, ~~options~~2025 ~~pricing~~and ~~model~~2024, ~~not~~despite ~~producing~~lower atrading ~~meaningful~~volume ~~volatility~~on ~~for~~ the ~~Founder~~Class ~~Warrants~~A ordinary shares and ~~Private~~Public ~~Placement~~Warrants, the fair value of the Public Warrants was based on its traded price as of December 31, ~~2024~~2025 and ~~2023,~~2024. This approach was deemed appropriate as the ~~fair~~implied ~~value~~probability of a successful business combination remained within the ~~Founder~~range ~~Warrants~~observed ~~and~~in ~~Private~~comparable ~~Placement~~publicly ~~Warrants~~traded ~~were~~companies. ~~set~~The ~~equal~~valuation toof the ~~fair~~Private ~~value~~Warrants ofslightly differed, as it was derived using the ~~Public~~Black-Scholes ~~Warrants~~option pricing model.

Class A Ordinary Shares Subject to Possible Redemption

All of the 28,250,000 Class A ordinary shares sold as part of the Units in the Initial Public Offering and subsequent partial exercise of the underwriters’ over-allotment option, that remain unredeemed, contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, including ifin ~~there~~connection iswith a shareholder ~~vote~~votes or tender ~~offer~~offers in connection with the Business Combination, ~~and~~as well as in connection with certain amendments to the Company’s Amended and Restated Memorandum and Articles of Association. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. Therefore, all Public Shares have been classified outside of permanent equity. On January 29, 2024, 12,433,210 Class A ordinary shares were tendered for redemption by shareholders for a total value of $134,059,215. The payment of these shares took place on February 27, 2024, after which 2,284,199 Class A ordinary shares subject to possible redemption remained outstanding.

F-14

On January 29, 2024, 12,433,210 Class A ordinary shares were tendered for redemption by shareholders for a total value of $134,059,215. The payment of these shares took place on February 27, 2024, after which 2,284,199 Class A ordinary shares subject to possible redemption remained outstanding. On January 16, 2025, 2,132,366 Class A ordinary shares were tendered for redemption by shareholders for a total value of $23,975,464. The payment of these shares took place on January 23, 2025, after which 151,833 Class A ordinary shares subject to possible redemption remained outstanding. On July 15, 2025, 109,347 Class A ordinary shares were tendered for redemption by shareholders for a total value of $1,252,434. The payment of these shares took place on July 21, 2025, after which 42,486 Class A ordinary shares subject to possible redemption remained outstanding. On December 22, 2025, the holders of 24,136 Class A ordinary shares, properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.61 per share, for an aggregate redemption amount of $280,219. The redemption is contingent upon the consummation of the Business Combination and will occur as promptly as practicable following the closing thereof; if the Business Combination is not consummated, the redeemed shares will be returned to the respective holders.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

As of December 31, ~~2024~~2025 and ~~2023~~2024, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:

Class A ordinary shares subject to possible redemption as of December 31, 2023	$	157,555,245
Redemption of Class A ordinary shares subject to redemption		(134,059,215	)
Remeasurement of Class A ordinary shares subject to redemption to redemption amount		2,134,255
Class A ordinary shares subject to possible redemption as of December 31, 2024	$	25,630,285
Redemption of Class A ordinary shares subject to redemption		(25,227,898	)
Remeasurement of Class A ordinary shares subject to redemption to redemption amount		92,034
Class A ordinary shares subject to possible redemption as of December 31, 2025	$	494,421

Income Taxes

The Company accounts for income taxes under ASC Topic 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, ~~2024~~2025 and ~~2023~~2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. Consequently, income taxes are not reflected in the Company’s financial statements.

Net (Loss) ~~Income~~ Per Ordinary Share

Net (loss) ~~income~~ per ordinary share is computed by dividing net (loss) ~~income~~ by the weighted-average number of ordinary shares outstanding during the period. Remeasurement associated with the redeemable Class A ordinary shares is excluded from net (loss) ~~income~~ per share as the redemption value approximates fair value. Therefore, the (loss) ~~income~~ per share calculation allocates (loss) ~~income~~ shared pro rata between Class A ordinary shares subject to possible redemption and non-redeemable Class A ordinary shares and Class B ordinary shares. As a result, the calculated net (loss) ~~income~~ per share is the same for Class A and Class B ordinary shares. The Company has not considered the effect of the Public Warrants (as defined in Note 3), Private Placement Warrants (as defined in Note 4), or the Founder Warrants (as defined in Note 5) to purchase an aggregate of 12,059,~~166~~165 shares, or the effects of the ~~803~~1,~~245~~349,911 warrants that would be issuable upon conversion of the Subscription Loan (as defined in Note 5) in the calculation of (loss) ~~income~~ per share, because the exercise of the warrants are contingent upon the occurrence of future events. As of December 31, 2025 and 2024, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares that then share in the earnings of the Company. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented.

F-15

The following table reflects the calculation of basic and diluted net ( loss) ~~income~~ per ordinary share (in dollars, except per share amounts):

	Year Ended December 31, 2024						Year Ended December 31, 2023
	Year Ended December 31, 2025						Year Ended December 31, 2024
	Class A			Non-Redeemable Class A andClass B			Class A			Non-Redeemable Class A andClass B
Basic net (loss) income per share:
Basic and diluted net loss per share:
Numerator:
Net (loss) income	$	(1,068,030	)	$	(1,493,199	)	$	7,994,725		$	2,423,904
Net loss	$	(204,050	)	$	(6,995,711	)	$	(885,147	)	$	(1,676,082	)
Denominator:
Basic weighted average shares outstanding		5,051,548			7,062,500			23,294,132			7,062,500
Basic and diluted weighted average shares outstanding		231,228			7,927,500			4,186,548			7,927,500
Basic net (loss) income per share	$	(0.21	)	$	(0.21	)	$	0.34		$	0.34
Basic and diluted net loss per share	$	(0.88	)	$	(0.88	)	$	(0.21	)	$	(0.21	)
Diluted net (loss) income per share:
Numerator:
Net (loss) income	$	(1,068,030	)	$	(1,493,199	)	$	7,997,125		$	2,421,504
Denominator:
Diluted weighted average shares outstanding		5,051,548			7,062,500			23,324,225			7,062,500
Diluted net (loss) income per share	$	(0.21	)	$	(0.21	)	$	0.34		$	0.34

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Sponsor Promissory Note

The Company accounts for the Sponsor Promissory Note within the scope of ASC 815 and has elected to bifurcate the embedded derivative within the convertible promissory note. The fair value of the embedded conversion feature upon the issuance of the Sponsor Promissory Note was determined to be de minimis (see Note 5).

Share-Based Compensation

The Company records share-based compensation in accordance with FASB ASC Topic 718, “Compensation-Share Compensation” (“ASC 718”), which requires a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Monte Carlo simulation. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value.

Fair Value of Financial Instruments

The Company applies ASC Topic 820, Fair Value Measurement (“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

The carrying amounts reflected in the balance sheets for current assets and current liabilities approximate fair value due to their short-term nature.

Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

See Note 9 for additional information on assets and liabilities measured at fair value.

F-16

Recent Accounting Pronouncements

~~In November 2023, the FASB issued ASU 2023~~F-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities are required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU became effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on January 1, 2024. The amendments will be applied retrospectively to all prior periods presented in the financial statements. See Note 10 for further information.16

NOTE 3. INITIAL PUBLIC OFFERING

The registration statement for the Company’s Initial Public Offering was declared effective on July 27, 2021. On July 30, 2021, the Company completed its Initial Public Offering of 25,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7).

The Company had granted the underwriters in the Initial Public Offering a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments, if any (see Note 6). On August 5, 2021, the underwriters partially exercised the over-allotment option and purchased an additional 3,250,000 Over-Allotment Units, generating gross proceeds of $32,500,000.

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Original Sponsor and certain Anchor Investors purchased an aggregate of 800,000 Units at a price of $10.00 per Private Placement Unit ($8,000,000 in the aggregate). Each Private Placement Unit consists of one Class A ordinary share (the “Private Placement Shares”) and one-third of one redeemable warrant (the “Private Placement Warrants”), which is exercisable at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units were added to the net proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Second Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.

Simultaneously with the closing of the exercise of the over-allotment option (see Note 6), the Company consummated the sale of 65,000 Over-Allotment Private Placement Units at a purchase price of $10.00 per unit in a private placement to the Original Sponsor, generating gross proceeds of $650,000.

F-17

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On February 5, 2021, an affiliate of the Original Sponsor paid an aggregate of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 7,187,500 founder units (“Founder Units”), which were subsequently transferred to the Original Sponsor. Each Founder Unit consists of one Class B ordinary share and one-third of one warrant (the “Founder Warrants”) that has the same terms as the Private Placement Warrants (2,395,833 Founder Warrants in the aggregate). The Class B ordinary shares included in the Founder Units (“Founder Shares”) included an aggregate of up to 937,500 Class B ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the Original Sponsor will own, on an as-converted basis, 20% of the Company’s issued and outstanding shares upon completion of the Initial Public Offering. The Founder Warrants included an aggregate of up to 312,500 Founder Warrants subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised. On August 5, 2021, the underwriters partially exercised the over-allotment option to purchase an additional 3,250,000 Units (see Note 6), leaving 125,000 Class B ordinary shares and 41,667 Founder Warrants subject to forfeiture. On September 11, 2021, the remaining option expired. As a result, 125,000 Class B ordinary shares and 41,667 Founder Warrants were forfeited.

The Original Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell (i) any of their Founder Units or Founder Shares until the earliest of (A) one year after the completion of an Initial Business Combination and (B) subsequent to an Initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after an initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property and (ii) any of their Founder Warrants and Class A ordinary shares issued upon conversion or exercise thereof until 30 days after the completion of an initial Business Combination. Notwithstanding the foregoing, if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after an initial Business Combination, the Founder Units or Founder Shares will be released from the lock-up.

On December 27, 2023, the Company, the Original Sponsor, and the Sponsor entered into a purchase agreement (the “Purchase Agreement”), pursuant to which, at a closing on December 28, 2023, the Sponsor (i) purchased 3,902,648 founder units of the Company from the Original Sponsor, each unit consisting of one Class B ordinary share and one-third of one redeemable warrant to acquire one Class B ordinary share, which founder units are subject to forfeiture in certain circumstances, and (ii) became entitled to 70% of the 2,030,860 founder units that Original Sponsor placed in escrow at the Closing to the extent such founder units are allocated to investors who hold and do not redeem their Class A ordinary shares of the Company at the time of the Company’s initial business combination, for an aggregate purchase price of $1. Original Sponsor agreed to pay, or cause its affiliates to pay, certain liabilities of the Company accrued and outstanding as of the Closing. Following the closing, Original Sponsor has no further obligations with respect to the Company, and the Sponsor has assumed all obligations relating to the Company. Pursuant to the Amended Purchase Agreement, the Original Sponsor shall retain 665,000 Class A private placement units and 1,128,992 Class B founder units.

F-1817

On August 22, 2024, the Company, the Original Sponsor, and the Sponsor entered into a second amendment to Purchase Agreement (“Amendment No. 2 to the Purchase Agreement”) which revises the founder-unit forfeiture and transfer mechanics by requiring the acquirer to absorb all forfeitures or investor incentive transfers up to 2,030,860 founder units, allocating excess forfeitures 78% to the acquirer and 22% to the sponsor, while also establishing that 2,030,860 sponsor units will be held in escrow for potential transfer to sponsor anchors, with any remaining escrowed units allocated 70% to the acquirer and 30% to the sponsor at closing. On September 5, 2025, the Company, the Original Sponsor, and the Sponsor entered into a third amendment to Purchase Agreement (“Amendment No. 3 to the Purchase Agreement”) that provides that any Sponsor Incentive Units (as defined in the Sponsor Support Agreement) that have been retained by the Sponsor after the Closing, up to half of such Sponsor Incentive Units may be transferred prior to the Closing to a third party, with any Sponsor Incentive Units remaining after such transfer subject to allocation between the Sponsor and the Original Sponsor as provided for in the Purchase Agreement.

The Company and the Sponsor entered into non-redemption agreements (the “Non-Redemption Agreements”) with certain shareholders of the Company pursuant to which, if such shareholders do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares (the “Non-Redeemed Shares”) in connection with the January 2024 Extraordinary General Meeting, the Sponsor agreed to transfer to such investors ordinary shares of the Company held by the Sponsor immediately following the consummation of an Initial business combination if they continue to hold such Non-Redeemed Shares through the Extraordinary General Meeting.

Administrative Support Agreement

The Company entered into an agreement, commencing on the effective date of the Initial Public Offering, to pay an affiliate of the Original Sponsor $55,000 per month for office space, secretarial and administrative support services. Upon the completion of an initial Business Combination or liquidation, the Company will cease paying these monthly fees. ~~For the year ended December 31, 2024, the Company incurred no expenses under this agreement. For the~~ ~~year ended December 31, 2023, the Company incurred expenses of $660,000 under this agreement and is included in operating and formation costs on the accompanying statement of operations.~~ In connection with the Purchase Agreement on December 27, 2023, the obligations of the Administrative Support Agreement transferred from the Original Sponsor to the Sponsor. Any outstanding administrative support fees owed to the Sponsor as of December 27, 2023 were forgiven by the Original Sponsor and the agreement was then cancelled. AsFor ofthe year ended December 31, 2025, the Company incurred no expenses under this agreement. For the year ended December 31, 2024, ~~and~~the ~~2023~~Company incurred no expenses under this agreement. As of December 31, 2025 and 2024, the Company had no outstanding balance for accrued expenses - related party.

Related Party Loans

In order to finance transaction costs in connection with the Business Combination, the Original Sponsor, the Sponsor or an affiliate of the Original Sponsor or the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”).

On August 15, 2023, the Company entered into a Working Capital Loan with APTM Sponsor Sub LLC (the “Affiliate”), in the principal sum of $1,500,000, expected to be funded on an as-needed basis. The principal balance shall be payable on the earlier of (i) the date on which the Company liquidates its Trust Account or (ii) the date on which the Company consummates a Business Combination. On August 24, 2023, September 6, 2023, September 28, 2023, September 29, 2023, October 11, 2023, and November 9, 2023, the Company withdrew $150,000, $225,000, $124,874, $225,126, $275,000 and $280,000 respectively, from the Working Capital Loan. As of December 31, 2025 and 2024, there was no principal amount outstanding under the Working Capital Loan, as the Working Capital Loan was forgiven by the Original Sponsor. The aggregate fair value of the Working Capital Loan upon issuance was $219,441. The aggregate fair value of the Working Capital Loan was $123,500 upon forgiveness. The Working Capital Loan was forgiven by the Original Sponsor on December 27, 2023.

Reimbursements—Related Party

Accounts Payable - Related Party

As of December 31, ~~2024~~2025 and ~~2023~~2024, the Company had $~~18,824~~0 and $018,824, respectively, ~~was~~ was payable by the Company to the Sponsor or other related parties for services related to the search and consummation for an initial Business Combination ~~target~~.

Subscription Agreement and Sponsor Promissory Note - Related Party

On January 3, 2024, the Company, the Sponsor, and Investor entered into a Subscription Agreement, pursuant to which the Sponsor may raise up to $1,500,000 from the Investor to fund extension payments to the Trust Account and working capital for the Company, including $250,000 upon the execution of the Subscription Agreement and $250,000 on February 20, 2024 and as otherwise called by the Sponsor in its discretion. At the closing of the Company’s initial Business Combination, the Sponsor will forfeit 0.85 Class B shares, and the Company will issue an equal number of shares of its ordinary share to the Investor, for each dollar funded by the Investor pursuant to the Subscription Agreement. If the Company’s initial Business Combination does not occur, the Sponsor will not forfeit any shares.

F-1918

In July 2024, the Company entered into a promissory note with Mercury Capital (the “Sponsor Promissory Note”), pursuant to which the Sponsor may loan up to $1,500,000 to the Company. The funds that will be loaned to the Company under the Sponsor Promissory Note consist of a portion of the up to $1,500,000 that was loan to the Sponsor by the Investor pursuant to the Subscription Agreement. If the Company completes a Business Combination, the Company would repay the Sponsor Promissory Note. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Sponsor Promissory Note, but no proceeds held in the Trust Account would be used to repay the ~~Working~~Sponsor ~~Capital Loans~~Promissory Note. Up to $1,500,000 of such loans may be convertible into warrants of the Company at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to the Private Placement Warrants. The Company accounts for the Sponsor Promissory Note within the scope of ASC 815 and has elected to bifurcate the embedded derivative within the convertible promissory note. The fair value of the embedded conversion feature upon the issuance of the Sponsor Promissory Note is de minimis.

~~The~~On ~~outstanding~~April ~~balance~~24, ~~under~~2025, the ~~Sponsor~~Company ~~Promissory Note~~and asSponsor ofentered ~~December~~an ~~31,~~amendment ~~2024~~to increase ~~was $1,204,867. This balance includes deposits made into~~ the ~~Trust~~maximum ~~Account~~amount byof the Sponsor ofPromissory ~~$112,500~~Note ~~each on~~to ~~January 9~~$2,200,000 ~~2024~~ and ~~January~~up ~~24,~~to ~~2024~~$2,200,000 ~~payments~~may ~~made~~be byconverted ~~the~~into ~~Sponsor~~Private onPlacement Warrants ~~behalf~~at ofa ~~the~~price ~~Company~~of ~~totaling~~ $~~243,867,~~1.50 ~~and~~per ~~total~~warrant ~~draw~~at the option of ~~$736,000~~the Sponsor.

On January 23, 2025, the Company entered into a promissory note with the Sponsor (the “Second Sponsor Promissory Note”), pursuant to which the Sponsor loaned $100,000 to the Company. The Second Sponsor Promissory Note bears no interest. The principal amount is to be repaid at the earlier of (i) the consummation of an Initial Business Combination, (ii) the date of liquidation, or (iii) 90 calendar days after entering into the promissory note. On May 6, 2025, the Second Sponsor Promissory Note was amended to extend the maturity date by an additional 180 calendar days, resulting in a new expiration date 270 calendar days from the original issuance. On March 30, 2026, the Second Sponsor Promissory Note was further amended to extend the maturity date to July 31, 2026. If the Company does not consummate the Business Combination or there is a liquidation, the Second Sponsor Promissory Note will not be repaid and the principal amount will be forgiven, except to the extent there are funds available to the Company outside of the Trust Account to make repayment. As of December 31, 2025, the total outstanding balance of the Sponsor Promissory Note and Second Sponsor Promissory Note is $2,124,867.

The Sponsor Promissory Note and Second Sponsor Promissory Note are reported as promissory note - related party on the accompanying balance sheets.

Non-Redemption Agreements

On each of January 17, 2024, January 23, 2024, and January 24, 2024, the Company and the Sponsor entered into non-redemption agreements (each, a “Non-Redemption Agreement”) with one or more unaffiliated third party or parties (the “Investors”) in exchange for each such third party or third parties agreeing not to redeem certain public Class A ordinary shares, $0.0001 par value per share of the Company sold in its initial public offering (the “Non-Redeemed Shares”) at the Adjourned Meeting. In exchange for the foregoing commitments not to redeem such Non-Redeemed Shares, the Sponsor will assign an economic interest in certain of its Founder Shares to the Investor at the rate of one Founder Share for each four Non-Redeemed Shares. The Company estimated the aggregate fair value of 331,180 Founder Shares transferrable to the Non-Redeeming Shareholders pursuant to the Non-Redemption Agreement to be $367,610 or $1.11 per share. The fair value was determined using a discount for the probability of an Initial Business Combination of 10.95% and a discount of 5% for the lack of redemption rights and the value per Founder Shares as of the valuation date of $10.71. The excess of the fair value of such Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, in substance, the indirect economic interest in the Founder Shares was recognized by the Company as a capital contribution in accordance with Staff Accounting Bulletin Topic 5T by the Sponsor to induce these Non-Redeeming Shareholders not to redeem the Non-Redeemed Shares, with a corresponding charge to additional paid-in capital to recognize the fair value of the Founder Shares subject to transfer as an offering cost.

F-2019

Consulting Agreement - Stock Based Compensation

On February 12, 2024, the Sponsor entered into an independent contractor agreement and securities transfer agreement concurrently with the Company’s Chief Financial Officer, for services related to due diligence of potential business combination partners and assisting with the negotiation and closing of an initial business combination. The Chief Financial Officer is entitled to receive a fee for service of $12,500 paid in amounts of $6,250 semi-monthly until the Company completes its initial business combination. These payments will be recorded as operating expenses of the Company. Additionally, the Sponsor has agreed to transfer 365,000 Founder Shares and 175,000 Founder Warrants of the Company to the Chief Financial Officer. At the earlier of the termination of the agreement and an initial business combination, the Chief Financial Officer has agreed to surrender a portion of the Class B ordinary shares based on the cash compensation paid multiplied by 1.5, up to a maximum of 165,000 Founder Shares. Lastly, the Chief Financial Officer shall be paid a success fee of $50,000 that is contingent upon the closing of the initial business combination. The compensation expense related to the Founder Share transfer will be amortized on a straight-line basis from the grant date of February 12, 2024 (the date at which the independent contractor agreement was signed, and the date at which all parties reached a mutual understanding of the key terms and conditions of the share-based payment) to November 1, 2024 (vesting period of 8 months). Such Investment Advisory Agreement was accounted for under ASC 718. The Company estimated the fair value of the Founder Shares to be $177,555 or $0.89 per share. The value was calculated by taking the February 12, 2024 trading price of $10.50, multiplied by the Company’s estimated probability of completing the business combination on that day of 8.9%, further multiplied 95.0% to factor in a discount for lack of redemption ability of the Founder Shares prior to an Initial Business Combination The Company estimated the fair value of the Founder Warrants to be $17,500 or $0.10 per warrant, which was the trading price on February 12, 2024.

On June 30, 2024, the Sponsor entered into an amendment to the independent contractor agreement. In connection with the amendment, the Sponsor will now assign and transfer all 365,000 Founder Shares and 175,000 Founder Warrants only upon the closing of an Initial Business Combination, and the 165,000 Founder Shares are no longer subject to forfeiture based upon cash compensation paid. As such, the Company determined that this was a modification to the original agreement. As such, as of December 31, ~~2024~~2025 no additional compensation will be recorded for the transfer of the shares until an Initial Business Combination has been consummated. ~~The compensation that has been recorded for year ended December 31, 2024, will remain within the Company’s Statements of Operations for those periods.~~ During the year ended December 31, 2024, the Company recorded compensation expense of $158,875.

Securities Transfer Agreement

On May 22, 2024, the Sponsor and a third party (the “Recipient”) entered into a Securities Transfer Agreement, whereby the Sponsor will transfer 138,000 Founders Shares and 62,000 warrant to the Recipient as compensation for the provisioning of advisory service rendered to the SPAC. No compensation expense was recorded as of December 31, 2025 and 2024, as the Recipient did not start providing advisory services and therefore the award has not vested.

On June 30, 2024, the Sponsor and the Recipient entered into an amendment to the Securities Transfer Agreement (the “Amended Securities Transfer Agreement”). Pursuant to the Amended Securities Transfer Agreement, the Sponsor will transfer 138,000 Founders Shares and 62,000 warrant to the Recipient upon successfully closing any business combination transaction involving the Company. In addition, the Recipient’s compensation would be in exchange for providing advisory services to the Sponsor. No compensation expense in respect of this arrangement was recorded as of December 31, 2025 and 2024, as the ~~performance~~ performance condition ~~was~~had not ~~considered~~been ~~probable~~met; the related expense will be recognized upon satisfaction of all conditions necessary to consummate the Business Combination.

NOTE 6. COMMITMENTS

Registration and Shareholder Rights Agreement

The holders of the Founder Units, Private Placement Units, warrants underlying the Founder Units and Private Placement Units and units that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the warrants underlying the Founder Units and Private Placement Units and units issued upon conversion of the Working Capital Loans) have registration and shareholder rights to require the Company to register a sale of any of its securities held by them pursuant to a registration and shareholder rights agreement entered into on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of an initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

F-2120

Underwriting Agreement

The Company granted the underwriters a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On August 5, 2021, the underwriters partially exercised the over-allotment option to purchase an additional 3,250,000 Units at an offering price of $10.00 per Unit for an aggregate purchase price of $32,500,000. On September 11, 2021, the remaining option expired. As a result, 125,000 Class B ordinary shares were forfeited.

The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $5,650,000 in the aggregate, upon the closing of the Initial Public Offering and partial exercise of the over-allotment option. In addition, $0.35 per unit, or $9,887,500 in the aggregate will be payable to the underwriters for deferred underwriting commissions. On December 27, 2023, the underwriters agreed to waive their rights to their portion of the fee payable by the Company for deferred underwriting commissions, with respect to any potential business combination of the Company. Of the total $9,887,500 waived fee, $9,551,325 was recorded as a reduction to accumulated deficit and $336,175 was recorded as a gain on the waiver of deferred underwriting commissions by underwriters in the statements of operations, following a manner consistent with the original allocation of the deferred underwriting fees.

Service Agreement

On August 10, 2024, the Sponsor and Freya Advisory, LLC (the “Consultant”) entered into a services agreement which sets forth certain mutual benefits and obligations of the Consultant and Mercury Capital LLC with respect to certain services rendered by the Consultant to the Company. The services entail supervising and performing due diligence on potential business combination transaction in coordination with, and with direction from, the Company’s senior management. The term of the services agreement shall commence on August 10, 2024 and terminate upon the earlier of: (a) termination of this engagement at will in accordance with the terms of the Agreement; or (b) the consummation of a business combination. As compensation for the services rendered by the Consultant both before and during the term, the Company shall pay to the Consultant a success fee in the amount of $200,000 at the closing of the business combination involving the Company.

On January 6, 2025, the Company entered into a service agreement with KingsRock Securities LLC (“KingsRock”), pursuant to which KingsRock was engaged to provide advisory services in connection with the Company’s efforts to secure capital for its initial business combination (the “Capital Raise”). Services to be provided by KingsRock include identifying and introducing potential investors and facilitating discussions with such investors.

In consideration for these services, the Company agreed to pay KingsRock (i) a success fee equal to 2% of the aggregate capital raised from investors introduced by KingsRock, payable upon the closing of the Capital Raise, and (ii) a retainer fee of $22,500, payable in installments, which is creditable against the success fee.

Standby Equity Purchase Agreement

F-21

Risks and Uncertainties

Ongoing global conflicts, including the war in Ukraine and the Russian sanctions, the Israel-Hamas war, and the conflict in Iran, continue to create significant geopolitical and economic uncertainty. The Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and potential future sanctions on the world economy and the specific impact on the Company’s financial position, results of operations or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OBBBA”). ASC 740, “Income Taxes”, requires the effects of changes in tax laws to be recognized in the period in which the legislation is enacted. The Company evaluated the provisions of the OBBBA and determined that adoption of the new law did not have a material impact on its financial statements or related disclosures.

NOTE 7. WARRANTS

As of December 31, ~~2024~~2025 and ~~2023~~2024, there were 2,354,166 Founder Warrants, 288,~~334~~333 Private Placement Warrants, and 9,416,666 Public Warrants outstanding. The exercise price of all warrants noted is $11.50.

Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants, Private Placement Warrants, and Founder Warrants will become exercisable 30 days after the completion of an Initial Business Combination. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. The Founder Warrants and the Private Placement Warrants will also expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to satisfying the obligations described below with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

F-22

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of an Initial Business Combination, the Company will use the commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement or a new registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use the commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of an initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so appoint, the Company will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of an Initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use the best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

F-22

Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00—Once the warrants become exercisable, the Company may call the warrants for redemption (except with respect to the Private Placement Warrants):

●

in whole and not in part;

●

at a price of $0.01 per warrant;

●

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

●

if, and only if, the last reported closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice of the redemption is given to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like and certain issuances of Class A ordinary shares and equity linked securities).

The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by the Company, the Company may exercise the redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00—Once the warrants become exercisable, the Company may redeem the outstanding warrants:

●

in whole and not in part;

●

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Class A ordinary shares (as defined below) except as otherwise described below; provided, further, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share; and

●

if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like and certain issuances of Class A ordinary shares and equity linked securities) on the trading day before the Company sends the notice of redemption to the warrant holders.

The fair market value of the Company’s Class A ordinary ~~shares~~ shares shall mean the volume weighted average price of the Class A ordinary shares during the 10 trading days immediately following the ~~date~~ date on which the notice of redemption is sent to the holders of warrants. The Company will provide its warrant holders with the final ~~fair~~ fair market value no later than one business day after the 10-trading day period described above ends. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).

F-23

In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of an initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance including any transfer or reissuance of such shares (the “Newly Issued Price”)), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination, and (z) the volume-weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day after the day on which the Company consummates an initial Business Combination is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices adjacent to “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00.” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

F-23

The Private Placement Units (including the Private Placement Shares, the Private Placement Warrants and Class A ordinary shares issuable upon exercise of such warrants) will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Units are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company accounts for the 9,705,000 warrants issued in connection with the Initial Public Offering (including 9,416,666 Public Warrants and 288,~~334~~333 Private Placement Warrants) and the 2,354,166 Founder Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The Founder Warrants and Private Placement Warrants are precluded from equity classification due to a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. The Public Warrants are precluded from equity classification due to a provision that in the event of a tender offer or exchange offer made to and accepted by holders of more than 65% of the outstanding ordinary shares, all holders of the warrants would be entitled to receive cash for their warrants.

The accounting treatment of derivative financial instruments required that the Company record the warrants as derivative liabilities at fair value at issuance. The Public Warrants were allocated a portion of the proceeds from the issuance of the Units in the Initial Public Offering equal to its fair value. The Private Placement Warrants were allocated a portion of the proceeds from the issuance of the Private Placement Units equal to its fair value. The warrant liabilities are subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liabilities are adjusted to current fair value, with the change in fair value recognized in the Company’s statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

F-24

NOTE 8. SHAREHOLDERS’ DEFICIT

Preference shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, ~~2024~~2025 and ~~2023~~2024, there were no preference shares issued or outstanding.

Class A ordinary shares — The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of December 31, ~~2024~~2025 and ~~2023~~2024, there were 3907,~~149,199~~486 and 153,~~582~~149,~~409~~199 Class A ordinary shares issued and outstanding, including 242,~~284,199~~486 and 142,~~717~~284,~~409~~199 Class A ordinary shares subject to possible redemption, respectively.

Class B ordinary shares — The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of December 31, ~~2024~~2025 and ~~2023~~2024, there were 7,062,500 Class B ordinary shares issued and outstanding.

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Prior to an initial Business Combination, only holders of the Founder Shares will have the right to vote on the election of directors. Holders of the Public Shares will not be entitled to vote on the appointment of directors during such time.

The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of an initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of an initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in an initial Business Combination and any Private Placement Warrants issued to the Sponsor, members of the team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

F-24

NOTE 9. FAIR VALUE MEASUREMENTS

The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of December 31, ~~2024~~2025 and ~~2023~~ 2024 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description	Amount at Fair Value		Level 1		Level 2		Level 3
December 31, 2025
Assets
Cash held in Trust Account:
Interest-bearing demand deposit	$	494,421	$	494,421	$	—	$	—
Liabilities
Warrant liability – Founder Warrants	$	1,337,166	$	—	$	—	$	1,337,166
Warrant liability – Private Placement Warrants	$	163,774	$	—	$	—	$	163,774
Warrant liability – Public Warrants	$	5,085,000	$	—	$	5,085,000	$	—
December 31, 2024
Assets
Investments held in Trust Account:
Cash held in Trust Account:
Money Market investments	$	25,630,285	$	25,630,285	$	—	$	—
Interest-bearing demand deposit	$	25,630,285	$	25,630,285	$	—	$	—
Liabilities
Warrant liability – Founder Warrants	$	423,~~750~~751	$	—	$	—	$	423,~~750~~751
Warrant liability – Private Placement Warrants	$	51,900	$	—	$	—	$	51,900
Warrant liability – Public Warrants	$	1,695,000	$	1,695,000	$	—	$	—
December 31, 2023
Assets
Investments held in Trust Account:
Money Market investments	$	157,330,245	$	157,330,245	$	—	$	—
Liabilities
Warrant liability – Founder Warrants	$	141,250	$	—	$	141,250	$	—
Warrant liability – Private Placement Warrants	$	17,300	$	—	$	17,300	$	—
Warrant liability – Public Warrants	$	565,000	$	—	$	565,000	$	—

The measurement of the Public Warrants as of December 31, 2025 is classified as Level 2 due to insufficient trading activity. The measurement of the Public Warrants as of December 31, 2024 was classified as Level 1 due to significant trading activity under the ticker PLMWF and PLMJW, respectively. The quoted price representing the fair value of the Public Warrants was $0.54 and $0.18 per warrant as of December 31, 2025 and 2024, respectively.

For the year ended December 31, 2025, the Company recognized a loss of $4,415,289 on the changes in the fair value of warrant liabilities in the statements of operations. For the year ended December 31, 2024, the Company recognized a loss of $1,447,101, on the changes in the fair value of warrant liabilities in the statements of operations.

The following table provides quantitative information regarding the warrant liability Level 3 fair value measurements:

	Founder		Private		Total
	Warrant		Warrant		Warrant
	Liabilities		Liabilities		Liabilities
Fair value as of December 31, 2023	$	141,250	$	17,300	$	158,550
Change in fair value		282,500		34,600		317,100
Fair value as of December 31, 2024		423,750		51,900		475,650
Change in fair value		913,416		111,874		1,025,290
Fair value as of December 31, 2025	$	1,337,166	$	163,774	$	1,500,940

The following table provides quantitative information regarding the warrant liability Level 3 fair value measurements:

	December 31,			December 31,
	2025			2024
Trading stock price	$	11.64		$	11.12
Exercise price	$	11.50		$	11.50
Expected term (in years)		5.13			5.50
Volatility		12.5	%		7.6	%
Risk-free rate		3.68	%		4.31	%

F-25

The measurement of the Public Warrants as of December 31, 2024 is classified as Level 1 due to significant trading activity under the ticker PLMJW. The measurement of the Public Warrants as of December 31, 2023 was classified as Level 2 due to limited trading activity under the ticker APTMW (subsequently PLMJW in February 2024). The quoted price representing the fair value of the Public Warrants was $0.18 and $0.06 per warrant as of December 31, 2024 and 2023, respectively.

In prior periods, the Company utilized a Black-Scholes Option Pricing model for the initial valuation of the Founder Warrants and Private Placement Warrants and the subsequent measurement of the Founder Warrants and Private Placement Warrants. Inherent in pricing models are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield, which are considered Level 3 inputs. However, since a reasonable and acceptable volatility cannot be inferred from the option pricing model performed for the Founder Warrants and Private Placement Warrants as of December 31, 2023, the fair value of the Founder Warrants and Private Placement Warrants were set equal to the fair value of the Public Warrants. As of December 31, 2024, the Company utilized a Black-Scholes Option Pricing model for the valuation of the Founder Warrants and Private Placement Warrants. The fair value of the Founder Warrants and Private Placement Warrants was $0.18 and $0.06 per warrant as of December 31, 2024 and 2023, respectively. As of December 31, 2024, the Founder Warrants and Private Placement Warrants are classified as Level 3 due to the use of a Black-Scholes Option Pricing model. As of December 31, 2023, the Founder Warrants and Private Placement Warrants are classified as Level 2 due to the use of an observable market quote for a similar asset using recent trading prices.

For the year ended December 31, 2024 the Company recognized a loss of $1,447,101 on the changes in the fair value of warrant liabilities in the statements of operations. The Company recognized a loss on changes in the fair value of warrant liabilities of $241,183 in the statements of operations for the year ended December 31, 2023.

NOTE 10. SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

The Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that there is only one reportable segment.

F-26

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

	December 31, 2024		December 31, 2023
	December 31, 2025		December 31, 2024
Trust Account	$	25494,~~630,285~~421	$	~~157~~25,~~330~~630,~~245~~285
Cash	$	2749,~~418~~870	$	-27,418

	For the Year Ended December 31, 2024		For the Year Ended December 31, 2023
	For the Year Ended December 31, 2025		For the Year Ended December 31, 2024
Operating and formation costs	$	32,~~023~~876,~~383~~506	$	~~833~~3,~~935~~023,383
Interest and dividend income on investments held in Trust Account	$	1,909,255	$	10,686,002
Interest and dividend income on cash held in Trust Account	$	92,034	$	1,909,255

The CODM reviews interest earned on the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

Operating and formation costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews ~~general~~operating and ~~administrative~~formation costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. ~~General~~Operating and ~~administrative~~formation costs, as reported on the statement of operations, are the significant segment expenses provided to the CODM on a regular basis.

All other segment items included in net income or loss are reported on the statement of operations and described within their respective disclosures.

NOTE 11. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions ~~that~~ that occurred after the ~~consolidated~~ balance sheet date up to the date that the ~~consolidated~~ financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the ~~consolidated~~ financial statements.

On ~~January~~March 1530, ~~2025 and with immediate effect~~2026, ~~Mr. Michael Dinsdale resigned his position as a member of~~ the ~~board~~Second ofSponsor ~~directors~~Promissory ~~(the~~Note ~~“Board”) of Plum Acquisition Corp. III (the “Company”). Mr. Dinsdale~~ was ~~a member of the Board’s audit committee and chairman~~amended ofto ~~the~~extend ~~Board’s nominating committee. Mr. Dinsdale’s resignation was not~~ the ~~result~~maturity ofdate ~~any disagreement with the Company on any matter relating~~ to ~~its~~July ~~operation~~31, ~~policies or practices~~2026.

~~F-27~~The Company is currently in discussions with Nasdaq to have the Pubco Common Shares and the Pubco Warrants accepted for listing on Nasdaq, which is a condition to the obligations of each party to consummate the Business Combination.

On January 16, 2025, as approved by its shareholders at the extraordinary general meeting of shareholders, the Company filed an amendment to its Amended and Restated Memorandum and Articles of Association (as amended, the “A&R Charter”) on January 17, 2025, which (i) extended the date by which the Company has to consummate a business combination to July 30, 2025 (the “Combination Period”), or such earlier date as shall be determined by the Company’s board of directors (the “Extension Proposal”) and (ii) amended Article 49.4 to remove language stating, in relevant part, that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, such business combination (the “NTA Proposal”). The holders of 2,132,366 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of $11.24 per share, for an aggregate redemption amount of $23,975,464.

Class A ordinary shares  included as part of the Units, par value $0.0001 per share NONE NONE NONE http://fasb.org/srt/2025#ChiefExecutiveOfficerMember 0001845550 false FY 0001845550 2025-01-01 2025-12-31 0001845550 aptm:ClassAOrdinarySharesIncludedAsPartOfTheUnitsParValue00001PerShareMember 2025-01-01 2025-12-31 0001845550 aptm:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member 2025-01-01 2025-12-31 0001845550 aptm:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantToAcquireOneClassAOrdinaryShareMember 2025-01-01 2025-12-31 0001845550 2025-06-30 0001845550 us-gaap:CommonClassAMember 2026-03-24 0001845550 us-gaap:CommonClassBMember 2026-03-24 0001845550 2025-12-31 0001845550 2024-12-31 0001845550 us-gaap:RelatedPartyMember 2025-12-31 0001845550 us-gaap:RelatedPartyMember 2024-12-31 0001845550 us-gaap:CommonClassAMember 2025-12-31 0001845550 us-gaap:CommonClassAMember 2024-12-31 0001845550 us-gaap:CommonClassBMember 2025-12-31 0001845550 us-gaap:CommonClassBMember 2024-12-31 0001845550 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassAMember 2025-01-01 2025-12-31 0001845550 us-gaap:CommonClassAMember 2024-01-01 2024-12-31 0001845550 aptm:NonredeemableClassAAndClassBOrdinarySharesMember 2025-01-01 2025-12-31 0001845550 aptm:NonredeemableClassAAndClassBOrdinarySharesMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001845550 us-gaap:RetainedEarningsMember 2023-12-31 0001845550 2023-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001845550 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001845550 us-gaap:RetainedEarningsMember 2024-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-12-31 0001845550 us-gaap:RetainedEarningsMember 2025-01-01 2025-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001845550 us-gaap:RetainedEarningsMember 2025-12-31 0001845550 2023-12-27 2023-12-27 0001845550 us-gaap:CommonClassBMember 2023-12-27 2023-12-27 0001845550 aptm:RedeemableWarrantMember 2023-12-27 2023-12-27 0001845550 aptm:FounderShares1Member 2023-12-27 2023-12-27 0001845550 aptm:SponsorMember 2023-12-27 0001845550 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-12-27 2023-12-27 0001845550 us-gaap:CommonClassAMember aptm:PrivatePlacementUnitsMember 2024-01-26 2024-01-26 0001845550 us-gaap:CommonClassBMember aptm:FounderShares1Member 2024-01-26 2024-01-26 0001845550 aptm:FounderShares1Member 2024-08-22 2024-08-22 0001845550 us-gaap:InvestorMember aptm:FounderShares1Member 2024-08-22 0001845550 us-gaap:InvestorMember aptm:SponsorMember 2024-08-22 0001845550 2024-08-22 0001845550 aptm:SponsorMember 2024-08-22 0001845550 2023-12-01 2023-12-31 0001845550 2024-01-24 2024-01-31 0001845550 aptm:SponsorMember 2023-12-31 0001845550 aptm:SponsorMember 2024-01-24 0001845550 aptm:UnderwritingAgreementMember us-gaap:CommonClassAMember us-gaap:IPOMember 2021-07-30 2021-07-30 0001845550 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2021-07-30 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-07-30 2021-07-30 0001845550 us-gaap:IPOMember 2025-01-01 2025-12-31 0001845550 aptm:AlphaPartnersTechnologyMember aptm:PrivatePlacementUnitsMember 2025-12-31 0001845550 us-gaap:PrivatePlacementMember 2025-01-01 2025-12-31 0001845550 us-gaap:IPOMember aptm:UnderwritingAgreementMember 2025-01-01 2025-12-31 0001845550 us-gaap:OverAllotmentOptionMember aptm:UnderwritingAgreementMember 2025-01-01 2025-12-31 0001845550 us-gaap:OverAllotmentOptionMember aptm:UnderwritingAgreementMember 2021-08-05 2021-08-05 0001845550 us-gaap:OverAllotmentOptionMember 2025-01-01 2025-12-31 0001845550 us-gaap:OverAllotmentOptionMember 2025-12-31 0001845550 us-gaap:IPOMember 2025-12-31 0001845550 2025-12-22 2025-12-22 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-12-22 0001845550 2025-12-22 0001845550 2025-01-16 0001845550 srt:MinimumMember 2025-01-01 2025-12-31 0001845550 srt:MaximumMember 2025-01-01 2025-12-31 0001845550 2025-11-07 0001845550 aptm:SecondPrePaidMember 2025-11-07 0001845550 aptm:ThirdPrePaidMember 2025-11-07 0001845550 us-gaap:CommonClassBMember 2025-01-01 2025-12-31 0001845550 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-12-31 0001845550 us-gaap:CommonClassAMember 2023-07-27 2023-07-27 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-07-27 0001845550 2023-07-27 0001845550 us-gaap:CommonClassAMember aptm:FounderShareAmendmentProposalMember 2025-01-01 2025-12-31 0001845550 us-gaap:CommonClassAMember aptm:FounderShareAmendmentProposalMember 2025-12-31 0001845550 2024-02-27 0001845550 aptm:TrustAccountMember 2023-08-02 0001845550 aptm:TrustAccountMember 2023-09-07 0001845550 aptm:TrustAccountMember 2023-10-10 0001845550 aptm:TrustAccountMember 2023-11-10 0001845550 aptm:TrustAccountMember 2024-01-10 0001845550 aptm:TrustAccountMember 2024-01-25 0001845550 srt:BoardOfDirectorsChairmanMember 2025-01-16 0001845550 us-gaap:CommonClassAMember 2025-01-16 2025-01-16 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-16 0001845550 aptm:ExtraordinaryGeneralMeetingMember us-gaap:CommonClassAMember 2025-07-15 2025-07-15 0001845550 aptm:ExtraordinaryGeneralMeetingMember 2025-07-15 0001845550 aptm:ExtraordinaryGeneralMeetingMember us-gaap:CommonClassAMember 2025-12-22 2025-12-22 0001845550 aptm:ExtraordinaryGeneralMeetingMember 2025-12-22 0001845550 2024-08-08 2024-08-08 0001845550 2024-08-08 0001845550 aptm:SponsorMember 2024-01-03 2024-01-03 0001845550 2024-01-03 2024-01-03 0001845550 2024-02-01 2024-02-01 0001845550 aptm:SponsorMember 2024-07-31 0001845550 aptm:SponsorPromissoryNoteMember 2024-07-31 0001845550 aptm:PrivatePlacementWarrantsMember 2024-07-31 0001845550 2025-04-24 0001845550 aptm:PrivatePlacementWarrantsMember 2025-04-24 2025-04-24 0001845550 aptm:PrivatePlacementWarrantsMember 2025-04-24 0001845550 aptm:PromissoryNoteMember 2025-12-31 0001845550 aptm:PromissoryNoteMember 2024-12-31 0001845550 aptm:SponsorMember 2025-12-31 0001845550 2025-01-27 0001845550 aptm:SponsorPromissoryNoteMember 2025-05-06 2025-05-06 0001845550 aptm:SecondSponsorPromissoryNoteMember 2025-05-06 2025-05-06 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2025-01-01 2025-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-01-29 2024-01-29 0001845550 us-gaap:CommonClassAMember 2024-01-29 2024-01-29 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-02-27 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2025-01-23 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2025-07-15 2025-07-15 0001845550 us-gaap:CommonClassAMember 2025-07-15 2025-07-15 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2025-07-21 0001845550 us-gaap:CommonClassAMember 2025-12-22 2025-12-22 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2025-12-22 0001845550 us-gaap:WarrantMember 2025-12-31 0001845550 us-gaap:WarrantMember 2025-01-01 2025-12-31 0001845550 aptm:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-12-31 0001845550 aptm:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2024-01-01 2024-12-31 0001845550 aptm:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2024-12-31 0001845550 aptm:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-12-31 0001845550 aptm:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2025-12-31 0001845550 us-gaap:IPOMember aptm:UnderwritingAgreementMember 2021-07-30 2021-07-30 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-07-30 0001845550 aptm:PublicWarrantMember us-gaap:IPOMember 2025-01-01 2025-12-31 0001845550 aptm:PublicWarrantMember us-gaap:IPOMember 2025-12-31 0001845550 aptm:AnchorInvestorsMember us-gaap:IPOMember 2025-01-01 2025-12-31 0001845550 us-gaap:InvestorMember us-gaap:PrivatePlacementMember 2025-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2025-01-01 2025-12-31 0001845550 aptm:RedeemableWarrantMember us-gaap:PrivatePlacementMember 2025-01-01 2025-12-31 0001845550 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2025-12-31 0001845550 aptm:SponsorMember us-gaap:CommonClassBMember 2021-02-05 2021-02-05 0001845550 aptm:FounderShares1Member us-gaap:CommonClassBMember 2021-02-05 2021-02-05 0001845550 aptm:FounderWarrantsMember 2021-02-05 2021-02-05 0001845550 aptm:SponsorMember us-gaap:CommonClassBMember 2025-12-31 0001845550 aptm:FounderWarrantsMember 2025-01-01 2025-12-31 0001845550 us-gaap:OverAllotmentOptionMember 2021-08-05 2021-08-05 0001845550 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-08-05 2021-08-05 0001845550 aptm:FounderShares1Member 2021-08-05 2021-08-05 0001845550 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-09-11 2021-09-11 0001845550 aptm:FounderShares1Member 2021-09-11 2021-09-11 0001845550 aptm:SponsorMember us-gaap:CommonClassBMember 2025-01-01 2025-12-31 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2025-12-31 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2025-01-01 2025-12-31 0001845550 aptm:SponsorMember 2023-12-27 2023-12-27 0001845550 aptm:SponsorMember us-gaap:CommonClassBMember 2023-12-27 2023-12-27 0001845550 aptm:PurchaseAgreementMember aptm:SponsorMember 2023-12-27 0001845550 aptm:FounderShares1Member aptm:PurchaseAgreementMember 2023-12-27 2023-12-27 0001845550 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-12-27 2023-12-27 0001845550 us-gaap:CommonClassBMember aptm:FounderShares1Member 2023-12-27 2023-12-27 0001845550 aptm:AdministrativeSupportServicesMember aptm:SponsorMember 2025-01-01 2025-12-31 0001845550 aptm:SponsorLoanCommitmentMember aptm:SponsorMember 2023-08-15 2023-08-15 0001845550 aptm:SponsorMember 2023-08-24 2023-08-24 0001845550 aptm:SponsorMember 2023-09-06 2023-09-06 0001845550 aptm:SponsorMember 2023-09-28 2023-09-28 0001845550 aptm:SponsorMember 2023-09-29 2023-09-29 0001845550 aptm:SponsorMember 2023-10-11 2023-10-11 0001845550 aptm:SponsorMember 2023-11-09 2023-11-09 0001845550 aptm:AdministrativeSupportServicesMember 2025-01-01 2025-12-31 0001845550 aptm:AdministrativeSupportServicesMember 2024-01-01 2024-12-31 0001845550 aptm:SponsorLoanCommitmentMember aptm:SponsorMember 2025-12-31 0001845550 aptm:SponsorMember 2024-01-03 2024-01-03 0001845550 2024-02-20 2024-02-20 0001845550 aptm:SponsorMember 2024-07-31 0001845550 us-gaap:WarrantMember 2024-07-31 2024-07-31 0001845550 2025-03-18 0001845550 2025-04-28 0001845550 2025-09-29 0001845550 2025-06-04 0001845550 2025-12-15 0001845550 aptm:SponsorMember 2025-12-31 0001845550 aptm:SponsorMember 2024-12-31 0001845550 aptm:SponsorMember 2024-01-09 0001845550 aptm:SponsorMember 2024-01-24 0001845550 2024-01-09 2024-01-09 0001845550 aptm:PromissoryNoteAndSecondSponsorPromissoryNoteMember 2025-01-01 2025-12-31 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2024-01-17 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2024-01-23 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2024-01-24 0001845550 aptm:SponsorMember 2024-01-17 2024-01-17 0001845550 aptm:SponsorMember 2024-01-23 2024-01-23 0001845550 aptm:SponsorMember 2024-01-24 2024-01-24 0001845550 aptm:FounderShares1Member 2024-01-17 2024-01-17 0001845550 aptm:FounderShares1Member 2024-01-23 2024-01-23 0001845550 aptm:FounderShares1Member 2024-01-24 2024-01-24 0001845550 2024-01-17 2024-01-17 0001845550 2024-01-23 2024-01-23 0001845550 2024-01-24 2024-01-24 0001845550 us-gaap:InvestorMember 2024-01-17 0001845550 us-gaap:InvestorMember 2024-01-23 0001845550 us-gaap:InvestorMember 2024-01-24 0001845550 srt:ChiefFinancialOfficerMember 2024-02-12 2024-02-12 0001845550 srt:ChiefFinancialOfficerMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-02-12 2024-02-12 0001845550 srt:ChiefFinancialOfficerMember aptm:SponsorMember 2024-02-12 2024-02-12 0001845550 aptm:FounderWarrantsMember 2024-02-12 2024-02-12 0001845550 srt:ChiefFinancialOfficerMember aptm:FounderShares1Member 2024-02-12 2024-02-12 0001845550 aptm:FounderShares1Member 2024-02-12 2024-02-12 0001845550 aptm:FounderShares1Member 2024-02-12 0001845550 2024-02-12 2024-02-12 0001845550 aptm:FounderWarrantsMember 2024-02-12 0001845550 aptm:SponsorMember aptm:FounderShares1Member 2024-06-30 2024-06-30 0001845550 aptm:FounderWarrantsMember 2024-06-30 2024-06-30 0001845550 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember aptm:FounderShares1Member 2024-06-30 2024-06-30 0001845550 aptm:SponsorMember 2024-01-01 2024-12-31 0001845550 aptm:FounderShares1Member 2024-05-22 2024-05-22 0001845550 us-gaap:WarrantMember 2024-05-22 2024-05-22 0001845550 aptm:FounderShares1Member 2024-06-30 2024-06-30 0001845550 us-gaap:WarrantMember 2024-06-30 2024-06-30 0001845550 us-gaap:OverAllotmentOptionMember aptm:UnderwritingAgreementMember 2021-08-05 0001845550 us-gaap:OverAllotmentOptionMember aptm:UnderwritingAgreementMember 2021-09-11 2021-09-11 0001845550 aptm:UnderwritingAgreementMember 2025-12-31 0001845550 aptm:UnderwritingAgreementMember 2023-12-27 2023-12-27 0001845550 aptm:UnderwritingAgreementMember 2023-12-27 0001845550 2024-08-10 2024-08-10 0001845550 aptm:KingsRockMember us-gaap:InvestorMember 2025-01-06 2025-01-06 0001845550 aptm:PrePaidAdvanceMember 2025-11-07 0001845550 aptm:SecondPrePaidAdvanceMember 2025-11-07 0001845550 aptm:ThirdPrePaidAdvanceMember 2025-11-07 0001845550 us-gaap:CommonClassBMember 2025-11-07 2025-11-07 0001845550 2025-11-07 2025-11-07 0001845550 aptm:FounderWarrantsMember 2025-12-31 0001845550 aptm:FounderWarrantsMember 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember 2025-12-31 0001845550 aptm:PrivatePlacementWarrantsMember 2024-12-31 0001845550 aptm:PublicWarrantsMember 2025-12-31 0001845550 aptm:PublicWarrantsMember 2024-12-31 0001845550 srt:MinimumMember aptm:PublicWarrantsMember aptm:ShareTriggerPriceOneMember 2025-01-01 2025-12-31 0001845550 aptm:PublicWarrantsMember aptm:ShareTriggerPriceOneMember 2025-12-31 0001845550 aptm:PublicWarrantsMember aptm:ShareTriggerPriceOneMember 2025-01-01 2025-12-31 0001845550 srt:MinimumMember aptm:ReferenceValueMember aptm:ShareTriggerPriceOneMember 2025-01-01 2025-12-31 0001845550 aptm:PublicWarrantsMember aptm:ShareTriggerPriceTwoMember 2025-01-01 2025-12-31 0001845550 srt:MinimumMember aptm:PublicWarrantsMember aptm:ShareTriggerPriceTwoMember 2025-01-01 2025-12-31 0001845550 aptm:PublicWarrantsMember aptm:ShareTriggerPriceTwoMember 2025-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:CommonClassAMember aptm:ShareTriggerPriceTwoMember 2025-01-01 2025-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:CommonClassAMember aptm:ShareTriggerPriceTwoMember 2025-12-31 0001845550 srt:MaximumMember us-gaap:CommonClassAMember 2025-12-31 0001845550 aptm:NewlyIssuedPriceMember 2025-01-01 2025-12-31 0001845550 us-gaap:WarrantMember us-gaap:CommonClassAMember 2025-12-31 0001845550 aptm:AsAPercentageOfMarketValueMember 2025-01-01 2025-12-31 0001845550 aptm:AsAPercentageOfNewlyIssuedPriceMember 2025-01-01 2025-12-31 0001845550 us-gaap:WarrantsAndRightsSubjectToMandatoryRedemptionMember us-gaap:CommonClassAMember 2025-01-01 2025-12-31 0001845550 aptm:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember aptm:AsAPercentageOfMarketValueMember aptm:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember 2025-12-31 0001845550 aptm:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember aptm:AsAPercentageOfNewlyIssuedPriceMember aptm:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember 2025-12-31 0001845550 aptm:PrivatePlacementWarrantsMember 2025-01-01 2025-12-31 0001845550 us-gaap:WarrantMember us-gaap:IPOMember 2025-01-01 2025-12-31 0001845550 srt:MaximumMember aptm:PublicWarrantsMember 2025-01-01 2025-12-31 0001845550 us-gaap:InterestBearingDepositsMember 2025-12-31 0001845550 us-gaap:InterestBearingDepositsMember us-gaap:FairValueInputsLevel1Member 2025-12-31 0001845550 us-gaap:InterestBearingDepositsMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001845550 us-gaap:InterestBearingDepositsMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member 2025-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member 2025-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2025-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001845550 us-gaap:InterestBearingDepositsMember 2024-12-31 0001845550 us-gaap:InterestBearingDepositsMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001845550 us-gaap:InterestBearingDepositsMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001845550 us-gaap:InterestBearingDepositsMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001845550 us-gaap:WarrantMember 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001845550 aptm:FounderWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001845550 aptm:PrivateWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001845550 aptm:WarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001845550 aptm:FounderWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-12-31 0001845550 aptm:PrivateWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-12-31 0001845550 aptm:WarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-12-31 0001845550 aptm:FounderWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001845550 aptm:PrivateWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001845550 aptm:WarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001845550 aptm:FounderWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-12-31 0001845550 aptm:PrivateWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-12-31 0001845550 aptm:WarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-12-31 0001845550 aptm:FounderWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001845550 aptm:PrivateWarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001845550 aptm:WarrantLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2025-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure aptm:segment

On January 28, 2025, the Company and Tactical entered into Amendment No. 2 to the Business Combination Agreement. Amendment No. 2 provides that certain recently issued convertible debentures of Tactical (and future issuances of convertible debentures by Tactical, if any, to the extent permitted under the Business Combination Agreement) shall be subject to the same terms under the Business Combination Agreement, and shall be subject to the same treatment upon closing of the Business Combination, as certain existing convertible debentures issued by Tactical and already subject to the terms of the Business Combination Agreement.

On January 28, 2025, the Company’s Class A ordinary shares, warrants and units were listed and began trading on the Pink Current tier of the OTC Markets. The Company’s Class A ordinary shares, warrants and units are listed under the symbols “PLMJF”, “PLMWF”, and “PLMUF”, respectively.

On February 21, 2025, Plum III Merger Corp. filed Amendment No. 1 to the Registration Statement on Form F-4 (as amended, the “Form F-4”) pursuant to which the Company will solicit approval of the Business Combination from the Company’s shareholders.

On March 18, 2025, the Sponsor loaned $250,000 to the Company pursuant to the Sponsor Promissory Note. The outstanding balance under the Sponsor Promissory Note as of March 18, 2025 was $1,454,867.

F-28

Plum Acquisition Corp. III NONE NONE NONE P1Y P1Y 0001845550 false FY 0001845550 2024-01-01 2024-12-31 0001845550 aptm:ClassAOrdinarySharesIncludedAsPartOfTheUnitsParValue00001PerShareMember 2024-01-01 2024-12-31 0001845550 aptm:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member 2024-01-01 2024-12-31 0001845550 aptm:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantToAcquireOneClassAOrdinaryShareMember 2024-01-01 2024-12-31 0001845550 2024-06-30 0001845550 us-gaap:CommonClassAMember 2025-03-24 0001845550 us-gaap:CommonClassBMember 2025-03-24 0001845550 2024-12-31 0001845550 2023-12-31 0001845550 us-gaap:RelatedPartyMember 2024-12-31 0001845550 us-gaap:RelatedPartyMember 2023-12-31 0001845550 us-gaap:CommonClassAMember 2024-12-31 0001845550 us-gaap:CommonClassAMember 2023-12-31 0001845550 us-gaap:CapitalUnitClassBMember 2024-12-31 0001845550 us-gaap:CapitalUnitClassBMember 2023-12-31 0001845550 us-gaap:CommonClassBMember 2024-12-31 0001845550 us-gaap:CommonClassBMember 2023-12-31 0001845550 2023-01-01 2023-12-31 0001845550 us-gaap:CommonClassAMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassAMember 2023-01-01 2023-12-31 0001845550 us-gaap:CommonClassBMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassBMember 2023-01-01 2023-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001845550 us-gaap:RetainedEarningsMember 2022-12-31 0001845550 2022-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001845550 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001845550 us-gaap:RetainedEarningsMember 2023-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001845550 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0001845550 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001845550 us-gaap:RetainedEarningsMember 2024-12-31 0001845550 2024-10-01 2024-12-31 0001845550 2023-12-27 2023-12-27 0001845550 us-gaap:CommonClassBMember 2023-12-27 2023-12-27 0001845550 aptm:RedeemableWarrantMember 2023-12-27 2023-12-27 0001845550 aptm:FounderSharesMember 2023-12-27 2023-12-27 0001845550 aptm:SponsorMember 2023-12-27 0001845550 aptm:FounderSharesMember 2023-12-27 2023-12-27 0001845550 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-12-27 2023-12-27 0001845550 us-gaap:CommonClassAMember aptm:PrivatePlacementUnitsMember 2024-01-26 2024-01-26 0001845550 us-gaap:CommonClassBMember aptm:FounderSharesMember 2024-01-26 2024-01-26 0001845550 aptm:SponsorMember 2023-12-31 0001845550 aptm:SponsorMember 2024-01-24 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-07-30 2021-07-30 0001845550 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2021-07-30 0001845550 us-gaap:IPOMember 2024-01-01 2024-12-31 0001845550 aptm:AlphaPartnersTechnologyMember aptm:PrivatePlacementUnitsMember 2024-12-31 0001845550 us-gaap:PrivatePlacementMember 2024-01-01 2024-12-31 0001845550 us-gaap:IPOMember aptm:UnderwritingAgreementMember 2024-01-01 2024-12-31 0001845550 us-gaap:OverAllotmentOptionMember 2024-01-01 2024-12-31 0001845550 us-gaap:OverAllotmentOptionMember 2021-08-05 2021-08-05 0001845550 us-gaap:OverAllotmentOptionMember 2024-12-31 0001845550 us-gaap:IPOMember 2024-12-31 0001845550 aptm:PublicSharesMember 2024-12-31 0001845550 aptm:PublicSharesMember 2024-01-01 2024-12-31 0001845550 us-gaap:SubsequentEventMember 2025-01-16 0001845550 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-12-31 0001845550 us-gaap:CommonClassAMember 2023-07-27 2023-07-27 0001845550 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-07-27 0001845550 2023-07-27 0001845550 us-gaap:CommonClassAMember aptm:FounderShareAmendmentProposalMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassAMember aptm:FounderShareAmendmentProposalMember 2024-12-31 0001845550 2024-02-27 0001845550 aptm:TrustAccountMember 2023-08-02 0001845550 aptm:TrustAccountMember 2023-09-07 0001845550 aptm:TrustAccountMember 2023-10-10 0001845550 aptm:TrustAccountMember 2023-11-10 0001845550 aptm:TrustAccountMember 2024-01-10 0001845550 2024-01-25 0001845550 aptm:TrustAccountMember 2024-01-25 0001845550 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2025-01-16 2025-01-16 0001845550 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2025-01-16 0001845550 2023-07-26 2023-07-26 0001845550 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-04-13 2023-04-13 0001845550 2024-08-08 2024-08-08 0001845550 2024-08-08 0001845550 aptm:SponsorMember 2024-01-03 2024-01-03 0001845550 2024-01-03 2024-01-03 0001845550 2024-02-01 2024-02-01 0001845550 aptm:SponsorMember 2024-07-31 0001845550 aptm:SponsorPromissoryNoteMember 2024-07-31 0001845550 aptm:PrivatePlacementWarrantsMember 2024-07-31 0001845550 aptm:SponsorPromissoryNoteMember 2024-12-31 0001845550 aptm:SponsorMember 2024-08-31 0001845550 aptm:SponsorMember 2024-09-30 0001845550 us-gaap:SubsequentEventMember 2025-01-27 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-01-29 2024-01-29 0001845550 us-gaap:CommonClassAMember 2024-01-29 2024-01-29 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-02-27 0001845550 us-gaap:WarrantMember 2024-12-31 0001845550 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2024-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-07-30 0001845550 aptm:PublicWarrantMember us-gaap:IPOMember 2024-01-01 2024-12-31 0001845550 aptm:PublicWarrantMember us-gaap:IPOMember 2024-12-31 0001845550 us-gaap:IPOMember aptm:UnderwritingAgreementMember 2021-08-05 2021-08-05 0001845550 us-gaap:InvestorMember us-gaap:PrivatePlacementMember 2024-12-31 0001845550 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2024-01-01 2024-12-31 0001845550 aptm:RedeemableWarrantMember us-gaap:PrivatePlacementMember 2024-01-01 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2024-12-31 0001845550 us-gaap:CommonClassBMember 2021-02-05 2021-02-05 0001845550 aptm:FounderWarrantsMember 2021-02-05 2021-02-05 0001845550 aptm:SponsorMember us-gaap:CommonClassBMember 2024-12-31 0001845550 aptm:FounderWarrantsMember 2024-01-01 2024-12-31 0001845550 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-08-05 2021-08-05 0001845550 aptm:FounderSharesMember 2021-08-05 2021-08-05 0001845550 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-09-11 2021-09-11 0001845550 aptm:FounderSharesMember 2021-09-11 2021-09-11 0001845550 aptm:SponsorMember us-gaap:CommonClassBMember 2024-01-01 2024-12-31 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2024-12-31 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2024-01-01 2024-12-31 0001845550 aptm:SponsorMember 2023-12-27 2023-12-27 0001845550 aptm:SponsorMember us-gaap:CommonClassBMember 2023-12-27 2023-12-27 0001845550 aptm:PurchaseAgreementMember aptm:SponsorMember 2023-12-27 0001845550 aptm:FounderSharesMember aptm:PurchaseAgreementMember 2023-12-27 2023-12-27 0001845550 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-12-27 2023-12-27 0001845550 aptm:FounderSharesMember us-gaap:CommonClassBMember 2023-12-27 2023-12-27 0001845550 aptm:AdministrativeSupportServicesMember aptm:SponsorMember 2024-01-01 2024-12-31 0001845550 aptm:SponsorLoanCommitmentMember aptm:SponsorMember 2023-08-15 2023-08-15 0001845550 aptm:SponsorMember 2023-08-24 2023-08-24 0001845550 aptm:SponsorMember 2023-09-06 2023-09-06 0001845550 aptm:SponsorMember 2023-09-28 2023-09-28 0001845550 aptm:SponsorMember 2023-09-29 2023-09-29 0001845550 aptm:SponsorMember 2023-10-11 2023-10-11 0001845550 aptm:SponsorMember 2023-11-09 2023-11-09 0001845550 aptm:AdministrativeSupportServicesMember 2024-01-01 2024-12-31 0001845550 aptm:SponsorLoanCommitmentMember aptm:SponsorMember 2024-12-31 0001845550 aptm:SponsorMember 2024-01-03 2024-01-03 0001845550 2024-02-20 2024-02-20 0001845550 aptm:SponsorMember 2024-07-31 0001845550 us-gaap:WarrantMember 2024-07-31 2024-07-31 0001845550 aptm:SponsorMember 2024-01-09 0001845550 aptm:SponsorMember 2024-01-24 0001845550 2024-09-30 2024-09-30 0001845550 aptm:SponsorMember 2024-09-30 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2024-01-17 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2024-01-23 0001845550 aptm:SponsorMember us-gaap:CommonClassAMember 2024-01-24 0001845550 aptm:SponsorMember 2024-01-17 2024-01-17 0001845550 aptm:SponsorMember 2024-01-23 2024-01-23 0001845550 aptm:SponsorMember 2024-01-24 2024-01-24 0001845550 2024-01-17 2024-01-17 0001845550 2024-01-23 2024-01-23 0001845550 2024-01-24 2024-01-24 0001845550 us-gaap:InvestorMember 2024-01-17 0001845550 us-gaap:InvestorMember 2024-01-23 0001845550 us-gaap:InvestorMember 2024-01-24 0001845550 srt:ChiefFinancialOfficerMember 2024-02-12 2024-02-12 0001845550 srt:ChiefFinancialOfficerMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-02-12 2024-02-12 0001845550 srt:ChiefFinancialOfficerMember aptm:SponsorMember 2024-02-12 2024-02-12 0001845550 aptm:FounderWarrantsMember 2024-02-12 2024-02-12 0001845550 2024-02-12 2024-02-12 0001845550 aptm:FounderSharesMember 2024-02-12 2024-02-12 0001845550 aptm:FounderSharesMember 2024-02-12 0001845550 aptm:FounderWarrantsMember 2024-02-12 0001845550 aptm:FounderSharesMember 2024-06-30 2024-06-30 0001845550 aptm:FounderWarrantsMember 2024-06-30 2024-06-30 0001845550 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-06-30 2024-06-30 0001845550 aptm:FounderSharesMember 2024-05-22 2024-05-22 0001845550 us-gaap:WarrantMember 2024-05-22 2024-05-22 0001845550 aptm:FounderSharesMember 2024-01-01 2024-12-31 0001845550 us-gaap:OverAllotmentOptionMember aptm:UnderwritingAgreementMember 2024-01-01 2024-12-31 0001845550 aptm:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2021-08-05 2021-08-05 0001845550 aptm:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2021-08-05 0001845550 aptm:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2021-09-11 2021-09-11 0001845550 aptm:UnderwritingAgreementMember us-gaap:IPOMember 2024-01-01 2024-12-31 0001845550 aptm:UnderwritingAgreementMember 2024-12-31 0001845550 aptm:UnderwritingAgreementMember 2023-12-27 2023-12-27 0001845550 aptm:UnderwritingAgreementMember 2023-12-27 0001845550 2024-08-10 2024-08-10 0001845550 aptm:FounderWarrantsMember 2024-12-31 0001845550 aptm:FounderWarrantsMember 2023-12-31 0001845550 aptm:PrivatePlacementWarrantsMember 2023-12-31 0001845550 aptm:PrivatePlacementWarrantsMember 2024-12-31 0001845550 aptm:PublicWarrantsMember 2023-12-31 0001845550 aptm:PublicWarrantsMember 2024-12-31 0001845550 aptm:PublicWarrantsMember 2024-01-01 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember 2024-01-01 2024-12-31 0001845550 srt:MinimumMember aptm:PublicWarrantsMember aptm:ShareTriggerPriceOneMember 2024-01-01 2024-12-31 0001845550 aptm:PublicWarrantsMember aptm:ShareTriggerPriceOneMember 2024-12-31 0001845550 aptm:PublicWarrantsMember aptm:ShareTriggerPriceOneMember 2024-01-01 2024-12-31 0001845550 srt:MinimumMember aptm:ReferenceValueMember aptm:ShareTriggerPriceOneMember 2024-01-01 2024-12-31 0001845550 aptm:PublicWarrantsMember aptm:ShareTriggerPriceTwoMember 2024-01-01 2024-12-31 0001845550 srt:MinimumMember aptm:PublicWarrantsMember aptm:ShareTriggerPriceTwoMember 2024-01-01 2024-12-31 0001845550 aptm:PublicWarrantsMember aptm:ShareTriggerPriceTwoMember 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:CommonClassAMember aptm:ShareTriggerPriceTwoMember 2024-01-01 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:CommonClassAMember aptm:ShareTriggerPriceTwoMember 2024-12-31 0001845550 srt:MaximumMember us-gaap:CommonClassAMember 2024-12-31 0001845550 aptm:NewlyIssuedPriceMember 2024-01-01 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:CommonClassAMember 2024-12-31 0001845550 aptm:AsAPercentageOfMarketValueMember 2024-01-01 2024-12-31 0001845550 aptm:AsAPercentageOfNewlyIssuedPriceMember 2024-01-01 2024-12-31 0001845550 us-gaap:WarrantsAndRightsSubjectToMandatoryRedemptionMember us-gaap:CommonClassAMember 2024-01-01 2024-12-31 0001845550 aptm:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember aptm:AsAPercentageOfMarketValueMember aptm:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember 2024-12-31 0001845550 aptm:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember aptm:AsAPercentageOfNewlyIssuedPriceMember aptm:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:IPOMember 2024-01-01 2024-12-31 0001845550 srt:MaximumMember aptm:PublicWarrantsMember 2024-01-01 2024-12-31 0001845550 aptm:PublicWarrantsMember 2023-01-01 2023-12-31 0001845550 aptm:PrivatePlacementWarrantsMember 2023-01-01 2023-12-31 0001845550 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001845550 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 aptm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 aptm:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001845550 us-gaap:SubsequentEventMember 2025-01-16 2025-01-16 0001845550 us-gaap:SubsequentEventMember 2025-03-18 0001845550 aptm:SponsorPromissoryNoteMember us-gaap:SubsequentEventMember 2025-03-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Filing Compare · Plum Acquisition Corp. III